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SUMMARY
This study was designed to define in standardised fashion, 
the deficits of chronic schizophrenia and the correlates of these, 
and to evaluate two neurological parameters - spontaneous involuntary 
movements and lateral ventricular enlargement - in relation to the 
illness and its treatment.
The study population comprised all those schizophrenics receiving 
long-term care in the one mental hospital who conformed to the 
St. Louis criteria for schizophrenia and who had been in-patients for 
at least 1 year continuously. This basic group consisted of 510 
subjects.
Analysis of standardised assessments covering mental state, 
cognition, neurological status and behaviour showed these patients to 
be extremely impaired. While historical correlates of functioning 
in particular spheres could be identified, the present clinical 
picture was in general related to the form of the initial illness 
and to factors reflecting the passage of time. Past physical treatment 
was not related to present deficits. Two broad patterns of disability 
were established. While the presence of prominent productive features 
in the mental state was not associated with the presence of deficits 
in other areas examined, prominent 'negative* features were related 
to the presence of cognitive impairment, extrapyramidal neurological 
signs and behavioural deterioration.
Involuntary movements were assessed in 411 subjects using two 
standardised recording schedules. Abnormality was extremely common.
The base-line prevalence of disorder in those with no history of 
neuroleptic exposure was comparable with that of those treated with 
neuroleptics, although with factors reflecting the passage of time
accounted for, movement disorder was associated with past neuroleptic 
treatment. In addition however, the presence of abnormal movements 
related to features of the illness itself - namely 'negative1 
mental state features, cognitive impairment and behavioural deterior­
ation.
C.T. scans from 110 of the total population described above 
and controls representing non-institutionalised out-patient (1 8) 
and first episode (8 ) schizophrenics, institutionalised and out-patient 
manic-depressives (10 and 22 respectively) and neurotic out-patients 
(1 9), demonstrated that schizophrenia is associated with enlargement 
of the lateral ventricles, although only the institutionalised 
schizophrenics differed significantly from the neurotic controls.
The group mean differences were not great and there was considerable 
overlap between groups. There was no evidence of a characteristic 
radiological change associated with schizophrenia. Lateral ventricular 
enlargement in schizophrenia was not consequent upon physical treat­
ments administered in the past. The historical and examination 
variables which related to increased ventricular size in the long- 
stay schizophrenic population were few and the nature of certain 
relationships surprising. While behavioural deterioration and 
involuntary movements were significantly and linearly associated with 
ventricular enlargement, 'negative' mental state features, cognitive 
impairment and an absence of hallucinations were more commonly found 
in those at both extremes of ventricle size. The results suggest 
that although brain structure is genuinely altered in certain schizo­
phrenics, the relationship between cerebral structure and clinical 
aspects of the condition is not straightforward.
This study indicates that both neurological abnormality and
structural brain change can be related to certain clinical features 
of established schizophrenia when other potentially relevant 
historical and treatment variables are accounted for. Such a 
general conclusion refers to statistical associations within large 
groups of patients and the relationship between neurology and 
psychopathology is complex. Nonetheless, the findings lend support 
to the view that in some patients at least, schizophrenia is a brain 
disorder whose cerebral basis can be inferred from the nature of 
some of the associated multiple deficits.
INTRODUCTION
"Suffering is one very long moment. We cannot divide it by 
seasons. We can only record its moods, and chronicle their 
return"
OSCAR WILDE 
DE PROFUNDIS
INTRODUCTION
1. GENERAL
Schizophrenia is a common condition, presenting a life-time 
expectancy of illness of approximately 8 per 1000. (Shields & Slater 
1975). The mean annual incidence in the United Kingdom has been 
calculated as 3*3 1000 (Cooper 1978), and estimates suggest
that about 1 5 0 ,0 0 0 individuals are affected at any one time 
(The Office of Health Economics 1979)* More people of working age 
suffer from this illness than any other, and with the control of 
the infectious diseases, schizophrenia has now been identified as 
the major public health problem of developed societies 
(Freeman 1980).
Unlike the infectious diseases, this problem is not one 
of acute mortality, but rather one of chronic morbidity. 
Schizophrenia tends to become manifest in early adult life 
(Slater & Roth 1969; Wing 1978), and to be associated subsequently 
with deficits which are both incapacitating and enduring. The 
burden of the illness remains to be measured in decades.
It has been estimated that the cost of schizophrenia in 
the United States amounts to approximately 2 % of the Gross 
National Product, only about one-fifth of which is incurred in 
delivery of services (Gunderson & Mosher 1975)* These figures 
are likely to be comparable for all developed nations. In purely 
financial terms therefore the problem is substantial.
In contrast to the size of the problem, the research 
commitment to long-standing schizophrenia has been small, as 
Arieti has pointed out (Arieti 1974) • It has been suggested that
the now predominant interest in the florid, productive 
manifestations of the condition can he dated to the Second World 
War and the associated concern about the acute manifestations of 
psychotic disturbance at such a time (Shakow 1972). However it 
is likely that the war was a catalyst precipitating a change 
that began over the previous decade with the introduction of 
physical therapies. The advent of the neuroleptic drugs in 1952 
(Delay et al 1952) maintained this shifting emphasis. Not only 
were these preparations therapeutically efficacious in productive 
psychotic states (National Institute of Mental Health, Collaborative 
Study Group 19&4)> but their mode of action offered the prospect 
of investigating the pathophysiology underlying the florid 
symptomatology (Matthysse 1973 ; Snyder et al 1974; Carlsson 1978)* 
In recent years there has been a growing interest in the 
study of chronically incapacitated schizophrenic patients. This 
has largely evolved out of an awareness of the limitations of 
traditional clinical classifications and an increasing desire to 
identify biological parameters on which new classifications may 
be based (Meltzer 1979> Wyatt et al 198l).
2. THE CONCEPT OF SCHIZOPHRENIA
By the 1870s, the work of Griesinger, Emminghaus and others 
had resulted in general psychopathology reaching a new level of 
comprehensiveness and refinement, yet the practical implementation 
of this clinical dimension alone did not result in the anticipated 
advances (Jaspers 1963)* While in other branches of medicine 
disease concepts were being validated and defined on the basis of 
pathological and laboratory techniques, within psychiatry these 
same techniques yielded little of diagnostic significance.
The idea that evolution of the illness over time might he a
legitimate additional dimension in clarifying diagnostic groupings
was not new at the end of the last century. It can he traced hack
to Pinel and his studies on 'mania' (Ackerknecht 1 9 6 8) hut it was
Kahlbaum who brought it to the fore as a valid extension of clinical
observation in diagnosis. He wrote :
The task is "to use clinical methods for the development 
of pictures of disease, in which as far* as possible all 
the phenomena of the individual patient's life are 
evaluated for purposes of diagnosis and the whole course 
of the illness is taken into account" (Kahlbaum 1874) •
Emil Kraepelin made this approach pivotal in diagnosis and
classification. Kraepelin was in the descriptive tradition and
believed that psychopathological symptom clusters which could be
shown to have similar aetiologies, forms, outcomes and pathologies
were, what Jaspers later called "natural disease entities" (Jaspers
1963). Failures and limitations in the other areas, made outcome
not only a legitimate, but according to Kraepelin, the valid index
on which to base diagnosis and classification . (Kraepelin 1919)*
His dementia praecox concept was far from static and underwent many
refinements following its introduction in I8 9 6, but it remained
firmly rooted in adversity of outcome (Havens 19&5)•
Bleuler, while acknowledging Kraepelin's initial proposals,
did not concur with the subsequent development of the dementia
praecox concept. He was much more an analyser than the essentially
descriptive Kraepelin (Jaspers 1 9 6 3), and shifted the emphasis in
diagnosis away from the outward psychopathology of the descriptive
writers. Bleuler believed the characteristic disturbance of
'schizophrenia' lay in the underlying psychic "processes", and hence
that the diagnosis should be based on recognition of these underlying
abnormalities (Bleuler 1911). He radically de-emphasised outcome,
devoting only a brief review to this in his substantial monograph. 
Bleuler was in effect advocating the psychoanalytic principle of 
inferred dynamics, and sought to establish diagnosis and 
classification on the identification of an 'essential property’ 
characteristic of that diagnosis and the basis of its clinical 
manifestations.
These two conceptualisations remain the theoretical 
references of most psychiatrists with regard to schizophrenia. The 
Kraepelinian view is identified with a narrow concept of 
schizophrenia and is in general the one that has been adhered to 
in Europe (Neale & Oltmanns 1980). In classificatory work, the 
tendency here has been to maintain the integrity of the poor - 
outcome concept by allocating atypical cases to discrete categories, 
varyingly independent of schizophrenia itself - e.g. Langfeldt's 
schizophreniform psychosis ; Leonhard's cycloid psychoses etc.
Adopting this generally conservative approach to what constitutes 
schizophrenia has ensured a relative consistency in the proportion 
of patients thus diagnosed over almost half a century (Kuriansky
et al 1974)-
For many, however, the Kraepelinian approach was too restrictive 
and dogmatic. Many conditions with a consistent aetiology and 
symptomatology have varying outcomes and to ascribe the authentic 
illness to only those patients with one particular pattern of outcome 
was seen as fallacious. Furthermore, a diagnosis whose implication 
was, by definition, one of poor outcome and decline suggested a 
degree of therapeutic impotence which many found unacceptable.
The Bleulerian concept avoided these objections. Under the tutelage 
of Adolf Meyer among others, Bleuler's writings found widespread
acceptance in the United States where they dominated psychiatric 
thinking for many decades.
This metaphorical legacy of diagnosis based on "interrupted" 
or "tom threads","sometimes single threads, sometimes a whole 
group", was however a confusing one. Bleuler repeatedly emphasised 
that
"as far as the true schizophrenic symptoms are concerned
  ......they are distortions and exaggerations of normal
processes Thus, the individual symptom itself is
less important than its intensity and extensiveness, and 
above all, its relation to the psychological setting" 
(Bleuler 1911, pp 294 - 295)-
Bleuler thereby opened the flood-gates to multivarious 
interpretations and applications of his principles. With diagnosis 
based on nebulous characteristics, atypical cases were readily 
incorporated into the concept (e.g. Kasanin's schizoaffective 
psychosis, Hoch & Polatin's, pseudoneurotic and Hoch and Bunaif's 
pseudopsychopathic schizophrenias etc) resulting in its degeneration 
to the point where it became virtually devoid of meaning (Stierlin 
1 9 6 7). In the New York State Psychiatric Institute, the prevalence 
of schizophrenic diagnoses rose from approximately 20 % in the 1 9 3 0* s 
to a quite astonishing 80 % in the 1950's (Kuriansky et al 1974)*
In recent years, American psychiatry has moved closer to 
European thought in taking an interest in outcome as a validating 
parameter of the schizophrenic condition. Applying a liberal 
interpretation of 'recovery', a number of studies have shown that 
it is valid to state that a diagnosis of schizophrenia still carries 
an implication of negative outcome (Hoenig 1974; Stephens 1970;
Harrow et al 1970; Pfohl & Winokur 1902). Such an evaluation is true 
today as it was at the beginning of the century, and stands in
contradistinction to general assessments regarding the outcome of 
other non-organic psychiatric diagnoses (Norris 1959; Hawk et al 
1975; Harrow et al 1978; Strauss & Carpenter 1979)* Adversity of 
outcome is now a stated criterion in a number of operational 
definitions of schizophrenia - for example, the St. Louis criteria 
(Feighner et al 1972). The latest edition of the Diagnostic and 
Statistical Manual of the American Psychiatric Association 
(L.S.M. - 111) (American Psychiatric Association 1980) states that 
"schizophrenia always involves deterioration from a previous level 
of functioning" (p 181), and by requiring 6 months duration of 
symptoms to qualify, the authors "suggest that schizophrenia is a 
disorder with a tendency to chronicity" (Fox 1981).
The Kraepelinian concept, despite its limitations, has 
therefore continued to find widespread acceptance in clinical and 
research practice, and at the level of our current knowledge, 
adversity of outcome has, with some qualification, stood as a reliable 
parameter on which to base diagnosis and classification.
Using outcome as a validating criterion is not, however, as 
straightforward as may at first seem. Outcome data depend on such 
factors as the era during which the study was performed, the duration 
of follow-up and, perhaps most importantly of all, the definitions 
of outcome categories (W.H.O. 1979) • Many studies show recovery to 
occur frequently (Stephens 1978; M. Bleuler 1978), but within these 
groups are patients whose post-psychotic potential is reduced from 
pre-illness expectations. Some workers view with optimism 
independence at any level after an acute episode (M. Bleuler 1978), 
but when the total morbidity of an illness is to be recorded and its 
costs evaluated, loss of potential and productivity are essential
considerations (Gunderson & Mosher 1975)•
Schizophrenic patients who experience loss of potential 
and, consequently, a poor outcome, tend to be designated 'chronic1.
As applied to schizophrenia, the term 'chronic' is misleading.
In addition to an implication about the mode of onset and of 
irreversibility, there is the understanding of a qualitative 
difference in symptom pattern from that of the illness in an acute 
phase. It has even been suggested that these two states represent 
different disease entities (Robins & Guze 1970; Ollemshaw 1975;
Strauss et al 1974) or different syndromes mediated by different 
pathophysiological mechanisms (Crow 1980).
What constitutes 'chronicity' when applied in this fashion 
is not clear. Studies which have sought to investigate such patients 
show little agreement on the features comprising the clinical 
picture (cf, for example, Wing 1961; Strauss et al 1974; Johnstone 
et al 1978 (a) and (b); Crow 1980; Angrist et a! 1980; Andreasen 1982). 
The position is further complicated by the widespread use of the 
term 'defect state'. In English-language psychiatry the tendency has 
been to apply 'chronic' and 'defect state' interchangeably, using 
both to indicate a loss of certain attributes that go to make up a 
healthy, integrated personality (jilek 1968). Persistent, post - 
acute schizophrenic features, however, may not be restricted to 
deficits of this type, as continental - and especially German - workers 
have pointed out (Huber 1966).
At a clinical level, both these terms allow patients to be 
categorised as disabled without having to specify in what areas of 
mental functioning the disabilities lie. Whether they have a more 
specific potential in implying differing patterns of deficit is not
clear. Furthermore, if schizophrenia itself is viewed as implying 
'adversity of outcome', the relationship between the concepts of 
'chronicity' and 'defect state' and that of the illness - if not 
tautological - is confused.
Recently, the terminology 'positive' and 'negative' has been 
applied to schizophrenia, based on Hughlings Jackson's ideas on the 
functional organisation of the central nervous system (Jackson 1887,
1894; Levin, 195^), and has gained widespread, though not uncritical 
(Freeman 1982), acceptance. However, changing the terminology does 
nothing to unravel the psychopathological deficits behind that 
personal decline viewed by many as the major validating criterion of 
schizophrenia. If the new terminology results in no meaningful 
distinction based on clinical data, it will serve only to complicate 
an already confused situation.
The European/American distinction in conceptualisation of the 
condition was, understandably, reflected in differences regarding 
aetiology. In the United States, the approach to schizophrenia has 
always been what Neale & Oltmanns describe as "theoretical" - with 
numerous theories attempting"to derive the main symptoms of 
schizophrenia from a core problem" (Neale & Oltmanns 1980). These 
authors add :
"This focus on theory building seems to have deflected 
attention from the definition and description of the 
disorder itself. Indeed, many of the early theorists 
went on to define the disorder in terms of the defective 
hypothetical constructs they inferred rather than in 
terms of observable behaviour".
(Neale & Oltmanns 1980 p 12).
In Europe, 'theory building' has always been less prominent.
It has in general been accepted by many psychiatrists that the 
underlying disturbance lies in some as yet undefined physical disruption
of brain function. This view was characterised in its purest form
e
by Wemicki' and the school of Brain Psychiatry which flourished 
in Germany at the end of the last century - though even the analytical 
Bleuler could write
"Complete justice to all these factors can only be done 
by a concept of the disease which assumes the presence 
of (anatomic or chemical) * disturbances of the brain". 
(Bleuler 1911. p 463)*
This view has been maintained despite the relative absence 
of clinically useful, objective parameters of specific brain 
dysfunction. Indeed, the prevailing practice has been to avoid a 
diagnosis of schizophrenia if signs of brain dysfunction present 
themselves. Hence while the theoretical stance is in favour of an 
aetiology based on brain abnormality, routine diagnosis continues 
to be predicated on the specific absence of evidence of such 
abnormality.
Many psychiatrists would accept the views of Gerstmann and 
the Viennese school (Gerstmann 1958) - that the conventional 
functional/organic dichotomy of mental illness is more apparent than 
real, and depends on a quantitative evaluation, the basis of which 
lies in our inability to detect brain change rather than its absence. 
Schneider put it thus :
"Our concept of psychiatric illness is based entirely on 
morbid bodily change. General pathology may be unable at 
present to give any uniform answer to the exact point at 
which a bodily change becomes morbid, but this need not 
prevent us holding to the above definition for theoretical 
purposes".
(Schneider 1959* P 7)»
In recent years advances in neuroscience techniques have led 
to a number of findings which indicate that the views of Gerstmann, 
Schneider and others do have foundation. Increasingly psychiatrists
Bleuler’s parenthesis.
on both sides of the Atlantic are searching for biological variability in 
schizophrenic patients, especially variability indicative of 
brain dysfunction. Indeed, some workers now feel able to state 
categorically that
"multiple lines of evidence  ....  clearly point to
biological alterations in the schizophrenic brain"
(Henn & Kety 1982 p 1 3).
This evidence is nascent and requires consolidation though 
one direction for future progress may lie in a combination of 
meticulous clinical observation and application of the new and 
sophisticated investigative techniques.
ju_____ THE PRESENT STUDY
J) BACKGROUND
From what has been said, Kraepelin1 s concept of functional 
illness predicated on adversity of outcome is still accepted by a 
large, and possibly increasing, body of psychiatric opinion. The 
characteristics which constitute the decline and the substrate out 
of which it emanates are, however, poorly understood. While many 
would favour an aetiology based on brain dysfunction, the evidence 
for this remains elusive and the widespread use of neuroleptic drugs 
now makes it difficult to evaluate whether potential neurological 
abnormality is a consequence of the illness or its treatment.
No large scale study of the deficits of long-standing 
schizophrenia has been undertaken for many years, and to the author's 
knowledge, no systematic investigation of an entire, diagnostically 
homogenous mental hospital population of such patients has ever 
been undertaken. Furthermore, although in widespread use for almost 
half a century, the role of physical forms of treatment in contributing 
to the clinical deficits has not been comprehensively evaluated.
In particular, modern standardised assessment and recording techniques 
have not been applied in this area since the use of neuroleptic drugs 
became generalised.
11) THE GENERAL QUESTIONS
The present study was designed to assess the deficits associated 
with long-standing, disabling schizophrenia and to identify factors 
associated with their development. This was intended to provide basic 
descriptive data of relevance in itself. In addition, this generated 
a range of parameters of importance in evaluating two neurological 
questions :
a) In established schizophrenia, can damage to the central 
nervous system be implied from the findings of clinical 
neurological examination ?
b) In established schizophrenia, can damage to the central 
nervous system be implied from examination of brain 
structure in vivo ?
In response to the first general question, the clinical 
neurological feature selected for evaluation was spontaneous involuntary 
disorders of movement.
It was clear, for reasons set out in the Introduction to 
Part 1 (pp 52/3 ), that gross localising signs would not be a rewarding 
area of study and that 'soft' signs would be difficult to administer 
and evaluate. Involuntary movements were chosen as they represent 
a relatively objective sign of brain dysfunction. With regard to the 
study population, they offered a particular attraction. Considerable 
evidence from the early descriptive literature suggested that involuntary 
movements were to be found in long-standing schizophrenic patients.
This whole question has however been overtaken by the putative effects 
of neuroleptic drugs, which are themselves implicated in the production 
of involuntary movements. Because of their varied treatment histories,
the present population offered an ideal opportunity to address two 
neurological issues, embodied in a refinement of the general question, 
a), above :
i) Is established schizophrenia, unmodified by neuroleptic
drugs, associated with the development of spontaneous 
involuntary movements ?
ii) In established schizophrenia, can the concept of tardive
(neuroleptic - caused) dyskinesia be shown to have 
validity, and if so, what are its correlates ?
Hi) THE SPECIFIC HYPOTHESES
The first stage of the work was descriptive and no specific
hypotheses were formulated. For subsequent parts, the basic postulate
was that :
Long-standing schizophrenia, inherent to which is personal 
decline, is a subtle disorder of brain function, evidence of 
which can be established both clinically and by the application 
of radiological imaging.
The specific hypotheses were :
i) a) That schizophrenia in patients of this type would, of
itself, be associated with spontaneous involuntary disorders 
of movement.
b) Even if the concept of tardive dyskinesia can be shown to 
have validity, involuntary movements in the context of neuroleptic 
ingestion in such patients would relate to features of the 
illness, independent of drug history.
ii) That such schizophrenics would show evidence of structural brain 
change (atrophy) and that this would relate to aspects of the 
illness and its severity, but not to physical treatments.
IY) THE STUDY SAMPLE
The study sample conforms to the Kraepelinian concept of
schizophrenia, in that deterioration was an explicit inclusion criterion.
It was drawn from the hospitalised, long-stay, schizophrenic population
of Shenley Hospital, Radlett, Herts, the institution providing continuing
care facilities for the London Boroughs of Brent and Harrow.
In the United Kingdom, most schizophrenics with illnesses of
long-standing do not now come to long-term care, and so the present 
population may be said to be unrepresentative. This mental hospital 
group was chosen for several reasons :
i) It provided ready access to a sufficiently large sample.
ii) Detailed records were available of past historical information, 
progress and treatments administered, going back over many years 
which provided an incomparable and, in general, reliable source 
of data.
iii) It was likely that the deficits of such patients would reflect 
the spectrum of abnormality characteristic of the illness in 
its severe form(s). While there are many reasons why patients 
remain in hospital severity/illness is likely to be one 
(Pryce 1972).
iv) The treatment policies for schizophrenia that operated in this 
hospital over many years varied widely, from dynamically - 
orientated psychotherapy through the gamut of physical therapies 
Consequently different groups of patients had been exposed to 
different ranges of treatment. This population thus allowed a 
unique opportunity to distinguish between the long-term effects 
of the illness and those of its treatment.
v) The hospital was close at hand and readily accessible and the 
staff were happy for the project to be conducted. This 
accessibility and co-operation greatly aided its execution.
V) EXECUTION OP THE STUDY
The study was executed in three parts.
Part I : This was designed to identify the deficits exhibited by the
patients at examination and to relate these to historical information 
of a personal nature and regarding the illness itself, including past 
physical treatments.
Part II : This concentrated specifically on spontaneous involuntary
movement disorder, and used standardised examination procedures and 
recording techniques.
Part III : This concerned the application of computerised axial
tomography to the study of brain structure in selected subjects 
from the total sample.
Each of these three stages of the investigation will be presented 
separately and comprehensively (Parts I - III ), with introduction, 
methodology, results and discussion relevant to each. The final part 
(Part IV) comprises a general comment and conclusions.
PART I 
THE CLINICAL DEFICITS
"The tower of Babel never yielded such confusion of tongues as 
the chaos of melancholy doth variety of symptoms .... As in 
a river we swim in the same place, though not in the same 
numerical water ... so the same disease yields diversity of 
symptoms"
ROBERT BURTON 
THE ANATOM OF MELANCHOLY
PART I
THE CLINICAL DEFICITS
Chapter 1 - Literature Review
1.1 INTRODUCTION
Early descriptive psychiatrists would have found a rigid acute/ 
chronic dichotomy in schizophrenia somewhat surprising. In the era 
before the introduction of physical treatments, long (often life-long) 
periods of institutional care were the norm. Living in close proximity 
to their patients, their work was largely with long-stay, 'chronic1 
cases and much of their typology was founded on the observations of such 
patients over many years. Their writings reveal little attempt to 
separate 'acute' and 'chronic' manifestations of the condition in the 
way that it was suggested earlier these terms are now used. This 
contrasts sharply with a modem text where great emphasis is laid on 
acute symptoms and signs, the more chronic sequelae usually being 
included under outcome headings (cf for example Slater & Roth 1 9 6 9).
Attempts have been made however to study the clinical features 
of the chronic state per se, though investigators have tended to focus 
on particular areas of functioning. This work is largely descriptive, 
and, as Hall has pointed out, much uses unstandardised or unpublished 
methodology, rendering the findings non-reproducible (Hall I960). Any 
review of the literature in the field of long-standing schizophrenia 
has, of necessity, to be selective. This review will therefore focus 
on studies of relevance to the present work, considered under three main 
headings:
i) Psychopathology and behaviour
ii) Cognition
iii) Neurology
1.2_____ The psychopathology of chronic schizophrenia.
It is to the German literature that one must turn for the most
i
detailed descriptions of the psychopathological features associated with 
established schizophrenia, a fact that has made most of this work 
inaccessible to English-speaking psychiatry. Kraepelin in particular 
has provided meticulous accounts of the clinical features of long­
standing schizophrenic illnesses which remain some of the finest sources 
of descriptive psychopathology (Kraepelin 1919)*
In the post-Kraepelinian era the most outstanding examples of 
descriptive symptomatology come from the works of Kleist (Fish 1957) 
and Leonhard (Pish 1956; Van Epen 1969; Astrup 1978; Leonhard 1979)*
Both these workers detailed the clinical pictures of large numbers of 
established schizophrenic patients over many years, though they used 
rather different methods. Kleist studied all referrals to a psychiatric 
clinic while Leonhard started with a sample of patients ill for at 
least 10 years.
Their conclusions are not specifically comparable and, in 
particular, their terminology is not synonymous. However, both observed 
two broad groups of patients - a specific schizophrenic form ( termed 
'typical1 and1 systematic' respectively) and a separate group(termed 
'atypical'and 'non-systematic') having a distinctive episodic course 
and more favourable outcome. Kleist believed the separate schizophrenic 
subtypes he defined were the clinical representatives of "psychic 
system diseases" analogous to the neurological system disorders such as 
motor neurone disease (Pish 1957; Kleist i9 6 0). This view was generally 
accepted by Leonhard who stated that these established 'chronic' 
schizophrenic states could be defined by the presence of a characteristic 
feature that, once elicited, was stable over time and which, having
genetic and biological foundations, could be reliably used to identify 
true and separate disease processes (Leonhard 1979)*
The descriptive German psychiatrists were attempting more than 
a presentation of the range of mental state and behavioural features 
to be found in established schizophrenia. They were aiming at organising 
clinical typologies based on symptomatology. To this extent they were 
largely unsuccessful and their views have not received widespread 
attention. Kleist’s system is particularly unwieldy (Pish 1958)? and. 
while incidental attempts to match the Leonhard subtypes to long-stay 
samples in the U.K. have shown some coincidence (Wing 196l), the system 
remains largely untried in English-speaking circles. Several 
publications in English by German-speaking practitioners have attempted 
to validate the Leonhard system outside Germany (Pish & Astrup 19&4 5 
Van Epen 19&9) which Astrup's survey in Norway is the largest 
(Astrup 1978). With slight modification he found the system useable 
and, when retrospectively applied, it did identify groups of varying 
outcome severity.
It is unlikely that these systems will gain widespread acceptance 
by English-speaking psychiatrists. Partly, this is due to the relative 
inaccessability of most of these writings. Although English translations 
of both Kraepelin and Leonhard's works are available their heavy, 
unfashionable style is against them being widely studied. Partly also 
these systems were devised before the introduction of neuroleptic drugs 
and whether they could now be meaningfully employed is uncertain. Mainly 
however their neglect is likely to stem from a widespread scepticism 
in the English-speaking world that valid typologies can be established 
on the basis of symptomatology alone. Despite this, the writings of the
German school of descriptive psychiatry remain a rich and neglected 
source of information on the varied clinical states associated with 
established schizophrenia.
Whatever the pragmatic and theoretical objections to these systems, 
the writings highlight the restricted view of schizophrenic deficits 
employed in English-speaking practice. The descriptive German literature 
emphasises that the post-acute state may be characterised by more than 
just 'negative1 type deficits, and can in fact be largely coloured by 
productive features.
In a theoretical paper, Huber has provided one of the few 
recent discussions of schizophrenic defects (Huber 1 9 6 7).' In contrast 
to English-language psychiatry's conventional emphasis on the affective 
disturbance in post-acute schizophrenic defects, Huber, in line with 
Germanic tradition (Conrad 1958)? believed the problem to be one of 
motivation. The importance of this according to Huber, is that 
motivation is only amenable to quantitative change, unlike affect which 
may also be qualitatively altered. Consequently a 'defect state' based 
on the concept of "impoverished drive" or motivation is not seen as a 
specific schizophrenic phenomenon, but could result from any psychosis, 
functional or organic. Huber used the term "uncharacteristic" to highlight 
the non-specificity of drive reduction, and emphasised that only the 
presence of additional characteristic features allowed any defect to 
be attributed to schizophrenia as opposed to any other psychosis.
Huber divided post-acute, residual schizophrenic states into 
four types, represented schematically in Fig 1:1:1. Patients with pure 
psychosis, mainly on-going paranoids, are able to function intact 
despite their symptomatology. The typical schizophrenic defect psychosis
FIG  1:1:1
Schematic representation of Huber's classification of defect states
Characteristic Noncharacteristic  
schizophrenic features  
features
Pure psychosis
Typical schizophrenic  
defect psychosis
Mixed defect
Pure defect
is also dominated by productive features, and decline associated with 
the loss of motivation can only be detected by observation of performance 
over time. In mixed defect, "uncharacteristic" lack of drive impairs 
the patient markedly and only the presence of additional characteristic 
features - which increasingly lose their impact on the patient - allows 
this state to be attributed to schizophrenia. Pure defect is not at 
all specific to schizophrenia. No residual characteristic schizophrenic 
features persist, the dominant abnormality being marked lack of drive, 
of which the patient may be aware. They may, in addition, have minor 
neurotic-type symptoms such as depression and especially hypochondriacal 
preoccupations. Pure states are, according to Huber, irreversible, 
unamenable to pharmacotherapy and organic (diencephalic) in origin, 
being highly correlated with pneumoencephalographic evidence of cerebral 
atrophy. They are not caused by neuroleptics, as they were described 
before the drug era, though it is possible that drugs may facilitate 
their development.
Huber's approach is novel to English-language psychiatry. Its 
strength is to highlight that the terms 'chronic schizophrenia' and 
'defect state' may not be synonymous and that distortions of affective 
display may not be essentials of either. However, his views have not 
been subjected to experimental evaluation and the idea that the 
established deficits of divergent psychiatric states do not 
qualitatively differ in their fundamental aspects would be challenged 
by many. Huber's pneumoencephalo graphic work will be reviewed 
subsequently ( Part III).
The belief that socially impoverished environments of the sort 
that especially characterise institutions could be detrimental to the 
individual has been a popular sociological idea since the war, and
many workers have described these effects graphically (Goffman 1968). 
Barton, in an influential monograph, attempted to identify clinically 
specific features of this which manifest as 'symptoms’ in long-stay 
psychotic patients (Barton 1959).
Since the late 50s, Wing, Brown and their colleagues have 
attempted to clarify some of these issues by objectively studying the 
influence of social factors upon the clinical features of established 
schizophrenic illnesses ( Wing & Brown 19&1, Wing & Freudenberg 196l). 
Their most pertinent study was an investigation of long-standing 
female schizophrenics hospitalised in three different mental hospitals 
which represented different social milieus (Wing & Brown 19&1, Wing & 
Brown 1970). The examination indices and classifications, combined 
with the aims of the work, dictated an uneven emphasis in this study. 
However, in terms of the ratings performed, only 11 % of their randomly 
chosen sample had normal mental states - though such features as 
hallucinations, anxiety and depression were not evaluated.
A strong relationship was demonstrated between the presence of 
what they called the "clinical poverty syndrome" (the predominance of 
features such as poverty of speech and flattened affect as defined in 
the study) and a socially unstimulating and restrictive environment. 
Four years later, during which time improvement had occurred in all 
measures of environment, approximately one third of the non-discharged 
patients (i.e. one third of 250) had improved - this ranging from 
"fairly marked" (about 20%) to "less definite changes for the better" 
(about 10 %). Improvement was most pronounced in 'negative' type 
features and occurred most in the hospital where social changes were 
greatest. The greater part of this improvement seemed to have taken 
place in the first 2 years of the study, but after 8 years, most of it
had receded - a finding the authors describe as "disappointing".
This work represents one of the most comprehensive
investigations of the clinical and behavioural characteristics of
patients with established schizophrenia in institutional care, and
was the first to apply reliable and standardised techniques in this
area. Although designed to test particular sociological theories,
it illustrates the degree of mental state and behavioural abnormality
to be found in such patients and the relative intransigence of these
in the majority. Despite the orientation of this work, Wing and
Brown state that "a substantial biological component is involved"
in the production of 'negative* type deficits (Wing & Brown 1970?
p 18), and elswhere Wing has concluded that :
"Social withdrawal is a characteristic of most forms of 
chronic schizophrenia, irrespective of social setting,
and a biological component must be accepted".
(Wing 1963)
1.5 COGNITION
1.3.1 GENERAL
Since the first delineation of the condition, a persistently 
controversial area has been that of intellectual ability in 
schizophrenic patients. The first question has been :
Is schizophrenia associated with impaired intellectual 
performance ? The second, and more fundamental one is:
If so, is this impairment permanent and 'real', and a primary 
manifestation of organic disorganisation of neural substrate, or 
is it apparent, but reversible and a secondary consequence of other 
mental state abnormalities, such as apathy, autistic withdrawal, 
preoccupation with psychotic phenomena and the like ?
The term dementia (la Demeuce) can be traced back to
Phillipe Pinel who used it to describe a group of insane patients 
without emotional excess colouring the clinical picture (Neale & 
Oltmanns 1980). However in the 19th century differentiation between 
cognitive and affective components of mental life was poorly 
understood and ’dementia1 continued to be applied to "mental 
enfeeblement'f or "deterioration" in the most general sense. Bleuler 
says of the term, that it was "applicable to all cases at hand" 
(Bleuler 1911? P 7). It did not have the specific implication - 
organic, i.e. structural, aetiology and irreversibility of symptom 
pattern - that it has since acquired.
Nonetheless, in the introduction to his book, Kraepelin 
justified his use of the term 'dementia' thus :
"It appears that this form of mental weakness, in spite 
of great differences in detail, exhibits many features 
in common with other forms of dementia, such as are known 
to us as the result of paralysis, senility or epilepsy". 
(Kraepelin 1919* P l)*
Thus the term was already becoming refined by the begining of the
century and Kraepelin was drawing the clear conclusion that
'deterioration' associated with the illness he was describing was
similar to that found in other organic brain conditions. While he
hesitatingly accepted the view that 'deterioration' could be halted
or sometimes reversed, he left open the possibility that in some
cases it may indeed be organically mediated.
Although Bleuler believed in a basic anatomical or chemical 
abnormality as the ultimate 'cause' of schizophrenia he remained 
adamant that structural degeneration and immutability of clinical 
features were not associated with this condition. Intellectual 
deterioration was more apparant than real, being secondary to autistic 
withdrawal from reality ( Bleuler 1911). He did not believe the
illness permitted " a full restitutio ad integram " (p. 9) but did 
believe that within every chronic schizophrenic lay the dormant 
potential for recovery and behind every deteriorated facade was an 
active mental life awaiting release - the latter in particular being 
recently reiterated by M Bleuler (M. Bleuler 1978)*
These two poles of opinion represented the prevailing views 
within psychiatry for most of this century. In the 50s and 60s 
tentative steps we re taken to explore these questions using standardised 
test techniques, though by the early 70s cognitive testing in 
schizophrenia had become an unpopular area of investigation (Payne 
1973, Rabin et al, 1979)* In recent years however effort has once 
again been invested in this area, inspired partly by improved tools 
for cognitive evaluation and partly because the introduction of 
imaging techniques has opened up the prospect of producing an objective 
correlate for any abnormalities that may be found. The older and the 
newer studies will be reviewed separately.
1. 3- 2. OLDER STUDIES OP COGNITIVE PERFORMANCE IN SCHIZOPHRENIA 
The earliest work in this field used the Stanford-Binet 
test which, as it is only standardised for children, left age as an 
uncontrolled variable (Payne i960). Subsequently the Wechsler 
Adult Intelligence Scale (WAIS) was used, which overcame this problem.
Tested when acutely ill, schizophrenics as a group perform in 
the low average range of intelligence ( Payne I960, 1973)* However 
they clearly represent a heterogeneois group, having a wider range of 
scores than the normal population. This has been attributed to 
differential abilities within the classical subtypes of the illness 
with some agreement that hebephrenic and catatonic patients perform 
particularly badly compared to paranoids. (Payne i9 6 0, 1973)*
While paranoids may appear to remain relatively preserved 
(Payne I960; 1973)> 'the conventional view of intelligence holding 
up intact in such patients has been challenged (Lubin et al 1962; 
Kingsley & Struening 1966). Whether differential subtype 
capabilities represent sampling bias or reflect the fact that those 
who perform badly tend to be specifically labelled is unclear 
(Payne i9 6 0).
None-the-less it can be said that, for whatever reason, 
intellectual ability is compromised during the more active shifts 
of the illness - according to reasonable estimates by about two- 
thirds of one standard deviation (Payne 1973) or 10 IQ points on the 
Wechsler-Bellvue scale (Winder i9 6 0).
With regard to the more established (or 'chronic*) state, 
the question as to whether the deficits believed to accrue are 
ireversible or not, and if not, whether they are progressive, 
remained largely unresolved in the older literature. While quite 
marked improvements in IQ scores, including those of chronic 
schizophrenics who had been 'activated', were reported (Goldstein 
& Salzman 1967; Haywood & Moelis 1963; Hamilton 1 9 6 3)* most 
studies found either no progressive deterioration (Payne 1973;
Smith 1963) or reported that intellectual deterioration could 
continue throughout prolonged periods of hospitalisation (Payne I960; 
Schwartzman et al 1962; Haywood & Moelis 1 963). It was in addition 
suggested that scores on cognitive testing had certain prognostic 
value (Payne I960; Hamlin & Ward 1973; Heffner et al 1975)*
A further unresolved question was whether schizophrenic 
patients had premorbid cognitive disadvantage and hence were 
potentially predisposed to the psychosis, or whether their
intellectual deficits arose with the illness itself - the so - 
called prodromal and concomitancy hypotheses (Martin et al 1977)*
Evidence exists in favour of both these theories. The 
prodromal theory is supported by the finding that schizophrenic 
adults achieve lower IQ, scores in childhood than their siblings 
(Lane & Albee 1965; Offord & Cross 1971) matched peers
(Offord 1974; Watt & Lubensky 1976), and by the fact that IQ scores 
in the premorbid phase can show a deficit (Schwartzman & Douglas 
1962). Mason examined the IQ results of conscripts who subsequently 
developed a functional psychiatric disorder and compared them with 
controls (Mason 1956). While the psychiatric group as a whole 
showed no significant deviation from controls, those who subsequently 
became schizophrenic were significantly duller prior to the onset 
of the psychosis. Against this, is the finding of some workers that 
schizophrenics perform at a poorer level in the morbid than in the 
premorbid state (Kingsley & Struening 1 9 6 6; Schwartzman et al 1 9 6 2), 
thus supporting the concomitancy theory. The difficulty in deciding 
when premorbid becomes morbid, the selection of patients and 
especially the lack of strict, standardised criteria for schizophrenia, 
account for some of these discrepancies.
Thus the older literature was inconclusive in its findings.
In addition, the question of whether demonstrable deficits were the 
result of psychological factors such as impairment of ’’attention 
and effort”, ’’mental control”, "volition" or the like (Hunt &
Cofer 1944; Huston & Shakow 1949) or of "organic" ones (Lubin et al 
1962) could not be readily answered. Based on qualitative 
comparisons of test performance it was possible to speculate on the
likelihood of schizophrenic cognitive deficits being organically 
mediated (Lilliston 1970 > 1973; Depue 1976) but prediction 
regarding an organic pathology or aetiology was not possible at high 
levels of confidence. The Kraepelin/Bleuler polarity remained 
essentially unresolved.
Perhaps for this reason, interest wained. In recent years 
the area has once again received attention, largely following the 
introduction of CAT scanning, and the development of more refined 
psychometric tests.
I.3 .3  NEWER STUDIES OP COGNITIVE PERFORMANCE IN SCHIZOPHRENIA
Newer work in this field has been less concerned with purely 
IQ assessment than with more widespread neuropsychological 
evaluations. The interest of recent studies lies in attempts to 
correlate cognitive performance with objective parameters of 
structural brain change. Findings to date however tend to be 
’spin-offs' from larger C.T. investigations, and serious endeavour has 
yet to be applied to this area on its own. The literature is summarised 
in TABLE 1:1:1.
Four of these studies used intra-group comparisons and only 
that of Johnstone et al used a normal and a morbid control group.
These workers found their schizophrenics were more impaired than
both control groups on three different cognitive tests, but only
8
impairment on Wither/and Hinton total scores correlated with one
A
parameter of brain pathology, namely ventricular enlargement. No 
correlations were noted with cortical indices. Weinberger et al 
reported that WAIS total and subtotal scores were significantly lower 
in a group of 14 chronic schizophrenics compared to a small group
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of controls, though the nature of their controls is unclear. Rieder 
et al found that the 4 schizophrenics in their study who had cortical 
prominence also had cognitive test scores that "substantially 
exceeded accepted cut-offs for brain impairment" while only one of 
a matched quartet without C.T. abnormality exceeded the limits. The 
study of Donnelly et al used a similar methodology, comparing 
neuropsychological performance in members of a group with C.T. change, 
with that of those in whom scans were normal. The 8 of their group 
who had "morphological abnormalities" (ventricular enlargement and/or 
sulcal prominence) performed significantly worse than the 7 with no 
abnormality. The scan status of 12 of the 15 subjects could be 
predicted from their neuropsychological results. Golden et al 
likewise found test scores could predict JO % o f those with 
ventricular enlargement. Results on 8 of the 14 subscales of the 
Luria -Nebraska battery correlated with ventricular size. More than 
half their sample however was referred for testing because of a 
clinical suspicion of brain damage. Andreasen et al found deficits 
on tests of "the sensorium" in 16 patients with ventricular 
enlargement selected from a larger C.T. group, compared with 16 
matched subjects without ventricular enlargement.
Evidence from investigations of dementia alerts one to the 
likelihood that any relationship between brain structure and function 
will be far from strong (Roberts & Caird 1976; Kaszniak et al 1979)> 
and the need for large samples, carefully documented, is obvious.
This requirement has not yet been met in this type of work. Furthermore, 
it is necessary to be clear about what is being measured with 
neuropsychological batteries and what is meant by the word ’cognition1 
in the context of their use. These newer studies are less concerned
with IQ in schizophrenia than the older ones reviewed previously 
(only Weinberger measured IQ alone) but assess a range of higher 
cerebral activities. It is important that general statements 
regarding 'cognitive1 ability assessed by neuropsychological batteries 
do not detract from the fact that total performance may be 
compromised by subscores reflecting the presence of abnormality 
of a 'soft' neurological kind.
There is much scope for work of this type, offering as it 
does the prospect of correlating clinical parameters of brain 
dysfunction with objective features of cerebral structural change 
in schizophrenia. Studies thus far, however, are not of sufficient 
size or quality to allow any dogmatic conclusions of a link between 
the two.
1.4 NEUROLOGY
1.4.1 GENERAL
The belief in an unequivocal structural abnormality underlying 
schizophrenic illnesses and the wish to demonstrate it have a long 
tradition.
The classical Greek physicians never considered any view 
other than that madness had a physical basis, though with their 
virtually non-exist ant knowledge of the brain, they believed the 
abnormality to be a bodily one (Ackerknecht 1968). Descriptions of 
insanity were fully integrated into their medical treatises with 
no attempt at segregation (cf, for example, Aretaeus The Cappadocian 
1972). The mind-body dualism of contemporaneous philosophy was 
an alient concept to them.
Despite repeated criticism and persuasive alternate theories
from the dynamic school, belief in an underlying brain disorder 
has remained the dominant orientation of many psychiatrists with 
regard to the aetiology of schizophrenia, especially in the United 
Kingdom. It is somewhat surprising that this should be the case, not 
because there is strong negative evidence to contradict it, but 
rather because there is a certain lack of positive evidence to 
support it. Some of the evidence that is available will be reviewed.
1.4.2. NEUROPATHOLOGY
Neuropathology was the obvious starting point and many 
psychiatrists made important contributions to the understanding of 
brain structure in health and disease,(for example Gudden, Wemicki', 
etc). Yet to date, neuropathological investigations have not 
revealed any abnormality in the brains of schizophrenics that can be 
consistently associated with the clinical condition far less one 
that can be said to be pathognomonic (Weinstein 1954; Dastur 1959)-
Perhaps as a result of past disappointments, such 
investigations have attracted little interest among neuropathologists 
in recent years and virtually all the reports of negative or 
inconclusive findings arose from work done many years ago. As
Stevens has pointed out, most of this work focused on the cortex
e,
(Stevens 1982a)which undoubtedly reflects - like Wernicki7’s 
cortical localisation theories - the preoccupation of the post- 
Darwinian age with that area.
Recent neurochemical work however has shifted ‘interest to 
subcortical structures (Crow et al 1976). Stevens, reviewing the 
literature, provides evidence to suggest that a re-evaluation of the 
neuropathology of these subcortical regions may prove more rewarding
(Stevens 1982a).' In her own controlled study, she reported the 
presence of discrete areas of gliosis with a predominantly 
periventricular distribution in 75 % of her schizophrenic sample. 
Furthermore, electronmicroscopy has not been widely used, though 
Miyakawa et al (1972)described the finding of intracellular 
irregularities and inclusions in schizophrenic brains by this method.
Thus, although neuropathological techniques have not so far 
produced consistent or characteristic abnormalities to support the 
idea of schizophrenia being an organic brain disorder, the application 
of improved clinical classifications, the study of subcortical areas 
and the use of new techniques, may yet provide important information 
on this question.
I.4 .3 . CLINICAL SIGNS
a) Gross signs
The first classification of major psychiatric disorders on 
the basis of gross neurological signs was probably also the last.
When in 1822, Bayle separated out those insane patients who had 
progressive neurological signs from those who had not (Bayle, 1822)he 
cleared the way for the study of a discrete form of insanity with 
an organic neurological basis. This was one of the major discoveries 
in the history of psychiatry (Moore & Solomon 1934)* His dichotomy 
allowed Esmarch & Jessen to make the connection between general 
paralysis and syphilis more than 30 years later (Esmarch & Jessen
1857) though conclusive demonstration of the cause being due to
c,L
spirok7aetal infection of the brain had to await Noguchi's work at 
the begining of the century (Noguchi 1909» 1910).
As to those for whom the diagnosis of general paralysis did
not apply, little comparable progress has been made in the past 
century and a half. Few would disagree with Arieti's statement 
that the chronic schizophrenic illness often appears to reach a 
stage "where psychology and neurology coalesce" (Arieti 1974 
p 4 2 3), but the clinical evidence for gross neurological disturbance 
has remained elusive.
Kraepelin in particular among the early descriptive 
psychiatrists considered the neurological status of his patients in 
detail (Kraepelin 1919)* I't was clear even then that localising 
neurological signs indicative of gross cerebral disorder were not a 
feature of dementia praecox. Indeed Bleuler wrote that "organic 
paralysis will hardly be manifested as partial symptoms of 
schizophrenia" (Bleuler 1911 p 17l)* Kraepelin however, remained 
intrigued by certain findings which, although not pointing to 
specific brain pathology, were sufficiently prevalent and persistent 
to be worthy of note. These included irregularity of the pupil 
and its absent response to pain and other stimuli, asymmetry of the 
tendon jerks and muscle spasms.
Half a century later, Lemke found similar subtle but definite 
neurological abnormalities in 25 - 3 % o£ 1000 untreated schizophrenics. 
This was ten times that found in control samples of soldiers and 
students (Lemke 1955)* However, Lemke examined all the schizophrenics 
(criteria unspecified) himself and in full knowledge of their diagnosis, 
while examination of most of the controls fell to a second physician.
The question of gross neurological abnormality in 
schizophrenia has, surprisingly, received only cursory attention to 
date. Stevens, in a recent review adopts an unequivocal stance in 
favour of the validity and relevance of such findings as have emerged,
and states :
"... neurological signs associated with schizophrenic 
illnesses strongly resemble experimental and clinical 
disorders of the limbic forebrain”. (Stevens 1982b).
The establishment of such a relationship would represent a major
clinical advance, but confirmation remains to be forthcoming.
b) Non-localising signs
In recent years, interest has grown in what have become known
as 'soft' neurological signs and their possible relevance to
schizophrenia. It is hypothesised that the presence of such signs
would be evidence of central nervous dysfunction of a different
order, although not of a lesser degree of severity, than 'hard* or
localising signs (Rochford et al 1970)•
'Soft1 signs are varied and difficult to characterise,
different workers using different tests to elicit ’abnormality*.
In general they assess involuntary activity and subtle motor function
within and across different sides of the body in response to verbal
instructions, aspects of co-ordination, balance and gait, and aspects
of complex sensation such as graphaesthesia and stereognosis.
Additional complex tests of cerebral ’integration’, such as the
Auditory-Visual Integration Test (Birch & Belmont 1965) Have also been
widely used.
Such tests have received their most widespread application in 
paediatric psychiatry (for review see Erlenmeyer-Kimling et al 1982) 
with children who have in common severe behavioural disturbance - of 
whom childhood schizophrenics represent extreme examples. ’Soft’ 
neurological abnormality appears to predict children at risk of 
developing schizophrenia with relatively high degrees of confidence.
In children, a certain objectivity is inherent in the tests
and their execution, adding to their validity as pointers to 
cerebral disorder. In adults, however, this type of investigation 
becomes much less an evaluation of uncorrupted neurological 
status than of motor responses which involve aspects of cognition 
such as concentration and comprehension. Performance is much more 
likely to be influenced by mental state factors and hence findings 
may reflect in large part the subjects' general level of competence 
rather than any putative cerebral lesion(s). It might therefore 
be predicted, for example, that a higher prevalence of 'soft' 
abnormality would be found in those of low IQ, as has been reported 
(Quitkin et al 1976).
In recent years a number of studies have found a greater 
prevalence of 'soft' neurological signs of varying type in 
schizophrenics compared with a number of control groups (Tucker 
et al 1974; Quitkin et al 1976; Cox & Ludwig 1979 (a) and (b);
Torrey 1980). However, straight comparisons of prevalence in 
schizophrenics as against other groups, which leave major factors 
such as intelligence and general cognition as uncontrolled 
variables must remain of doubtful validity as specific pointers to 
brain damage. While this area of study offers the interesting 
prospect of establishing parameters of brain dysfunction in 
schizophrenia by purely clinical means, much more careful 
investigation requires to be undertaken in validating the techniques 
applied.
c) Involuntary movements
In 1857> Griesinger wrote :
" of far greater significance are .... the persistent
automatic grimacing, strabysmus originating during the 
disease painful convulsions of the muscles
of the neck .... their continuance usually (indicating) 
a transition to a state of incurability. A constant 
trembling, grinding of the teeth, chorea-like movements 
in adult lunatics .... at least in the majority of cases, 
symptoms of the development of serious organic disease 
of the brain" (Griesinger 1857)
Griesinger was writing after the identification of general
paralysis but before the dementia praecox concept was formulated, so
although one cannot transpose his comments directly to schizophrenia
as now defined, it is unlikely that the spectrum of movements he
recorded in "the insane" was confined to patients now recognised
as having progressive neurological disorders.
However, since the delineation of dementia praecox a number
of authors have commented on the presence of involuntary movement
activity in schizophrenics (Kraepelin 1919; Reiter 1926; Jones &
Hunter 1969; Yarden & DiScipio 1971; Brandon et a! 197l)« Kraepelin
described them thus :
"The spasmodic phenomena of the musculature of the face 
and of speech, which often appear, are extremely 
peculiar disorders. Some of them resemble movements of 
expression .... which we bring together under the name 
of making faces or grimacing; they remind one of the 
corresponding disorders of choreic patients. Nystagmus 
may also belong to this group. Connected with these are 
further, smacking and clicking with the tongue ...(and) 
we observe especially in the lip muscles, fine lightening- 
like or rhythmical twitchings, which in no way bear the 
stamp of voluntary movements .... The outspread fingers 
show fine tremor. Several patients continually carried 
out peculiar sprawling, irregular, choreiform,outspreading 
movements, which I think I can best characterise by the 
expression "athetoid ataxia". (Kraepelin 1919 P 8 3).
Bleuler, too, wrote of patients
"performing all kinds of manipulations with their teeth... 
(with) grimaces of all kinds, (and) extraordinary movements 
of the tongue and lips" (Bleuler 1911 p 185/191)•
Bleuler tended to classify such movements as maimeristic/stereotypic
and chastised those who called them, "quite mistakenly" (p 19l)>
choreic. However, he himself used, at different points, words such 
as "involuntary" (p 191) and "unco-ordinated" (p 215 ) describe 
some of these movements. In addition, in describing other motor 
activity, he wrote :
" I cannot immediately differentiate many (such) acts 
from organic apraxia "
but concluded :
" I am convinced that all these various elements 
represent concomitant influences " (p 196 )
Thus although Bleuler recognised that many of the movements he
observed were virtually indistinguishable from organically mediated
disorders, he remained "convinced" that the underlying causes were
the emotionally laden psychic complexes, despite the views of others
to the contrary. One of the recurrent pieces of evidence he quoted
in favour of his view was the changeability of these motor signs
with mental state ("complexes"). It is however now widely accepted
that mental state is one of the major modifying variables determining
the clinical appearance of extrapyramidal (i.e. organic) involuntary
movements ( Marsden et al 1975? ABA Task Force 1979)*
More recently, involuntary movements have been described in 
drug-free schizophrenic patients. Jones & Hunter, noted tremors, 
choreoathetoid movements and tics, in addition to ’mannerisms' in 
40 % of a drug-free group admitted to hospital prior to 1946, while 
Brandon et al found a comparable prevalence of orofacial movements 
(BML triad) in schizophrenics never treated with neuroleptics as in 
those treated. Yarden & DiScipio noted "choreoathetosis" in 18 
young newly admitted schizophrenics, though some of these were 
believed to have had pharmacotherapy at some point. They, like 
Griesinger & Kraepelin, believed the appearance of these signs
angered a poor prognosis.
The whole question of the relationship between involuntary 
movement disorder and schizophrenia has now been overtaken by the 
introduction of neuroleptic drugs and the issues, surrounding what 
has become known as tardive dyskinesia. Notwithstanding, the older 
literature clearly indicates that schizophrenia was associated with 
spontaneous motor activity. Many of these accounts were written 
before the era of encephalitis lethargica and an association with 
this cannot be readily made.
Involuntary movements therefore may offer an objective 
neurological marker in schizophrenics if the effects of treatment 
can be accounted for. The present population offered such a 
prospect and these questions will be addressed in detail in 
Part II of the present work.
1.4.4 BRAIN STRUCTURE IN LIFE
The literature relevant to this question will be reviewed 
in Part III.
1.5_______THE PRESENT STONY
The present study was designed to record in standardised 
fashion the clinical deficits elicited at examination of a 
homogeneous population of long-stay schizophrenic patients and to 
seek correlations among the deficits, and between them and relevant 
aspects of historical information. The purpose of this was to 
clarify the nature of the deficits themselves, the terminology used 
to describe patients who exhibit them and the factors related to 
their development. It was further proposed to use this information 
to elucidate specific questions posed subsequently.
Chapter 2 - Methods
2. 1. GENERAL
At the begining of 1977 > the case records of the entire 
in-patient population of Shenley Hospital were surveyed. Of the 
1227 persons then receiving in-patient care, 635 Rad a case note 
diagnosis of schizophrenia and had been continuously hospitalised 
for at least one year at that time. Application of the criteria 
for schizophrenia proposed by Feighner et al(l972) to the records 
of this group produced 524 Feighner positive schizophrenic subjects. 
Of these, 14 died or were discharged before further work could be 
undertaken. The study sample therefore consisted of 510 Feighner 
positive schizophrenic in-patients.
The current status of the index subjects was assessed in 
terms of their present mental state, their cognitive ability, the 
integrity of their gross neurological functioning, and their 
overall behavioural competence. These four examination variables 
will subsequently be referred to as ’Assessed Abnormalities'.
Points of demographic and historical information, such as 
past physical treatments which the patient may have had, and the 
details of their illness at its worst were extracted from the 
notes. These data extracted from the case records will be referred 
to as 'Recorded Information'.
2. 2. ASSESSED ABNORMALITIES
2:2:1. MENTAL STATE
The features of the current mental state were recorded on 
the scale devised by Krawiecka et al for use with chronic psychotic
patients (Krawiecka et al 1977)* This allows for assessment of 
eight variables, each graded on a five point scale of severity, 
and is based on a semi-structured interview. For the purpose of 
the present study, the item on affect was subdivided to allow the 
separate recording of incongruity and flattening. Thus, nine 
mental state features were scored. These are shown in 
Appendix 1.
Throughout this study a division is maintained between 
mental state phenomena described as being (at least relatively) 
specific to schizophrenia - that is the ’positive’ and ’negative' 
features - and those which are relatively non-specific, being 
found in a wide range of psychiatric disorders - namely depression, 
anxiety and psychomotor retardation. This distinction is 
illustrated in the Appendix.
2.2.2 COGNITIVE PERFORMANCE
Cognitive ability was evaluated by applying the Withers 
and Hinton test battery (Withers & Hinton 1971; Hinton & Withers 
197l) (Appendix II). This provides an assessment of current 
awareness, concentration and attention, recall and abstract 
reasoning, and summates to provide a total numerical score. As 
no time limits apply, every encouragement can be afforded even 
very withdrawn patients, and its succinct format ensures the maximum 
likelihood of co-operation being maintained until the test is 
completed. Previous experience with patients similar to the 
subjects of the present study had shown that most could attempt 
the questions and could achieve some score at the end.
2:2:3- NEUROLOGICAL STATUS
The neurological status was assessed only in terms of motor 
functioning, with no attempt at evaluation of aspects of sensation.
It was felt that the value of any sensory findings would be offset 
by loss of patient co-operation.
The examination technique adopted was based on that described 
by Renfrew (Renfrew 1967) and consisted of a general assessment of 
motor function - namely cranial nerves, tone and power, co-ordination 
and limb reflexes. An additional assessment was made of the 
presence and gross regional distribution of any spontaneous 
involuntary movement disorder the patient exhibited at any time 
during the routine examination. Any abnormalities of gait were 
also noted. These data were recorded on a schedule devised for the 
project (Appendix III).
These three assessments were conducted one ward at a time, 
the patients being seen in random order. The examinations were 
performed before the case notes of the subjects concerned had been 
scrutinised and before the nurses had been interviewed in detail 
about patient behaviour. Thus they were performed in the absence 
of any information about the individual's past or present status, 
especially drug treatments administered at any time.
2:2:4. BEHAVIOURAL PERFORMANCE
It was realised that information resulting from examinations 
conducted on a single occasion provides only a cross-sectional 
picture and in particular gives little impression of the patients' 
behaviour over time. While a number of scales are available for 
recording behaviour in long-stay patients, there are major problems
associated with many of these (Hall 1980). Furthermore in this 
aspect of the present study it was intended to record the views 
of those in close contact with the patients regarding various 
psychopathological features and their relation to behaviour, in 
addition to seeking their descriptions of the patients' behaviour 
itself.
The Current Behavioural Schedule (Appendix IV) was devised 
for this purpose, although it is based partly on the scale of 
Wing (1961). This schedule was completed by the examiner on the 
basis of a semi-structured interview with the nurse in charge of
the ward where the patient resided. Although allowing the
possibility of considering behavioural deficits under separate 
headings - such as social behaviour, activities, manifest abnormality, 
incontinence - the separate items could be summated to provide 
a total score (maximum 50) indicative of overall behavioural 
functioning. This scale has been shown to have good inter-rater 
reliability (total scores .99 - unpublished data).
2.5 RECORDED INFORMATION
After the patients had been examined, the case notes of 
the study sample were scrutinised in detail.
2.3.1 PERSONAL HISTORICAL BATA
Details of the patients' early lives we re recorded on the 
first part of an In-patient Schizophrenia Survey Form (Appendix V) 
constructed for the survey. This form was based on the original 
questions which made up the Enquiry Form contained in the case 
records, which relatives had, since the hospital's inception,
been required to complete immediately after the patient's admission.
Hxest,
In recording this data definite statements were required to
make a positive notation. For 'past academic record', the term
a.
'higher' was applied to those subjects matriculating into or 
graduating from an institution of higher education, 'average' to 
those completing basic education without stated difficulty, and 
'poor' to those noted as experiencing educational 'backwardness' 
or who had attended an institution for the educationally subnormal.
2.3.2. PAST PHYSICAL TREATMENTS
The second section of this form was designed to record 
details of past physical treatments to which the patient had been 
exposed. This included, where appropriate, the number of treatments, 
if such information could be found.
This section also contained a global impression rating 
of the course of the illness since the patients' admission.
The final section of this form was reserved for additional 
noteworthy comments, including details of additional drug ingestion, 
for example anticholinergics.
2.3.3. THE FEATURES OF THE PSYCHOSIS AT ITS WORST
A psychopathological picture of the patient's psychosis at 
its most florid was constructed using the Syndrome Check List 
(S.C.L.) of the Present State Examination for recording salient 
features (Wing et al 1974)* This adaptation of the P.S.E. was 
devised for use in retrospective case note studies. When the data 
are submitted to computer analysis (the Catego program ), the patient 
is allocated to one of 50 Catego sub-classes which, although not 
intended as substitutes for diagnosis, do, in broad terms bear a
close relationship to clinical diagnoses. Standardisation of the 
description of the mental states of patients included in clinical 
investigations is one of the major recommended uses of this system 
(Wing et al 1974)•
In application of the Check List, items were only recorded 
positively in the situations where a clear description of the 
feature under consideration was present in the notes. Thus statements 
that the patient was felt to he ’’incoherent’1 or ’’hallucinated” did 
not qualify for positive rating.
For the purposes of storing and analysing data, and to 
maintain blindness to such variables as past neuroleptic treatment, 
each patient was assigned a code number from the start, by which 
he/she was identified subsequently.
2.4 STATISTICAL NOTE
Except where specified in analysis of data, the following 
principles were applied :
If two variables were continuous and likely to be normally 
distributed, then they were correlated, using Pearson’s product 
moment correlation.
If one variable was continuous and likely to be approximately 
normally distributed, and the other categorical, the population was 
divided into groups on the basis of the categorical variable and the 
means of the groups on the continuous variable compared using 
AITOVA.
2
If both variables were categorical, X analysis was 
calculated.
Analysis of examination variables - in particular 'positive'
and 'negative* totals - is more problematical than these stark 
rules suggest. In this initial analysis the examination variables 
were, for consistency, all treated as continuous, as it was felt 
that there were sufficient points in the range for each to permit 
this approach. However, it is accepted that the distribution 
poses a problem for this assumption, although the tests applied 
are considered sufficiently robust to absorb this difficulty.
(in later analyses (Parts II and III) a more cautious approach 
is adopted by dividing the examination variables into present/absent 
and degrees of severity categories).
Chapter 5 - Results
5. 1______ GENERAL
Recorded Information was obtained from the case notes of 
all 510 cases. Interviews with nurses provided behavioural data 
on 501, the remainder being known inadequately for ward staff to 
comment in detail. Clinical examinations of the three other 
Assessed Abnormalities were conducted on fewer subjects. The 
reasons for omissions are shown in TABLE 1:5:1.
Although patients were examined before information was 
extracted from their notes, for reasons of logical presentation, 
data subsumed under 'Recorded Information' will be presented first, 
followed by those from the examinations (Assessed Abnormalities).
The final part will concern correlations within and between these 
categories.
5. 2________ RECORDED INFORMATION
3:2:1 ITEMS ANALYSED
Certain items in the Schizophrenia Survey Form were not used 
in this analysis. These were :
i) Item on Febrile Illness : Very few patients were recorded as
having had no febrile illnesses. Either a long list of illnesses
was given, or the patient was said to have had "usual childhood 
illnesses", not further specified. It was felt that no meaningful 
comparisons could be made on the basis of such information.
ii) Item on Regularity of Employment : The sample was admitted to 
long-term care over half a century, during which time social 
circumstances and employment prospects had varied greatly. Such
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factors are difficult to evaluate at a distance and it was felt 
that patients' pre-admission work records might have reflected 
other than illness-related factors. Thus, comparisons made on the 
basis of premorbid employment appeared to be of dubious validity 
and were excluded.
iii) Items on Premorbid Personality and Alcohol Consumption :
Almost all index patients were said by their relatives to have had an 
'abnormal' personality before the admission illness was suspected, 
in that most were described as shy, withdrawn and with few interests. 
Likewise the vast majority of subjects were stated to have been 
total or relative abstainers from alcohol. It is likely that the 
predominance of such features in the histories to some extent 
reflects the fact that poor premorbid adjustment and absence of 
evidence of alcohol abuse are two of the features comprising the 
Feighner Criteria for Schizophrenia, so their inclusion in the 
Schizophrenia Survey Form probably represents a degree of 
duplication. For whatever reasons these statements were made, it 
was clear that the population could not be usefully sub-divided on 
the basis of these variables.
Other data which were collected but not used in the 
present analysis included treatment with barbiturates used as 
hypnotics, and paraldehyde, as there was no evidence that, in the 
way these drugs had been administered, they would be of relevance 
in promoting neurological or other deficits. Also excluded were 
treatments which at some time had enjoyed a brief vogue, such as 
T.A.B. vaccine, amphetamines and chemical convulsants.
The items of Recorded Information which were therefore 
considered, are shown in TABLE 1:3:2. With regard to those items
TABLE 1:3:2
ITEMS OF RECORDED INFORMATION ANALYSED
SEX
AGE
TIME AGE AT FIRST ADMISSION
FACTORS LENGTH OF TIME SINCE FIRST ADMISSION 
DURATION OF PRESENT ADMISSION
FAMILY HISTORY OF SCHIZOPHRENIA
HISTORICAL
FACTORS
HISTORY OF BIRTH TRAUMA/HEAD INJURY 
HISTORY OF FITS 
EDUCATIONAL ATTAINMENT 
P.S.E. SUBCLASS
PAST
PHYSICAL
TREATMENTS
LEUCOTOMY 
INSULIN COMA 
ECT
NEUROLEFT IC EXPOSURE
which reflect the passage of time, the use of the term ’length of 
time since first admission' requires some qualification. In the 
calculation of results this term is taken as equivalent to 
'length of illness'. While recognising that this is only an 
approximation, it has been used, (in common with other studies) as 
the firmest temporal landmark against which the duration of illness 
can be gauged. To have accepted hearsay statements from relatives 
as an alternative would have been to introduce considerable 
imprecision.
Past treatment items (except leucotomy) were sub-divided 
to provide more detailed information, and in particular, to attempt 
an evaluation of the effects of varying degrees of exposure. All 
subjects were assigned to categories of exposure designated 'none', 
'some' and 'much'. For insulin coma and electro-convulsive therapy 
the demarkation between 'some' and 'much' was taken as the mean 
number of treatments for the group who had received stated amounts 
of that therapy. For insulin coma, the mean was 61 treatments 
(range 1 - 206) and for ECT, the mean was 23 (range 1 - 234)* Only 
the precise number of treatments recorded in the notes was used.
If a patient was. recorded as having had " a course" of either, this 
was noted but the sample was large enough to allow for exclusion 
of these cases in analysing the results.
It was impossible to be precise about absolute amounts of 
neuroleptic exposure in extracting data from the drug cards. In 
recognition of this problem no attempt has been made to quantify total 
neuroleptic administration in terms such as chlorpromazine equivalents, 
which have recently been advocated ( Wyatt & Torgow 1976;Davis 1976).
To have done so would have implied undue confidence in the accuracy
TABLE 1:3:3
CONVENTIONS FOR RATING NEUROLEPTIC EXPOSURE
NONE NEVER GIVEN
CHLORPROMAZINE 100 rags TID
THIORIDAZINE 100 mgs TID
SOME ‘ FOR
1 YEAR
TRIFLUOPERAZINE 5 mgs TID
PERPHENAZINE k mgs BD
OR LESS
DEPOT FLUPHENAZINE 25 mgs 2 WKLY
DEPOT FLUPHENTHIXOL kO mgs 2 WKLY
MUCH MORE THAN THE ABOVE
of information on this very important variable. Thus arbitrary 
criteria were adopted for ’some* and ’much' neuroleptic exposure 
which reflected the trends in treatment in a relative fashion.
These criteria are shown in TABLE 1:3:3.
The basic descriptive de/fca on Recorded Information 
variables (excluding P.S.E. categories)are shown in TABLE 1:3:4*
3.2.2 BASIC HISTORICAL AMD PAST TREATMENT DATA
The sample consisted of 270 males and 240 females. The 
age distribution of the group is illustrated in Pig 1:3:1. As 
TABLE 1:3:4 shows the women were older than the men. While the 
length of time since their first admission was likewise greater, 
as was the duration of their current admission the major difference 
lay in the fact that the females were older when they first required 
hospitalisation. For 40.7 % of the males, and for 4 6 .3 % of 
females, the current admission was their first and only one. The 
distribution of the durations of current hospitalisation for the 
sample as a whole is shown in Fig 1:3:2. Although the majority of 
this elderly population was admitted to long-term care many years 
ago, 29 % were admitted after i9 6 0.
Fewer females than males fell into the category of 'higher* 
past academic attainment ( 3 % 8 .5 % respectively). Such sex
differences as did emerge on past physical treatment items 
(TABLE 1:3:4) most probably reflect the treatment biases of 
different consultants. This was certainly the case for past neuroleptic 
exposure, as those consultantswho advocated a dynamic treatment 
approach, had mainly commitments to male patients. Hence these
TABLE 1:3:4
RECORDED INFORMATION* (EXCLUDING P.S.E. SUBCLASSES)
HISTORICAL DATA
AGE AGE AT LENGTH OF TIME DURATION OF FAMILY HISTORY OF SCHIZOPHRENIA
(YRS) 1st ADMISSION SINCE 1st PRESENT
(YRS) ADMISSION (YRS) ADMISSION
(YRS) NEGATIVE POSSIBLE POSITIVE
TOTAL 59-2 28.2 31 26.5 217 67 65
SAMPLE ± SD + SD ± SD ± SD
(510) 13-9 8.9 11.1 13-1
MALES 56 26.5 29-6 25-2 116 • 31 34
(270) ± SD ± SD ± SD ± SD
13-4 7.85 10.7 12.4
FEMALES 62.8 30.1 32.7 27.8 101 36 31
(240) ± SD ± SD ± SD ± SD
13*6 9-7 11.3 13-7
BIRTH TRAUMA/ 
HEAD INJURY 
NO YES
FITS 
NO YES
PAST ACADEMIC ATTAINMENT 
HIGHER AVERAGE POOR
COURSE OF ILLNESS 
BETTER . SAME WORSE FLUCTUATINC
TOTAL
SAMPLE
(510)
MALES
(270)
FEMALES
(240)
232 69 323 56 31 314 46 76 298 43 81
117 45 169 33 23 164 28 31 159 32 41
115 24 154 23 8 150 18 45 139 11 40
PAST PHYSICAL TREATMENT DATA
LEUCOTOMY 
NO YES
INSULIN COMA 
NONE SOME MUCH
ELECTROCONVULSIVE THERAPY 
NONE SOME MUCH
NEUROLEPTIC MEDICATIO] 
NONE SOME MUC]
TOTAL
SAMPLE
(510)
MALES
(270)
FEMALES
(240)
425 42 310 81 57 281 119 41 65 140 305
229 16 154 4o 46 150 69 14 49 67 155
196 26 156 41 11 131 50 27 16 73 150
* TOTALS VARIABLE BECAUSE OF SUBJECTS WITH MISSING DATA ON DIFFERENT ITEMS 
+ FITS: EXCLUSIVE OF 5 PATIENTS RECORDED AS TRANSIENTLY FITTING POST-LEUCOTOMY
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findings probably reflect administrative idiosyncrasies which 
cannot be generalised, and so were not formally analysed.
5.2.3 THE CATEGO SUBCLASSES
The Catego subclasses into which the patients fell, based 
on the P.S.E. Syndrome Check List data, are shown in Pig 1:3:3*
The vast majority of subjects (83*5 %) fell into one of the four 
main subclasses : NS + (nuclear syndrome), LS + (schizophrenia
without first rank features), DP + (delusional (paranoid) psychosis), 
and CS + (catatonic syndrome). In this sample, 'NS' and 'DS' 
cannot really be separated, as the fact that nuclear features 
vere not recorded in the case notes does not mean that they were 
not present. With two-thirds of the sample being admitted prior to 
Schneider's classification in 1959 (Schneider 1959)> it is likely 
that in many instances they were not particularly sought.
Those cases illustrated in Fig 1:3-3 as 'possible' include 
ones with residual psychoses and combination psychoses as well as 
those with suggestive, but not categorical, schizophrenic ratings 
on the Syndrome Check List. The 'miscellaneous' group of 12 
patients, in fact all fell into affective classes, though in only 5 
of these was the classification definite. Thus in less than 1 % 
of cases only was there a definite disagreement between Feighner and 
P.S.E. criteria.
5.5._______ ASSESSED ABNORMALITIES
3.3.I MENTAL STATE
In considering the mental state data, results were calculated 
for the'positive', and 'negative' and 'non-specific' schizophrenic
FIG 1:3:3
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subtotals separately.
The distributions of Krawiecka 'positive’ and 'negative' 
subtotals in the sample are shown in Fig 1:3:4 and 1:3:5 
respectively. The maximal total obtainable for 'positive' features 
is 15 (as clearly a rating of 4 on incoherence precludes the 
coherent expression of delusions) and for 'negative' features is 
8 . In this sample the mean 'positive' score was 3.6 ( - S.D. 3*45) 
and the mean 'negative' score 2.4 ( - S.D. 2.27).
Using total or subtotal scores from multi-item rating 
scales where one of the categories of severity allows for 
noteworthy but normal features to be recorded i.e. item rating of 
1 , presents major problems regarding the cut-offs for normality 
adopted. This problem will be discussed in detail in the following 
section (Part II - Movement Disorders). However, with regard to 
'positive' features of the mental state, only one patient obtained 
a total of 2 that comprised two single scores of 1. Thus a 
total score of zero or 1 on the 'positive' schizophrenic items 
was taken as indicative of no abnormality. Adopting this criterion 
only 31*5 % of patients exhibited no 'positive* mental state 
phenomena.
For the 'negative* features, eight patients obtained a 
subtotal score of 2 comprising two single ratings of 1. However,
78 patients obtained this total on one single 'negative' item rated 
mildly, but nonetheless unequivocally, abnormal. It was thus 
deemed justifiable to adopt the same criteria of zero and 1 for 
normality, as the degree of contamination would be comparatively 
slight. By this standard, 39 % had no 'negative' features.
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Using an overall normality criterion of zero and 1 for 
loth 'positive* and 'negative' subscore totals, only 37 subjects 
(l8 males and 19 females) or 8.1 % of the sample demonstrated no 
abnormality in these areas of the mental state.
Applying the same criterion for normality to the non­
specific items, 112 (24*5 %) received positive ratings. This 
figure compirisedl6 % scoring 2 or more on depression and 15*1 % 
scoring 2 or more on anxiety. Of these patients, 30 were rated 
on both depression and anxiety. Thus for the 'non-specific' items 
on the Krawiecka Scale 9*4 % of subjects scored on depression 
alone, 8 .5 % on anxiety alone, with 6.6. % scoring for both.
Although retardation was recorded in 128 patients 
(27.9 % ), it never occured as the only abnormality. Only one 
patient was rated for psychomotor retardation in the presence of 
neurotic - type symptoms alone (i.e. anxiety and depression). 
Overwhelmingly this rating was confined to subjects who also 
demonstrated abnormality on items considered, for the purposes of 
the present study, to be indicative of a 'negative' schizophrenic 
state. Thus, of the 128 patients rating on retardation 117 
(or 9 1 *4 %) also obtained a score of 2 or more on affective 
flattening and/or poverty of speech/muteness. The associations of 
abnormal retardation scores and other mental state phenomena are 
shown in TABLE 1:3:.5*
The prevalence of 'non-specific' abnormality is of interest 
but, as the present work is concerned with the more specific 
features of schizophrenia, they will not be considered further.
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3-3.2 COGNITIVE PEEPOEMAECE
The total score obtainable on the Withers and Hinton test 
battery is 140. However the results to be presented here are 
based on a possible maximum of 131, as the Babcock Sentence was 
excluded. This was because a large number of these patients found 
the test difficult even after several attempts. To proceed further 
(to a maximum of 9 attempts as recommended) often produced 
frustration and irritability and hence in some cases the sentence 
was abandoned prematurely in order to maintain co-operation for the 
rest of the battery.
The range of performance on the Withers and Hinton battery 
was wide, the distribution of total scores being shown in 
Pig 1:3:6. The mean value and standard deviation illustrated on 
the figure refer to the mean scores obtained by two groups of 
patients used as controls when the test battery was applied in a 
previous study at Northwick Park Hospital (Johnstone et al 1976: 
Johnstone et al 1978b). One control group comprised volunteers 
from the normal male ancillary staff of the hospital ( mean age 
56 years) while the other was a sample of patients hospitalised for 
many years in the Royal Home and Hospital for Incurables, Putney, 
because of chronic physical disease (mean age 6 3.1 years). The 
mean score obtained by both these groups, with the Babcock Sentence 
score excluded, was 81 - S.D. 14•
As Pig 1 :3 :6 shows, the majority of the present sample did 
very badly on this test, the mean for the study group being 4 4 -6 - 
S.D. 2 5.3. Indeed 6 2 .5 % o f the patients scored less than 2 
standard deviations below the mean for the control group (i.e.53)>
FIG 1:3:6
Distribution of W ithers  and Hinton scores
70 n  
60
50 ■ 
40 - j
30
20 H  
10 
0 - 1
Mean and s.d. of normal 
control population
-O-
0+ 10+ 20+ 30+ 40+ 50+60+ 70+ 80+90+100+
and none obtained more than 2 standard deviations above the mean 
control groups’score (i.e. 109). Thus, for whatever reason, the 
ability of most of the patients to perform tests of this type was 
substantially impaired.
5.5 .3 NEUROLOGICAL STATUS
The initial breakdown of findings from the neurological 
examinations is shown in Fig 1: 3s 7- One hundred and one subjects 
demonstrated no motor abnormality whatsoever. Thus in 77*9 % 
of the population, at least one neurological sign could be 
demonstrated. These signs can be roughly divided into two main 
groups :
i) Those of a type conventionally referred to as
extrapyramidal. The major qualifying criteria for 
this classification were the presence of rigidity 
in agonist/antagonist limb musculature and/or the 
presence of a spontaneous involuntary disorder of 
movement, other than simple, fine tremor, in any 
body part. Both these signs are generally held to 
reflect disruption of activity in so-called 
extrapyramidal brain systems.
ii) Those not conventionally designated as extrapyramidal.
This group presented mainly abnormalities of pyramidal 
tract and lower motor neurone function (i.e. those 
usually called gross or localising neurological signs), 
but included a number of patients with miscellaneous 
disorders of motor activity. For this reason these 
patients will be referred to as the ’other' neurology 
group (i.e. ’other' = non-extrapyramidal). The 
presence of ’other’ neurological features would 
preferentially allocate a subject to this group, but 
would not of course exclude the possibility of that 
patient at the same time having extrapyramidal signs.
A total of 263 patients demonstrated clinically an increase 
in muscle tone. Four of these, however, had additional clear signs 
that this abnormality was due to pyramidal dysfunction, and are
included in the ’other’ neurology group. Thus 259 patients showed
FIG 1:3:7 NEUROLOGICAL ASSESSMENT
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MOVEMENT DISORDER IN IEUROLEPTIC-FREE PATIENTS
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rigidity believed to represent extrapyramidal abnormality. Of these 
103 (2 2 .6 %) had rigidity without coincident involuntary movements, 
while in 156 (34*2 %) both rigidity and movement disorder were 
found. Spontaneous involuntary movements in the absence of rigidity 
were present in 68 patients (14 *9 %) •
Spontaneous involuntary movements in at least one body part 
were noted in 229 subjects (49*8 %)• Of the 65 subjects whose case 
notes revealed no evidence of past neuroleptic treatment, 52 were 
available for examination. Twenty seven of these (51*9 % of 
neuroleptic-free patients) had involuntary movements. (TABLE 1:3:6). 
Thus the prevalence of abnormality, in terms of only the presence/ 
absence of involuntary movements, was comparable in those with no 
history of neuroleptic treatment to that in the sample as a whole.
'Other* neurology is shown in TABLE 1:3:7* For the most 
part of"” these abnormalities were not striking. In particular, 
features indicative of serious CNS disorder were uncommon.
Therefore, most patients had some neurological abnormality 
and in the majority this was a disorder of movement and/or tone.
3 .3 .4 BEHAVIOURAL PERFORMANCE
While the Current Behavioural Schedule considered behaviour 
under different headings (Appendix IV ), only total scores will be 
considered here.
It must be emphasised that this schedule was designed to 
record in standardised form only the rudiments of behavioural 
competence. Thus, obtaining a maximum score of 50 'means no more than 
that the patient could converse at an elementary and general level,both
FIG 1:3:8
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spontaneously and if approached, that they could occupy themselves 
in a routine and have some limited leisure pursuit, that the more 
bizarre outward manifestations of their illness were controlled, and 
that they were not incontinent. Maximal attainment therefore 
implies a far from sophisticated level of behavioural performance.
The distribution of total scores on the Current Behavioural
Schedule is shown in Pig 1:3:8* The mean score for the group was 
r|.
34.7 - S.D. 8 .2 6. These findings demonstrate a striking degree of 
behavioural abnormality in this population. Of note is the fact 
that 97 patients were reported by the nursing staff as being 
incontinent.
3.4 RELATIONSHIPS WITHIN AMD BETWEEN CATEGORIES
3.4 .I RELATIONSHIPS BETWEEN DIFFERENT ITEMS OP RECORDED INFORMATION
The correlations between different items of Recorded 
Information that attained statistical significance all related to 
the age of onset of the illness (as assessed from the time of 
first admission to hospital).
Firstly, age of onset was significantly related to PSE 
subclasses. The comparisons are shown in TABLE 1:3:8. No distinctions 
emerged between the ’NS’ and ‘DS1 subclasses with regard to age of 
onset, but both these groups had a significantly earlier age of onset 
than the *DP’ group. Each of these in their turn had later onsets 
than those classified as ’ CS*. PSE subclasses were not related to any 
other Recorded Information items., including other variables concerning 
the passage of time (TABLE 1:3:8).
TABLE 1:3:8
RELATIONSHIPS BETWEEN THE PASSAGE OF TIME AND PSE SUBCLASSES
. NS DS DP CS COMPARISONS PROBABILIT'
NUMBER 203 178 17 29
AGE OF ONSET (YEARS) 29.3 27.8 3 4.8 22.8
NS < DP 
NS > CS 
DS < DP 
DS > CS 
DP > CS
p < 0.05
p < 0.001 
p < 0.01
p < 0.02  
p < 0.001
CURRENT HOSPITAL (YEARS) 25 26.8 23.6 30
DURATION OF TOTAL ILLNESS 29-5 31.3 30 33.1
ALL OTHER COMPARISONS NON-SIGNIFICANT
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Secondly, age of onset was significantly correlated with 
family history, in that those with a definite family history of 
schizophrenia had a significantly earlier age of onset than those 
with no such history (TABLE 1:3:9).
Thirdly, there was a significant association between age 
of onset and the subject's academic attainment. Those of 'poor* 
past academic record (as defined previously - p 63 ) had an earlier 
onset than both those with a history of ’higher’ ability and those 
of ’average’ ability (TABLE 1:3:9).
There were no other significant relationships between items 
of Recorded Information.
3.4.2 RELATIONSHIPS BETWEEN DIFFERENT ITEMS OF ASSESSED
ABNORMALITY_____________________________________
There were no significant relationships between the 
presence of ’positive’ mental state features or those neurological 
features classified as ’other’ neurology, and the remaining items 
of Assessed Abnormality. There were, however, striking correlations 
between the presence of ’negative’ mental state features, cognitive 
impairment, neurological signs of extrapyramidal type and behavioural 
deterioration. These relationships are shown in Fig 1:3:9-
3.4 .3  RELATIONSHIPS BETWEEN ASSESSED ABNORMALITIES AND
ITEMS OF RECORDED INFORMATION__________________
a) Mental state
The relationships between the ’positive’ and ’negative’ 
features of the mental state and Recorded Information variables 
reflecting the effects of the passage of time are shown in TABLE 1:3:10.
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’Positive* features are not related to any time variables, while 
the presence of ’negative’ features is associated with an earlier 
age of onset, a longer length of illness and longer duration of 
current hospitalisation, but not with present age.
The only other correlations between mental state features 
and Recorded Information variables to attain significance concern 
the PSE subclasses reflecting the features of the illness at its 
worst. These are shown in TABLE 1:3:11* Thus 'positive' 
phenomena in the current mental state are more associated with past 
events giving rise to 'NS' and 'DS' Catego subclasses than with a 
past history compatible with a ’CS’ grouping, while the 'NS' 
subclass was also more associated with present 'positive' features 
than those defined as 'DP'. The presence of current 'negative' 
features was more associated with 'CS' types than any of the other 
main subclasses ('NS', 'DS', 'DP'), though 'negative' features 
were found more with 'DS' than 'NS' , and with 'DS' than 'DP' 
classifications.
The present mental state deficits therefore were determined 
only by the form the illness took at its worst and by events 
reflecting the passage of time since its onset. In particular, no 
past treatment variables were of significance in determining the 
present abnormalities in terms of 'positive' and 'negative' mental 
state phenomena.
b) Cognitive Performance
Relationships between the passage of time and cognitive 
performance are shown in TABLE 1:3:10. Present age, the length of
TABLE 1:3:11
RELATIONSHIPS BETWEEN MENTAL STATE, COGNITIVE AND BEHAVIOURAL PERFORMANCE AND FEATURES OF THE ILLNESS AT ITS 
WORST (PSE SUBCLASSES)
POSITIVE FEATURES 
(KRAWIECKA)
NS > CS
p < 0.01
DS > CS
p < 0.05
NS > DP 
p < 0.05
NEGATIVE FEATURES 
(KRAWIECKA)
NS < CS
p < 0.01
DS < CS
p < 0.001
NS < DS
p < 0.01
DP < CS
p < 0.001
DS > DP 
p < 0.05
WITHERS AND 
HINTON
NS > CS 
p < 0.01
DS > CS
p < 0.01
DP > CS
p < 0.05
BEHAVIOURAL
PERFORMANCE
NS > CS
p < 0.001
DS > CS
p < 0.01
DP > CS 
p < 0.01
the illness and the duration of the present admission were all 
associated with adverse effects on cognitive performance. Similarly, 
intellectual impairment was more associated with a 'CS' grouping 
than any other subclass (TABLE 1:3:11).
Past academic attainment had a significant and predictable 
bearing on Withers and Hinton test scores. Those of ’higher* past 
attainment did better than those of 'average' (P < O.OOl) and those 
of 'poor' ability (P <T O.OOl), while those with an 'average' 
history in this regard also performed better than those in the 'poor' 
academic group (P < O.Ol).
Only one past treatment variable significantly correlated 
with present cognitive functioning. Those in the category of 'much' 
treatment with past insulin coma (i.e. more treatments than the 
mean for the treated group) performed significantly better on the 
Withers and Hinton test when compared to those with no history of 
insulin treatment (P <  0.05).
Thus cognitive impairment was associated to some extent 
with the type of the basic illness, to certain factors reflecting 
its duration and to an early history of intellectual disadvantage. 
Insulin therapy was the only past treatment variable associated with 
present cognition, and this association was opposite to what might 
have been predicted. In particular, the gross destructive procedure 
of leucotomy, and ECT, reputedly a cause of intellectual impairment, 
were not associated with cognitive deficit in this sample.
c) Neurological Status
No significant relationships emerged between the presence
of ’other’ neurology and items of Recorded Information. This applied 
to past leucotomy also.
In analysing the extrapyramidal abnormalities the 
population was divided into those receiving neuroleptics (’ON* group) 
and those not receiving them ('OFF’ group) when examined. The 
significant relationships that emerged between extrapyramidal 
abnormality and Recorded Information variables concerned only age 
and length of illness as shown in TABLE 1:3:12. It is noteworthy 
that none of the past treatment variables, including exposure to 
neuroleptic drugs, correlated with present extrapyramidal signs 
as assessed here.
The regional percentage prevalences of involuntary 
movement and postural abnormality (face, limbs and also gait) by 
history of past neuroleptic exposure are shown in TABLE 1:3:13> 
where the currently ’ON' and currently 'OFF' distinctions have been 
maintained. In only one comparison did a past history of heavy 
neuroleptic treatment increase the prevalence of abnormality - 
namely those 'OFF' neuroleptics when seen, but with a history of 
'much' past treatment, had a significantly higher prevalence of gait 
abnormality (7 3 %) as opposed to those in the 'some' (3 3 %) and 
'none' (20 %) categories ( x  ^= 1 3 .8 4d£= 2j,P = < 0 .00l).
d) Behavioural performance
Current Behavioural Schedule total scores were inversely 
correlated with the duration of hospitalisation (TABLE 1:3:10), 
but there were no other relationships with time factors.
The only other significant relationships between behavioural
TABLE 1:3:12
SIGNIFICANT RELATIONSHIPS BETWEEN NEUROLOGICAL VARIABLES AND ITEMS OF RECORDED INFORMATION
AGE TIME SINCE FIRST ADMISSION
CURRENT NEUROLEPTIC 
STATUS
ON OFF ON OFF
MOVEMENT DISORDERS P < 0.001 N/S p < 0.001 N/S
INCREASED TONE P < 0.01 N/S p < 0.05 p < 0.05
TABLE 1:3:13
PREVALENCE OF INVOLUNTARY MOVEMENTS AND POSTURAL ABNORMALITY IN RELATION TO NEUROLEPTIC EXPOSURE
CURRENT NEUROLEPTIC 
STATUS OFFONPAST
NEUROLEPTIC STATUS"
TRUNK AND 
LIMBS
TRUNK AND 
LIMBS
GAIT FACEFACE
20■ 30
■SOME’
'MUCH'
performance and items of Recorded Information concerned the 
PSE subclasses (TABLE l:3sll)« Those in the ’CS1 subclass were 
more associated with behavioural disability than those in any of 
the other major groupings.
Chapter 4 - 'The Defect State*
4.1 INTRODUCTION
As has previously been discussed (p 40 ), English - 
language psychiatry appears to consider the sequelae of an acute 
schizophrenic illness in terms of attributes of normal mental 
activity that are lost or deficient, and tends to use the term 
’defect state' in a restricted sense. This study has confirmed 
that such patterns of deficit are not the only ones that can be 
demonstrated, in that many subjects exhibited clinical features 
of a florid, productive type. The results have also indicated 
however that patients whose mental state is characterised by 
’negative’ features are more likely to experience deficits-in 
other areas. The usage of English - language practice does 
appear to have merit in the sense of inferring a particular set 
of sequelae to an acute schizophrenic illness. In view of this 
finding, an attempt was made to identify the historical correlates 
of the 'defect state’ clearly and specifically defined.
4.2 DEFINITION - GENERAL PROBLEMS
Two of the major constituents of ’defect state’ as applied 
in English-language psychiatry (Jilek 1 9 6 8) have been utilised 
in the present work - namely affective flattening and poverty of 
speech/muteness. It must be acknowledged that these features are 
difficult to assess reliably, especially when rating severity as 
demanded by ordinal scales.
The problem however is more fundamental than one of grading 
severity, having adjudged definite abnormality to be present.
The difficulty centres on the subjective, and hence 
unquantifiable, judgements used by clinicians to determine what 
is normal in a given personality, of a given age, in a given set 
of environmental circumstances. For example, a certain taciturn 
reserve may be deemed acceptable and normal in an 80 year old, but 
considered to reflect mild ’negative' deficit in a younger subject. 
Related to this is the assumption implicit in rating ’negative’ 
features, that the signs being noted do indeed primarily reflect 
mental state phenomena and not neurological abnormality, in 
particular parkinsonism.
In the present state of knowledge it is unavoidable that 
judgements regarding the presence of ’negative' features are largely 
impressionistic (especially since such decisions are usually made 
in full knowledge of the basic diagnosis). However, in view of 
the interest of the ’defect state’ concept in the light of findings 
presented here, it was felt important to apply more strict criteria 
for defining the term before seeking historical correlates.
4.5_______ DEFINITION - PROPOSED CRITERIA
Two different but complimentary approaches were adopted in 
an attempt to define the 'defect state' more tightly.
The first was to increase the severity criterion on ’negative' 
features scores for inclusion of subjects in the 'defect state' 
category. This is the obvious choice, as clearly contamination of 
the ’negative' scores by factors such as age - related appearance, 
awkwardness in an interview situation, mild parkinsonism etc. is more 
likely when 'negative' scores are low and reflect only mild putative
abnormality. Higher ’negative' scores are likely to reflect an 
increased confidence that abnormality is present and is essentially 
one of mental state.
The second approach involved the introduction of another 
mental state criterion whose assessment was separate from that of 
’negative’ features. The addition of a second assessment criterion 
would increase the homogeneity of the group thus defined. As 
reviewed earlier (p 43 ) other workers have indicated that long­
standing schizophrenic patients may operate at an impaired level 
of cognitive performance - findings confirmed here. The present 
study allowed for evaluation of cognitive ability by means of a 
numerical score obtained on formal testing. It thus seemed 
appropriate to incorporate the principle of cognitive impairment 
into the criteria for ’defect state’.
The cut - offs adopted for ’negative’ features and cognitive 
impairment are arbitrary, and were chosen to reflect a balance 
between confidence in the presence of mental state abnormality and 
adequate numbers. TABLE 1:4:1 shows the distribution of patients 
with increasing Withers and Hinton total scores and increasing 
totals for Krawiecka ’negative’ features, from a minimum of 4 > 
to a maximum of 7 * Pour was taken as the minimum score acceptable 
for reflecting essentially mental state abnormality with reasonable 
confidence. Clearly with marked poverty of speech, inferences 
regarding cognitive ability become less valid, and no confident 
conclusions can be drawn in someone who is mute. In this type of 
patient profound intellectual impairment is a reasonable assumption 
from the general statistical association between 'negative' features
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and cognitive scores reported earlier. The distributions in 
TABLE 1:4:1 are however restricted to those who retain some verbal 
ability. A Withers and Hinton cut - off of less than the mean for 
the total sample was chosen as indicating evidence of cognitive 
impairment.
A Withers and Hinton total of 40 or less, and a Krawiecka
'negative* total of 7 or more and 6 or more yielded too few subjects
for reliable analysis, especially in view of the higher proportion 
of these groupings made up of mute patients. With 'negative' totals 
of 4 or more and 5 or more, application of the proposed Withers and 
Hinton criterion excluded approximately the same proportion of 
subjects ( 18.2 % and 1 5 *2 % respectively), while in both these 
groups, 20 % of patients were mute. Clearly the first Krawiecka 
grouping ( 4 or more ) secured the largest number of subjects.
Thus, in this study, patients having a schizophrenic 'defect 
state' were defined as those obtaining a total score of 4 or more 
from the two 'negative' mental state items of the Krawiecka scale 
and a score of 40 or less on the Withers and Hinton tests of 
cognitive ability.
4.4 HISTORICAL CORRELATIONS
Analyses were performed to elicit relationships between the
'defect state' as defined and items of Recorded Information. TABLE 
1 :3:10 shows that both 'negative' mental state features and cognition 
are correlated with time factors, which have thus to be accounted 
for. Also however, those time factors to which each relates are 
slightly different. To rationalise analysis, one time factor relating
to the patient per se and one relating to the illness were selected. 
Age was chosen as the obvious patient variable. With length of 
illness and duration of current hospitalisation being the same in 
almost half the sample, these two variables are clearly highly 
correlated. Other parts of this work utilised the length of illness 
variable and, for consistency, this was chosen in the present 
context.
The technique of maximum likelihood analysis was used to
assess whether the likelihood of having a 'defect state' as defined
was determined by age or length of illness, or by any of the other
Recorded Information variables analysed in this section (TABLE 1:3:2).
This analysis (Plackett 1974) is based on a log - linear model which
2
gives a maximum likelihood X analysis for each of the effects of 
interest. It provides a test of the partial association of the 
factors - for example, the association between 'defect state' and 
length of illness, with the effect of age removed. The results of 
this analysis are shown in TABLE 1:4:2.
The likelihood of having a 'defect state' is determined by 
the length of illness and not by age. The only other Recorded 
Information item of definite significance was past academic 
attainment, those in the 'poor' group having a highly significantly 
increased likelihood of showing a 'defect state'. Of the four items 
demonstrating a non - significant trend ( P < 0 .1 ), birth trauma/ 
head injury/fits combined, and PSE subclass had P - values that just 
missed the 5 % level of significance. The former item, being a 
combined one, should not be over-emphasised. However, it is of 
interest that being placed in the PSE subclass for catatonic syndrome
TA
BL
E 
1:
*t
:2
MA
XI
MU
M 
LI
KE
LI
HO
OD
 
AN
AL
YS
ES
: 
VA
RI
AB
LE
S 
IN
FL
UE
NC
IN
G 
TH
E 
PR
ES
EN
CE
 
.OF
 
TH
E 
'D
EF
EC
T 
ST
AT
E'
• • C/2O O \ 
V  V  s
oo <- • * wO O \  
V  V  s
VO OO LTV 
O J- v-
EH X 
p  w  
W CO
-=f
r~
cA
* 
TH
OS
E 
WI
TH
 
A 
HI
ST
OR
Y 
OF 
BI
RT
H 
TR
AU
MA
/H
EA
D 
IN
JU
RY
 
OR 
A 
HI
ST
OR
Y 
OF 
FI
TS
 
TA
KE
N 
TO
GE
TH
ER
(*
) 
MA
JO
R 
SU
BC
LA
SS
ES
 
ON
LY
 
- 
'N
S'
, 
'D
S'
, 
'D
P'
, 
'C
S'
 
o 
'N
ON
E'
, 
'S
OM
E'
, 
'M
UC
H'
( 'CS' ) increased the likelihood of developing a ’defect state' 
over those in the three other major subclasses.
Thus those historical factors which significantly determine 
the likelihood of developing a 'defect state' as defined in this 
study are a long duration of illness, a history of academic 
difficulty and possibly a catatonic diagnosis. A history of brain 
damage based on evidence of birth trauma, head injury or fits may 
also be relevant. Past physical treatments are not relevant.
Chapter 5 - Discussion
■3.1_______ GENERAL COMMENTS
This section was based on the standardised recording of 
historical and examination data. The validity of the findings 
however rests heavily on firstly, accounts provided by relatives 
and secondly, the accuracy and comprehensiveness of case note 
records.
Relatives’ accounts were given in close temporal proximity 
to the admission of the patient, when certain factual errors are 
less probable. This was however also likely to be a period of 
great stress for relatives, many of whom may have been, participating 
in the patient’s commital. This in its turn could influence the 
recall of emotionally laden information. The amount of historical 
data available regarding the patients’ mental states and progress, 
was greatly facilitated by statutory requirements under the mental 
health legislation that pertained prior to 1 9 5 9* At that time, the 
physician in charge of the case was required to provide a written 
statement of the patient's condition at regular intervals. As a 
result, older case notes were usually a bountiful source of 
information.
In addition to general caveats to the interpretation of 
results in all studies involving the retrospective collection of data, 
some comments specific to this study require emphasis.
The prevalence of a family history of definite schizophrenia 
is certainly an underestimate, which has bearing on the correlations 
reported. There are three reasons for this.
a) This item on the Schizophrenia Survey Form was rated 
conservatively. If any vagueness entered the relatives’ answer to 
this question on the Enquiry Form, the item was rated ’possible'.
b) The information was obtained by the case - note method, 
which has been shown to produce lower prevalences for family history 
than direct questioning of the relatives themselves (Thompson et al 
1982).
c) Enquiry Forms were completed, in general, when the 
patients were young and hence at a time when the lifetime 
expectancy of illness in other family members, especially siblings, 
remained high.
For these reasons, the real frequency of schizophrenia in the families 
of the index patients is now likely to be considerably higher.
The data on birth trauma which are not based on obstetric 
records, and head injury, must be considered 'soft'. Essentially 
they depend on what the relatives could, or chose to, remember.
Likewise qualification must be exercised in interpreting correlations 
with a history of fits. This is, in effect, a compound item.
Although all patients in this category were described as having had 
a seizure or seizures of grand mal (major convulsive) type, this may 
have represented anything from a febrile convulsion of childhood 
to idiopathic epilepsy or a reduction in seizure threshold by 
medication, particularly neuroleptics. In a handful of cases, the 
seizures followed leucotomy.
The credibility of a history of no exposure to neuroleptic 
drugs, and the reasons for accepting this, are discussed at length 
in Part II. It must be emphasised at this stage, however, that whether
or not a patient was managed along psychotherapeutic lines depended 
essentially on where he/she lived. With few exceptions, it is 
unlikely that factors of social class bias were operating here as 
what is now the London Borough of Brent was divided for the purpose 
of consultant responsibility, along geographical, not primarily 
class, lines. As Shenley was the only institution providing 
psychiatric care to this population, selective referral elsewhere 
was unlikely to have occurred often and would not be an issue with 
long - stay patients. Although a small number of patients remain 
who were admitted from the rest of Britain or abroad because of the 
hospital’s erstwhile reputation in the psychotherapy of schizophrenia, 
these are now few and all have received neuroleptics.
The only identifiable bias to operate in determining 
treatment was sex. By chance most of those interested in 
psychotherapeutic approaches had responsibility for male wards.
This was of course at a time when the accepted practice was to 
maintain sexual segregation. Hence most of those who now remain free 
from exposure to neuroleptic drugs are males.
Whether or not a patient received neuroleptics was largely - 
with the exception of sex - a matter of chance and those who remained 
neuroleptic - free are not considered to be otherwise different from 
the rest of the sample. There is no reason to believe that this 
sample as a whole differs from the generality of long - stay 
schizophrenic patients in the United Kingdom.
One year of continuous hospitalisation was one of the two 
initial inclusion criteria for the present work. Criteria based on 
time - be it duration of illness or of hospitalisation - are to some
extent arbitrary, .and little agreement exists in the literature on 
which is the more appropriate (Strauss 1973; Serban & Gidynski 
1975)* Evidence exists that with modern adminstrative and treatment 
policies the likelihood of discharge decreases substantially after 
6 - 1 2  months continuous in-patient stay (Gorwitz et al 1966;
Yolles & Kramer 1 969). Hence, in an attempt to increase the 
homogeneity of the hospital based population studied here, one year 
of continuous hospitalisation was adopted as the cut-off for 
inclusion.
5.2 THE FINDINGS
5.2.1 THE DEFICITS
The findings presented here show these patients to be an 
extremely impaired group. Their disabilities extend through many 
activities affecting mental state, cognitive performance, motor 
functioning and the subjects’ overall ability to behave in a manner 
adequate to satisfy basic personal and social needs.
The mental state abnormalities did not merely consist of 
the characteristic features of schizophrenia. Affective symptomatology 
was found in a substantial minority of patients. This is in 
agreement with Huber’s view that this,type of abnormality can be a 
part of the long - standing schizophrenic picture (Huber 1 9 6 6), 
but as no formal analysis of ’non-specific’ features was conducted 
here, the relationship of these to any particular pattern of long - 
term deficit cannot be evaluated. However, in the present sample 
affective symptoms (anxiety and/or depression) were the sole 
abnormality in only 9 patients (2 % of those examined). Cheadle et al
found a much higher prevalence of "neurotic" symptoms in their 
large schizophrenic out-patient group (Cheadle et al 1978)* They 
reported this to he the only type of abnormality in JO % of the 
sample. This study however used the PSE, which lists a very 
extensive range of ’neurotic’ symptoms as opposed to the two 
features rated on the Krawiecka scale, and had looser diagnostic 
criteria ( "current British criteria" ) than those employed here.
' Other ' (i.e. gross localising) neurological signs were 
uncommon and varied, and partly reflected an aging and 
behaviourally disturbed population. They formed no overall pattern. 
The prevalence of gross neurological abnormality was lower than 
that found in earlier work (Mettler & Crandall 1959)> which may 
reflect the strict diagnostic criteria applied to the present sample 
and also improved investigative techniques at the time of admission 
and since.
Pes cavus was found in 12 patients, 10 of whom were female. 
This sign was present bilaterally in 10 and unilaterally in 2 
cases. Pes cavus is uncommon, but has been described as a marker 
for neurological disorder in non - affected carriers of genetically 
transmitted conditions (Brain & Walton 1969; Harding 1981), and 
also as a permanent sequela to central nervous system disease 
(Brewerton et al 1962; Duthie & Bently 1983) • Its significance in 
this sample is uncertain, the numbers being too small for reliable 
statistical analysis.
5.2.2 PHYSICAL TREATMENTS
The current deficits exhibited by the patients in this study
bore no relationship to past physical treatments. Only one 
examination variable (cognitive performance) was related to one 
past physical treatment variable (insulin coma). The fact that 
patients who had received 'much* insulin coma performed significantly 
better cognitively probably reflects the operation of an incidental 
selection factor. The impression was gained that this approach 
was more enthusiastically adopted in those of higher educational 
attainment and/or social class. The relationship between past 
insulin and relative cognitive preservation may reflect the fact 
that present cognitive ability relates to past cognitive ability, 
as was shown.
The lack of a relationship between present deficits and 
past physical treatment is worthy of emphasis, as these treatments 
are all actually, or by repute, damaging.
The behavioural and intellectual deficits resulting from 
profound and prolonged hypoglycaemia are well known (Marks& Rose 
1965) and a syndrome referred to as insulin - induced hypoglycaemic 
encephalopathy was described in the older psychiatric literature 
(Spencer 1948; Halle & Ross 1951 )• Its features - paresis,confusion, 
EEG abnormalities especially the emergence of slow waves - may 
have been transitory but it appears that no long - term follow - up 
of such cases was performed. In the present sample it was not 
uncommon for hypoglycaemia to be of sufficient degree to cause major 
convulsions, and for some physicians at one point, this was the 
desired effect. Nonetheless, there is no evidence to suggest that 
controlled hypoglycaemia contributed to the deficits of those 
schizophrenics who received it.
When the leucotomies in the present sample were done, this 
was an unstandardised, essentially blind procedure which produced 
lesions of great variability, a point that will be illustrated in 
Part III. The sequelae of these ’free - hand’ leucotomies could be 
dramatic in terms of brain destruction, yet in the areas studied 
here, the sequelae in terms cf clinical deficits were striking 
by their absence.
Recently, Benson et al have studied a group of 16 
leucotomised schizophrenics up to 25 years after their operation 
with a view to establishing by clinical and special techniques, the 
long - standing neuropsychiatric sequelae of the procedure in the 
context of schizophrenia (Benson et al 198l). These authors were 
likewise struck by the lack of gross clinical abnormality in the 
presence of clear destructive frontal lesions on C.T. Indeed, they 
go so far as to state that any major neurological deficit following 
prefrontal leucotomy (the operation carried out in all but 1 of 
the present sample) represents ” a complication rather than a result 
of the procedure”. On neuropsychological testing, their 
leucotomised patients performed less well than normals but better 
than non - leucotomised schizophrenics. Without proper controlled 
studies, evaluation of such findings is extremely difficult. Benson 
et al interpreted this as reflecting illness or basic IQ, factors 
rather than factors associated with the operation itself. In the older 
literature leucotomy was reported to result in an increment in IQ 
after 12 months compared to pre-operation values (Struckett 1 9 5 3)* 
However, selection factors of the type mentioned earlier in relation 
to insulin coma are likely to operate with regard to leucotomy as well,
and any interpretation of the correlation, or lack of it, between 
leucotomy and cognition must be cautious.
The sample of Benson et al is not comparable with the 
present one, as it contained both out-patients and in-patients 
and used a different - and more complex - evaluation of cognitive 
ability, but in the much larger sample reported here no cognitive 
differentials could be established between leucotomised patients 
and the rest. However, both studies are in agreement in concluding 
that, when set against the deficits of the basic, long - standing 
schizophrenic illness, post - leucotomy residuae are difficult if 
not impossible to detect.
Electroconvulsive therapy continues to be a controversial 
form of management, with persistent assertions that its use results 
in brain damage, which is reflected especially in subtle impairments 
of memory (Priedberg 1977)* The investigation of this question is 
confounded by the fact that such impairment may emanate from 
residual features of the condition for which the treatment was given 
rather than from effects produced by the treatment itself. One 
recent study into the efficacy of EOT in the treatment of depressive 
illness (Johnstone et al 1980) compared aspects of memory in two 
groups of depressed patients, one of which received standard EOT, 
the other "simulated EOT" (anaesthetic without electrically 
induced convulsion). During a course of 8 treatments, definite 
but short - lived impairments were detected in those receiving 
the electrical shock, but no differences between the two groups 
could be found 6 months after the end of the course.
In the present sample, 8 ECT’s would represent minimal
exposure to this modality (one patient received 234 treatments in 
a single, uninterrupted course), and the effects on the brain - 
if any - of extensive or repeated courses are as yet unknown.
In the present sample however, past EOT did not relate to any of 
the present deficits, including cognitive performance.
One of the most interesting findings was the lack of a 
relationship between past neuroleptic exposure and neurological 
abnormality of extrapyramidal type. The only factors that did 
relate to these neurological features were those which are to do 
with the passage of time - i.e. age and length of illness. The 
fact that these associations are, with one exception, found only 
in those actually receiving neuroleptics when examined may reflect 
an equalising process of age on drug - effects, with neuroleptics 
being stopped because of the effects of increasing age/disability.
The precise relationship between involuntary movements 
and past neuroleptic administration - both in terms of cumulative 
exposure and duration of exposure - remains unclear. The literature 
relevant to this question will be reviewed in detail in Part II.
Many reasons undoubtedly contribute to the lack of clarity on this 
fundamental point - such as differing criteria for abnormality, 
diagnostic heterogeneity* inaccuracy in drug histories, different 
fashions in prescribing both geographically and over time - but 
few authors have considered the possibility that some of the 
disorder being studied may actually be intrinsic to the patient's 
psychiatric condition itself. This has been particularly overlooked 
with regard to schizophrenia, the major area of concern with 
'tardive dyskinesia’. The whole question of the prevalence of
spontaneous involuntary movement disorders in long -standing 
schizophrenics, and the correlations with these is the subject 
of detailed investigation forming the substance of Part II.
Taking an overview of the findings, the present deficits 
exhibited by the patients appear to relate to firstly, the 
features of the illness at its worst, and secondly to factors 
reflecting the passage of time (age of onset and past academic 
record each influenced deficits in particular areas only). Thus 
the clinical picture presenting now seems determined largely by 
the clinical picture of the basic schizophrenic disease process 
itself, by the operation of some additional influences occurring 
over time, or possibly by a combination of both. While it is not 
possible to say how much benefit, if any, past physical treatments 
effected, they do not appear to have made the patients worse, at 
least in terms of the areas of functioning examined in this study.
5.2.3 DETERMINANTS OF THE PRESENT PICTURE
In the present work, the features of the illness at its 
worst represented in PSE subclasses give a profile of the 
symptomatology inherent in the basic illness and can be considered 
as associated with various measures of severity. Consistently the 
’CS’ group emerged as particularly disadvantaged. They had a 
significantly earlier age of onset and the longest periods in 
hospital. They had significantly more prominent 1 negative' features 
in the ment&l state, performed significantly less well on cognitive 
testing and had the worst behavioural capabilities. The 'NS’ / ’ !)£>1 
patients in general adopted an intermediate position between 'CS*
and ’DP' groups. The 'DP* subjects had the latest age of onset, 
had fewer 'positive' features than the 'NS'/'DS' patients (which may 
merely reflect the paranoid's reticence in proferring symptoms), 
and also had significantly fewer 'negative' features than those in 
all other categories. Behaviourally and intellectually it was not 
possible to separate 'NS'/'DS' and 'BP' patients.
The Catego subclasses are strictly defined, patients being 
allocated in a rigid hierarchical fashion (Wing et al 1974)• They 
do not therefore correspond exactly to the more loosely applied 
conventional diagnostic subgroups of schizophrenia, which makes 
comparison with the published literature difficult. However, certain 
facts regarding subgroups were confirmed. Paranoid patients ('BP') 
had a much later onset than others and had a mental state less 
coloured by apparant, obvious psychopathology. They were a small 
group in the population, which reflects the tight Catego definition, 
the fact that application of the St. Louis criteria militates against 
their inclusion (Peighner et al 1972), and the reduced likelihood 
that such subjects will require long - term care. Furthermore the 
reduced proportion of 'chronic1 samples which are made up of paranoid 
patients even when this is more widely defined has been noted by 
others (Depue & Woodbum 1975; KLorman et al 1977)*
The idea that the pattern of the original presentation has 
echoes in the long - established defect symptomatology was noted in 
the older literature. Kant, for example, studying patients ill for 
at least 10 years, stated that "the three original basic subtypes *
...... are still very definitely recognisable in the end stages",
and that " transitions between the various subtypes are very few"
* Kant's sample included no simple schizophrenics.
(Kant 1943) • This was for him a general conclusion on 
consistency of syndromes, not of symptoms as advocated by 
Leonhard, whose views he criticised. Insofar as they refer to 
syndromes, Kant’s findings are in accord with those of the 
present work.
It is of interest that even within a sample who, because 
of their failure to be discharged may be said to have done badly, 
the PSE is able to identify a group whose illness appears to 
have run a particularly malignant course (CS +). Kant 
likewise found in his sample of long - standing schizophrenics 
that catatonic patients were small in number but represented 
the most severely deteriorated individuals (Kant 1943)• One 
must however be cautious of generalising this finding. Catatonic 
schizophrenia is a confusing condition - especially in its 
historical context - and one which is now infrequently seen.
Only 5*7 % of the present sample came out as CS 4-. At its height 
catatonic schizophrenia was recognised as being associated with 
two widely divergent prognoses. As Kant put it, catatonics were 
"destined either to recover completely or to deteriorate"(Kant 194l)* 
This good outcome/poor outcome dichotomy has recently been 
equated with the clinical patterns of excitation and retardation 
respectively (Morrison 1973) • This population of CS + patients
* PSE subclasses only approximate to clinical diagnoses (p 98)* 
Catatonic Syndrome, is derived from the major Catego class of 
'Other Psychoses' and not from the specifically 'Schizophrenic' 
class. Thus the presence of catatonic features alone would be 
sufficient for a subject to qualify. In the present context, where 
all subjects also conformed to St. Louis criteria for schizophrenia, 
the CS + subclass is likely to be equivalent to a clinical diagnosis 
of catatonic schizophrenia.
cannot therefore he considered representative of all 
schizophrenics who would initially be classified as catatonic.
It is possible that the good prognosis patients without 
deficit or recurrence did not actually have schizophrenia as 
currently conceived (and would in any case have been excluded 
from the present sample), whereas the very bad prognosis 
patients described by Kant are of the type represented as CS + 
in the population described here.
The effects of the passage of time on patients' deficits 
could reflect two factors :
- the cummulative effects of institutional environment 
on a damaged individual.
- the relentless progression of a disease process.
The work of Wing and Brown and their colleagues referred 
to earlier, suggests that both may be of relevance, although 
their finding of only a limited amelioration of ‘negative’ 
characteristics with the enrichment of the environment, indicates 
that the "biological component" reputedly underlying these 
deficits (Wing 1963; Wini & Brown 1970) is substantial.
The present study was not designed to unravel fully the 
relative contributions of illness and environment in producing 
the clinical deficits reported. However, certain points are 
worthy of note. The hospital providing care for this' study 
sample would be considered ’good’ by Wing & Brown's standards. All
patients were encouraged where possible to attend industrial 
and occupational therapy units on a regular basis and sheltered 
and open employment outside the hospital was fostered. All 
were encouraged to keep personal possessions and the wards 
often had a homely, domestic atmosphere. Outings and holidays 
were regularly organised. Such a social ambience is stated 
as militating against the development of the 'clinical poverty 
syndrome* (Wing & Brown 1970)*
Two pieces of evidence support the view that 'negative* 
features described here are primarily illness - related phenomena 
likely to be minimally determined by environment. The first 
is the strong correlations that were established between 
'negative' features and two organic, illness - related features - 
cognitive impairment and involuntary movement disorder. Even if 
the former is interpreted as reflecting poor attention, decreased 
motivation etc., there is no question that environment can 
cause involuntary movements, especially when a very determined 
effort was made to ensure that only involuntary and not manneristic/ 
stereotypic movement was recorded. The strong correlation between 
'negative' features and movement disorder in particular, make 
it unlikely that environment was making a major contribution to 
the presence of the former.
Secondly, and more importantly, Johnstone et al have 
reported the findings of a parallel study to the present one, 
where schizophrenics who had not come to long - term care but had 
been discharged from the same hospital formed the study group 
(Johnstone et al 198l). In this investigation, 201 patients were
found to have been discharged from Shenley hospital during the 
years 1970 - 1974 inclusive with a case note diagnosis of 
schizophrenia. Of these, 120 were Feighner positive, 105 of 
whom were traced and 77 examined by the same techniques as 
were used with the in-patient group reported on here.
The authors found that taking age, sex and length of 
illness into account, both groups were equally impaired in 
terms of ’positive' and 'negative' mental state features and 
behavioural ratings. However, the institutionalised group were 
significantly worse on cognitive testing than the out-patients. 
This study indicates that the deficits of established 
schizophrenia may well be continuing features of the illness, 
regardless of whether the setting is one of long - term 
institutional care or not. Further, it suggests that prolonged 
hospitalisation may be the consequence of cognitive disability 
rather than vice versa.
The strong relationships that emerged between the 
separate items of Assessed Abnormality are probably the most 
striking findings of the present section and argue in favour 
of the predominantly biological nature of the deficits described. 
Two explanations of these relationships are possible. Firstly, 
such strong correlations could be generated if the various 
assessments overlapped in what they were measuring. 'Negative' 
features, poor cognitive performance and behavioural deterioration 
could all reflect the presence of some single underlying deficit, 
as for example, impairment of motivation. This argument could 
not however apply to the presence of extrapyramidal neurological
abnormality, such as hyperkinetic involuntary movement disorder.
While mental state or other non-specific factors may be of 
relevance in modifying the severity of this type of clinical 
sign, they could not be primarily implicated in cause.
The second explanation is preferred - namely that the 
deficits detected in this sample represent, in general, 
limitations in separate areas of functioning, which develop 
together and which may represent the clinical manifestations 
of common or related pathophysiological processes.
5-2.4 PATTERNS OF DEFICIT
It has long been realised that some schizophrenics do 
well in terms of outcome, while others do badly, many studies 
going back to the pre-neuroleptic era showing this common 
finding (for review, see Stephens 1978)*
The present study was restricted to the worst prognosis 
patients, yet it is of interest that even within this group, 
two 'patterns' of deficit also appear to emerge. In the one, 
'positive' mental state features do not correlate with any other 
type of deficit, while in the other, 'negative' features of the 
mental state correlate with extrapyramidal neurological 
abnormality, cognitive impairment and behavioural disorganisation.
Such a distinction is relative, not absolute. Although 
'positive' and 'negative' features were not positively 
correlated with one another, neither were they negatively 
related. The presence of one type of abnormality did not exclude 
the presence of features of the other. The overlap was considerable.
Thus, conclusions can only be general - namely, that patients 
in whom ’negative' features are prominent are more likely to 
exhibit related deficits in other areas of functioning, while 
patients in whom the mental state is coloured by prominent 
'positive' features are not.
Recently, Crow has suggested a classification of 
schizophrenia into what he calls a Type I syndrome and a 
Type II syndrome, based on hypothesised pharmacological and 
structural differences (Crow 1980). The former is characterised 
by productive 'positive' mental state features probably 
mediated by dopaminergic mechanisms, while the latter is 
characterised by 'negative' features and structural brain 
change and is not primarily associated with disruption of 
dopaminergic systems. The limited nature of the present sample 
does not allow comment on such a hypothesis for the generality 
of schizophrenia, but the theory does present major conceptual 
problems such as the reported resolution of 'negative' 
symptomatology, the question of long-established productive 
symptomatology not responsive to dopamine blockade by neuroleptics, 
etc. The present study has shown that no sharp distinction 
exists between 'positive' and 'negative' features. In view of 
the implications of irreversibility and structural brain change 
in the Type II syndrome, it would appear that Crow's system 
would require classification to be hierarchical, with 'negative' 
features always taking precedence over 'positive' features when 
both coexist in the same patient. This runs the risk of mild 
abnormality of 'negative' type - or even of contaminating,
extraneous clinical features - being given classificatory 
priority over ‘positive1 features unequivocally morbid and 
of marked degree. At the level of our present knowledge, 
this may be in error.
Exactly what clinical features should be used in 
attempts to subclassify long - established schizophrenic illnesses 
remains unclear. Although different authors appear to describe 
features, on the face of it, similar, this is usually not the 
case, and comparisons based on the assumption of similarity 
are misleading. Even when the same general terminology is used, 
the specific constituent features may differ.
The confusion in this area can be readily illustrated.
Both Wing and Brown (cf p 42 ) and the present study refer to 
’negative’ features, but the constituent psychopathology is 
different. Wing’s poverty of speech item refers to poverty of 
content of speech on 4 of its 5 severity points (Wing 196l) 
while the present work was essentially rating reduced amount 
of talk or words used, both spontaneously and on questioning.
Only at the most extreme severity point (muteness) do both 
studies concur. Likewise, Wing’s affective item incorporates 
both restricted affect and incongruity of affect, while the 
present work separated these and considered only the former to 
be a ’negative’ feature.
Depue and his colleagues have utilised a simple split 
based on Venable's'behavioural axis of activity - withdrawal 
(Venables 1957)? and have found important differences in 
patients grouped this way (Depue & Dubicki 1974; Depue et al
1975; Depue 197&). Psychomotor activity was not assessed in 
the present study and for this reason alone comparisons would 
be unjustified, but the need for caution is emphasised by the 
realisation that Depue* s withdrawn patients have more 
hallucinations and delusions than those in the active group 
(Depue & Dubicki 1974)* Hence the reasonable assumption of a 
general similarity between 'withdrawn* and 'negative' patients 
is inaccurate.
Andreasen has published a number of detailed studies 
of what she refers to as "positive and negative symptoms" 
(Andreasen 1979; 1982; Andreasen & Olsen 1982). Despite the 
similarity in name to 'positive' and 'negative* features 
described throughout the present work, they are fundamentally 
different. Andreasen's "positive symptoms" comprise 
hallucinations, delusions and positive formal thought disorder 
in common with 'positive' features used here, plus two 
behavioural items - "bizarre behaviour" and "catatonic motor 
behaviour". Her "negative symptoms" comprise alogia, avolition, 
anhedonia, affective flattening and attention deficit, some of 
which are compound items. For example alogia is used to rate 
poverty of speech and poverty of content as well as "blocking", 
while "affective flattening" is also recommended for the rating 
of incongruity. Hence Andreasen's "symptoms" (which are strictly 
speaking mainly clinical signs) bear little resemblance to the 
'features' employed here.
In advocacy of Crow's two syndromes theory Angrist et al 
utilised withdrawal as one of the constituents of their negative
state (Angrist et al 1980), although Crow had not included 
this behavioural characteristic in his original definition 
of the syndromes (Crow 1980). Although ’withdrawal* was not 
used in the present dichotomy based on mental state variables, 
it could be argued from the findings that ’psychomotor' 
retardation1 should not be considered as a non-specific item 
but should be included in the definition of ’negative’ features. 
Over 90 % of those rating 2 or more on psychomotor retardation 
also obtained a score of 2 or more on affective flattening 
and/or poverty of speech/muteness.
Exclusion of retardation was arbitrary but had it been 
reclassified ’negative’ this would not have altered the basic 
findings. No subject scored on this item alone and only 11 
had a retardation rating in the absence of either or both of 
the other two components of ’negative’ features. It is important 
to note however that confident elucidation of psychomotor 
retardation as an independent feature distinct from flattening 
of affect and, especially, poverty of speech/muteness, is 
difficult. Although the fact that half (64) of those who rated 
on retardation did so only in the presence of both flattening 
and poverty of speech could be seen as indicative of a 
relationship between the three, equally this may merely reflect 
the difficulty in separating them, and the examiner’s consequent 
tendency to rate retardation automatically when the others are 
present.
Almost all these proposed systems are derived theoretically 
and confusion will continue until features are defined whose
validity can be shown in experimental settings.
The pattern of deficit referred to here as 'defect 
state1 was defined as part of the present work and is not 
comparable to similar terms applied elsewhere. It is hence 
open to the charge of idiosyncrasy of the type illustrated 
earlier from the literature. Its justification lies in an 
attempt to create a degree of homogeneity within those patients 
with 'negative' type deficits in their mental state who have 
been shown by the results to represent an interesting subgroup 
of the total population.
Two points of note emerged in analysis of those 
conforming to 'defect state' criteria :
i) the positive association with length of illness, 
ii) the absence of a relationship with past 
neuroleptic treatment.
These relationships certainly reflect in large part the basic 
findings with regard to 'negative' mental state features and 
cognitive performance analysed independently, and the relationship 
between impairment in these two areas - both of which were 
referred to earlier. They do however serve to underline those 
basic findings, especially as the literature gives little 
guidance on these two important questions.
Using "deterioration" or other broad terminology, some 
authors state that such deficits progress throughout the course 
of the illness (Kraepelin 1919; Tsujino 1966), while others 
believe ■ they reach a plateau in the years immediately following 
an acute episode (Shakow 1946; Huber et al 1975)» while others
yet again refer to their unpredictable resolution 
(M Bleuler 1978). That 'defect state' in the present work 
related to length of illness is compatible with the idea of 
progressive evolution. However, it must be borne in mind that 
this finding refers to a progressive fulfilling of the criteria 
over time, and not to a subsequent increase in severity, once 
established. It is possible that more specific defect patterns 
of the type defined here bear a more predictable relationship 
to the duration of illness than looser, impressionistic concepts.
It is striking that the 'defect state' was not determined 
by age. Thus it would appear that the deficits evaluated were 
not being contaminated by the non-specific changes of advancing 
years. Age and length of illness are of course closely related 
in this sample and it must be stated that while separation of 
the effects of each may be statistically meritorious this may 
in actuality represent a somewhat spurious distinction. Nonetheless 
in statistical terms at least, the contribution of length of 
illness to the defects was highly significant while that of age 
did not even approach significance.
Although it has been claimed that the introduction of 
neuroleptic drugs has modified the post - acute schizophrenic 
picture (Van Epen 1969; Pasnik-Kisiel 1970; Huber et al 1975) 
the evidence for this remains unclear. Pish (1964) has however 
reported that groups of schizophrenics classified into Leonhard 
subtypes show differential improvements with neuroleptic treatment. 
With the present population of severely ill patients it could not
■be demonstrated that neuroleptics made any contribution to 
the presence of the ’defect state' as specifically defined or 
indeed to its individual components.
Following from the findings discussed here, some comments 
are justified on terminology. The results indicate that 
maintaining a distinction between the terms ’chronic’ and 
'defect state' is useful even within a population who have 
all experienced personal decline as a specific criterion of 
their diagnosis. ’Chronic’ is probably most appropriately 
applied in a purely descriptive sense, to infer the presence 
of persisting, post - acute abnormalities without any 
implication as to their form or duration. 'Defect state’ 
would then be reserved for that situation where a particular 
pattern of ’negative' type abnormality is implied. As has 
been shown, such a specific usage can identify a type of 
patient with multiple deficits. In association with ’negative' 
features in their mental state, they are likely to have cognitive 
impairment (evidenced on formal testing as well as in a history 
of academic difficulty), behavioural deterioration in extra- 
pyramidal signs. They may also exhibit, or have exhibited, 
catatonic features. Such deficits are likely to relate to the 
duration of the illness rather than the patients age, and will 
not be associated with any forms of physical treatment 
administered in the past. By this usage all 'defect state' 
patients would also be 'chronic' but the corrollary would not 
be the case.
These proposals, based on experimental data have much
in common with Huber's theoretical views referred to earlier 
(p 40 )• They recognise the variability of post-acute states
while reserving specific terminology for a pattern of deficit that 
may allow specific inferences of aetiology based on brain dysfunction.
Not all psychiatrists would espouse such views however. 
Manfred Bleuler, for example has written :
"the term 'defect state' itself does not fully 
correspond any longer to present day concepts.
It indicates too strongly something unchangeable 
and irrevocable and ignores the fact that behind 
the pathological condition, healthy life lies 
concealed. These conditions do not indicate that 
anything has been permanently destroyed: 
pathological behaviour simply replaces healthy 
behaviour."
(M. Bleuler 1978 P 191).
The present work provides no support for such an 
assumption, and indeed suggests that 'defect state', as defined 
here, is a valid clinical entity with correlations which make it 
highly likely that it is mediated by some abnormality of cerebral 
functioning.
Dichotomisation of established schizophrenics on the basis 
of some variant of the 'positive'/'negative' distinction has been 
advocated by a number of workers. The distinction based on mental 
state suggested here has the advantage of simplicity, is derived 
from present evaluations and not assessments of distant, historical 
information which may be unreliable, and has been shown empirically 
to have potential relevance.
The ultimate worth of any classificatory system depends on 
its usefulness in making valid predictions about some major aspect 
of a condition. The 'positive'/'negative' feature distinction
will be applied in Part II and Part III in the analysis of 
movement disorder and C.T. scan data. The likelihood of ’negative’ 
features being based on brain disorder will be explored in these 
contexts.
PART II
SPONTANEOUS INVOLUNTARY DISORDERS OP MOVEMENT
"It is natural that the central nervous system should have been 
the object of much research in schizophrenia. Bnil Kraepelin ... 
always hoped that science would one day duplicate for dementia 
praecox the triumphant actualisation of the medical model, as it 
took place in reference to general paresis. Such hope has not 
been realised"
SILVANO ARIETI 
INTERPRETATION OF SCHIZOPHRENIA
PART II
SPONTANEOUS INVOLUNTARY DISORDERS OP MOVEMENT
Chapter 1 - Literature Review
1.1 INTRODUCTION
"Tardive dyskinesia (TD) is not now considered rare or 
controversial and may he the most frequently diagnosed 
iatrogenic disease of the nervous system. Diagnosis of 
TD in individual cases can occasionally he difficult, 
hut in contrast to a decade ago the existence of TD is 
unquestioned. There is no serious effort at this time 
to attribute tardive dyskinesia to tics or to hahits, 
nor to the ’stereotypes' of schizophrenia nor even to 
voluntary mannerisms in edentulous or senile patients" 
(Paulson 1981)
Pew psychiatrists would challenge the ahove statement though 
lingering douhts as to the validity of the concept of 'tardive 
dyskinesia’, expressed over the past 20 years, still persist. However, 
Paulson's outwardly dogmatic view is carefully worded, and two points 
are striking hy their omission. Firstly, the concept of ’tardive 
dyskinesia' rests on epidemiological evidence of a statistical 
association. The transposition of this statistical relationship 
within populations to the individual case is the major conceptual 
difficulty in diagnosis. Secondly, while Paulson rightly refers to 
all the things that ’tardive dyskinesia' would not he attributed to, 
especially "the 'stereotypes' of schizophrenia", he makes no 
reference to authentic involuntary movements, that it was suggested 
earlier, may be a part of the schizophrenic illness per se.
1.2 THE CONCEPT OP TARDIVE DYSKINESIA
The term 'neuroleptic1 was used by Delay and Deniker 
shortly after the introduction of chlorpromazine, to emphasise that 
drugs of this type appeared to act directly on the central nervous 
system (Delay & Deniker 1 9 6 8). Acute postural and movement 
abnormalities and a parkinson-like syndrome were soon recognised 
as features associated with treatment (Hall et al 1956; Deniker 1961; 
Melvin 1962; American College of Neuropsychopharmacology Task Force, 
1973)* As side-effects, these manifestations were rarely thought 
of as serious and never as permanent. In particular, it was not 
thought that they could be indicative of an irreversible neurotoxic 
effect of the drugs.
In 1957) Schonecker described a syndrome of abnormal 
involuntary movements in 3 elderly chronic psychiatric patients with 
cerebral arteriosclerosis (Schonecker 1957)- The abnormalities 
consisted of " automatisms with licking and smacking movements of 
the lips " - that is, they were complex and orofacial - and occured 
in subjects who had all been on chlorpromazine. Although often 
accredited as the first report of 'tardive dyskinesia', it must be 
doubtful if Schonecker's patients had this condition as subsequently 
conceived. Two of the 3 bad severe parkinsonism develop 
concomitantly and duration of exposure ranged from " the first days 
of treatment " to a maximum of only 8 weeks.
Three years after this Uhrbrand and Faurbye described an 
apparently similar appearance in 33) mainly psychotic long-stay 
patients treated by a variety of physical means (Uhrbrand and Faurbye
I960) Nonetheless, they concluded that the outstanding factor 
in their patients was prolonged exposure to what they referred to 
as "psychopharmaca". In fact what these authors were proposing was 
the concept of ’neuroleptic - caused 1 involuntary movement disorder, 
where the spontaneous motor activity was "bucco-linguo-masticatory" 
in distribution, though whole body movements were mentioned in 
passing. This syndrome was subsequently designated ’tardive 
dyskinesia’ - 'tardive' representing the view that onset occurred 
late in the course of neuroleptic treatment compared to the other 
known neurological sequelae (Faurbye et al 1 964)* Since that time 
the concept has widened in its essentials.
The term 'dyskinesia' was not commonly used prior to its 
introduction in the present context. Strictly speaking, 'dyskinesia' 
in neurological context is a generic term for any abnormal kinesis. 
Applied thus, it would cover choreiform, athetoid and myoclonic 
movements, tics etc, and would even include tremor (Marsden - 
Personal communication). As a generic term there is no specific 
implication of cause involved in its usage.
Many of the early authors, including Uhrbrand and Faurbye, 
focused on the bucco-linguo-masticatory triad of features, presumably 
as these were the most striking and conspicuous abnormalities. Other 
movements such as "rocking and torsionary body movements" were 
briefly mentioned in "the most serious cases" (Uhrbrand and Faurbye 
I960), as was tremor, but the emphasis was overwhelmingly orofacial.
In the psychiatric literature, the general descriptive term 
'orofacial dyskinesia', where dykinesia meant only 'abnormal kinesis', 
became synonymous with 'tardive dyskinesia' involving an implication
of neuroleptic causation. Such conceptual confusion was 
facilitated by the fact that the movements being described not 
only had an apparently specific distribution but were also slow, 
complex and even co-ordinated, setting them apart from movements 
of the choreic, athetoid, myolonic or tic-type more familiar to 
psychiatrists. Thus Crane and Naranjo could write :
"Complex dyskinesias are the most common disorders 
observed in long-term patients and are often 
referred to as tardive dyskinesias".
(Crane & Naranjo 197l)
Crane and Naranjo do mention that peripheral movements 
could be found in psychiatric patients but their description 
gives clear emphasis to slow, "complex" repetitive orofacial 
activity. In particular they separately define and describe 
chorea, athetosis, tics etc from "complex" or "tardive" 
dyskinesias.
For many of the descriptive writers, therefore, 
'dyskinesia* was a special word implying neuroleptic causation, 
complexity of form, and a distribution of abnormality largely 
restricted to the orofacial region. This would perhaps have 
been acceptable had it been convincingly shown that drug history 
and specifically that of neuroleptic exposure - could be used as 
the validating criterion of this syndrome. The widespread use of 
neuroleptics and the resultant lack of satisfactory non-treated 
control groups, made this difficult to demonstrate.
With the introduction of standardised rating scales and 
their demands for a more comprehensive examination covering all 
body areas, it has become clear that movements in all body parts 
can be found in long-standing 'chronic' schizphrenic patients.
Abnormalities of movement axe not just restricted to orofacial 
areas and may not be complex or co-ordinated. Most workers would 
now accept that the term ’dyskinesia' can be applied widely to 
virtually any abnormal movement regardless of its characteristics 
or distribution, though there remains a strong tendancy to confuse 
the definition of the term with the implications of its use in 
specific situations. When it is used with an implication of 
neuroleptic cause, it has still not widened to its generic sense however. 
Marsden et al, for example have stated that "tremor is not a part of 
tardive dyskinesia" (Marsden et al 1975)•
The second point of diversification in the concept 
relates to the drugs implicated in causation. Uhrbrand and Faurbye 
referred only to neuroleptics and reserpine though since that time 
a number of different categories of drug have become involved, such 
as tricyclic antidepressants (Fann et al 1967; Bekret et al 1977)> 
antihistamines (Thach et al 1975) > and even benzodiazepines 
(Kaplan and Murkovsky 1978)• Thus, 'neuroleptic-caused' dyskinesia 
has widened to dyskinesia produced by psychoactive drugs. Even the 
word 'psychoactive' must be used selectively as not all drugs which 
can affect mental functioning and can 'cause' orofacial or other 
involuntary movements would be included, a noteable exception being 
L-dopa. The hyperkinetic syndrome sometimes associated with its 
adminstration (Barbeau et al 197l) is not referred to under the 
'tardive dyskinesia1 heading.
Likewise a change has occurred in the duration of treatment 
required before involuntary movements can be considered 'tardive'. 
Originally it was suggested that 2 years or more was necessary
(Sigwald et al 1959; Faurbye 1964; Crane 1973) but more recently 
this limit has been revised downwards considerably. Movements have 
been labelled 1 tardive' after only a few months of treatment 
(Degkwitz 1969; Moline 1975; Stimmel 1976; Chouinard & Jones 1979)* 
It therefore seems the original concept of tardive 
dyskinesia has been extended and now has a more general meaning.
It appears to be applied to most, although not all, forms of 
spontaneous involuntary movement activity occurring in the setting 
of treatment with most psychoactive drugs for a period of more than 
a few weeks.
1.3  THE CLINICAL FEATURES
Review of the literature on the clinical features of 
involuntary movements attributed to psychotropic drugs reveals 
a variable mixture of orofacial and lingual dyskinesias, chorea, 
athetosis, dystonia, tics and complex facial grimacing. Detailed 
descriptions have been published elsewhere (Marsden et al 1975;
APA Task Force 1979) and only a brief resume^ will be presented 
here.
Ct
Course vermicular movements of the tongue without its 
displacement (lingual myokymia) may be the earliest manifestation 
(Crane & Naranjo 197l)> though such movements are easily missed. 
Alternatively, it has been suggested that tic-like movements of the 
lips or face, or increased frequency of blinking may be the earliest 
signs (Karson 1979)-
Traditionally however, lingual dyskinesias are considered 
the most characteristic features. These movements may be of the
slow, sustained dystonic type, but are usually described as being 
of the course, irregular, choreoathetoid kind, producing varying 
degrees of displacement of the tongue inside and outside the mouth. 
Clinically, descriptive terms such as snail-like contractions, 
bon-bon sign and fly-catcher sign are often applied to these 
abnormalities. An inability to siistain voluntary lingual 
protrusion for 30 seconds has been described as characteristic 
of severe cases (Pi and Simpson 198l). While descriptions in the 
literature imply that different varieties of tongue abnormality 
represent step-wise progressions in severity, this remains to be 
established. Pursing, puckering, smacking and bridling lip and 
perioral movements can occur, separately or in combination, as can 
chewing, grinding jaw movements. Elevation or frowning of the 
brows, upward deviation of the eyes, increased blinking or 
blepherospasm can result from involvement of periorbital muscles 
while co-ordinated expressive abnormality produces complex 
grimacing.
In addition to these typical orofacial dyskinesias, restless 
choreiform and athetoid limb movements can occur not infrequently, 
especially in a distal distribution, and the postural antigravity 
muscles may be affected either locally (e.g. neck) or generally. 
Whole body involvement gives rise to a striking writhing, 
restlessness with disturbance of both posture and gait. Finally 
dyskinesias of the respiratory and pharyngeal musculature can give 
rise to periodic tachypnoea or irregularity of respiratory rhythm, 
difficulty in swallowing occasionally reported as life-threatening 
(Casey & Rabins 197$) and. forced spontaneous vocalisations.
Thus the range of involuntary motor activity attributed to 
psychotropic (particularly neuroleptic) ingestion is extensive, and 
the variability of the clinical picture between cases remains one 
of the major problems in diagnosis. It has been suggested that age 
may have a bearing on the pattern of abnormality in that older 
subjects (i.e. over 50 ) niay be more likely to develop orofacial 
dyskinesias, while in younger patients, especially children and 
young adults, peripheral movements may predominate (Marsden et al 
1975; Polizos & Englehardt 1980)
1.4 CHARACTERISTICS OE THE DYSKINESIAS
The conspicuous distribution has often been taken as 
characteristic of so-called 'tardive dyskinesia'. As was mentioned 
earlier however, (and as the aforegoing descriptive account 
illustrates) this is not the case. Peripheral dyskinesias have 
been described as the only abnormalities detectable, especially in 
younger subjects (McAndrew et al 1972; Polzios et al 1975)* Syndromes 
of involuntary movement attributed to L - dopa can feature 
predominantly orofacial dyskinesias (Yahr 1970)> though Gerlach 
has suggested that peripheral movements make proportionately a 
greater contribution to total abnormality in this situation than when 
neuroleptics are the putative cause (Gerlach 1977)*
However, spontaneous movements attributed to drugs share 
characteristics common to all extrapyramidal, choreoathetoid 
syndromes. They are typically responsive to features of the mental 
state, being exacerbated by anxiety and emotional stress and 
alleviated - at least partially - in a setting of composure. They
diminish with decreasing states of arousal and so ease with 
drowsiness or sedation and disappear during sleep. They can be 
suppressed for varying periods of time by conscious effort at 
least in the initial or milder stages, though this effect is 
often unpredictable. On the other hand attempts to inhibit one 
portion of a complex dyskinesia can produce exacerbation in 
other portions. Related to this, a repetitive voluntary motor 
activity in distant body parts or concentration on fine motor 
tasks may enhance the movements. Spontaneous motor activity may 
first become manifest when neuroleptics are stopped or the dose 
reduced, while increasing the dosage may, temporarily at least, 
suppress it.
Patients are not infrequently unaware of their movements 
the reasons for which are unclear. It has been suggested that 
affectively ill patients may be more likely to complain than those 
with more serious conditions such as schizophrenia (Simpson &
Lee 1977)* On the other hand, subjective awareness may partly 
reflect the distribution in that peripheral and truncal movements 
are more likely to be disabling and recognised as abnormal than 
dyskinesias of the face - an area which -in anyone can be characterised 
by considerable motor activity, even at rest. Only rarely do 
orofacial movements interfere with speech, eating, or respiration, 
or produce oral ulceration (APA Task Force 1979)*
1.5 THE EVIDENCE IN SUPPORT OF THE CONCEPT - THE ROLE OF
NEUROLEPTIC DRUGS IN ESTIMATES OF PREVALENCE
Although, as was mentioned earlier, a range of drugs other 
than neuroleptics have been implicated in the production of involuntary
movements, the evidence is largely anecdotal (APA Task Force 1979)* 
For this reason, the following review will restrict the concept of 
tardive dyskinesia to one of ’neuroleptic - caused movement disorder'
The concept of neuroleptic - caused movement disorder is 
based on epidemiological evidence of a statistical association 
between the two. Assessments of this evidence range from "thoroughly 
convincing" (Marsden et al 1975) through "compelling" ( Kane &
Smith 1982) to sceptical (Crow et al 1 983). In general, the 
scientific quality of the evidence is poor, with reports covering 
heterogeneous patient groups studied by unstandardised methods. Even 
now, there are no universally accepted criteria for establishing 
the diagnosis and mild or doubtful cases, which may be highly 
relevant pointers to the establishment of more serious disorder 
(Kane et al 1980), are easily missed.
Notwithstanding, Kane and Smith (1982) have calculated the 
mean prevalence of abnormality from 56 sets of data published in 
49 studies of neuroleptic treated subjects from i960 to 1979* They 
arrived at a figure of 20 % ( i 14 %) based on almost 35? 000  
patients. These authors also calculated that the prevalence in 
neuroleptic-free subjects was 5 % ( - 9 %) from 19 sets of data in 
14 studies encompassing 1 1 ,0 0 0 subjects published over the same 
period. The statistical difference in the prevalences is highly 
significant (P<10 )^.
Jeste and Wyatt (l98l) reviewed those 12 "major studies" 
which compared the prevalence of involuntary movements in neuroleptic 
treated and neuroleptic-free samples and calculated that the
prevalence in the former group was 3 i  times that reported in 
fbhe latter group.
Both sets of reviewers agree on a prevalence attributable 
to neuroleptic drugs of 13 - 15 % with pooled data, and in 
suggesting that about 5 % is attributable to spontaneous disorder.
Reviews of this kind present striking data. However,the 
comparisons they make are not strictly justified, as subjects 
differ on many important variables other than exposure to 
neuroleptics. For example, while most of the figures for prevalence 
in those on neuroleptics are derived from long-stay psychiatric 
patients especially schizophrenics, data on spontanous rates are 
often based on nursing home residents or other non-psychiatric 
subjects. Furthermore, pooled data from studies using different 
assessment and recording techniques cannot take account of the 
important variable of severity criterion. These major criticisms 
apply to both the comprehensive review of Kane and Smith, and also 
to the more limited contrasts between treated and untreated samples 
within the same study evaluated by Jeste and Wyatt.
Ideally, proving the validity of the concept of ’neuroleptic- 
caused movement disorder’ would require to account not only for the 
fact that clinically similar conditions can occur spontaneously, 
as is attempted in comparing pooled data. It would also be necessary 
to take account of diagnosis as a possible interposing aetiological 
factor. Schizophrenia, the major indication for long-term 
neuroleptic administration, is a condition which may itself be 
associated with the development of abnormal motor activity (cf Part i).
The literature is surprisingly lacking in reports of 
putative TD in non-psychotic and non-psychiatric patients. This 
undoubtedly reflects the relatively infrequent use of neuroleptics, 
and possibly the smaller doses employed, in these situations.
Klawans et al (1974) reported 7 cases aged 41 - 69 years, all of whom 
had developed involuntary movements after "prolonged” neuroleptic 
treatment. Five had diagnoses of "anxiety neurosis" and 2 of 
"chronic gastritis". All developed lingual-facial-buccal movements 
but in 6, other abnormalities were also detectable. Kataria et al 
(1978) reported 3 elderly subjects with "chronic tardive dyskinesia" 
associated with metaclopramide, which although not conventionally 
classed as a neuroleptic, does exhibit dopamine blocking activity. 
Such reports are however isolated. Recently, several publications 
have suggested that patients with affective disorder may be at 
higher risk of developing ’TD’ than those with other psychiatric 
diagnoses (Davis et al 1976; Rosenbaum et al 1977)» though the 
evidence is anecdotal.
Thus while data on the prevalence, severity and 
distribution of movement disorder developing in non-psychiatric 
and non-schizophrenic psychiatric patients could provide valuable 
evidence in support of a primary role for neuroleptics in the 
aetiology of involuntary movements and on the role of diagnosis, 
systematic investigation in these areas has not been undertaken 
to date and no suitable figures are available for comparison.
One study has looked at matched groups of schizophrenics 
varying on neuroleptic exposure. Crane, using his own criteria, 
studied the prevalence of "dyskinesia" in "two fairly typical
populations" of young and middle aged chronic psychiatric in­
patients (Crane 1968b). One group, in the U.S.A., had been heavily 
exposed to neuroleptics, while the other, in Turkey, consisted 
of "minimally" and "moderately" treated patients. He found no 
dyskinesia in the minimally treated patients and significantly 
more in the heavily than moderately treated subjects. This finding 
persisted when only schizophrenics matched for age and sex were 
compared. The difference between those heavily treated and the 
rest with regard to dyskinesia was highly significant (P <  O.OOl).
This study provides compelling evidence for a direct role 
of neuroleptics in the production of involuntary movements in 
schizophrenics, but has been criticised on administrative grounds, 
in that in Turkey, patients exhibiting neurological signs are 
segregated from the rest, rendering the Turkish sample less 
"typical" of Western patients than was thought (Turek 1975)*
1. 6_______ PREVALENCE OVER TIME
It is clear that the reported prevalence of putative TD 
has increased in the past two decades (Fig 2:l:l).
Originally, nominal present/absent ratings or crude 
clinical impressions were the basis of recording findings, leaving 
individual authors to establish what was significant enough to 
warrent recording. More recently, standardised ordinal scales which 
take account of differing severities of abnormality have been 
introduced and the question arises as to whether this increased 
prevalence is apparant or real.
Kane and Smith concluded that this phenomenon was "not entirely"
FIG  2:1:1 The mean prevalence of 'tardive  
dyskinesia' (continuous line) in 
neuroleptic treated patients, and 
'spontaneous' dyskinesias (broken 
line) in neuroleptic-free patients 
over time
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attributable to the increasing use of rating scales, because 
ratings based on nominal categorisation showed no significant 
increase in reported prevalence (Kane & Smith 1982). Equally 
however, it is possible this means only that the prevalence of 
severe abnormality, more likely to be considered noteworthy in 
nominal categorisations, has not changed. It still allows the 
interpretation that milder degrees of severity are more likely 
to be increasingly sought and recorded in fulfillment of the 
demands of multi-item rating scales.
Jeste and Wyatt also concluded that this phenomenon was 
unlikely to reflect solely over-diagnosis consequent upon 
increasing awareness of the condition (though they did not 
specifically discuss the role of increasingly comprehensive 
recording techniques), an aging study population, or emphasis 
on particularly disadvantaged in-patient groups (Jeste & Wyatt 
1981).
In confirmation of the fact that the reported increase 
in prevalence over time is to some extent apparent, is the point 
that a similar phenomenon can be demonstrated using data from 
studies of patients never exposed to neuroleptics (Eig 2:l:l).
There is no evidence that the earlier of these investigations 
studied younger subject and that the prevalence of later ones reflects 
the ’cumulative’ effects of some incidental factor such as age.
The trend appears to be continuing. Studies published 
between 1980 - 1982 are summarised in TABLE 2:1:1. Of these, 
the study of Kane et al is striking in the low prevalence it 
reports. This is likely to reflect the authors' more stringent
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requirements, in that the prevalence illustrated is that from 
two raters assessing independently. Including any rating by 
either examiner increases the prevalence to 22.2 %.
Using the criterion ’mild or more’, the mean prevalence 
of abnormality from 8 of these studies (that of Ital et al is 
excluded as they were only considering "severe” abnormality) 
encompasing 1147 patients, is 33*6 % though using Kane et al’s 
more liberal figure it becomes 35*9 %• All these studies used 
standardised recording techniques.
Thus, it is concluded that a statistical association 
can be demonstrated between a history of neuroleptic exposure 
and the prevalence of spontaneous involuntary disorders of 
movement. This association is on the basis of pooled data from 
studies over 25 years, where different diagnostic criteria and 
recording methodologies have been used and is calculated without 
consideration of other potentially relevant variables.
1.7 INCIDENCE
There are no reliable data on the incidence of neuroleptic 
caused dyskinesia. Gibson (1978) followed 374 schizophrenic 
out-patients for 3 years and noted a progressive increase from 
7 % to 22 % in the number of patients with at least mild oral 
dyskinesia - an annual incidence of approximately 5 %• Severe 
dyskinesia remained constant at 1.6 % throughout. However, all 
his patients had been receiving neuroleptics for many years (mean 
13 years) prior to commencement of the study. Nonetheless
Gibson's figure is comparable to the 4 - 5 % annual incidence 
calculated by Gardos and Cole in Boston (Gardos & Cole 1980), 
and to the 12 % over 4 years reported by Kane et al (1982 b).
I
\
1.8_______ PUTATIVE PREDISPOSING FACTORS
A number of risk factors were reported in the earlier 
literature based on uncontrolled observations, and many of these 
have gained widespread clinical acceptance. In the following 
evaluation of putative predisposing factors, investigations 
presenting comparisons between dyskinetic and non-dyskinetic 
groups will be considered. Studies for and against each variable 
are summarised in TABLE 2:1:2.
1.8.1 DRUG-BELATED FACTORS
a) TYPE OP NEUROLEPTIC
All currently available neuroleptic drugs have been 
implicated in the production of involuntary movements. Uhrbrand 
and Paurbye's original report noted that 15 patients had received 
trifluoperazine and a number of workers emphasised the potential 
role of the more potent neuroleptics. Despite theoretical merits, 
however, there is no clinical evidence to support the view that 
the more potent dopamine blocking drugs produce a greater risk 
of movement disorder (APA Task Force Summary 1980)(TABLE 2:1:2).
In the United States, fluphenazine has been suggested as 
producing a greater risk (R.C. Smith et al 1978). This is 
however the only marketed depot neuroleptic in the U.S. and any 
implied risk may relate to non-specific factors inherent in depot
TABLE 2:1:2
STUDIES FOR AND AGAINST PROPOSED PREDISPOSING FACTORS IN TARDIVE DYSKINESIA
A. DRUG-RELATED FACTORS
PREDISPOSING
FACTOR
FOR AGAINST
TYPE OF GARDOS et al 1977 HUNTER et al 196^
NEUROLEPTIC R.C. SMITH et al 1978 PRYCE & EDWARDS 1966
(POTENCI) FAMUYIWA et al 1979 DEMARS 1966
JESTE et al 1979a DEGKWITZ et al 1967
CHOUINARD et al 1979 DYNES 1968
KANE et al 1980 HEINRICH et al 1968
EZRIN-WATERS et al 1981 HIPPIUS 8c LANGE 1970
MUKHERJEE et al 1982 JUS et al 
SIMPSON et al 
PERRIS et al 
GARDOS et al
1976a
1978
1979
1980
MAXIMUM CRANE 197^ JUS et al 1976b
DAILY R.C. SMITH et al. 1978 GARDOS et al 1977
DOSAGE GARDOS et al 1980 EZRIN-WATERS et al 1981
MUKHERJEE et al 1982 RICHARDSON 8c CRAIG 1982
DURATION PRYCE 8c EDWARDS 1966 DEMARS 1966
OF HEINRICH et al 1968 DEGKWITZ et al 1967
EXPOSURE CRANE 8c SMEETS 197^ LEHMANN et al 1970
CRANE 197^ HIPPIUS 8c LANGE 1970
GARDOS et al 1977 KENNEDY et al 1971
JESTE et al 1979a BRANDON et al 1971
EZRIN-WATERS et al 1981 JUS et al 
GARDOS et al 
SIMPSON et al 
GIBSON 
JOSE et al 
CHOUINARD et al 
PERRIS et al 
FAMUYIWA et al 
MALLYA et al
1976a
1977
1978
1978
1979 
1979 
1979 
1979 
1979
CUMULATIVE HEINRICH et al 1968 DEGKWITZ et al 1967
EXPOSURE CRANE Ec SMEETS 197^ SIEDE 8c MULLER 1967
GARDOS et al 1977 CRANE 1970
JESTE et al 1979a LEHMANN et al 
HIPPIUS 8c LANGE 
KENNEDY et al 
' BRANDON et al 
JUS et al 
SIMPSON et al 
R.C. SMITH et al 
JOSE et al 
PERRIS et al 
FAMUYIWA et al 
MALLYA et al
1970
1970
1971 
1971 
1976a 
1978
1978
1979 
1979 
1979 
1979
TABLE 2:1:2 continued
PREDISPOSING
FACTOR
FOR AGAINST
EXPOSURE TO BELL & SMITH 1978 DEMARS 1966
MULTIPLE CRANE 8c PAULSON 1967
NEUROLEPTICS JUS et al 1976b
SIMPSON et al 1978
ANTI­ CRANE 1974 KENNEDY et al 1971
CHOLINERGICS PERRIS et al 1979 JUS et al 1976b
MALLYA et al 1979 GARDOS et al 1977
EZRIN-WATERS et al 1981 ASNIS et al 1977
ITAL et al 1981 CHOUINARD et al 1979
SIMPSON et al 1978
JOSE et al 1979
PERRIS et al 1979
GARDOS et al 1980
NEUROLEPTIC- JESTE et al 1979 CRANE 1974
FREE GARDOS et al 1980
INTERVALS
B. NON-DRUG RELATED FACTORS
AGE DEGKWITZ et al 1967 HUNTER et al 1964
HIPPIUS & LANGE 1970 CRANE 8c PAULSON 1967
BRANDON et al 1971 TURUNEN 8c ACHTE 1967
CRANE 1974 CRANE 1968a
OGITA et al 1975 HEINRICH et al 1968
JUS et al 1976a LEHMANN et al 1970
J.M. SMITH et al 1978 KENNEDY et al 1971
SIMPSON et al 1978 FANN et al 1972
BELL & SMITH 1978 GARDOS et al 1980
SMITH et al 1979^b
JOSE et al 1979
CHOUINARD et al 1979
EZRIN-WATERS et al 1981
R I C H A R D S O N  8c CRAIG 1982
MUKHERJEE et al 1982
McCREADIE et al 1982
SEX (F > M) HUNTER et al 1964 CRANE 8c PAULSON .1967
DEMARS 1966 CRANE 1968b
TURUNEN &  ACHTE 1967 CRANE 1970
DEGKWITZ 8c WENZEL 1967 HIPPIUS & LANGE 1970
HEINRICH et al 1968 OGITA et al 1975
JONES 8c HUNTER 1969 JESTE et al 1979a
LEHMANN et al 1970 GARDOS et al 1980
BRANDON et al 1971 EZRIN-WATERS et al 1981
KENNEDY/HERSHON et al 1971/ MUKHERJEE et al 1982
1972
J.M. SMITH et al 1978
FAMUYIWA et al 1979
PERRIS et al 1979
TABLE 2:1:2 continued.
PREDISPOSING FACTOR FOR AGAINST
1ORGANICITY'
(VARIOUS PARAMErERS)
EDWARDS 1970 
FAMUYIWA et al 1979 
WEGNER et al 1979 
ITAL et al 1981
HUNTER et al 196  ^
PRYCE 8c EDWARDS 1966 
DEMARS 1966 
DEGKWITZ 8c WENZEL 1967 
SIEDE 8c MULLER 1967 
GREENBLATT et al 1968 
HEINRICH et al 1968 
EDWARDS 1970 
BRANDON et al 1971 
FANN et al 1972 
CRANE 1973 
CRANE 197^ 
JUS et al 1976a 
GELLENBERG 1976 
GARDOS et al 1977 
ASNIS et al 1977 
SIMPSON et al 1978 
BELL 8c SMITH •' 1978 
JOSE et al 1979 
CHOUINARD et al 1979 
FAMUYIWA et al 1979 
JESTE et al 1980 
GARDOS et al 1980
PAST INSULIN
PHYSICAL
TREATMENTS
DEGKW I T Z  8c W E N Z E L  1967 
H E I N R I C H  et al 1968 
B R A N D O N  et al 1971 
JUS et al 1976a
ECT HUNTER et al 196^ DEGKWITZ 8c WENZEL 1967 
DEMARS 1966 
HEINRICH et al 1968 
EDWARDS 1970 
BRANDON et al 1971 
JUS et al 1976a 
ASNIS et al 1977 
GARDOS et al 1977 
CHOUINARD et al 1979 
GARDOS et al 1980
LEUCOTOMY HUNTER et al 
DEMARS 
EDWARDS 
BRANDON et al 
JUS et al
196^
1966
1970
1971 
1976 a
"SOMATIC THERAPIES" ITAL et al 1981
FEATURES OF THE 
MENTAL STATE
CHOUINARD et al 1979 
ITAL et al 1981 
McCREADIE et al 1982
preparations, such as differing bioavailability and compliance.
b) MAXIMUM DAILY DOSE
There is no evidence of a relationship between higher 
maximal daily doses and frequency of movement disorder.
c) DURATION OP EXPOSURE
The bulk of the literature is against this being of 
relevance.
d) CUMULATIVE EXPOSURE
The assumption that cumulative neuroleptic exposure is 
relevant in predisposing to involuntary movements is not borne 
out in the literature.
e) EXPOSURE TO MULTIPLE NEUROLEPTICS
This has not been shown to be relevant.
f) NEUROLEPTIC - FREE INTERVALS
Jeste et al (l979a) found that the variable which 
maximally distinguished between dyskinetic and non-dyskinetic 
patients was the number of drug-free intervals of 2 months or 
more, which were reported to be significantly more frequent in’ 
the former group. This has not been replicated, but remains of 
interest as its practical implications are quite contrary to 
those of the widely advocated ’drug holidays’.
g) ANTICHOLINERGIC MEDICATION
There is no clinical substantiation for the view, 
however theoretically plausible, that anticholinergic medication 
promotes the development of involuntary movements.
1.8.2 NON - DRUG - RELATED FACTORS
a) AGE
Age remains one of the most striking positive associations 
reported in literature on involuntary movements. A number of 
studies which did not find a relationship with age examined patients 
within relatively narrow age ranges. Kane and Smith (1982) suggest 
a minimum of 3 decades of age range in a study sample, with patients 
under 50 represented. Applying these criteria, the bulk of the 
literature is in favour of a relationship between age and the 
presence of involuntary movements. Jeste and Wyatt (l98l)calculated 
an overall unweighted mean prevalence of abnormality in patients 
over 40 that was three times that in younger subjects.
Although age can be quite consistently shown to be a 
significant correlate of involuntary movements the exact nature 
of this relationship remains unclear. Smith and Baldessarini
(1980) reviewed 9 studies and found that strong correlations 
existed between age and both prevalence and severity of movement 
disorder. In addition they concluded that there was a strong 
negative relationship between age and spontaneous remission of 
involuntary movements attributed to neuroleptics. Both increased 
severity and low spontaneous remission rates could contribute to
higher prevalence rates in older subjects even if incidence 
were not affected by age per se. Furthermore, sex may complicate 
evaluation of the effects of age. It has been reported that 
middle aged males may show slightly more severe dyskinesia 
(Chouinard et al 1979) though it has also been suggested that 
elderly females may have especially severe abnormal movements 
(Smith et al 1979b). Such discrepancies may reflect the differing 
age ranges of subjects who form the cohorts of different 
investigations (Smith & Dunn 1979)*
A further complication in evaluating this question is 
the suggestion, mentioned earlier, that the distribution of 
abnormal movements may differ in different age groups. Thus, 
younger patients, especially males, may be more prone to develop 
generalised dystonic and choreoathetoid syndromes while in older 
patients, especially females, orofacial movements may be more 
likely (APA Task Force 1979)* Using blanket descriptive 
terms such as 'dyskinesia* or basing evaluations on multi-item 
rating scale total scores or global impressions may mask regional 
body variations.
The exact nature of the association between age and 
involuntary movement disorders remains to be determined.
b) SEX
One of the earliest suggestions was that 'TD' was more 
common in women. A number of the pioneering descriptive studies 
were, however, confined to female wards, and others did not examine 
the role of sex independent of age.
A recent review of the subject (quoted by Kane and 
Smith 1982) calculated that the average unweighted F;M 
prevalence was 1.68 : 1 from a total of 31 studies. This is a 
comparable finding to that of Jeste and Wyatt (l98l) who 
calculated an overall weighted mean prevalence for women that was 
41 % higher than for men, using a more selective series of 19 
studies.
However, a number of studies have failed to show a 
significant relationship between female sex and neuroleptic - 
related movement disorder (TABLE 2:1:2), and as Jeste and Wyatt
(l98l) have pointed out, there are as yet too few studies to 
allow the determination of the differential effects of age on 
males and females with regard to the production of 'TD1. A 
further difficulty relates to the suggestion of Smith et al (l979t>) 
that the sexes may differ in prevalence only at the highest criterion 
of severity. In view of the relative rarity of ’severe1 cases 
this finding could be secondary to sampling fluctuations, as the 
number of subjects on whom analysis was conducted was small.
Despite the above statistical association from pooled data, 
it remains unclear whether sex differences are consequent upon the 
intruding effect of some secondary factor such as age, or whether 
they reflect some biological variant such as brain neuro transmit ter 
differences, the effect of sex hormones on central systems or 
merely different patterns of neuroleptic treatment. In this regard, 
several authors have noted that women tend to receive longer or 
higher dose treatments than do men (Degkwitz & Wenzel 1967; Jones & 
Hunter 19&9; Faun et al 1972; Simpson et al 1978).
t
c) ORGANICITY
As with sex, one of the earliest anecdotal associations 
with dyskinesia was organic brain disorder. Despite this early 
impression, this is a question that remains remarkably poorly 
investigated. A variety of parameters of organicity have been 
adopted, from the conventional such as a diagnosis of organic 
brain syndrome, to the more controversial such as a history of 
ECT.
Pryce and Edwards could not distinguish between an 
experimental group of 21 dyskinetic subjects and a group of 
matched controls in terms of "organicity". This term however 
encompassed a variety of parameters, many of doubtful validity. 
Although no differences emerged between the groups on Walton’s 
Modified Word-Learning Test, this could not be performed in 
over 25 % of the sample. Subsequently, Edwards assessed 34 
matched pairs drawn from a larger pool of I8 4, using the same 
parameters. Significantly more of the experimental group had a 
diagnosis of dementia and fulfilled "organicity" criteria in 
general. Despite a large group who once again could not be 
tested, significantly more dyskinetic patients were impaired on 
the Word-Learning Test than patients free from dyskinesia.
Edwards concluded that his findings were not just the result of 
a preponderance of dementing cases in his experimental (dyskinetic) 
group, as more patients with a functional diagnosis and 
dyskinesia showed evidence of "brain damage" than functional 
subjects without dyskinesia. More recently, Ital et al showed 
significant impairment on items of the Goldfarb scale (of
orientation and memory) in a severely dyskinetic group compared 
to a matched, non-dyskinetic group.
Three other studies using different neuropsychological 
tests have been reported. Famuyiwa et al found no difference on 
Withers and Hinton totals in their dyskinetic patients compared 
to dyskinesia-free controls, though both were significantly 
impaired in comparison to normals. The groups studied in this 
work were however relatively young and had short durations of 
illness. The degree of their cognitive inpairment was slight 
compared to that reported with other schizophrenics using this 
test (e.g. Johnstone et al 1978b). However, the authors did 
report significant impairment on the Inglis Paired Associate 
Learning Test in the dyskinetic group compared to controls.
Jose* et al found a relationship between impaired 
norientation/memory" on the Missouri Mental State Examination 
and "tardive dyskinesia", though this was certainly due in large 
part to the fact that those comprising their small sample with 
involuntary movements (6/76) were older than the rest.
Asnis et al reported no differences in a group of 
dyskinetic out-patients compared to dyskinesia-free patients 
using both the Mental Status Questionnaire and the Face-Hand 
Test of Kahn et al, though the study sample was again relatively 
young and the latter test in particular was devised for use 
with elderly subjects.
No association has been reported between involuntary 
movement disorder and a positive neurological history (other than 
dementia) or with leucotomy, and although Wegner et al have
suggested an association with the B-mitten complex on EEG, 
two other studies have reported no association with EEG variants 
(Gardos et a! 1977; Ital et al 1981). The CT scan data(which 
in general is negative) will be discussed subsequently (Part III).
Thus, although the idea is widespread that neuroleptic- 
caused movement disorder is associated with brain damage, the 
evidence to confirm it is equivocal (TABLE 2:1:2).
d) PAST PHYSICAL TREATMENTS
As mentioned above, no studies have found an association 
between dyskinesia and leucotomy. On the contrary, four studies 
have reported no association.
Nine of the 13 patients described by Hunter et al had 
received EOT, some in considerable amounts (from 14 - 212 
treatments), but apart from this uncontrolled observation there is 
no evidence to suggest an association with EOT. Indeed 10 studies 
have reported no association (TABLE 2:1:2).
Brandon et al (l97l) reported significantly less orofacial 
abnormality in patients with a history of insulin coma therapy 
than in patients who had not received this, though believed the 
explanation lay in the relatively lower age of the insulin- 
treated patients. Four other studies found no relationship 
(TABLE 2:1:2).
Thus there is no evidence to implicate past physical 
treatments in the production of movement disorders.
e) FEATURES OF THE MENTAL STATE
This area is probably the most neglected with regard to 
predisposing factors in neuroleptic-related movement disorder. 
Chouinard et al (1979) found that among schizophrenics of the same 
age, those for whom neuroleptic treatment was producing little 
therapeutic effect were more likely to have a greater prevalence 
and severity of abnormal movements. Unfortunately the mental 
state features on which this finding was based are not described.
Ital et al (l98l), using the 28 item Expanded BPRS , 
found significant relationships between movement disorder and a 
number of items of the type associated with 'negative* or 'defect ' 
states (e.g. impaired communication, emotional withdrawal, 
blunted affect, apathy or disinterest etc.). These authors note 
that no relationships were established with the so-called 
'productive' symptomatology of psychosis. As their dyskinetic 
and non-dyskinetic samples were closely matched for age and sex 
these two variables could not account for the finding.
Recently, McCreadie et al reported similar results in a 
study of schizophrenics within a defined geographical area.
Movement disorder was significantly related to affective flattening 
(Krawiecka Scale) and social withdrawal (Wing Scale).
Thus, although there is some evidence to suggest that 
involuntary movements may be more prevalent in patients with 
persisting mental state abnormality - especially that of the 
'negative' or 'defect' type - insufficient work has been published 
in this area to allow definite conclusions.
1.9________COURSE AND PROGNOSIS
This remains a controversial area. While early reports 
were concerned with the "apparent" irreversibility of the syndrome, 
more recent work has sought to establish the role of reversibility 
in the course and prognosis.
Earlier reports were not encouraging with regard to the 
resolution of dyskinesia on neuroleptic withdrawal, but more 
recent studies since the mid-JO’s have reported increasing 
proportions of patients whose symptoms resolve or significantly 
improve. This probably reflects the fact that newer studies 
with higher prevalences included milder abnormality in patients 
treated for shorter periods, and also the longer follow-up 
intervals employed.
The American Psychiatric Association Task Force Report 
on Tardive Dyskinesia, calculated an average remission rate of 
22 % from 12 studies from I960 - 1980 (APA Task Force Summary 
1980). The rate rises to JO % if only studies from 1970 are 
considered, and to 64 % for those after 1976. Jeste and Wyatt, 
reviewing the literature up to 1980, concluded that the syndrome 
is reversible in slightly more than one-third of patients 
(jeste & Wyatt 1981).
Recently, Seeman reported a 2 year follow-up of out­
patient schizophrenics diagnosed as having TD, and who had either 
been on "prolonged" drug holidays or had their neuroleptic 
dosage reduced (Seeman 198l). She noted disappearance or marked 
reduction in dyskinesia ratings in 56 % of subjects. This is in 
line with more recent published remission rates. In addition,
Seeman found the signs had disappeared or reduced markedly in 
76 % of those under 40 years of age, but in only 37 % o f those 
older than 40* This may reflect the view mentioned earlier, 
that such movements are more severe in older patients.
Systematic studies which have so far looked at this
question have used total rating scale scores so there is as yet
no information on which distributions of abnormality may be most 
S. I
su/cept^ble to improvement or on shifts of distribution that may 
follow dose reductions.
Underlining the confusion about the question of reversibility/ 
irreversibility, is the finding of Gardos and Cole who sent 
questionnaires to 20 investigators specialising in the area of 
’tardive dyskinesia^ (Gardos & Cole 1980). They asked for opinions 
regarding the frequency with which dyskinesia persisted in 
patients whose drugs had been withdrawn for 3 - 2 4  months. The 
experts’ reported figures ranged from 0 % to 100 %. Such striking 
variability is likely to reflect more than variation in symptomatology 
and treatment policies, but probably reflects profound differences 
in understanding of 'tardive dyskinesia'. It would appear that 
for some, irreversibility is becoming incorporated in the concept 
of the syndrome.
1.10 PROPOSED PATHOPHYSIOLOGY
The similarity between involuntary movements associated 
with neuroleptic administration and other choreoathetoid 
syndromes has suggested a common biochemical basis. It is beyond 
the scope of the present work to review the substantial literature
that has been generated in this area. Comprehensive reviews 
have been published elsewhere (Tarsy & Baldessarini 1977; 
Baldessarini & Tarsy 1979; Marsden & Jenner 1980; Be Veaugh - 
Geiss 1982). In summary, evidence has accrued to support the 
view that the pathogenesis of 'tardive dyskinesia1 relates to 
chronic dopamine receptor site blockade, which may be considered 
as a form of chemical denervation, and that the pathophysiology 
resides in the resultant receptor site hypersensitivity, which 
develops in conformity with Cannon’s Law.
While this view is in keeping with a number of clinical 
observations and has gained widespread acceptance, other facts 
cannot be readily accommodated within this model in its 
simplest form. Some of these difficulties have been reviewed by 
KLawans et al (1980). Recently Jeste and Wyatt (l981a) have 
suggested an alternative model implicating other amine systems.
The pathophysiology of movement disorder associated with 
neuroleptic intake is complex and, at present, poorly understood. 
Exploratory pharmacological investigations which do not take 
account of the non-specific modifying influences of the study 
drugs on factors such as mental state, and which necessitate 
the probing of central neurotransmitter systems in isolation, 
are likely to provide misleading, or at best, partial information. 
The question of the relationship between dopamine receptor change 
consequent upon neuroleptic administration and that which it has 
been suggested, may underline the schizophrenic process itself 
(Owen et al 1978), is of great interest but remains to be 
elucidated.
1.11 NEUROPATHOLOGY
No consistent neuropathological abnormality has been 
found in the brains of patients with neuroleptic-related 
movement disorder. In the only controlled study to date, 
Christensen et al (1970) did find nigral degeneration in 27 out 
of 28 brains from patients with dyskinesia, and mid-brain and 
brain-stern gliosis in 25- In control material from non- 
dyskinetic subjects the respective figures were 7 and 4»
Although matched, the controls differed from subjects on variables 
other than the absence of dyskinesia (e.g. age, neuroleptic 
treatment etc).
1.12 ______SUMMARY OF THE LITERATURE
1) The statistical association between involuntary 
movements and neuroleptic administration rests on 
epidemiological data which in general are of poor 
quality, and require caution in their interpretation. 
Nevertheless, the strength of the association is 
striking.
2) The prevalence reported in the literature is increasing, 
which may partly reflect a genuine increase in 
frequency though is likely also to reflect apparant 
changes consequent upon greater recognition.
3) The reported annual incidence of 3 - 5 % requires 
confirmation.
4) No specific drug-related factors have been clearly 
demonstrated as increasing the risk of developing 
movement disorders.
5) Only age, of the non-drug related variables, has shown 
relative consistency of effect. Female sex, organic 
predisposition and features of the mental state remain 
either unclear or unconfirmed with regard to 
predisposition.
6) The course and prognosis of the involuntary 
movements remains controversial. This relates to the 
reversibility/irreversibility phenomenon with neuroleptic 
reduction or cessation.
7) The pathophysiology underlying involuntary movements 
in this context is ill-understood. Straightforward 
theories linking the features solely to post - synaptic 
dopamine receptor supersensitivity are likely to be 
over-simplifications.
8) No neuropathological lesion has yet been identified.
Chapter 2 - The Present Study
2.1 GENERAL
The review presented in this section has concentrated 
on the literature relevant to ’tardive dyskinesia’. This is 
now voluminous and swamps the few sketchy hints in the older, 
descriptive writings which suggested that schizophrenia itself 
may possibly be associated with the development of involuntary 
movements (Part I). The discrepant size of the two literatures 
should not justify the implications of the larger over­
shadowing those of the smaller. As has been shown, the concept 
of ’tardive dyskinesia’ rests on evidence open to quite basic 
methodological criticisms, and in those most at risk of 
developing abnormal movements - namely schizophrenics in whom 
the condition is established - aspects of the illness per se 
have not been systematically explored.
Ideally, for the role of neuroleptics and illness to 
be adequately evaluated, a large number of subjects with 
standardised diagnoses would require to be randomly allocated 
to neuroleptic or no neuroleptic and assessed, blind to 
treatment, over many years. The scale, complexity and ethics 
of such a study are against it ever being done. Howaver, 
valuable information could still be obtained by investigating 
diagnostically homogeneous and symptomatologically defined 
schizophrenics who have and who have not been treated with 
neuroleptic drugs, and who have all in addition been managed in 
the same administrative environment. No such study has yet
"been reported.
2.2_______ THE SPECIFIC QUESTIONS
The specific questions addressed in this part of the 
study have been laid out previously hut will he re-stated for 
clarity.
1) Is established schizophrenia, unmodified by 
neuroleptic drugs, associated with the development 
of spontaneous involuntary movements ?
2) In established schizophrenia can the concept of 
tardive (neuroleptic-caused) dyskinesia be shown to 
have validity and if so what are its correlates ?
2.5_______THERAPEUTIC BACKGROUND
The study population that is the basis of the present 
work was ideally suited for the evaluation of these questions, 
because of the widely differing treatment policies operated for 
many years, and which were briefly referred to earlier 
(introduction 3 IV : Part I Chapter 5*l)»
Shenley Hospital has, since it opened in 1934» provided 
psychiatric care for the adjacent London Boroughs of Brent and 
Harrow. Prom the administrative point of view, the two 'halves’ 
of the hospital were separate. Admission either to the Harrow 
Division or the Brent Division depended entirely on what borough 
the patient resided in. Prom its early years the hospital's 
two Divisions began to diverge in treatment orientation with 
Brent Consultants adopting a more psychotherapeutic approach.
By the time neuroleptics were introduced into the hospital in
195  ^an essentially therapeutic community orientated programme 
was established for Brent patients. The Consultants concerned 
were particularly interested in the application of these 
principles to the management of schizophrenia. Intrinsic to 
this programme was the avoidance where possible of physical 
treatments of all kinds. In the 1960's when neuroleptics were 
becoming widely prescribed, this dynamic approach reached its 
zenith. Shenley acquired a considerable international reputation 
in the psychotherapeutic management of schizophrenia and one of 
the Brent Consultants, Dr. David Cooper, became a prominent 
member of the so-called 'anti-psychiatry1 movement. His accounts 
of the work of his unit ('Villa 21')were widely read and 
influential? This practice persisted well into the 1970's 
(the Senior Consultant only retired in 1975)*
This philosophy of treatment was not imposed by 
medical staff but rather evolved over many years. Hence non­
medical personnel (nurses, social workers, occupational 
therapists etc.) were attracted and recruited into the system 
because they shared the belief in its humaneness and efficacy.
For these reasons, it is felt that a history of no 
exposure to insulin coma, ECT, and especially neuroleptic drugs 
is reliable. In view of the staff's commitment, it is unlikely 
that neuroleptics were given without being recorded on drug 
sheets and certainly there is little question that this could 
have taken place regularly.
None of the aforegoing is meant to imply an absolute 
proscription on the use of physical treatments for Brent patients.
* see : Cooper D., "Psychiatry and Antipsychiatry'.' Tavistock
London 1967.
It was merely that alternative methods of management were 
emphasised and the administration of physical treatments 
avoided. Medication was used. For example, barbiturate 
hypnotics were sometimes given and acute behavioural disturbance 
was occasionally managed with parenteral barbiturates or 
paraldehyde. Some patients were eventually given neuroleptics.
Because of these general principles it was possible for 
some patients to pass the greater part of their years without 
receiving physical forms of treatment and in particular without 
being managed with neuroleptic drugs. This has been confirmed 
in informal conversation with a number of nurses whose careers 
span many years at the hospital and who were in the past 
involved in psychotherapeutic programmes for schizophrenic 
patients.
Chapter 5 - Methods
5.1 EXAMINATION AND RECORDING TECHNIQUES
The population was re-examined between May and July 1980.
This second neurological examination focused solely on spontaneous 
involuntary disorders of movement and abnormalities of gait and 
posture. The assessments were conducted according to a format 
which combined the procedural recommendations for the rating scales 
adopted for recording of findings.
Two different scales were chosen for recording purposes - 
the Abnormal Involuntary Movement Scale, or AIMS, (Guy 1976) 
and the Rockland (or Simpson Dyskinesia Rating) Scale (Simpson et 
al 1979)* Tbe AIMS, (Appendix VI) devised at the National Institute 
of Mental Health, is succinct, of proven reliability on its major 
items, and has been widely used. Its classification is, however, 
gross, all involuntary movements being subsumed under 7 regional 
headings each on a 5 point severity scale, and it has a strong 
facial bias. It specifically excludes tremor from its ratings.
Hence the information it notes is compatable with a more 
restricted definition of 'dyskinesia*.
The scale devised by Simpson et al at the Rockland 
Institute, New York * (Appendix VII) is somewhat wider in its 
conceptualisation. It consists of 45 items each with a 6 point 
scale severity, 34 of which demand the evaluation of specific, named 
movements arranged systematically. The remaining 9 items are left for
* This scale was in preprint form when used in the present study 
and at that stage was referred to by the name of the Institute where 
it was devised. Since publication, it has become generally known by 
the name of its principal author and is usually called the Simpson 
Dyskinesia Rating Scale. The original designation has been retained 
in the present work.
the rating of non-specified movements felt to he present but 
not ratable on the specific items. The Rockland Scale (RS) 
includes tremor in its main items and there is nothing to 
preclude the examiner from using non-specific items to record
tremor of different clinical types. This scale records
I
abnormality compatible with a wider definition of 'dyskinesia'.
Patients were examined individually, one ward at a 
time and in random order. The assessments were conducted 
in a side room. Subjects were observed unobtrusively as 
they entered the room, sat down and were engaged in general 
conversation. Facial movements were assessed with mouth 
closed and open and tongue resting passively on the floor of 
the mouth and protruded. Distal upper limb and periorbital 
movements were evaluated with the patient standing upright, 
arms extended in front, both with fingers horizontal and 
abducted and with wrists limp. This stance was adopted with 
eyes open and closed.
Two 'activating' or 'reinforcement' techniques were 
employed to enhance dyskinetic activity - namely, rapid 
thumb and sequential finger opposition and alternate foot - 
tapping.
Posture, gait and associated arm movement were noted 
as the patient walked away from and toward the examiner in their 
normal walk in the open ward.
A final unobstrusive observation was made as the patient 
left, or if necessary, after the formal examination.
Both scales were completed at the time on the basis of
the definition of items and severity points required for each. 
For severity, the maximal abnormality at any time during the 
interview was taken. The AIMS requirement for movements 
"that occur upon activation to be rated one less than those 
observed spontaneously" was suspended. To have enforced this 
would have meant that the T11 rating, by definition for 
movements considered doubtfully abnormal in either type or 
degree, would have been contaminated by definitely abnormal 
activity (e.g. choreoathetosis) only detectable in certain 
circumstances. As it was felt that a number of such movements 
should always be considered abnormal, regardless of the 
circumstances in which they are elicited, the AIMS rule was 
regarded as conceptually unsound.
These examinations were conducted after completion 
of the initial assessments described in Part I. For this 
reason alone it would not have been possible for the examiner 
to recall the drag status of individual patients. In. addition 
however, throughout the project patients were identified by 
code numbers, thus ensuring blindness as to treatment past and 
present.
Following the second examination, the patients1 drug 
intake during the interim period was re-checked. Where 
individual records continued to indicate that the subject 
remained neuroleptic-free, confirmation was sought from the 
nursing staff and, where possible, from the patients themselves.
As neither the AIMS nor the RS makes provision for 
recording movement activity of a ’manneristic’ or ’stereotyped1
variety, abnormalities of this type were not assessed and not 
knowingly rated.
5.2_______STATISTICAL NOTE
3.2.1 ANALYSIS OF DATA
No entirely satisfactory method exists for the analysis 
of data recorded on multi-item rating scales. Three main methods 
have been advocated :
1) TOTAL SCORES: This is the obvious method, but the
regional sensitivity of the scale is lost. Furthermore, it 
presents the major problem of adequately separating pathological 
from non-pathological ratings, which will be discussed below.
With distributions of scores which are not bimodal, adoption
of cut-offs in accounting for severity is of necessity arbitrary.
2) SINGLE SYMPTOM CRITERIA: This is based on the numbers
attaining at least one rating at a defined point on the severity 
continuum on at least one item of the scale and is a straight­
forward method of accounting for severity in prevalence estimates. 
It is obvious that a subject fulfilling a specified criterion 
must also fulfill all lower criteria. Thus prevalence based on
a single symptom criterion of, say, '31? is the number of 
subjects who score at least one 13 1 on any item. It however, 
takes no account of the number of items rated at the specified 
criterion and consequently greatly compromises the scale's 
sensitivity.
3) GLOBAL IMPRESSIONS: It is possible on the basis of
the number of items scored at each severity point to estimate
a global impression of the degree of abnormality, and to use 
this single numerical value in analysis. This has the advantage 
of simplicity and flexibility but this is gained at the total 
sacrifice of regional sensitivity. This method would appear 
to introduce a subjective quality into analysis which runs 
counter to the basic purpose of standardised multi-item 
recording techniques.
In the following analyses, both total scores and single 
symptom criteria will be used as stated. The global impression 
method was not utilised.
3.2.2 ADOPTING CUT - OFFS
The major part of the following analyses uses the total 
scores method. This necessitates the adoption of cut-offs to 
distinguish abnormality from normality, and to define varying 
degrees of severity.
In common with most multi-item rating scales in clinical 
psychiatry, both those used here reserve one point on the 
severity continuum (’I1) for recording signs which are present 
but not considered to be abnormal in either type or degree.
This means that totals represent all motor activity noted, not 
just that considered pathological. Injudicious use of total 
scores could result in someone scoring 4 on one item, and hence 
having an abnormality of note, being considered for analytical 
purposes the same as someone who scored *1' on four separate 
items who, by the definitions of the schedule, had no definite 
pathology. A low cut-off increases the likelihood of contamination
of the abnormal group this way, while raising it too high will
exclude some subjects with mild but definite abnormality. In
the present work cut-offs for normality were based on the 
minimal misclassification of subjects either way, while those 
for analyses involving severity were arbitrary.
a) AIMS DATA
Eleven subjects had a total AIMS score of ’l1. Only 
three were rated 111 on more than one item, and of these, only 
one had a total (this was 2) comprising solely 'l's. No totals 
of three arose from ’l's. On the other hand, 38 patients had 
a total of 2 made up of single, mild ratings. Hence on the 
basis of minimal misclassification, an AIMS total of 0 or 1 is 
defined in the basic analyses as normal, while abnormality is 
taken as a total score of 2 or more.
Although based on the data, many would say this defines 
normality too conservatively, so some of the later analyses 
were repeated, defining normality by the higher cut-off of 
0 - 2.
Ranges of totals reflecting the normal/mild-moderate/ 
severe distinctions were mainly chosen on statistical 
considerations to provide roughly equal numbers in comparison 
cells. These are defined as they arise.
b) ROCKLAND DATA
Ten subjects had an RS total of '1'. Of 12 subjects 
with two single ratings of ’1’, these were the sole ratings in
just two and, as with the AIMS, no-one obtained a total of 3 
from three ’l's. Thirty two subjects had an RS of * 21 comprising 
single, mild ratings while raising the cut-offs total to 3> 
misclassified 52 subjects. Hence in the initial analyses an 
RS total of 0 or 1 was taken as normal, 2 or more as abnormal.
While minimal misclassification occurred with this cut­
off, a normality criteria of 0 - 1 on a 43 item scale is 
undoubtedly parsimonious. Raising the cut-off to account for 
both a wider concept of normality and the size of the scale is 
arbitrary. In the present work the higher normality criterion 
was fixed at an RS total of 4*
In addition to using grand totals from all 43 RS items,the 
regional pattern of relationships with past neuroleptic exposure 
was explored using Rockland subscore totals for Face, Neck and 
Trunk, Upper Limbs and Lower Limbs items. The low normality 
cut-off for these subscore totals was maintained at 0 - 1. The 
higher cut-off was arbitrarly taken as 0 - 3* This value, 
slightly lower than that chosen for use with grand totals, 
reflects the fewer number of items comprising the subscore totals 
and the fact that grand totals included the three whole body 
ratings of the RS (items 41 - 43) not included in any of the 
subscores.
Arbitrary ranges of totals in estimates involving severity 
are defined in the text.
3.2.3 STATISTICS
As was mentioned (Part I, Chap. 2 .4 .) in this detailed 
evaluation of involuntary movements a more cautious approach 
to the analysis of examination variables was adopted. In both 
this and the subsequent section they were treated as ordinal 
measures, distinctions being drawn between those not scoring 
and those scoring positively by defined cut-offs for normality, 
and between different ranges of scores to represent severity 
of abnormality. This recognises the patterns of distribution 
of the Assessed Abnormality scores and keeps the present 
analyses in line with the published literature.
Groups defined on this basis were compared using the
2
X statistic. Group mean score differences and mean number 
of movements were compared using t - tests, while the relative 
contributions of age and length of illness to the development 
of movement disorders were assessed using analysis of variance 
(ANOVA) and co-variance (ANCOVA).
The maximum likelihood/log linear technique referred 
to earlier (Part I Chap. 4*4) was used as stated.
The relationship of prevalence and severity of movement 
disorder to individual items of Recorded Information and 
Assessed Abnormality was investigated using unified analysis 
of variance by ranks (Meddis 1980). This technique requires 
only that the measures being evaluated are ordinal, but not 
that their distributions are normal.
The following data were subjected to a large number of 
analyses increasing the risk of significance being achieved by
chance. In view of the unique characteristics of the study 
sample and the importance of the.questions being explored, a 
conservative approach to the interpretation of statistical 
significance was adopted. Thus, notwithstanding the 
hypotheses set out in the Introduction (3 , iii ), a 2 - tail 
interpretation was employed throughout Part II.
Chapter 4 - Results
4.1 GENERAL
Of the original sample of 510 subjects, 411 were available for 
the second examinations concentrating specifically on involuntary 
movement disorders. Of these, 3^4 bad a history of exposure to 
neuroleptic drugs, and 47 bad remained neuroleptic-free. The 
demographic and treatment details of this sample are shown in TABLE 2:4:1*
In the first examination, when only presence or absence of 
involuntary movements was considered, 5 0 .4 % of the sample had 
demonstrable abnormality. On the second examination, using the AIMS 
scores (which, being free of tremor are more compatible with the 
initial assessments), this prevalence corresponds to a cut-off point 
of 3 (moderate) on the severity continuum (Fig 2:5:2). Adopting 
this 'moderate1 criterion, a highly significant relationship was
established between the way a patient was rated on the first and on
2 2 the second examinations (Face: X = 51*05> df = 1 : Limbs: X =
19*25, df = 1).
Results of data recorded on AIMS and RS will be presented 
separately.
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Chapter 5 - Results - The AIMS Data
5.1 THE TOTAL SAMPLE
5.1.1 PREVALENCE AND SEVERITY
Fig 2:5:1 shows the distribution of total scores of 2 or more 
in the sample of 411- The prevalence of abnormality by this criterion 
is 64 .9 6 %•
The distribution of scores is roughly, though not precisely, 
exponential, and certainly offers no definite cut-off points for the
division of abnormality by severity. The high prevalence of a score
of 6, which is the major flaw in the exponential!ty of the distribution, 
may reflect the central tendancy phenomenon - i.e. the examiner's 
tendancy to rate in the centre of the severity continuum - operating 
on facial items which, by the nature of the abnormalities in that 
region, are likely to be rated in pairs. Thus, of the 46 scores of 
6, over half (2 4) arose from two ratings of 13 1 on facial items.
The skewed distribution shown in Fig 2:5:1? is reflected in 
the mean AIMS total for the group, which was 4*28 - SL 4*68.
Fig 2:5:2 shows the prevalence of abnormality at increasing 
criteria of severity in all body regions together and in each separately 
using the single symptom criterion technique. This illustrates the 
crucial dependence of prevalence on the criterion of severity adopted.
In general, very high prevalences of involuntary movement 
disorder were found in this group of long-stay schizophrenics. With
a single symptom criterion of 3 “ that is a moderate degree of
abnormality on at least one item - $0 *6 % o f patients had demonstrable
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disorder. As Fig 2:5:2 shows, the major component of total 
abnormality was contributed by ratings of facial movements.
5.1.2 THE DISTRIBUTION OF MOVEMENT PATTERN
The percentage of the total sample who attained a pathological 
rating (i.e. at least a single rating of 2 or more) is shown for each 
AIMS item in order of frequency in TABLE 2:5:1*
This confirms that movements involving the tongue, lips and 
jaws, (the buccomasticatory lingual or EML, component) are the most 
prevalent dyskinesias in patients such as these, with movements of 
the axial/girdle musculature being least common.
5.2._____ COMPARISON OF NEUROLEPTIC TREATED and NEUROLEPTIC-FKEE SUBGROUPS
As was mentioned earlier, the concept of 'tardive dyskinesia' 
rests on epidemiological data from comparisons of samples differing 
on many variables other than neuroleptic exposure. However, at a 
clinical level the diagnosis is essentially made on the basis of a 
history of exposure to neuroleptic drugs.
In its elementary form the concept of neuroleptic-caused 
movement disorder could be validated if diagnostically homogeneous 
groups who had and had not been exposed to neuroleptics could be shown 
to differ in the prevalence and/or severity and/or distribution of 
involuntary disorders of movement. The present population offered 
an ideal opportunity to test this simple form of the concept.
TABLE 2:5=1
DISTRIBUTION OF INVOLUNTARY MOVEMENTS ON AIMS IN ORDER OF FREQUENCY
AIMS AREA %  PREVALENCE 
(RATING 2 OR MORE)
TONGUE 35-*+
LIPS 28.1
JAWS 23-7
FACIAL EXPRESSION 18.3
EXTREMITIES - LOWER 15.6
EXTREMITIES - UPPER
NECK, SHOULDER, HIPS 13.7
5.2.1 PREVALENCE AND SEVERITY
Of the 411 schizophrenics examined for the second time, 47 
continued to he neuroleptic-free. (During the first part of the 
study 65 such patients had been identified - Part I).
The prevalences of abnormality at increasing criteria of 
severity, in patients with a history of neuroleptic treatment (564) 
and those who had remained neuroleptic-free (47) are shown in 
Pig 2:5:35 which considers all body regions together and each 
separately. No differences reaching conventional levels of statistical 
significance were found between the groups at any severity or in 
any region ( X analysis). The prevalence of abnormality is again 
high in those free from neuroleptic exposure. With a single symptom 
criterion of 2, 53*2 % o f these patients had movement disorder.
5.2.2 MEAN SCORES
The mean total and regional scores for neuroleptic-treated 
and neuroleptic-free groups are illustrated in Pig 2:5:4* None of
the differences between the groups attained statistical significance
\
at the 5 % level, though there was a non-significant tendancy towards 
higher upper limb scores in the neuroleptic-treated group (t = 1.935 
df = 409, P < 0.1).
5.2.5 MEAN NUMBER OF MOVEMENTS
As it is possible that one group might exhibit fewer 
movements of greater severity than the other, the mean number of 
movements was calculated for all regions together and face separately.
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(The corresponding value for the other separate body regions was too 
small to be of use). As Fig 2:5:5 shows, no significant differences 
emerged between the groups.
5.2.4 DISTRIBUTION OF MOVEMENT PATTERNS
To investigate possible differences in the distribution of
2
abnormal movements between the groups, X analysis was conducted on 
2 x 2  contingency tables, those showing no pathological movements 
(0 and l) being compared with those rating an involuntary movement 
in pathological degree (2 or more). This was performed for each of 
the 7 AIMS items.
The distribution of abnormality for the neuroleptic-treated 
and free groups is shown in Fig 2:5:6. The only significant difference 
was that those exposed to neuroleptics exhibited upper limb abnormality 
more frequently than those in the neuroleptic-free group (X = 4*06, 
df = 1, P< 0.05) . When a similar comparison was performed taking 
severity into account, no significant differences emerged between 
the groups.
If those patients who attained a pathological rating (2 or more) 
in any one or more AIMS items are defined as the 'morbid* sample 
from the point of view of involuntary movements, 267 subjects can be 
identified. The distribution of abnormal movements within neuroleptic- 
treated and neuroleptic-free subgroups of this 'morbid' sample 
likewise showed no significant differences.
Thus, the distribution of abnormal movements within the total 
sample and also among 'morbid' patients considered separately was 
remarkably similar for those who had been exposed to neuroleptic
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medication and those who had not.
In summary, these results do not provide support for the view 
that in long-standing schizophrenic patients the concept of neuroleptic- 
caused involuntary movement disorder can he validated solely by the 
presence of a history of neuroleptic exposure. Involuntary movements 
with a predominantly orofacial distribution can be commonly found 
in patients such as these whose illnesses have remained unmodified 
by neuroleptic drugs.
However, in order to assess accurately a possible role for 
neuroleptics in relation to movement disorder, and to evaluate the 
relevance of involuntary movements to the schizophrenic illness 
per se, it is necessary to take account of the fact that the 
neuroleptic-free patients, with a mean age of 66.7 ( - SD 11.66 years), 
were considerably older than the neuroleptic-treated patients 
(mean age 56*9 ~ SD 13*29 years).
5.3 THE ROLE OF TIME ADD SEX
Total scores were used to evaluate the role of age and sex 
in the prevalence and severity of movement disorder in the total 
sample. A possible separate contribution from length of illness was 
sought with regard to severity. Although data on age using single 
symptom criteria are presented, this method was used mainly to explore 
the relationship with sex, in line with the published literature.
5-3.1 THE ROLE OF AGE AND SEX IN PREVALENCE
The relationship between an AIMS total score of 2 or more
and increasing age in the total sample and in females and males 
separately is shown in Fig 2:5-7? and the results of analysis by 
the maximum likelihood/log linear method, in TABLE 2 :5:2 .
As can be seen, a highly significant association between sex 
and age emerged, more of the females being older, and although a 
significant association between age and prevalence could be 
demonstrated no association between sex and prevalence could be 
established.
This lack of a role for sex in prevalence of abnormal 
movements in this sample is illustrated by the corrected F:M ratio 
for each age band. This is the ratio of the percentage of females 
to the percentage of males scoring 2 or more in each age group.
CORRECTED F : M RATIO
<40 1.19
40-49 0.95
50-59 1 .2
60-69 0.89
> 70 1.08
This shows little apart from random variation.
Thus, while age was of importance in determining prevalence 
of abnormal movements in the present sample, sex per se could not 
be shown to be so. It is of interest, as Fig 2:5:7 shows, that 
although both sexes appear to plateau with age this occurred a decade 
earlier in the females than in the males.
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TABLE 2:5:2
ANALYSIS (MAXIMUM LIKELIHOOD/LOG LINEAR) OF THE RELATIONSHIP BETWEEN THE PREVALENCE OF 
MOVEMENT DISORDER, AGE AND SEX
EFFECT D.F. CHI-SQUARE PROBABILITY
SEX 1 3-98 p = O.OA6
AGE k 70.71 p < 0.0001
PREVALENCE 1 37.5 p < 0.0001
SEX x AGE k 35.06 p < 0.0001
SEX x PREVALENCE 1 0.26 p = 0.61
AGE x PREVALENCE k 12.^ p = 0.014
SEX x AGE x PREVALENCE k 3.05 p = 0.55
5-3-2 THE ROLE OF AGE, LENGTH OF ILLNESS AND SEX IN SEVERITY
In Part I it was noted that although age and length of illness 
were closely related, some variables remained significantly correlated 
with length of illness even when age had been partialled out. Thus, 
with regard to movement disorder, an attempt was made at this point 
to evaluate the effects of both these components of the passage of 
time.
Three arbitrary ranges of AIMS totals were defined to 
reflect the normal - mild/moderate - severe continuum. These were :
No abnormality 
AIMS total <  5 
AIMS total > 6
Two way ANOVA was used to assess differences in age and length of 
illness in each of these ranges in both sexes.
ANOVA with age as the dependent variable demonstrated 
significant main effects of both sex and AIMS total score (P = 32.05, 
df = 1, 405 , P <  0.0001 : P = 5-78 , df = 2, 405 , P = 0 .0 0 3  
respectively). Thus males were significantly younger than females 
in all categories and there was a significant (positive) 
relationship between higher AIMS totals and increasing age. The 
absence of an interaction between sex and AIMS totals in the ANOVA 
indicates the positive effects of age on these totals to be the 
same in both sexes.
ANOVA with length of illness as the dependent variable likewise 
showed significant main effects of sex and AIMS totals (P = 1 4 .4 6 , 
df = 1,404 > P < 0 .0 0 0 2 : P = 5-58 , df = 2,404 > P = 0.004 respectively). 
Thus, males had significantly shorter lengths of illness than females,
and higher AIMS totals were associated with longer lengths of 
illness. Once again there was no sex/AIMS total interaction, 
demonstrating consistency of effect in both sexes. These results are 
summarised in TABLE 2:5:3*
Thus, significant effects of time were demonstrated, with 
differences emerging between the sexes, in that females were older 
and had longer lengths of illness. Such an analysis however, does 
not assess the relevance of that part of each component of time 
that is independent of the strong correlation between the two. In 
order to examine the effect of age independent of length of illness 
and vice versa, analysis of covariance (ANCOVA) was conducted for 
each time component with the effect of the other removed. The same 
groupings were used as for the ANOVA.
ANCOVA with age as the dependent variable and length of 
illness covaried again revealed the significant main effect of sex 
(F = 17.26 , df = 1 ,405 i P <0.000l). The corrected age values 
(i.e. the estimated age of the groups had they all the same lengths 
of illness) confirmed that the explanation of this lay in the males 
being significantly younger than the females in all groups 
(TABLE 2:5:4).
However, by removing length of illness from age by means of 
ANCOVA, the significant main effect of AIMS totals disappears 
(F = 1.04 , df = 2, 405 , N/S). There is once again no significant 
interaction term.
ANCOVA with length of illness as the dependent variable and 
age covaried revealed no significant main effects of either sex or 
AIMS totals (P = 0.3 , df = 1, 404 , N/S : F = O .8 3 , df = 2, 404 ,
TABLE 2:5=3
ANALYSIS OF VARIANCE: AGE AND LENGTH OF ILLNESS IN MALES AND FEMALES
AGE NO <  5 >  6
ABNORMALITY
MALES 52.8 55-3 59.3
FEMALES 61. ^ e z . k 6 ^ .9
SEX F = 32.05 df = 1,^05 p < 0.0001
AIMS F = 5.78 df = 2,^05 p = 0.003
LENGTH OF NO < 5 > 6
ILLNESS ABNORMALITY
MALES 2 7 . 2 29.3 32.2
FEMALES 32.6 32.^ 35.^
SEX F = 1 ^ 6  df = I t k O b  p = 0.0002
AIMS F = 5.56 df = 2,^0^ p = 0.0C&
TABLE 2:5=^
ANALYSIS OF COVARIANCE: AGE AND LENGTH OF ILLNESS IN MALES AND FEMALES
CORRECTED AGES NO
ABNORMALITY
<  5 >  6
MALES 56.6 57-2 58 .6
FEMALES 60.3 61.5 61.3
SEX F = 17.26 df = 1,^05 p < 0.0001
AIMS F = 1.04 df = 2,^05 N/S
CORRECTED LENGTHS NO < 5 >  6
OF ILLNESS ABNORMALITY
MALES 31 31.6 32
FEMALES 31.2 30.^ 31-9
SEX F = 0.3 df = 1,^04 N/S
AIMS F = 0.83 df = 2 , b O h N/S
N/S respectively) and no interaction. The corrected length of 
illness values (the estimated lengths of illness of the groups had 
they “been of the same age) were comparable in all groups (TABLE 2:5*4)*
Thus although time factors were of great importance with 
regard to AIMS total scores this study was unable to separate the 
interwoven effects of age and length of illness. Sex only appears 
to be of relevance in this sample insofar as females are older than 
males. Although females are older, both sexes have comparable 
lengths of illness, thus the women must have in general been 
admitted to long-term care at a later age than the men.
5 .3 .3 FURTHER EVALUATION QE THE ROLE OE SEX
These results assessing time and sex factors in relation to 
the presence of involuntary movement disorders have used AIMS total 
scores, arbitrarily divided, to determine correlations. However, 
it remains possible that subtle differences between the sexes may 
be masked by such a technique. It could be that with the passage of 
time the sexes may respond differentially in terms of the number 
and severity of the individual movements constituting the total AIMS 
scores.
Although it has been shown that in the present sample the 
cumulative effects of age/length of illness are inextricable, the 
question of potential but subtle differential sex effects was 
examined only in relation to age. This was to keep the analysis 
manageable, to maintain adequate numbers in comparison cells, and 
to make the present analysis comparable with the published literature. 
It is however.accepted that this may present limitations in
FIG 2:5:8
AIMS: Prevalence by age at single symptom 
criterion of 4 and 3 in both sexes
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interpreting the following data.
The prevalence of movement disorder using (a) a single 
symptom criterion of 4> and (b) one of 3> was compared for both 
sexes in five age bands. Pig 2:5:8 shows that females do have a 
significantly higher prevalence of at least a single rating of 
*4* compared to males (X  ^= 9*98 , df = 4 > P = 0.04)» but that 
this is due entirely to a higher prevalence in females over 70 
years of age (X  ^= 7*38 , df = 1 , P = 0.007). With a single
symptom criterion of 3? there is again a highly significant
2overall difference between the sexes (X = 18.8 3 , df = 4 5 
P <0.00l). However, in this case the effect springs from an interaction 
between sex and prevalence in those oyer 60 years of age (Pig 2:5:8). 
This may represent a chance finding.
TABLE 2:5:5 shows the F:M ratio at increasing criteria of 
severity, and increasing age. The total sample and only those 
treated with neuroleptics are shown separately. The relatively small 
number of neuroleptic-free patients and their male predominance 
precluded a similar analysis in this group. As can be seen, there was 
a slight, but not significant nor exclusive female predominance 
throughout. Only at a single symptom criterion of 4 in the over JOs 
is this striking and this was found in both the total sample and those 
exposed to neuroleptics considered separately.
TABLES 2:5:6 and 2:5:7 show the results of the same analysis 
considering the AIMS facial items and limbs/trunk items separately.
The difference in total scores persists on facial items, but there is 
no evidence of a similar excess of females scoring at least a single 
4 in limbs/trunk regions. Indeed if anything, the opposite is
iA
LA
s
a \  l a
V- J -  
• • 1
A -  CT\ 
Ov CM
r -  (A -4 -  
CM f A  CM
CM CM LA 
CT\ c o  CM
CTv Ov r -  
CM f A  fA
P>h V-  V~ O  d  1 r *  v  v— o d d v  v— .4-
>h O  
(O S
o i l
lA• i v -  A -  LA LA  CM CM A -  f A  LA
EH K  ^cR
O  A -  
IA  fA
o  o  1
LA LA
IA  A -  fA  
M A r
fA  A -  fA  
V D 4  r
f A  O  LA 
C ^ v o  r -
a
EH
O
H
S  C5
a s
O  g  ^
OVOO LA J -  ON A - fA  CM OV v -  c rvvo r -  LA VO
B a *
r -  LA VO 
CM
v-O O  CM 
LA f A
O  CM o  
VO -4- r~
ON A -  O  
L D I A r
A -  I A  fA  
L A -4 -
CT\ LA 
v -  J -  
• • 1
CM fA  
OV A
(A -4 -  
CM f A  CM
VO I A  r -  
OO A -  v—
-4- crv 
r -  r -  VO
r "  v - O  d  1 V~ V~ r * o d d r -  r -  J -
e n g  
£3 H
3 1 LA• i V - A -  LA CM CM CM VO ON
1
O  A -  
LA rA
o  o  1
LA LA
IA  A -  fA  
M A r
- d  A -  fA  
U ) 4  r
-4- r -  VO 
A -V O  r *
W  
, n
3
8  a
Eh  S  
H  
W  EH
a a
CTv CO LA r  L A A - ON CM o v VO CM Ov Ov v o  VO
S i >R
t -  LA VO 
-4- 0J
4 -  O  W  
LA -4 -
o d d
VO _4* r -
-4" -4" r -  
A -v O  r -
A -  f A  fA  
v o  LA
k s
«  g
>  H  
W  P? 
C/3 O CM fA -4 - CM fA -4 - CM IA -4 * CM fA -4 - CM I A  -4"
AG
E O-4"
V
Ov 1 
J -  
1
O
-4*
ON
LA
1
O
LA
Ov
VO
1
O
VO
O
A -
A
TA
BL
E 
2:
5=
6
X O
cQ S
y  h
O  *-H EH
*i gj t r \  i a
9 1q i> - 0 -
Eh EH ^ K \  K \
tA <c- CM 
CM VO K'i
CO r 4
CO OO o
odc^
mow
O  V-
C3 
M EH
2! S!
gC
s
ON OJ • 1 1
ON<m in C ON ONno mj- m  co a- no in no no in a-OI J- -0-
P4 N“ x~ n~ . V* N- o N“ N- V- v1 o
>H CD
Q Si Si in • 1 1 co mco n- in m NO ON A-A-tn m  m  1 co co m  oj m  m-o- OJ -4- A-m  co clArrn OJ
EH
OH
S CDS a3 H O EH
g S g -4- m -4- a- m  no oo A- r- in ON NO
g g^ R on on noCO v- ON NO n- v- m  no a- m  co ON NO -4- v— C* m  a- mOJ r-
s onCO• i i
NO CO V- tn 
* * 1
OJ ON ONno m-4- ON ON A- N- O NO NO r- A- rn m-4-
£ V“ V- N- N~ N— O X~ V V N“ O
CDs
g g  
g a m■ i i CO toco v- in m ON i- A-
gg*c
£
CQ
a-m m  m  1OJ OJ in co mm-4- OJ -4* t>* m  co rn A- v-m  co
t-3
SiO CD EH S H EH
g g •4- m NO ON -4" NO CO on .4- m ON NO
li >r
ON ON NOco x- v-co 1 OJ v -4- NO A-m  oj NO CO -4- OJ OJ m  a- mOJ V-
>H O
s a
°a PW EH > Mw « w o co rn-4- oj rO-4- oj rn-o- oi m-4- co m-4-
AG
E o-3"
V
ON-4-io-4"
ON
miom
ONNOioNO
oA-
A
demonstrated.
It would seem reasonable to postulate that if females 
are more likely to rate at least one severe rating of 4 when 
over 70 years of age, some difference in mean scores, hidden in 
the earlier ANOVA/ANCOVA may be detectable on closer analysis.
Fig 2:5:9 shows that this is not the case. The sexes do not 
significantly differ in their mean AIMS totals at any age band, 
a finding which applies to the total sample as well as to the 
neuroleptic-treated patients alone (Fig 2:5:10). While 
Fig 2:5:10 also shows the neuroleptic-free females to have lower 
means than their male counterparts, the small number of these 
women (7) makes this a doubtful finding.
It is still possible that the sexes may differ on the 
mean number of abnormal movements recorded with increasing age. 
However, Fig 2:5:11 shows that no such difference could be 
detected.
Thus, while females over 70 years of age show 
approximately 4 - 5 times the prevalence of severe abnormality 
than males when the single symptom criterion method is used, 
this is only found in ratings of facial movements, and is not 
reflected in this sample in corresponding differences between the 
sexes in AIMS mean scores or mean number of movements rated 
positively (2 or more).
FIG 2:5:9
A IM S  mean totals as a funct ion  of age and  
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THE ROLE OF NEUROLEPTIC MEDICATION PAST AND PRESENT
By combining information gathered after the first and 
second examinations, six categories of neuroleptic status were 
devised. With reference to these categories, neuroleptic 
treatment "in the past" means 'at any time up to the second 
examination*.
The categories were :
1) Never on neuroleptics at any time.
2) 'Some'* neuroleptic exposure in the past 
but not receiving them when examined for 
the second time.
3) 'Much'* neuroleptic exposure in the past 
but not receiving them when examined for 
the second time.
4) Never on neuroleptics in the past but 
receiving them when examined for the 
second time.
5) 'Some'* neuroleptics in the past and 
receiving them when examined for the 
second time.
6) 'Much'* neuroleptic exposure in the past 
and receiving them when examined for the 
second time.
Those not 
receiving 
neuroleptics when 
examined for the 
1,2,3: second time.
i.e.'currently' 
OFF.
Those receiving 
neuroleptics 
when examined 
for the 
second time.
4,5,6:
i.e.'currently' 
ON
* For definitions of 'some' and 'much' see TABLE 1:3*3 Fart 1.
Categories 2 and 3 represent patients whose neuroleptics 
have been discontinued at some point. Owing to the quality of the 
information available in the drug records no mean duration of time 
that they had been off these drugs could be calculated. For some, 
drug withdrawal may have occurred at some point between examinations 
while for others, it could have taken place many years ago. Some 
may have had depot drugs stopped while others may only have been on 
oral preparations. Category 4 represents the small but important 
group who were commenced on neuroleptics for the first time between 
the two examinations. Again this may have been oral or depot in type
Categories 5 and 6 are those with continuity of neuroleptic 
exposure. This does not mean however that account can be taken of
minor changes in drug regime that may have been prescribed between
the two examinations.
Such a division is not highly specific. It has been 
adopted in order to allow a general evaluation of the role of 
neuroleptic administration at the time of the examination and also 
of past neuroleptic exposure. In addition, the importance of the 
degree of past exposure to these preparations could be assessed.
The patients represented in these categories of neuroleptic 
status also differed in terms of mean ages and lengths of illness.
The mean ages and lengths of illness are shown in TABLE 2:5:8.
The differences between the groups are highly significant 
(AGE : F = 20.98 , df = 5, 405 , P < 0.0001 ; LENGTH OF ILLNESS:
F = 12.28 , df = 5, 405 , P <  0.0001).
It was therefore necessary to account for these differences 
before assessing the relationships between neuroleptic status and
TABLE 2:5:8
MEAN AGE AND LENGTH OF ILLNESS QF SUBJECTS IN EACH CATEGORY OF NEUROLEPTIC STATUS
NEUROLEPTIC CATEGORY MEAN AGE 
(± S.D.)
MEAN LENGTH OF ILLNESS 
(± S.D.) IN YRS
1 68.18 (11.82) 36.5 (10.3)
2 67.15 (11.5*0 37.15 (9)
5 6k.91 Cl2 .b) 35.87 (9.85)
b 58.-b (19-57) 35.8 (16.33)
5 60.97 (10.66) 32.01 (9-39)
6 53.76 (12) 28.03 (10.1)
involuntary movement disorder. This was attempted by arbitrarily 
adopting an age range which was both narrow enough to militate 
against age effects on AIMS scores yet broad enough to include 
representatives of each neuroleptic status category. The age range 
thus adopted was 58 - 82 years. While considering only subjects 
within this constant age band dramatically reduced the very highly 
significant age differences in the different categories of neuroleptic 
status, unfortunately it did not dispel them completely 
(F =4*29 > df = 5>405 > F <  O.OOl). In particular, those in 
category 6 remained younger than the rest. However, narrowing the 
age band further would have considerably reduced the numbers of 
subjects in each category and would have eliminated the small but 
important group in category 4* Since the relationship of age 
to movement disorder is a positive one, the major effect of the 
inequality of age in categories of neuroleptic status is likely to 
be that of somewhat diminishing the comparative abnormality of those 
in category 6, which will require to be considered in interpretation 
of the findings.
Thus, subsequent analyses were conducted in the knowledge 
that the significant relationships between age and neuroleptic status 
as delineated had been reduced greatly but not completely abolished.
On the other hand, the significant overall differences between 
neuroleptic categories and lengths of illness disappeared when 
considering only the age band 58 - 82 years. With the above proviso 
therefore, those being studied within this age band will be referred 
to as the 'age - controlled' group.
Frequency distribution histograms were obtained of the total
scores achieved hy patients in each of the categories of neuroleptic 
status. Using the basic 0 - 1  normality cut-off, the prevalence 
of movement disorder was compared across categories. The statistical 
technique employed was unified analysis of variance by ranks.
Fig 2:5:12 illustrates the findings with regard to the role 
of current and previous neuroleptic exposure in the prevalence of 
movement disorder in the age - controlled group of the total study 
sample. The top half of the diagram represents the prevalences 
in each of the six categories of neuroleptic status, while the 
bottom half shows the prevalence considering current (bottom left) 
and past (bottom right) neuroleptic exposure.
Overall, there was a non-significant relationship between 
AIMS abnormality and categories of neuroleptic status separately 
(H = 9*56 , df = 5 > F = 0.088). Likewise, there was no significant 
effect of receiving neuroleptics at the time of the ATMS assessment 
(Fig 2:5:12 bottom left) - i.e. of 'current' neuroleptic status 
(z - value = 0.17 ? ^/s).
There was a highly significant relationship between the 
presence of abnormality on the AIMS and categories representing past 
neuroleptic exposure (Fig 2:5:12 bottom right). A progressive and 
significant increase was found in the prevalence of movement disorder 
with increasing past neuroleptic exposure ('none' v 'some' v 'much' : 
z - value = 2.54) F = O.Oll).
The base-line of involuntary movement disorder was very high in
this population. Of those never exposed to neuroleptics at any time
46.1 % achieved AIMS totals of 2 or more. Despite this, the effects of
£.
past neuroleptics were striking. Although there was a tendahcy for
FIG 2:5:12
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more of those heavily treated in the past (groups 3 ancL 6) to rate 
abnormality than the others combined (groups 1, 2, 4» 5)
(z - value = 1.86 , P = 0.06), the major difference lay between 
those never exposed to neuroleptics in the past (categories 1 and
4) and those who had received these drugs regardless of degree 
(categories 2, 3> 5> 6). As Pig 2:5:12 demonstrates, while 45*2 % 
of those never exposed in the past had abnormality, the corresponding 
figure in categories representing past exposure was 66.1 %
(z - value = 2.5 5 P = 0.012).
There was no interaction between past neuroleptic exposure 
and ’current’ neuroleptic administration.
By arbitrarily, dividing the AIMS totals into three bands, 
it was possible to assess the role of past exposure with regard to 
severity of movement disorder. AIMS totals were divided into the 
ranges 0 - 1, 2 - 6  and 7 + • The relationship between increasing 
AIMS totals and past neuroleptic exposure is shown in Pig 2:5:13*
Using these divisions, there was a positive relationship 
between neuroleptic exposure and severity of movement disorder 
(z - value = 2.20 , P = 0.026). There was a non-significant trend 
towards more severe movement disorders in those heavily treated in 
the past (categores 3 and- 6) compared to the rest (z - value = 1.66 ,
P = 0.094)> but the major contribution to this overall relationship 
came from significantly more severe movement disorder in those 
exposed to neuroleptics than was found in those never treated 
(z - value = 2.11 , P = O.O32).
This general classification, in addition, allowed consideration 
of what happened when neuroleptics were stopped in this population
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and what was the effect of recently commencing them. The top half 
of Fig 2:5:12 shows the prevalence of abnormality in each category 
of neuroleptic status. By considering only the three left hand 
categories (i.e. 1 - 3) it is possible to get some impression of 
the effect of discontinuing neuroleptics, as categories 2 and 3 
represent patients whose drugs had been stopped at some time.
There was a significant linear relationship between the 
prevalence of movement disorder and these first three categories 
of neuroleptic status (z - value = 2.65, P = 0.008). This was due 
largely to a significantly higher prevalence in those exposed to 
neuroleptics (categories 2 and 3) compared to those in category 1 
who had never been exposed (z - value = 2.54 > P = O.Ol). The 
prevalence in those heavily treated but then discontinued (category 3) 
was only slightly higher than that found in the ’never1 and lightly 
treated subjects together (z - value =1.77 > P = O.O72). There 
was, in addition, a significant relationship between severity and 
having had neuroleptics stopped. Those in categories 2 and 3 had 
more severe movement disorder than those in category 1 (z - value =
2.10 , P = O.O34).
Analysis of the effects of having had neuroleptics recently 
commenced - i.e. at some time in the 2 years between examinations - 
is less reliable than the above results because of the small number 
of patients to whom this applied (those in category 4)* Nonetheless, 
it can be said that those recently commenced did not differ 
significantly in prevalence from those who had never been exposed 
at any time ( X = 0.43 , df = 1 , N/s). Severity could not be 
evaluated. There was a tendancy to a greater prevalence of abnormality
of greater severity in those consistently treated (categories 
5 and 6) than in the recently treated patients, but these 
associations did not achieve statistical significance, probably in 
view of the discrepant numbers in the comparison cells.
5.5 THE ROLE OF ANTICHOLINERGIC MEDICATION
In order to investigate the role of anticholinergic 
medication in involuntary movement disorder, two types of analysis 
were conducted. The first was evaluation by analysis of trends,
(i.e. unified analysis of variance by ranks) of prevalence and 
severity based on categories of medication status similar to those 
produced previously for neuroleptics. The second was by a 
maximum likelihood/log linear analysis of prevalence.
It was not appropriate to divide the sample for the first 
of these analyses by current neuroleptic status as the small number 
of subjects on anticholinergics, but not having neuroleptics would 
be receiving treatment in exceptional circumstances - e.g. coincidental 
Parkinson's Disease. Only categories of past neuroleptic exposure 
were maintained.
The sample was divided along the lines of 'none', 'some' and 
'much' past neuroleptic exposure as before and each category then 
subdivided according to whether or not patients were receiving 
anticholinergics when examined. This subdivision made no reference 
to the amount or duration of anticholinergic exposure, only to its 
presence or absence at that point in time. There were therefore six 
trend/contrast groupings.
No patient with a history of never being exposed to neuroleptics
had received anticholinergics. As analysis of trends is 
inappropriate when one cell comprises entirely zeros, an arbitrary 
value of ’l 1 was inserted into this cell for all comparisons. 
Prevalence analysis was conducted using a low (0 - l) and a higher 
( 0 - 2) normality cut-off, and severity using the three arbitrary 
divisions of AIMS total scores defined earlier (p 172 ).
No significant relationships could be established between 
anticholinergic medication and either the prevalence or the severity 
of involuntary movement disorder. This was true for all patients 
together, for males and females separately and for a low or a 
higher cut-off for normality with AIMS total scores.
The maximum likelihood/log linear analysis, which takes 
account of the effects of the individual components of the analysis 
(in this case age, sex, past neuroleptic exposure, anticholinergic 
treatment and movement disorder), gave a similar result. Movement 
disorder was significantly related to past neuroleptic exposure 
(X  ^= 6.81 , df = 2 , P = O.Oj) but not to treatment with 
anticholinergics (X  ^= 0.02 , df = 1 , P = 0.9).
5.6 RELATIONSHIPS BETWEEN MOVEMENT DISORDER AND ITEMS OF
RECORDED INFORMATION
Relationships were sought between the presence of spontaneous 
involuntary movement disorder and the major items of Recorded 
Information described in Part I. These items, and the groupings 
of patients on the basis of these items, are shown in TABLE 2:5:9.
Age and length of illness, previously considered separately, 
were shown to be of importance with regard to AIMS scores. Hence
TABLE 2:5=9
RECORDED INFORMATION AND MOVEMENT DISORDERS: ORGANISATION OF DATA FOR ANALYSIS
RECORDED INFORMATION COMPARISON CATEGORIES
FAMILY HISTORY OF 
SCHIZOPHRENIA
DEFINITELY ABSENT DOUBTFUL DEFINITELY PRESENT
HISTORY OF BIRTH TRAUMA/ 
HEAD INJURY
PRESENT ABSENT
FITS PRESENT ABSENT ■
PAST ACADEMIC RECORD ABOVE AVERAGE 
('SUPERIOR')
AVERAGE BELOW AVERAGE 
('BACKWARD')
LEUCOTOMY YES NO
HISTORY OF EXPOSURE.TO 
INSULIN COMA
'NONE' 'SOME' 'MUCH'
HISTORY OF EXPOSURE TO 
E.C.T.
'NONE' 'SOME' 'MUCH'
analyses were conducted only on subjects within the ’age-controlled* 
group. In accounting for the effects of neuroleptic drugs,
’current’ status, shown to be irrelevant to AIMS totals, was 
disregarded, with only categories of past neuroleptic status being 
retained.
For purposes of this analysis, the data were arranged as 
follows. Within the ’age-controlled’ sample, frequency distributions 
of AIMS totals were determined under each of the sub-headings of 
Recorded Information items - e.g. ’present’/’absent' : 'Yes'/’No’ 
etc. These cells were then further divided according to past 
neuroleptic status - i.e. ’none’, 'some', ’much’. Thus, for 
Recorded Information items broken down three ways (e.g. family 
history of schizophrenia) nine separate sub-divisions of the 'age- 
controlled' sample were generated. For those items broken down 
two ways, six sub-divisions for comparison were produced.
In the initial search for relationships between movement 
disorder and items of Recorded Information, the AIMS total cut­
off for normality defined previously ( 0 - l) was adopted.
Statistical evaluation was by unified analysis of variance by ranks.
The relationships between these additional items of Recorded 
Information and involuntary movements using the 0 - 1  cut-off are 
shown in TABLE 2:5:10. With the highly significant effects of 
past neuroleptics accounted for, no independent relationships 
between these items, and movement disorder could be established.
A significant interaction term emerged between past neuroleptic 
and past insulin coma treatment, though this is an artifact of 
small numbers in those categories of patients who had received ’much’
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insulin. Of the nine such patients, only one had no movement 
disorder, and this subject was in the middle (i.e. 'some') 
category of past neuroleptic treatment. A non-significant trend 
towards an interaction between past neuroleptics and a history of 
fits is similarly artifactual.
5.7 RELATIONSHIPS BETWEEN MOVEMENT DISORDER AM) OTHER ITEMS
OF ASSESSED ABNORMALITY
Relationships were sought between the presence of involuntary 
movements and thosaother abnormalities assessed at examination - 
namely the 'positive' and 'negative' features of the mental state 
(Krawiecka Scale), cognitive performance (Withers and Hinton 
battery) and overall behavioural performance (Current Behavioural 
Schedule).
For each of the four items of assessed abnormality, the 
'age - controlled' sample was arbitrarily divided into three groups 
on the basis of the distribution histograms shown in Part I. The 
divisions were chosen to allow for roughly equal numbers in each 
group. The ranges selected were :
'Positive'features of the Mental State (Krawiecka Scale)
0 - 1  ; 2 - 5  ; 6 - 1 5
'Negative' features of the Mental State (Krawiecka Scale)
0 - 1  ; 2 - 3  ; 4 - 8
Cognitive Performance (Withers and Hinton battery)
0 - 2 0 ; 2 1 - 6 0  ; 6l - 107
Behavioural Ability (Current Behavioural Schedule)
0 -30 ; 31-40 ; 4 1 -50
For each Assessed Abnormality variable, the subjects in 
these three arbitrary groups were then sub-divided on the basis of 
their history of past exposure to neuroleptic medication (’none1, 
’some1, ’much’). There were thus nine sub-divisions for each 
variable. Frequency distributions of AIMS totals within these 
sub-divisions were determined for each Assessed Abnormality variable 
in turn. Statistical evaluation was by ufnified analysis of variance 
by ranks, comparing those with no abnormality (AIMS totals 0 - l) 
with those having higher scores.
The results are illustrated in Figs 2:5:14 to 2:5:17* The
lay-out of these is as for Fig 2:5:12. The top half of each
diagram represents the prevalence in each category of past neuroleptic 
status for each range of scores adopted for the Assessed Abnormality 
variables. Bottom left is the past neuroleptic effect and bottom 
right the independent relationship between movement disorder and 
the variable under consideration. The statistical analysis is 
summarised in TABLE 2:5:10.
Accounting for the highly significant effect of past 
neuroleptics, there was no significant independent relationship of 
AIMS abnormality to 'positive' features of the mental state - either
overall or with any comparisons between the different ranges of
scores of 'positive' features defined above.
There was a highly significant association between the 
presence of abnormal movements and 'negative' features in the mental 
state. The major contribution to this relationship came from the 
much greater prevalence of movement disorder in those scoring 2 or 
greater for 'negative' features than in those with a ’negative'
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feature total of 0 - 1 (z - value = 2.67 , P = 0.008), although 
those in the highest score range for negative mental state features 
(total 4 - 8) also had a significantly greater prevalence than the 
others (z - value = 2.07 > P = O.O36).
Maintaining the nine trend categories of cognitive 
performance separate, the relationship of this to movement disorder 
did not reach statistical significance. However, when the two 
highest Withers and Hinton ranges (21 - 60 and 6l - 107) were 
combined and compared with the lowest range ( 0 - 20 ) those in 
the latter category rated movement abnormality with significantly 
greater prevalence than the rest (z - value = 2 .0 9 » P = 0 .0 3 4)*
Impaired behavioural performance was highly significantly 
correlated with the presence of movement disorder. This came 
equally from differences between the lowest behavioural grouping 
(0 - 30) compared to the rest (z - value = 2*39 5 P = 0 .0 1 6), 
and the highest (41 - 50) compared to the rest (z - value = 2 .5 6,
P = 0.0l). There was therefore a gradual decrease in the 
presence of abnormal movements from the most behaviourally impaired 
group to the least.
Thus the presence of abnormal movements can be shown to 
be significantly more common in those with 'negative* features in 
the mental state, marked cognitive impairment and behavioural 
deterioration.
5*8_____ RAISING THE AIMS CUT-OFF FOR NORMALITY
As mentioned earlier the aforegoing analyses were conducted 
on a cut-off for normality on the AIMS of 0 - 1. However, as an
AIMS total of 0 - 1 may be considered too limited a criterion for 
normality, the analyses of Recorded Information and Assessed 
Abnormality variables were repeated raising the cut-off for normality 
to 0 - 2. The results are summarised in TABLE 2:5:11, and the 
relationships with Assessed Abnormalities illustrated in Pigs 2:5:18 
to 2:5:21.
As can be seen this did not alter the basic relationships 
established with the lower AIMS total cut-off. Once again, none 
of the relationships between the presence of movement disorder and 
items of Recorded Information approached statistical significance.
The same applied to 'positive' mental state features. For the other 
Assessed Abnormality variables, the association with AIMS abnormality 
remained, and indeed for cognitive and behavioural performance, the 
negative relationships increased in significance.
Thus, allowing that the lower cut-off may be overinclusive, 
while the higher one may slightly underestimate abnormality, a balance 
of the two strongly indicates that the presence of spontaneous 
involuntary movements of the type recorded on the AIMS is associated 
with the presence of 'negative' features in the mental state, with 
cognitive impairment and with behavioural deterioration, and that 
these relationships are independent of time factors (age/length of 
illness) and exposure to neuroleptic drugs.
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5.9 SUMMARY OP ANALYSIS OP AIMS LATA
In this population of long-stay schizophrenics :
1) The prevalence of movement disorder depends on the 
criteria of severity, but overall is high.
2) Abnormal movements are predominantly orofacial in 
distribution, with tongue, lips and jaw being the 
commonest sites.
3) Spontaneous involuntary disorders of movement of the 
sort recorded on the AIMS are commonly found, and can
be a feature of long standing schizophrenia which has
not been modified by neuroleptic drugs. In this 
situation movements do not differ in form or distribution 
from those commonly attributed to neuroleptics.
4) The presence of a history of neuroleptic exposure is
insufficient in itself to differentiate those who have
been exposed from those who have not, with regard to
their movement disorders.
5) Time factors are potent determinants of AIMS total 
abnormality. Increasing age is associated with increasing 
prevalence of movement disorder, though there appears to 
be some evidence of a plateau effect in middle age. Age 
and length of illness are inextricably interwoven with 
regard to their effects on severity of abnormality.
6) The role of sex is complicated and to some extent 
dependent on the technique of analysis used, but has not 
in general been shown to be of relevance. It is not 
important with regard to prevalence using total scores 
and is only a determinant with regard to severity insofar 
as females are older. Using single symptom criteria 
females over 'JO years of age have a prevalence of abnormality 
four times that of males of the same age. This results
from facial abnormality only. However, this difference is 
not reflected in mean scores or mean number of movements.
7) Time factors are potent determinants of neuroleptic 
treatment patterns. Those being consistently and heavily 
treated with these drugs are significantly younger than 
those in other treatment groups.
8) When attempts are made to account for these effects of age/ 
length of illness on patterns of drug administration, 
significant positive relationships do exist between the 
presence of movement disorder and past neuroleptic exposure 
with some relationship demonstrable with the degree of past 
treatment. The differences lie especially between those
who have never been exposed in the past and those who 
have. Receiving neuroleptics or not at the time of 
assessment is not of relevance.
Past neuroleptic exposure is, in addition, related to the 
severity of movement disorder.
Those on neuroleptics in the past but whose drugs have 
been stopped at some point, have not returned to the base­
line of abnormality shown by comparable patients never 
exposed. The degree of past exposure is only marginally 
relevant in this regard.
Those recently commenced on neuroleptics for the first 
time do not significantly differ in prevalence of movement 
disorder from those never exposed at any time.
Anticholinergic status at examination is not of relevance 
with regard to either the prevalence or severity of 
abnormal movements.
Present movement disorder is not related to historical 
items of Recorded Information apart from time factors.
Spontaneous abnormal movements are related to the presence 
of 'negative1 features in the mental state, cognitive 
impairment, and behavioural deterioration. These relation­
ships are independent of time factors and past exposure 
to neuroleptic drugs.
Findings 12, 13> and 14 remain valid regardless of whether 
a low or a higher cut-off for normality is adopted.
Chapter 6 - Results - The Rockland Scale Data
Similar analyses were performed on data recorded on the 
Rockland Scale (RS), as were carried out on AIMS data. As was 
mentioned, this scale is used here to record dyskinesias in the 
sense of ’any abnormal kinesis’. The results to be presented 
concentrate on abnormality recorded in any body part, but in 
particular contexts where more detailed information can be extracted, 
regional subscores will be examined separately.
The lay-out of the presentation is the same as was used for 
AIMS data, and the detail behind this will not be repeated.
6.1 THE TOTAL SAMPLE
6.1.1 PREVALENCE AND SEVERITY
The distribution of RS total scores in the sample of 411 is 
shown in Fig 2:6:1. The prevalence of abnormality (RS total 2 or 
more) is extremely high - namely 82.97 %• The distribution of scores 
is more closely exponential than with the AIMS and there is no 
middle - range score which occurs especially frequently. This 
probably reflects the fact that with ‘four grades of severity, there
e.
is less chance of the central tendency effect operating. The mean
+
score for the total sample was 8 .6 3 - SD 8 .295 which, as with the
*
AIMS data, reflects the distribution.£
Fig 2:6:2 shows the prevalence of dyskinesia at increasing 
criteria of severity in all body regions together and each separately 
using single symptom criteria. The prevalence rates of abnormality
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FIG 2:6:2
Regional prevalences at different severity criteria 
on Rockland
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were even higher with this recording instrument than with the 
AIMS. Using criterion 3 (moderate), 67.6 % of subjects had 
demonstrable abnormal movements, which again came mainly from ratings 
of facial items.
6.1.2 THE DISTRIBUTION OF MOVEMENT PATTERN
The percentage of the total sample who achieved a pathological 
rating (at least one rating of ’2’) is shown for each RS item in 
TABLE 2:6:1. For comparative purposes, the comparable figures with 
the AIMS that were illustrated previously in TABLE 2:5:1 have been 
incorporated. This allows some impression of the individual movements 
constituting the AIMS items. Those RS movements that would not be 
appropriately recorded on the AIMS are listed on the right-hand side 
of the table.
Two points must be noted however. Firstly, RS items can 
only be approximated to those of the ATMS. Thus, the RS items are 
those which involve predominantly but not exclusively, the AIMS 
area against which they are listed.
Secondly, discrepancies arise between AIMS and RS percentages 
because certain movements rated in the grosser regional classifications 
of the former are not covered by any of the 34 specified items of 
the RS and are therefore recorded as one of the nine items reserved 
for movements not otherwise specified. The conventions adopted in 
this study for the use of these non-specific RS items are shown in 
Appendix VII.
Tongue movements were the commonest group of abnormalities 
in this sample. Choreoathetosis (including lingual myokymia) affected
TABLE 2:6:1
DISTRIBUTION OF INVOLUNTARY MOVEMENTS ON AIMS AND ROCKLAND SCALE AT SEVERITY CRITERION OF 2 OR MORE 
(TOTAL SAMPLE N = *H1)
AIMS ROCKLAND
AREA %  PREVALENCE
MAJOR COMPONENT
MOVEMENTS OF AIMS AREAS %  PREVALENCE ADDITIONAL MOVEMENTS %  PREVALENC
TONGUE 3 5  A CHOREOATHETOID MOVEMENTS 21 
OF TONGUE
BON-BON 12.7 
TONGUE PROTRUSION 8 .8
TONGUE TREMOR 17-8 
•'RABBIT SYNDROME' 2
LIPS 28.1 PUCKERING OF LIPS 12 
SUCKING 7 .8  
SMACKING 7 .6  
POUTING 5 .9
ITEM 16 ('OTHER PERIORAL 20.5 
MOVEMENTS')
JAWS 2 3 - 1 CHEWING 17.3
FACIAL EXPRESSION 18.3 GRIMACING 7 .3  
EYE BLINKING 6  A  
♦FACIAL TICS 0.7
EYE LID TREMOR 9-8 
ITEM 15 ('OTHER PERIORBITAL 7 .6  
MOVEMENTS')
EXTREMITIES - UPPER A  A •BALLISTIC MOVEMENTS 2 A  
CHOREOATHETOID MOVEMENTS-FINGERS 11.7 
•CHOREOATHETOID MOVEMENTS-WRISTS 3 - 7
PILL-ROLLING MOVEMENTS 10.7 
•CARRESSING OR RUBBING FACE 
AND HAIR 3 - 9  
•RUBBING OF THIGHS 3 .9  
ITEM 31 ('OTHER' MOVEMENTS -
REGULAR FAST TREMOR) 19.8 
ITEM 32 ('OTHER' MOVEMENTS -
NOT SPECIFIED ELSEWHERE) A  A
EXTREMITIES - LOWER 15-6 ROTATION AND/OR FLEXION OF ANKLES 5 A  
♦TOE MOVEMENTS ' 1 * 5  
•STAMPING MOVEMENTS-STANDING 1.5  
STAMPING MOVEMENTS-SITTING 5  A  
RESTLESS LEGS 3 .^  
•CROSSING/UNCROSSING LEGS-SITTING 1.5
ITEM 39 ('OTHER' MOVEMENTS
REGULAR FAST TREMOR) 5.1  
ITEM k O  ('OTHER' LEG MOVEMENTS
NOT SPECIFIED ELSEWHERE , 5 .6
NECK, SHOULDER,
HIPS 13.7
HEAD NODDING k A  
•RETROCOLLIS 0.7 
•SPASMODIC TORTICOLLIS 1.3 
•TORSION MOVEMENTS (TRUNK) 2-7 
•AXIAL HYPERKINESIA • 2.2 
ROCKING MOVEMENT k A
•ITEM 23 ('OTHER' MOVEMENTS
UPPER LIMB GIRDLE) Z A  
•ITEM 2 k  ('OTHER' MOVEMENTS -
TRUNK) 1.7 
•HOLOKINETIC MOVEMENTS 0.5 
•AKATHISIA 1.2 
•ITEM k 3  0.7
* NUMBERS TOO SMALL FOR STATISTICAL ANALYSIS
21 %, while tremor of the tongue was found in 17.8 %. Although 
uncommon, dystonic type abnormalities were found, and tremor of 
the ’pill-rolling’ variety was present in over 10 % of subjects.
6.2 COMPARISONS OF NEUROLEPTIC TREATED and NEUROLEPTIC-FREE
SUBGROUPS
6.2.1 PREVALENCE AND SEVERITY
Pig 2:6:3 shows the prevalence of abnormality at increasing 
criteria of severity using RS scores in the 364 patients with a 
history of neuroleptic exposure and the 47 who had remained 
neuroleptic-free. All regions together and each separately are 
shown.
2
X analysis revealed no significant differences between the 
groups on any comparison. The prevalence of abnormality was very 
high using the RS recording technique, even in those never exposed 
to neuroleptics, 76. 6 % of whom scored at least a single rating of 
2.
6.2.2 MEAN SCORES
The mean total and regional scores for neuroleptic-treated 
and neuroleptic-free groups *are shown in Pig 2:6:4. None of the 
differences between the groups reached significance at the 5 % 
level.
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6.2.3 M E M  NUMBER OF MOVEMENTS
These are illustrated for both groups in Pig 2:6:5: (all 
regions together plus face alone). There were once again no 
significant differences.
6.2.4 DISTRIBUTION OP MOVEMENT PATTERNS
2
As with AIMS data, X analysis was conducted on 2 x 2 
contingency tables, comparing the prevalence of a pathological 
rating on each item in neuroleptic-treated and free groups. This was 
carried out for the 25 RS items rated 2 or more sufficiently often in 
the total sample to allow of reliable statistical analysis. Those 
items which occurred insufficiently frequently for this analysis 
are indicated in TABLE 2:6:1.
The profile of abnormality for neuroleptic-treated and non­
treated groupsin terms of the RS items is shown in Pig 2:6:6. Only 
one statistically significant difference emerged between the groups.
Head nodding (RS item 17) occurred more frequently in the neuroleptic-
2free group than in the neuroleptic-treated sample (X = 9*03 , 
df = 1 , P <  0.005).
A similar analysis taking severity into account showed more 
severe choreoathetosis of the tongue (P <  0.05) and grimacing 
( p <  0.025) in the neuroleptic-treated group, but more severe head 
nodding in the neuroleptic-free patients (P<0.005).
As in the AIMS analysis, those patients rating 2 or more on 
any one or more items were defined from the point of view of 
movement disorder as the ’morbid' group (341 subjects). The
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distribution of abnormality within this morbid sample again showed 
a significantly greater preponderance of ’head nodding’, and in 
addition more 'eyelid tremor’, in those never exposed to neuroleptics.
In summary, analysis of RS data, like that from the AIMS, 
did not identify any striking differences of note between patients 
with and without a history of treatment with neuroleptic drugs, 
when only this historical treatment variable is considered. Such 
differences as did emerge were few and must be seen in the light 
of the large number of comparisons conducted.
6.5 THE ROLE OF TIME AI1D SEX
The following analyses are identical to those conducted on 
AIMS data (Chapter 5*3)*
6.3.1 THE ROLE OF AGE AMD SEX IN PREVALENCE
The relationship between an RS grand total of 2 or more 
and increasing age in the whole sample and in females and males 
separately is illustrated in Pig 2:6:7* Analyses are laid out in 
TABLE 2:6:2.
As with the AIMS, age is highly important with regard to 
prevalence while sex, independent of age is not. The corrected 
P : M ratios for RS totals are as shown and illustrate the lack 
of a role for female sex in relation to prevalence.
Relationship of prevalence (R.S. total 2 
or more) to age
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TABLE 2:6:2
ANALYSIS (MAX. LIKELIHOOD/LOG LINEAR) OF THE RELATIONSHIP BETWEEN THE PREVALENCE OF 
MOVEMENT DISORDER, ACE AND SEX
EFFECT D.F. CHI-SQUARE PROBABILITY
SEX 1 1.29 p = 0.26
AGE b 77.65 p < 0.0001
PREVALENCE 1 209-95 p < 0.0001
SEX x AGE b b2.22 p < 0.0001
SEX x PREVALENCE 1 0.82 p = 0.56
AGE x PREVALENCE b 9.83 p = 0 .0A
SEX x AGE x PREVALENCE b ^ .^ 9 p = 0 .3^
CORRECTED P : M RATIOS
40 1.18
40-49 1.08
50-59 1.01
60-69 0.89
70 1.06
With this wide concept of 'dyskinesia1, the plateauing 
effect noted with AIMS scores appears to occur even earlier in 
the females.
6.5.2 THE ROLE OP AGE, LENGTH OP ILLWESS AND SEX IN SEVERITY
The arbitrary cut-offs adopted for RS total scores were 
taken to represent the normal/minimal - mild/moderate - severe 
ranges on the severity continuum while allowing a roughly equitable 
distribution of numbers for analysis.
The ranges defined with each sex were:
RS total 0 - 3
RS total 4 - 9
RS total 10 or more
AROVA with age as dependent variable (TABLE 2:6:3) demonstrated 
significant main effects of both sex and RS totals (P = 34? df = 1 , 
405, P <  0.0001 ; P = 5.83 , df = 2 , 405 t P = 0.003 respectively).
The main effect of age on sex was that males were significantly 
younger than females in all ranges, while age was significantly
TABLE 2:6:3 
ROCKLAND SCALE DATA
ANALYSIS OF VARIANCE: AGE AND LENGTH OF ILLNESS IN MALES AND FEMALES
AGE « 3 4-9 > 10
MALES 53-3 54.3 38.9
FEMALES 60.2 63.3 65
SEX F = 34.00 df = 1,405 p < 0.0001
ROCKLAND F = 5-83 df = 2,405 p = 0.003
LENGTH OF < 3 4-9 ^ 10
ILLNESS
MALES 27.5 28.1 32 .3
FEMALES 33 32.5 35
SEX F = 16.45 df = 1,404 p = 0.0001 
ROCKLAND F = 5.12 df = 1,404 p = 0.006
TABLE 2:6:4 
ROCKLAND SCALE TOTALS
ANALYSIS OF COVARIANCE: AGE AND LENGTH OF ILLNESS IN MALES AND FEMALES
CORRECTED
AGES
« 3 4-9 > 10
MALES 56.8 57-2 58
FEMALES 58.7 62.2 61 .6
SEX F = 16.98 df = 1,405 p < 0.0001
ROCKLAND F = 2.43 df = 2,405 p = O.O89
CORRECTED < 3 4-9 > 10
LENGTHS OF
ILLNESS
MALES 31 31 32.4
FEMALES 32.2 29.9 31.4
SEX F = 0.16 df = 1,404 p = N/S 
ROCKLAND F = 1.73 df = 2,404 p = N/S
positively associated with RS totals. There was no significant 
interaction.
ANOVA with length of illness as the dependent variable 
(TABLE 2:6:3) also showed significant main effects of sex and RS 
totals (P = 16.45 , df = 1, P =0.0001 ; P = 5.12 , df = 2,
404 , P = 0.006 respectively). Thus, males have significantly 
shorter lengths of illness than females and higher RS totals were 
associated with longer lengths of illness. Again no significant 
interaction emerged.
Thus, significant effects attributable to the passage of 
time could be demonstrated as could the fact that females were 
older and had longer lengths of illness than males. As with AIMS 
results, analysis of covariance was carried out in an attempt to 
separate the effects of the two time components.
AECOVA with age as the dependent variable and length of 
illness covaried revealed once again a persistently significant 
main effect of sex (TABLE 2:6:4)> but in addition a persistent, 
though only marginally significant effect of RS totals. The corrected 
age values shown in TABLE 2:6:4 confirm that when length of illness 
is accounted for, males are significantly younger than females.
Unlike findings with AIMS data, however, a marginally significant 
effect of age on RS totals persists, even after the strongly 
correlated variable of length of illness is removed. The interaction 
term was again non-significant.
ARCOVA with length of illness as the dependent variable and 
age covaried gave no significant main effect of sex or RS totals 
(TABLE 2:6:4) and there was no significant interaction term. The
corrected length of illness values shown in TABLE 2:6:4 were 
comparable in all ranges.
Thus, although once again time factors of age and length of 
illness are closely related, there is some evidence from these 
analyses that age may provide the dominant contribution with regard 
to RS total scores. As in the previous (AIMS) analysis, sex is 
only important with regard to severity of movement disorder insofar 
as females are older than males, though the comparable lengths of 
illness in both sexes again indicate that females must have been 
admitted to long-term care at a later age.
6.5.5 FURTHER EVALUATION OF THE ROLE OF SEX
A comparison was conducted of the prevalence of abnormality 
in males and females with advancing age using the technique of 
single symptom criteria.
Comparison of the prevalence of abnormality with a decreasing 
single symptom criterion (5» 4 and 3) by sex and age is shown in 
Fig 2:6:8. In general terms the pattern is comparable to the AIMS 
findings but the overall difference between the sexes is more striking, 
at least statistically. This is especially true for those over 70 
years of age.
At a single symptom criterion of 5» "the females differed in
p
prevalence overall from the males (X = 9*76 , df = 4> P = 0.045) •
This was largely, but not exclusively, accounted for by the 
significantly higher prevalence recorded in females over 'JO years 
(X 2 = 7-89 , df = 1 , P = 0.005).
FIG 2:6:8
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At the two lower single symptom criteria, the position is 
complicated by the effects of age on prevalence. At criterion 4 the 
age effect is comparatively much greater in females while at criterion 
3, that for females is roughly linear but that for males, curvilinear. 
Nonetheless, at both these criteria levels, the females over 70 showed 
a strikingly greater prevalence than the males (Criterion 4 : X = 
15.92 , df = 1 , P <0.0001 : Criterion 3 : X 2 = 25.85 , df = 1 ,
P <  0.00001).
The P : M ratios at increasing single symptom criteria with 
advancing age are shown for all body areas together and for face and 
limbs/trunk separately in TABLES 2:6:5? 2:6:6 and 2:6:7 respectively. 
The total sample and only those exposed to neuroleptics are shown 
separately.
In general, comparing those in the total sample, this does not
reveal the striking sex differences in the over 70*s noted above.
Only at criterion 5? is the female prevalence, at 2 - 2-|- times in 
excess of that for males, strikingly greater. It is likely that with 
very high rates of abnormality differences revealed using absolute 
numbers are diluted in the calculations of percentages, thus tending 
to abolish the differences described above (which may represent a valid 
criticism of the data presented in each of these three tables). As 
was found using the AIMS data, this difference in the total sample is
due entirely to a greatly increased female prevalence on facial ratings
only.
When just those exposed to neuroleptics are considered, the 
overall increase in female prevalence in the elderly using severe 
criteria is striking, being 6 - 7  times that in males. However, as
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TABLES 2:6:6 and 2:6:7 show, in this situation the difference is 
fairly evenly accounted for by increases in both facial and limb/trunk 
abnormality.
The mean RS scores for males and females in each of the five
age-bands is illustrated in Fig 2:6:9- None of these differences
reach conventional (5 %) significance levels. In Fig 2:6:10, the
neuroleptic-treated and non-treated patients have been separated. As
will be seen, the form of the curves does not alter, though the
impression is that differences between the sexes over 60 heighten
when only neuroleptic-treated patients are considered - in the
direction of higher mean scores in males. However, none of the
S
differences between the sexes in any age band achieve^ conventional 
levels of significance. While male values in the 60 - 69 years age 
band are 35 % higher again than the females, the variance is also 
very large. With both the AIMS and RS, the pattern in the neuroleptic- 
free subjects is the same - namely a stabilisation, or even a slight 
but not significant fall, in the mean scores after the age of 60. As 
the figure shows, with RS scores, the pattern in neuroleptic-free males 
almost exactly mirrors that for neuroleptic-treated males, but at a 
slightly (but not significantly) lower level.
The mean number of RS movements rated 2 or more was not 
significantly different between the sexes considering the total sample 
(Fig 2:6:11).
Thus, as with the AIMS, a much greater prevalence of severe 
abnormality is noted with the RS in females over 70 using the single 
symptom criterion method, especially in those treated with neuroleptics. 
In the case of the RS however, differences in the drug-exposed group
FIG 2:6:9
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are not restricted to a greater frequency of severe facial ratings. 
These sex differences are not reflected in differences in mean scores 
with age, or in the mean number of movements rated positively.
6.4 ADDITIONAL INFORMATION FROM ROCKLAND DATA - THE! ROLE OF AGE
AND SEX ON INDIVIDUAL ITEMS
Additional information was extracted from the Rockland data
by analysing those individual items rated often enough, in order to
assess those to which age and sex made major contributions. Pig 2:6:12
illustrates the prevalence of abnormality (2 or more) in four
arbitrarily defined age bands (20- 50* 51 - 60: 61 - 70: 71 +) for
males and females separately. The slope of the lines represents
graphically the effect of age on each item, while the separation
represents that of sex. Significance of these differences was gauged 
2
by X analysis.
Of the twenty five items rated positively with sufficient 
frequency to allow examination (TABLE 2:6:l) only the orofacial 
components of pouting (item 4)» puckering (item 5)> chewing (item 7)> 
smacking (item 8), bon bon (item 9)> and. tongue protrusion (item 10) 
showed significant positive age effects (Fig 2:6:12). The significance 
with rocking (item 22) which was somewhat inconsistent and negative, 
was probably a chance phenomenon resulting from small numbers. Only 
tongue tremor (item ll), sucking (item 6), and pill-rolling (item 28) 
showed significant sex effects, the first of these being commoner in 
males while both the others were more common in females.
This analysis took no account of the possible effects of past 
neuroleptic status considered subsequently or length of illness, as
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to have done so would have reduced the numbers beyond those suitable 
for statistical analysis. This must be borne in mind when 
interpreting this finding. However, subdividing the total sample 
into those scoring only on individual items can be expected to 
dilute considerably the age effects found in the group as a whole.
Thus for individual items to show age effects suggests that these 
effects are powerful. It is thus of some interest that the 
buccomasticatory lingual (EMI) features of involuntary movement 
disorder stand out so strikingly in this regard, even allowing for 
the necessary limitations of the analysis.
6.5 THE ROLE OF NEUROLEPTIC MEDICATION PAST AND PRESENT
As the Rockland Scale provides more detail of involuntary 
movements of a wider range than the AIMS, the analyses in this 
section were performed not only on RS total scores but also on 
each of the regional subscores separately, where sufficient positive 
ratings made this possible. The subscores examined were those for 
Face (items 1 - 16), Heck/Trunk (items 17 - 24), Upper Limbs 
(items 25 - 32) and Lower Limbs (items 33 ~ 40). Whole body movements 
(items 41 - 43) were rated too infrequently to be analysed separately.
The same neuroleptic status categories were employed as in 
analysis of AIMS data presented previously (Categories 1 - 6 ,
Chapter 5*5), and the same ’age - controlled’ group (with the 
previously stated proviso) selected to obviate the effects of age 
and length of illness.
The analyses were conducted with the basic RS normality 
cut-off used to date - i.e. 0 - 1 .  In light of the comments made
earlier regarding this (Chapter 3*2.2) and the importance of the 
questions being evaluated here, they were repeated using the 
higher cut-offs for total scores and regional subscores noted 
previously (Chapter 3*2.2). The statistical technique was unified 
analysis of variance by ranks.
6.5.1 THE ROCKLAND SCALE TOTAL SCORES
The relationships between RS total scores and the six 
categories of neuroleptic status are illustrated in Fig 2:6:13*
The organisation of this diagram is identical to that for the 
presentation of AIMS data (Fig 2:5:12) and the explanation will not 
be repeated.
Overall, there was a relationship between RS total scores 
and categories of neuroleptic status (H = 12.06 , df = 5 , P = 0.034)* 
There was no effect of being on neuroleptics at the time of 
examination (z - value = 1.27 , P = 0.2), but increasing exposure 
to neuroleptics in the past (Fig 2:6:13 : bottom right) was 
significantly associated with an increasing prevalence of movement 
disorder (z - value = 3*1 > P = 0.002). This was due to approximately 
equal differences between the groups. Thus, when those never exposed 
to neuroleptics were compared with those treated (73*8 %  v 89.7 %  
abnormality), the difference remained highly significant (z - value =
2.7 , P = 0.006) and comparable to that between the heavily treated 
sample and the rest (93*5 % v 81.6 % abnormality) (z - value = 2.54 ,
P = 0.01). There was no significant interaction between past and 
present neuroleptic therapy (z - value = O.56 , N /s).
By arbitrarily dividing RS totals into three ranges relationships
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were sought between severity of movement disorder and current/past 
neuroleptic exposure. The RS ranges were 0 - 2 ,  3 - 10, and 11 +.
There was a non-significant trend towards severe movement 
disorder being found more often in those receiving neuroleptics at 
the time of examination (z - value =1.78 , P = 0.07). Of those 
’currently' on these preparations, 46 *3 % had totals in the severe 
range compared to 35*4 % °f those ’off neuroleptics when examined.
Much more striking relationships, however, were found 
between severity and past neuroleptic exposure (Fig 2:6:14)
( z - value = 2.69 , P = 0.007)» This was largely, though not 
exclusively, due to the fact that severe abnormality was more common 
in those with a history of exposure regardless of degree, compared 
to those with no past history (z - value = 2.55 > F = O.Ol), though 
severe movement disorder was also significantly more frequent in the 
heavily treated patients than in the rest combined (z - value = 2 .0 5 ,
P = O.O38).
As with the AIMS results,- consideration was given to the 
effect of having had neuroleptics stopped at some point in time. The 
data being analysed here are represented in the top, left-hand side 
of Fig 2:6:13* In general, the relationship between the prevalence 
of movement disorder and the first three categories of past neuroleptic 
status represented only a trend (z - value = I .5 8 , P = O.l). This 
was due entirely to the fact that movement abnormality was more 
frequently to be found in those whose neuroleptics had been stopped 
at some time, compared to those never exposed (z - value = 1.94 >
P = 0.05). Those in the former categories had a non-significant trend 
towards more severe disorder when compared with those in the latter
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category (z - value = 1.80 , P = 0.068).
No difference was found in prevalence of abnormality in 
those recently commenced on neuroleptics compared to those never 
exposed (X ^ = 0.29 > df = 1 , N/s). The question of differing 
severity in these two groups could not be explored owing to the 
small numbers in the former group (Category 4)* There was a 
significant linear relationship between increasing prevalence in 
terms of RS totals and categories 4 - 6 of neuroleptic status 
(z - value = 2.63 ? P = 0.008), though differences due to increasing 
severity did not reach significance.
6.5.2 ROCKLAND SCALE FACE SUBSCOKES (items 1 - 16)
The subtotal of the 16 RS items devoted to facial movements 
was analysed in the same way as the grand totals for the whole scale. 
Pig 2:6:15 illustrates the findings from all four subscores analysed. 
The lay-out is as for grand total scores (Fig 2:6:13).
Considering these facial scores alone, there was overall, a 
highly significant relationship between the prevalence of movement 
disorder and categories of neuroleptic status (H = 19*87 , df = 5 >
P = 0.002). There was no effect of being on neuroleptics when 
examined (z - value = 0.34 > N/s) but a very striking relationship 
with categories of past neuroleptic exposure was found (z - value = 
3.56 , P = 0.0006). Fifty-eight percent of those never exposed in 
the past showed some facial abnormality compared with 82 % of those 
given neuroleptics (z - value =3*55 > P = 0.0012). While comparisons 
of the difference in prevalence in the heavily treated category 
with that in the other two categories combined (8 6 .3 % v 70.6 %
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abnormality) continued to show significance, this was of a lesser 
order (z - value = 2.75 > P = 0.006). Thus the major difference 
within the facial subscores appears to lie in fewer of those never 
exposed to neuroleptics showing abnormality than the rest. There 
was no interaction between past and present neuroleptic status.
Severity of facial disorder was not related to ’current1 
neuroleptics (z - value = 0.4 , W/s) but was associated with past 
status (z - value = 2.31 > P = 0.02). This effect was contributed 
to roughly equally by the difference between those never exposed 
in the past compared to those treated regardless of degree (z - value
2.00 , P = 0.044) as it was by the difference between the heavily 
exposed subjects and the others combined (z - value = 1.92 ,
P = 0.05).
As for the effect on facial scores of having had neuroleptics 
stopped at some time, there was a highly significant linear 
relationship between facial subscores and the first three categories 
of neuroleptic status (z - value = 2.75 » P = 0.006). This was due 
entirely to the higher prevalence in patients whose drugs had been 
stopped than in those never on them (z - value = 3*14 > P = 0.002). 
There was a trend towards a greater amount of severe abnormality in 
patients whose drugs had been discontinued but this narrowly missed 
significance (z - value =1.88 , P = O.O58).
Facial prevalences did not differ in patients only recently
2
started on neuroleptics from those never treated (X = 0.9 > df = 1 , 
N/s). A striking linear relationship existed between facial 
prevalences and categories 4 - 6 of neuroleptic status (z - value =
3.O6 , P = 0.0026). A similar linear relationship was established
for severity (z - value = 1.95 > P = O.O48).
6.5.3 ROCKLAND SCALE NECK AND TRUNK SIIBSCORES (items 17 - 24)
No significant differences emerged between categories of 
current or past neuroleptic status and RS neck and trunk subscores. 
None of the analyses looking at prevalence, severity, or the effect 
of discontinuation or commencement of medication revealed any 
differences of note. The numbers rating pathological abnormality 
on these items were, however, small (TABLE 2:6:1).
6.5.4 ROCKLAND SCALE UPPER LIMB SIIBSCORES (items 25 - 52)
Overall, there was no significant relationship between 
categories of neuroleptic status and the prevalence of upper limb 
abnormality as recorded on the RS (H = 3*72 , df = 5 > N/s). There 
was however a marginal effect of actually receiving neuroleptics 
when examined, with 55*4 % of those on neuroleptics rating 
abnormality compared with 44*8 % of those not having them at the 
time (z - value =1.54 > P = O.l).
In the upper limbs, there was no significant relationship 
between past neuroleptic treatment and local movement disorder, 
though a trend in the anticipated direction could be detected 
(z - value = 1.38 > P = 0.16). Thus,the prevalence of movement 
disorder in each category of past neuroleptic status was 42.9 %,
49.4 %and 55.4 % ('none* - 'some* - 'much* respectively). No 
interaction emerged between past and present neuroleptic 
administration.
As with prevalence, there was a trend towards more severe 
abnormality in those taking neuroleptics when seen (z - value = 1.70 > 
P = 0.086), though severity significantly related to past neuroleptic 
exposure (z - value = 2.00 , P = 0.04). This resulted from small, 
but roughly equal differences between the categories in the direction 
established for other areas.
There was no difference in prevalence or severity of abnormal 
upper limb movements in those whose neuroleptics had been stopped 
at some time compared to those never exposed. Likewise, analysis 
of the effects of recently commencing neuroleptics revealed no 
findings of note.
6.5.5. ROCKLAND SCALE LOWER LIMB SHBSCORES (items 55 - 40)
There was an overall relationship between RS lower limb 
subscores and categories of neuroleptic medication (H = 11.25 » 
df = 5 > P = 0.045)« In ‘fcb.e lower limbs, however, the components 
of this general association were different from what had been 
established in other body regions.
Although past neuroleptic treatment was related to lower 
limb movements, this amounted to only a trend (z - value = I .6 5 >
P = 0.09). The increase in prevalence was progressive from those 
never exposed, to the heavily treated group. However, there was 
a highly significant effect of actually receiving neuroleptics 
when the lower limb examinations were performed. While 27*9 % of 
those ’currently1 on these drugs had abnormal movements, the 
comparable prevalence in those not receiving them was 12.4 %
(z - value = 2.79 , P = 0.005).
This basic reversal of prevalence findings noted in other 
body regions also applied to severity. Thus although there was a 
weak relationship between severity of movement disorder and categories 
of past neuroleptic exposure in the previously reported direction
(z - value = 1.87 , P = 0.058), more severe abnormality was
strikingly commoner in those receiving neuroleptics when assessed
(z - value = 2.79 > P = 0.006).
No differences were found in the lower limb movements of 
those whose neuroleptics had been stopped at some time compared to 
those never prescribed them.
As Pig 2:6:15 shows, these lower limb findings - strikingly
divergent from those reported for other body regions - can be
accounted for by the much greater prevalence ( and severity ) of
movement disorder occurring in this region in those whose neuroleptic
treatment was only recently commenced (i.e. category 4)* This
group demonstrated significantly more lower limb abnormality than
2
patients never exposed ( X  = 2.73 > df = 1 , P = O.OO3), though, 
despite the appearances shown in Pig 2:6:15, not significantly more 
than patients consistently exposed. There were no differences in 
severity.
6.5.6. THE EFFECT OF RAISING- R.S. CUT-OFF FOR NORMALITY
Comparison of the significance levels achieved for 
relationships between the prevalence of movement disorder reflected 
in the RS grand totals and regional subscores, and categories of 
neuroleptic status using the low and the higher cut-off for 
normality, is shown in TABLE 2:6:8. In general, it will be seen
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that raising the cut-off did not fundamentally alter the pattern 
of relationships in the comparisons conducted. For the RS face 
subscore, the relationship with past neuroleptic status is reduced 
to borderline significance, while that comparing patients heavily 
treated in the past with the other categories combined fails to 
achieve signficance with the higher cut-off. Otherwise, those 
associations attaining conventional levels of statistical 
significance at a cut-off of 0 - 1, remained significant when the 
cut-off for normality was raised. Indeed, particularly with upper 
and lower limb subscores, a number of the relationships strengthen 
considerably.
With regard to the question of having had neuroleptics 
stopped ( neuroleptic status categories 1 and 2/3), raising the 
cut-off in general reduced the strength of the significant values. 
With total scores, the difference between the persisting prevalence 
in those whose drugs had been discontinued and those never treated 
was reduced to a trend, while in the face it remained significant, 
but with a slightly diminished P - value (P = 0.016). The trend 
towards a relationship between severity and the first three categorie 
of neuroleptic status with grand total and facial subscores 
disappeared at the higher cut-off. There continued to be no 
relationship with either prevalence or severity on the limb subscores
In view of the small sample size of category 4> it was felt 
unjustified to reanalyse the data on the effects of recently 
commencing neuroleptics with a higher cut-off.
6.6 THE ROLE OF ANTICHOLINERGIC MEDICATION
This was analysed in the same way as was described with 
AIMS data. Only Rockland grand totals were used and the maximum 
likelihood/log linear analysis was conducted using only the low 
( 0 - 1 ) normality cut-off. The higher cut-off, which was in 
addition used in the analysis of trends, was again 0 - 4 *
Analysis of trends showed no difference in prevalence of 
involuntary movements in those on anticholinergics as compared 
to those not receiving them, using the low normality cut-off for 
RS total scores (z - value = 1.54 ? P = 0.12). However, movements 
present were more severe in the former group (z - value = 2.14 >
P = 0.03). With the higher cut-off, both the prevalence (z - value = 
2.25 , P = 0.024) and the severity (z - value = 2.06 , P = O.O38) 
were significantly greater in those on anticholinergics (Fig 2:6:16 
and 2:6:17).
Analysis of males and females separately, revealed little 
difference with regard to prevalence. Both had a tendency (slightly 
more marked in the males) to show a higher prevalence when on 
anticholinergics using the higher cut-off for normality. However 
only the females showed more severe abnormality on anticholinergics, 
which emerged especially at the high cut-off (LOW : P = 0.024 *
HIGH : P = 0.012). In this situation, 14*7 % of women not on 
anticholinergics had severe movement disorder while the comparable 
figure for those receiving anticholinergics was 37* 8 %.
Maximum likelihood/log linear analysis confirmed the role of 
past neuroleptics in relation to the presence of movement disorder 
on the RS (X ^ = 8.0 , df = 2 , P = 0.018), and also the lack of a
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role for anticholinergics in prevalence (X = 0.22 , df = 1 ,
P = 0.64).
Thus, the prevalence of abnormal movements cannot be 
related to anticholinergic status at examination by two different 
analyses when a low cut-off point is used to define normality.
However, when a more liberal definition of what is normal is applied 
by raising the total score cut-off, movement disorder of the kind 
appropriately recorded on the RS is found to be more common in those 
receiving anticholinergic drugs. In addition, more severe abnormality 
is noticeable in those on anticholinergic medication, though 
examination of the sexes separately shows this effect to be confined 
to the females.
6.7 RELATIONSHIPS BETWEEN MOVEMENT DISORDER AND ITEMS OF
RECORDED IKFQRMATIOH.
This analysis is identical to that described with AIMS data 
(Chapter 5*6). The Recorded Information variables are as shown 
in TABLE 2:5:8* Only RS grand totals were used. Hence, this 
presentation concerns the relationships between the overall prevalence 
of movement disorder and historical information. The initial cut­
off for normality adopted was 0 - 1 .
The relationships are shorn in TABLE 2:6:9* With the effects 
of past neuroleptic exposure accounted for, no unequivocal, 
independent associations emerged between the prevalence of involuntary 
movements and any of the Recorded Information variables. There was a 
marginally significant correlation between both a positive family 
history of schizophrenia and a history of birth trauma/head injury
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such that patients with each of these tended to demonstrate 
abnormal movements less frequently than those without such histories. 
This statistical association is likely to be artifactual.
Both leucotomy and past insulin coma produced highly 
significant interaction terms. For past insulin, the probable 
explanation is the same as that suggested in the AIMS analysis 
(Chapter 5*6). With leucotomy, it was striking that of those in the 
’age-controlled1 band with a history of this procedure (1 9 subjects), 
only one did not show movement disorder. The significant interaction 
term arose from this one subject falling into the intermediate 
(‘some’) category of past neuroleptic exposure. It is possible that 
this one case served to blurr an underlying relationship between 
the operation and present movement disorder rated on the RS, though 
in this regard it is noteworthy that the main effect term of 
leucotomy on RS totals did not even approach significance 
(z - value = 0 .9 7 ? F >  5)•
6 .8 RELATIONSHIPS BETWEEN MOVEMENT DISORDER AND OTHER ITEMS OF
ASSESSED ABNORMALITY
The items of Assessed Abnormality considered, the arbitrary 
divisions of scores adopted for each, and the statistical technique 
for gauging significance were the same as those used for comparable 
analysis of AIMS data (Chapter 5*7) • The cut-off for normality was 
initially an RS grand total of 0 - 1.
The results are shown in TABLE 2:6:9. Figs 2:6:18 to 2:6:21, 
which illustrate the findings, are laid out as was described 
previously (Chapter 5*7)• No significant independent relationships
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emerged between the presence of movement disorder using an RS 
cut-off of 0 - 1 and any of the other items of Assessed Abnormality, 
and there were no interactions.
6.9 RAISING THE R.S. CUT-OFF FOR NORMALITY
The above analyses investigating relationships between the 
prevalence of abnormal movements and Recorded Information and 
Assessed Abnormality variables were repeated adopting a higher 
cut-off of normality on RS grand total scores (Chapter J.2.2.b).
The effect on the findings of raising the cut-off is shown 
in TABLE 2:6:10. Pigs 2:6:22 to 2:6:25 illustrate the consequences 
with regard to Assessed Abnormality variables.
The effect of raising the cut-off was that a marginally 
significant independent relationship emerged between RS totals and 
'negative' mental features, while relationships with cognitive 
impairment and behavioural deterioration attained significance.
These are the same Assessed Abnormality variables which bore a 
significant relationship to the prevalence of involuntary movements 
using the AIMS data (TABLE 2:5:10 and 2:5:ll).
Choosing a cut-off for normality on the RS is difficult, 
but as the present work shows, the choice is crucial with regard to 
the correlates which can consequently be established. In general, 
a balanced evaluation of the findings regarding the correlates of 
dyskinesias widely defined, would indicate that relationships can be 
established between the presence of these and 'negative* features 
in the mental state, cognitive impairment and behavioural deterioration 
and that these are independent of time factors and exposure to 
neuroleptic drugs.
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6.10 SUMMARY OF ANALYSIS OF ROCKLAND SCALE DATA
In this population of long-stay schizophrenics:
1) The prevalence of movement disorder depends on the 
severity criteria adopted, hut is in general very 
high.
2) Movements are predominantly orofacial, 
choreoathetoid abnormality of the tongue being the 
commonest single positive rating. Tremor items were 
frequently recorded in all body parts.
3) Spontaneous involuntary motor activity of the type 
recorded on the RS is common, and can be a feature of 
established schizophrenia whose course has not been 
modified by the administration of neuroleptic drugs.
Such differences in severity and distribution as can 
be attributed to drugs and nothing else are slight 
and of little clinical importance.
4) A history of neuroleptic exposure does not of itself 
allow neuroleptic-treated subjects to be distinguished 
from neuroleptic-free subjects with regard to their 
involuntary movements.
5) Time factors strongly correlate with RS total abnormality. 
The prevalence of involuntary movement disorder is 
positively correlated with age. There is some evidence 
that age may make a greater contribution to severity 
than length of illness.
6) An independent role for sex is difficult to establish.
No relationship between prevalence or severity and sex 
per se can be established except when the single symptom 
criterion method is used to calculate prevalence. In 
this situation elderly females have a strikingly higher 
frequency of abnormality which, when only neuroleptic- 
treated patients are considered, results from increased 
ratings in all body parts. However this difference is 
not reflected in mean scores or number of movements.
7) Significant relationships exist between past neuroleptic 
exposure and the presence of abnormal movements using
RS total scores, an increasing degree of treatment in the 
past being associated with an increasing prevalence of 
movement disorder. This overall association reflects 
heavily the increased prevalence of facial abnormality.
Although overall no effect can be demonstrated of 
actually receiving neuroleptics when examined, this does 
tend to increase the prevalence of movement disorder 
found in the upper limbs, and to strikingly increase 
lower limb abnormality.
More severe movement disorder is found in those with a 
history of past neuroleptic therapy, especially in facial 
and upper limb regions, though also to a lesser extent 
in lower limbs. More severe leg abnormality is found in 
those receiving these drugs when examined.
Movement disorder remains more common in patients who 
have been on neuroleptics but have had them stopped at 
some time, than in those never exposed, and the previously 
treated also have a tendency to exhibit more severe 
abnormality. This overall finding reflects the situation 
in the facial region.
Extending the cut-off for normality did not fundamentally 
alter these findings with regard to prevalence and 
severity when the summated scores method is used.
Those whose neuroleptic treatment is of relatively short 
duration do not differ in their prevalence of abnormal 
movements from those never exposed, in all regions taken 
together and for all separately, except for the lower 
limbs, where they have much more disorder. Recent 
exposure is associated with less spontaneous motor activity 
than moderate or heavy past exposure held consistently 
till the time of examination, except for the lower limbs. 
Facial movements are increasingly severe in those treated 
for longer periods compared to those recently commenced.
The presence of abnormal movements is not related to 
anticholinergic status at examination using a low total 
score cut-off to define normality. A greater prevalence 
is found in those receiving anticholinergics when a high 
cut-off is used. More severe movement disorder is 
associated with anticholinergic prescription at both cut­
offs, due entirely to the female patients.
Movement disorder is not related to historical items of 
Recorded Information, apart from time factors. This 
applies whether a low or a higher cut-off for normality 
is used.
With a low cut-off for normality, RS totals are not related 
to items of Assessed Abnormality. However, using a higher 
cut-off, the presence of abnormal movements tends to be 
associated with ’negative’ features of the mental state, and 
is definitely related to cognitive impairment and behavioural 
deterioration.
Chanter 7 - Discussion
This section of the project was concerned with evaluating a 
clinical neurological parameter in relation to both the schizophrenic 
illness and its treatment. Examinations were performed to a 
predetermined format that was maintained as far as possible with 
subjects of this type, and findings were recorded in standardised 
fashion. The examiner remained blind to the patients’ personal and 
treatment histories.
No a priori judgements were made regarding the aetiology 
of such neurological abnormality as the patients may have demonstrated. 
To commence from this starting point was possible as approximately 
1 in 9 of the sample had no history of neuroleptic exposure. Thus 
those neurological features related to the treatment of schizophrenia 
could be separated from those associated with the illness per se.
7.1 DIAGNOSTIC ISSUES
The question of the validity of the drug histories has already 
been discussed, but it is also relevant at this juncture to assess 
the validity of the diagnoses attributed to those comprising the 
study sample. The population was as stated diagnostically homogeneous 
by psychiatric criteria (Feighner and P.S.E. - cf Part l). However, 
such criteria are fundamentally mental state based, and although a 
definite history of features compatible with organic brain disease 
effectively excludes a subject, psychotic symptoms can be prodromal 
manifestations of slowly evolving brain disease, the organic nature 
of which may be overlooked once a patient is admitted to long-term care.
It is therefore possible that the study population was contaminated 
by an assortment of neurological disorders manifesting as involuntary 
movements and psychosis.
Such a view seems untenable. Applying the inclusion criteria 
excluded one-fifth of the in-patient population given a case-note 
diagnosis of schizophrenia. Thus by predominantly mental state 
criteria alone, the sample was tightly defined. Omitting the 
features of parkinsonism and global cognitive impairment, which in 
a high proportion of subjects are likely to be illness and/or 
treatment related phenomena, gross localising neurological abnormality 
was not common (cf Part l). In Part 1, the gross neurological 
features found in the total sample at first examination were noted 
(TABLE 1:3:7)o In view of its relevance to the present point, these 
data are presented again in TABLE 2 : 7 : 1 , As none of the patients 
omitted from the second examination had gross (’other neurology’) 
signs, the numbers are the same as those in the earlier TABLE, but 
the findings are divided on the basis of the patients’ history of 
exposure to neuroleptic drugs. Abnormality can be seen for the most 
part to be minor and peripheral.
In two cases only, could an alternative neurological diagnosis 
be entertained, though both were asymptomatic with regard to their 
motor systems. The first was a lady with gross horizontal nystagmus 
and bilateral pes cavus. The second lady had hyperreflexia of the 
lower limbs with sustained clonus and unilateral pes cavus. The 
significance of this latter feature was difficult to assess as she 
had suffered a gun-shot wound in adolescence resulting in an arterio­
venous fistula in the lower third of the same leg. Nonetheless, her
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father had died of "spinal degeneration" at a young age. The question 
is clearly raised that both these patients, especially the second, 
may have been carriers of, or have suffered a forme fruste of, some 
type of spino-cerebellar degeneration in which psychotic features 
predominated.
It remains possible that underlying brain pathology 
inappropriate in either degree or situation for the production of 
gross localising signs but sufficient to contribute to the production 
of involuntary movements, may be relevant. While unsuspected 
intra-cerebral lesions were detected on CT scan, the prevalence of 
these would be insufficient to account for the findings of the 
present section (this aspect will be discussed in Part 111).
Pertinent to the question of alternative neurological 
diagnoses is the fact that a number of the sample were old enough 
to have potentially been exposed to encephalitis lethargica. 
Approximately 75 % were over 50 years of age when examined and 
virtually all those in the neuroleptic-free group were in the older 
age range. Encephalitis was often manifest in vague, flu-like 
symptoms whose significance could have been overlooked in early life 
(Wilson 1940). It was however, a condition which caused great 
concern not only to the medical profession but to the lay public also, 
and it is a reasonable assumption that there was a high index of 
suspicion among admitting psychiatrists of the time. No evidence 
could be elicited that this diagnosis was entertained in any of the 
subjects of the study, all of whom conformed to two sets of criteria 
for what is now called schizophrenia. On admission, the next of kin, 
usually the parents, were required to complete the detailed Enquiry
Norm which included information on past physical illnesses and 
infectious diseases the patient had contracted. It could not be 
established from this source either that encephalitis may have 
been a contaminating factor in these patients.
Thus it is concluded that the study population was 
diagnostically homogeneous and suffered from schizophrenia as this 
concept is currently understood in both the United Kingdom and 
among the more conservative authorities in the United States. As 
the findings presented in Part 1 show, the sample does, however 
represent schizophrenia in a severe form.
7.2 THE PREVALENCE
Comparison of results from the first examination, where 
only the presence or absence of movement disorder was considered, 
and the second using standardised recordings of severity, confirms 
that when severity of abnormality is recorded on an ordinal scale, 
prevalence rates increase due to the inclusion of milder degrees 
of abnormality. In other words the more closely the patient has 
to be examined, the more abnormality is found. This emphasises the 
role of ordinal ratings in inflating prevalence. These findings 
also suggest that, notwithstanding any short-term fluctuations, 
involuntary movements in chronic schizophrenics of the type described 
in this study, seem to exhibit considerable stability in gross 
distribution and severity (at least above a certain threshold)oyer 
an 18 month - 2 year period.
The findings presented here illustrate how the reported 
prevalence of involuntary movement disorder is dependent on two major
factors unrelated to the clinical condition itself :
1). The criterion of severity applied
2) The recording schedule used - implicit in which is the 
concept of dyskinesia being adopted
Figs 2:5:2 and 2:6:2 show the dramatic effects of different 
severity criterion. With ’mild1 criteria the majority of this 
population showed abnormality with both scales, while using 'severe' 
criteria the prevalence shrank to a small minority. The difference 
in prevalence at ’moderate1 severity criteria on both scales amounted 
to approximately 17 %. Such differences in breadth of concept and 
degree of spontaneous movement necessary to qualify as abnormal 
undoubtedly underly much of the discrepancy in prevalence reported 
over the years and illustrate the weakness of using pooled data 
to validate the idea of ’neuroleptic-caused’ dyskinesia.
Allowing for this, the present investigation revealed a 
high prevalence of involuntary movement disorder in the study sample. 
Half the patients exhibited at least moderate abnormality using the 
AIMS scoring procedure and two-thirds using the more comprehensive 
Rockland ratings. Items of fast, regular tremor were the most 
frequently recorded ones in this population and although more 
sustained dystonic-type truncal and limb movements were recorded, 
albeit infrequently, abnormality was overwhelmingly of a dynamic 
kind.
It is only in recent years that standardised rating scales 
have been applied to record abnormality, of which the most frequently 
used is the AIMS. Of the published studies that of Smith et al 
(Smith et al 1979^0 is the only one to provide information comparable 
to the present work, as the others have used either heterogeneous
diagnostic groups or outpatient samples. Using the AIMS, Smith et al 
assessed the prevalence of "tardive dyskinesia" in long stay patients 
(average length of hospitalisation 22.7 years) with "either a 
primary or secondary diagnosis of schizophrenia sometime during 
their hospitalisation". Their prevalence rates at criteria 2 
(mild) or more and 4 (severe) on any AIMS item are similar to those 
reported here, but they found a much lower prevalence (^0 %) using 
a moderate (5 or more) criterion than the ^0.6 % presented earlier.
Consideration of individual items shows a highly significant 
difference between the present findings and those of Smith et al 
in all items except upper and lower limbs using the moderate 
criterion (TABLE 2:7:2). When the distribution of abnormalities 
among patients with dyskinetic activity is considered, significant 
differences persist on facial expression, lips/perioral and jaw 
items (TABLE 2:7:2). Thus, not only were more facial abnormalities
found in the present study population as a whole, but also a
significantly greater contribution to the total abnormality came 
from expressive, perioral and masticatory involvements.
Age differences cannot account for these discrepancies as 
both populations had comparable mean ages. However two other 
explanations are possible. Smith et al have shown elsewhere the 
relevance of rater bias in accounting for differences in prevalence
rates (Smith et al 1979b). This is an obvious source of discrepancy
in studies using standardised schedules which has been widely 
commented upon, and which is difficult to militate against with any 
permanency. This does however appear to be a fairly consistent 
phenomenon across items and although bias may contribute to the
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differences between the two studies, it is hard to see how raters
achieving agreement on some items could differ by a factor of
ten on others by the operation of this alone. In Smith et al's
?
work, the magnitude of the discrepancy attributable to this was 
between 25 % and $0 % of a. scale point - i.e. of a much lesser order 
than that found between the two studies.
A more likely explanation lies in differences in the study 
populations. Subjects of the present investigation conformed to 
more rigorous inclusion criteria than those of Smith et al, who 
used a case-note diagnosis of schizophrenia applied at any time 
over the patients’ admission period. With a mean hospitalisation 
of almost 25 years it is likely that many such American patients 
would not fulfill operational criteria currently used. It is 
therefore probable that the clinical deficits of the present sample 
were more severe. As was shown in the results above, and as will 
be discussed subsequently, neurological abnormality of this type 
correlates with certain other indices of severity in long-standing 
schizophrenia, and it is likely that samples showing greater deficits 
in other, predominantly mental state areas, exhibit more and severer 
movement disorder.
7.5 SCHIZOPHRENIA AND INVOLUNTARY MOVEMENTS
The first basic question posed concerned whether or not 
established schizophrenia, unmodified by neuroleptic drugs, could be 
associated with involuntary movement disorder. As 3^.2 % of the 47 
neuroleptic-free patients had abnormality of ’moderate' severity on 
the AIMS (single symptom criterion method), with a comparable RS figure
of 55*5 %t 'the answer is affirmative. The movements represented in 
these prevalences are indistinguishable in type and distribution 
from those found in samples who have been treated with neuroleptics. 
The point for consideration then becomes whether or not these 
prevalences are higher than those found in (a) non-psychiatric, 
elderly subjects and (b) non-schizophrenic, psychiatric patients.
It is not possible at this stage to make satisfactory 
consideration of these two questions separately from the evidence 
published in the literature. As a rule, studies have not addressed 
the potential role of psychiatric diagnoses in general and 
schizophrenia in particular as specific contributing variables.
Involuntary movements with an essentially orofacial 
distribution have been described in the non-neuroleptic treated, 
non-psychiatric elderly, with the designation of senile chorea 
(Brain & Walton 19&9? Weiner & KLawans, 1975)5 and "mouthing" 
(Appenzeller & Biehl 1968), a presumed cerebellar sign, and attention 
has been drawn to the syndrome of blepharospasm - oromandibular 
dystonia or Meige’s syndrome (Marsden 197&, Tolosa & Klawans 1979)*
No figures are available for the frequency of these diagnoses but 
they are likely to be uncommon.
Only one systematic study of normal elderly patients provides 
data that can be compared with the present work. Kane et al (1982a) 
examined 127 people (mean age 72.5 years) attending community-based 
activity programmes for senior citizens. None had psychiatric or 
neurological histories. Ratings were made on the Simpson (R.S.) Scale 
though abnormality was calculated on the basis of a single global 
impression. They found a 4 % prevalence of disorder all of which was
of mild severity. Of the 12 positive ratings made in 5 patients 
only 1 was not facial. These authors concluded that while 
involuntary movements can be found in the healthy elderly, " the 
aging process itself is not likely to produce abnormal involuntary 
movements without some additional factors coming into play".
Global impressions were not used in the present work, so 
comparisons cannot be exact. However, using the single symptom 
criterion technique, the present study provided strikingly different 
findings. Of the neuroleptic-free schizophrenics, 76.6 % scored 
at least a single 2 on the RS, the prevalences at increasing criteria 
of 3> 4 and 5 being respectively 55*3 % j  25*4 % and 8.5 %• Only 
5 patients with some positive rating had no abnormality on facial 
items.
In actual fact the differences between two studies are unlikely 
to be quite as dramatic as would at first seem. Biases operating 
in deducing a global impression rating would favour less import 
being given to, say, upper limb tremor than choreoathe^tosis of the 
tongue, when both items were rated at the same point on the severity 
continuum. Hence if a number of subjects have only fine tremor or 
other movements not considered by the examiner to represent much in 
the way of overall disorder, the prevalence of abnormality using 
global impression will be lower than that found using, a single symptom 
criterion, which avoids such subjective judgements. Nonetheless, even 
with the more restrictive AIMS, 53*2 % of neuroleptic-free subjects 
scored at least a single ’ 21. It should also be noted that the elderly 
subjects of Kane et al were approximately 6 years older than the 
neuroleptic-free schizophrenics described here.
The most widely available figures for movement disorder in 
neuroleptic-free elderly people are derived from pooled data which, 
as was previously mentioned, give a prevalence of 5 - 6 %
(jeste & Wyatt 1981? Kane & Smith 1982). This is strikingly 
similar to the figure reported by Kane et al discussed above. It is 
however not usually possible in this literature to divide samples 
on the basis of psychiatric status or otherwise from the data presented 
and hence the question of diagnosis cannot be reliably evaluated 
retrospectively. Only at the most severe criteria are the present 
findings in any way comparable with the pooled data or the figure 
of Kane et al. The prevalence in this study for all areas in the 
neuroleptic-free schizophrenics at criterion 4 on the AIMS was 
4.25 % and at criterion 5 on the Rockland Scale was 8.5 %.
It does not seem tenable that the prevalence differences 
under discussion are attributable simply to the adoption of differing 
levels of severity. Most of the authors who have reported on neurolepti 
free samples are recognised authorities in the field of involuntary 
movements and it is very unlikely that they would note only the most 
severe disorder. Indeed, this cannot be so as several workers used 
standardised recording schedules which would have been unnecessary 
if only severe abnormality was to be noted. In studying geriatric 
patients, Crane and Smeets did not require to use the last two 
severity points on their 7 - point scale " since no patient exhibited 
dyskinesia of a severe nature" (Crane & Smeets 1974)* As was noted 
Kane et al found only mild abnormality in the normal elderly they 
studied.
It has previously been shown (p156 ) that the application of
standardised, ordinal scales tends to inflate prevalence rates, 
though it seems improbable that different recording techniques 
alone could account for the wide discrepancies under discussion.
While a number of those studies from which the pooled data prevalence 
has been computed did not use standardised methodology of this type 
(Mettier & Crandall 1959 ? Demars 1966, Siede & Muller 1967* Jones &
Hunter 1969), a number did (Greenblatt et al 1968, Crane
Crane & .Smeets, 1974? Kane et al 1980, Kane et al 1982a),most of
which also reported low prevalences.
The survey of Mettler and Crandell (1959)5 conducted in a 
mental hospital prior to the introduction of neuroleptics, is often 
quoted as evidence that involuntary movements in mental hospital 
patients were uncommon at that time in the absence of an alternative 
primary organic diagnosis. This study was designed to investigate 
the prevalence of major neurological conditions in mental hospital 
residents, regardless of their psychiatric diagnoses. From the authors' 
comments, it seems clear that 'dementia' was an important factor in 
allocating patients to a neurological category. Thus, with regard 
to schizophrenics,movement disorders were likely to have been worthy 
of separate note only if they occurred in the absence of such features 
of organicity. There is, however, growing evidence - reviewed 
earlier - (cf Part l) - that 'dementia' may itself be a feature of 
chronic schizophrenia and that those who demonstrate it may have more 
movement disorder (vide-infra). Giving such patients a primary 
neurological diagnosis would clearly deflate the prevalence of isolated 
involuntary movement disorder associated with schizophrenia. Furthermore, 
the boundaries of the schizophrenic concept were much wider in the
United States at that time and the number of those who would now 
fulfill criteria for schizophrenia would have been diluted by many 
who would not now be considered as such. The 0.5 %  prevalence of 
involuntary movement reported by Met tier and Crandall is likely to 
represent an underestimate by present standards.
Three more recent studies have reported higher prevalence 
rates in neuroleptic-free patients and the non-psychiatric elderly 
than those calculated from pooled data. Varga et al (1982) found 
a frequency of "not less than 10.3 %" in nursing home residents 
and attenders at senior citizen centres. This was in fact an 
underestimate, as the drug histories of all their study group were 
not noted. Bourgeois et al (1980), using a standardised recording 
system, studied residents of a retirement home and found "dyskinesias" 
in 18 % of the neuroleptic-free group, which were overwhelmingly 
orofacial, while Belwaide and Desseilles (1977)5 also studying 
a retirement home population, reported a prevalence of orofacial 
dyskinesia of 29 %•
These studies are difficult to evaluate. Varga et al's data 
were incomplete and their assessments unstandardised. Both the other 
groups used counting techniques but do not discuss the cut-off 
adopted in designating abnormality. In none is it possible to be 
confident that all the subjects were non-psychiatric.
The study of Delwaide & Desseilles (1977) provides further 
information of interest on the role of diagnosis. These authors in 
addition examined a group of psychogeriatric in-patients "with varying 
degrees of senile dementia", and found a 38 °/o prevalence of facial 
abnormality. Only 9 % of these patients had no associated neurological
signs. The point worthy of note is that this very high prevalence 
rate - higher than the authors' reported in another group without 
apparent psychiatric diagnoses - was found in patients with a specific 
diagnosis implying organic brain deterioration, all of whom by 
definition must have exhibited cognitive impairment.
7.3.1 SUMMARY
In summary, it is concluded that spontaneous involuntary 
movements can be found not uncommonly in severe, long-standing 
schizophrenic patients whose illnesses have not been modified by 
neuroleptic drugs. The frequency of such disorder reported here 
is considerably in excess of the figure suggested in the literature 
for heterogenous, neuroleptic-free groups and the normal elderly, 
and it is concluded that this increase is likely to be genuine. The 
prevalence found in the schizophrenics of the present study is more 
compatible with the high rate reported for a homogeneous diagnostic 
group of senile dements, than for other neuroleptic-free groups 
presented in the literature.
The movements found in long-standing, unmodified schizophrenia 
are predominantly orofacial in distribution and, in accordance with 
the requirements of the rating schedules used here, not of the 
manneristic/stereotypic variety. They are therefore identical in 
clinical form to movement disorders widely held to have a physical 
basis. None of the neuroleptic-free schizophrenics had regularly 
received tricyclic antidepressants or other drugs proposed - however 
tentatively - as being associated with the development of involuntary 
movements. Hence drugs cannot readily be implicated in explanation
of this abnormality.
One is left with the conclusion that involuntary movements 
in long-standing, neuroleptic-free schizophrenics represent the 
clinical manifestations of some underlying brain dysfunction. It 
is therefore reasonable to assume that in some cases at least, 
schizophrenia and involuntary movements have a pathophysiological 
basis in some way related, and that in the unmodified state, the 
latter are a pointer to the neurochemical disturbance underlying the 
former. Such tentative conclusions are compatible with the views 
expressed by a number of the early descriptive writers (Part 1 
Chapter 1.4*3°)> though of course not with those of Bleuler.
7.4 NEUROLEPTICS AND INVOLUNTARY MOVEMENTS
Having established the presence of involuntary movements to 
be a feature of unmodified schizophrenia, the second major question 
was concerned with how neuroleptic drugs relate to this clinical 
sign in such patients.
7 .4 .I THE ROLE OF A HISTORY OP NEUROLEPTIC EXPOSURE
Following on from the above discussion, it is logical to 
begin by searching for distinctions between movements occurring in 
schizophrenics never exposed to neuroleptics (what might now be 
referred to as schizophrenic dyskinesias) and those found in patients 
treated with these preparations. Going back to Uhrbrand & Faurbye’s 
concept of ’neuroleptic - caused movement disorder’ (Uhrbrand & Faurbye 
i960) it is reasonable to assume that differences would exist between
two groups divided on the basis of a history of neuroleptic exposure.
At a clinical level this is usually taken as the validating criterion 
of the diagnosis of 'tardive dyskinesia' and it is certainly the 
assumption behind most of the published work. In this study it was 
not possible to separate confidently two groups of patients on the 
basis of the prevalence, severity and distribution of involuntary 
movements using solely the variable of a history of exposure to 
neuroleptic drugs.
Throughout this part of the work where appropriate, a 2 - 
tail interpretation of significance has been adopted. This stringent 
rule was used in accordance with the fact that no aetiological 
assumptions were to be drawn beforehand. If however a 1 - tail 
test were applied - that is, that the hypothesis under consideration 
allows for the difference between neuroleptic treated and free groups 
to be in one direction only - then certain comparisons of mean scores 
did achieve significance at the 5 % confidence level. With the AIMS 
these were comparisons of means from
a) all regions together (t = 1.48, df = 409):
b) upper limbs (t = 1.93j elf = 409) •
c) lower limbs (t = 1.67, df = 409)» With the RS, they were
a) all regions together (t = 1.1, df = 409)• and.
b) lower limbs (t = 1.76, df = 406). In each case the difference
was in the direction of greater means in those exposed to neuroleptics.
The unique characteristics of the study population described here made 
it mandatory to adopt a conservative approach to data interpretation, 
but even if a 1 - tail analysis were adopted, the above significances 
were only achieved with small t - values by virtue of the large sample
size.
Thus it is concluded that the mere presence of a history of neuroleptic 
exposure in patients such as those studied here, is insufficient in 
itself to validate the assumption that these drugs have, de novo, 
caused involuntary movements. This in itself does not of course imply 
that the concept of 'neuroleptic-caused movement disorder’ has no 
validity whatsoever, but it does suggest that if that validity is to 
be proven, as opposed to assumed, factors other than the neuroleptic 
history will require consideration. This study examined a sufficiently 
large sample for the relevance of several potential contributory 
factors to be assessed.
7.4.2 THE ROLE OF TIME AND SEX
Age is one of the major points of agreement in the literature, 
most, though not all, studies reporting a significant association 
between age and spontaneous motor activity (Chapter 1.8.2.a). If this 
were relevant in the present population the fact that the neuroleptic- 
free subjects were on average older by a decade than the treated sample 
could clearly have acted to decrease and even abolish any difference 
between them due to the drugs. The study population fulfilled Kane 
and Smith's criterion of spanning more than three decades of age 
(Kane & Smith 1982) and in line with the bulk of the literature in 
this situation, the prevalence of abnormality was significantly 
associated with increasing age.
Advancing age is, however, clearly associated with lengthening 
duration of illness and the relative contribution of each of these 
components reflecting the passage of time is unknown. In the present
work no separation of age and length of illness could be shown with 
regard to the severity of movement disorder. There was some indication 
that age may have been the more dominant part of the time component 
with the RS results, which would emphasise that different types of 
recording scale may produce totals resulting from the operation of 
different variables. Essentially however, age and length of illness 
were inextricably interwoven with regard to their relationship to the 
severity of movement disorder. In this context it cannot merely be 
that length of illness is operating as an indirect measure of the 
likelihood of exposure to neuroleptics in the past as previous 
neuroleptic exposure was accounted for. This finding, combined with 
those discussed in Part 1, indicates that length of illness may in 
itself make an important contribution to some of the deficits of 
chronic schizophrenia.
Although there were limitations to the analyses of individual 
movements, orofacial activity appears to be particularly sensitive 
to development with age, though unfortunately other variables of 
potential importance could not be assessed. The buccomasticatory 
lingual (BML) triad may indeed have validity as an age phenomenon as, 
for example, the findings of Kane et al suggest (Kane et al 1982a).
It is perhaps of relevance in this regard that a number of studies, 
particularly earlier ones, which concentrated on facial abnormality, 
studied older patients.
The role of sex that emerged was not straightforward and the 
present work was unable to confirm the widely held impression of a 
simple female excess in prevalence and severity of involuntary 
movements. The practice of calculating figures on the basis of pooled
data is particularly inappropriate to this question in view of the 
interposition of modifying variables such as age. Thus the F : M 
ratio computed by Smith and Dunn (quoted by Kane & Smith 1982) of 
1.68 from 31 different samples may reflect nothing more than the fact 
that females, in some studies at least, were older.
Using the technique of single symptom criteria to calculate 
prevalence, this study found a female excess at AIMS criterion 4 
in the over 7 0’s that is strikingly similar to that reported by 
Smith and Dunn (1979)* These authors found a femaleimale ratio of 
4:1 at criterion 3*5 (mean of 2 raters), while at criterion 4>
21.3 % of women over 70 rated abnormality but none of the men. In 
the present work, the comparable ratio at AIMS criterion of 4 was 
4 .3I with the prevalence in females of 15*5 % greatly outweighing 
the 3*6 % found in males (TABLE 2:5:5 - neuroleptic treated only 
to make the comparison appropriate). However it is there that the 
similarity ends. The present work was not able to confirm the 
divergent effect of age in the sexes using mean scores, which in the 
report of Smith et al showed a significant increase for females over 
70 compared with males (Smith et al 1979U). As Fig. 2:5:9 showed, the 
sexes in the present study did not significantly differ in mean scores 
with age, including the tendency to plateau over 60 years of age - 
a result which was not altered by considering only those exposed to 
neuroleptics. Furthermore, the sexes did not differ in the mean 
number of movements rated in each age band, a factor not previously 
assessed.
The only plausible interpretation of the present findings is 
that elderly females have a tendency to score at the extremes while 
the older males are more likely to remain intermediate in severity
(i.e. a score of 6 is more likely to comprise a 4 and- a 2 in the 
females but two 3's in the males). This finding with the AIMS data 
applies equally to the RS results. However while the female excess 
of severe AIMS - type disorder in the geriatric patients treated with 
neuroleptics was confined to facial items, the excess of RS - type 
disorder in the same patients, which was striking overall (6.34: l)
was more generally represented - i.e. in limb/trunk items as well 
as face.
The present work was in addition unable to attribute a role 
to sex in severity of abnormal movements as assessed by the numbers 
of patients scoring within arbitrary ranges of total scores. The 
only differences detectable were due to the increased age of the 
females compared to the males. With this accounted for, no 
independent role for sex in severity could be elicited with the data 
from either scale.
It is hard to see how the sex differences in prevalence 
found in this study greatly advance our understanding of involuntary 
movement disorder in schizophrenia. It is moreover important to 
emphasise that such differences as did emerge, or the incompatibility 
of the present findings with the conclusions drawn from the literature 
(Jeste & Wyatt 1981; Kane & Smith 1982), may not reflect anything more 
than the role of indirect modifying factors in determining the 
clinical presentation. They may tell us nothing about the neuro­
pathophysiology of the condition and may be false indicators of risk.
In the present study, 17*9 % o f the males over 70 years of 
age still had their own teeth, while the comparable figure for the 
females was only 3 . 4 %. The edentulous state was discussed as an 
aetiological factor in early publications in this field
(Joyston-Bechal 1965) and, while few would now accept this as the 
only causative factor in the context under discussion (as Paulson, 
quoted earlier, has stated) there equally can he little doubt that 
such factors can be of relevance (Sutcher et al 197l)* In the 
present population varying states of dentition could easily account 
for the difference between, say, an average rating of 3 and one of 
4, regardless of neuroleptic status.
Furthermore others have noted the different prescribing 
factors that may apply to the sexes with women tending to receive 
more drugs in higher doses (Degkwitz & Wenzel 1967; Jones & Hunter 
1969; Fann et al 1972; Laska et al 1973; Prien et al 1975; Simpson 
et al 1978)* In the present study only 10.3 % of the geriatric 
males ( over 70 ) were receiving neuroleptics when examined, while 
for the females the figure was 55*9 %• By contrast, in the group 
assessed by Smith et al it appears that all were receiving drugs, 
including the geriatric patients (J.M. Smith et al 1978)- Although 
actually being on neuroleptics when seen was shown here not to 
affect the prevalence of abnormal movements, it is possible that 
such differences at examination - or over time prior to examination 
which was shown to be of relevance in prevalence - may affect 
mean scores. Such differences could readily account for the 
discrepancies between the present findings and those in the literature, 
especially those of Smith et al, the major source of contention with 
the present findings. It would be an error, with variables such as 
these unaccounted for, to consider female sex as a primary risk factor.
It is concluded therefore that the present study was unable to 
attribute any noteworthy role for sex in determination of both the
prevalence and severity of spontaneous movement disorder.
The potent role of age in neuroleptic usage that has been 
commented on by others (J.M.Smith et al 1978; Smith et al 1979) 
was illustrated here. Apart from the fact that those never exposed 
to neuroleptics were older than those treated with these drugs, 
which reflects the era during which the former group was admitted, 
those heavily treated were significantly younger than the other 
exposed groups and those who had their neuroleptics commenced for 
the first time in the period between the two assessments were the 
youngest patients to have remained neuroleptic-free up to that time. 
This is likely to be related to the feeling among clinicians that 
the illness tends to "bum out" in older patients and hence that 
drug efficacy declines or that older patients are less able to 
tolerate potent, centrally-acting medication.
7.4.3 THE ROLE OF NEUROLEPTIC DRUGS
The problem posed for analysis by the age differences in the 
categories of neuroleptic status was mentioned earlier (Chapter 5*4). 
The compromise adopted means in effect that any differences in movement 
disorder to emerge between neuroleptic-treated and untreated groups, 
and between the ’some’ and 'much’ categories of past neuroleptic 
exposure, represent an underestimate as the full effects of the lower 
mean age of the consistently and heavily treated group (category 6) 
were not accounted for.
This study represents the first direct evidence in a 
comprehensive, homogeneous in-patient sample of a role for neuroleptic 
medication in determining both the prevalence and severity of
spontaneous involuntary movements. The unequivocal drug effect 
could be demonstrated with both a narrow and a wider definition of 
'dyskinesia' as reflected in AIMS and RS data respectively.
The prevalence figures in relation to neuroleptic exposure 
(Figs 2:5:12 and 2:6:1 3) represent extremely high levels of abnormality. 
This partly reflects the overall prevalences reported for the whole 
sample. In addition however, they are calculated on an elderly 
(essentially over 60) population and also adopt cut-offs for 
normality which some might consider unduely lo w . Thus, Smith et al 
have written:
"Since a rating of 2 (mild) on a single AIMS item could 
result from a variety of nervous habits, in no way should 
this be considered a definite indication that a patient 
has tardive dyskinesia"
(J.M. Smith et al 1978).
It is important to remember that the present work was not 
concerned with 'tardive dyskinesia' per se, but with the generality 
of dyskinesia in schizophrenia, and its correlates - one of which was 
neuroleptic medication. The cut-offs were therefore chosen on the 
basis of the degree of misclassification of mild, but definitely 
abnormal, movements and not in order to arrive at a diagnosis based 
on aetiology, which would in any case represent a misuse of rating 
scales. Hence, comparisons of these specific figures with other 
published data are inappropriate and criticisms of the findings on 
the basis of over-rating or undue conservatism in defining normality, 
are unjustified.
The division of past neuroleptic exposure into 'some' and 
'much' was arbitrary. Almost every author who has published in this 
field has commented on the difficulty in obtaining accurate and reliable 
drug histories on the study patients. The present work was no exception.
Even where clear information is forthcoming, it cannot he taken for 
granted that prescribed regimes bear any relationship to the amount 
of drug available to achieve the pharmacologically desired effect. 
Pharmacodynamic and kinetic variables and the simple fact that many 
patients have been shown not to take their medication (Willcox et al 
1965) may modify the anticipated action. In recognition of such 
problems, the division of neuroleptic intake was purposely kept 
simple. Nonetheless, the arbitrary divisions adopted were felt to 
have validity within the limits of the quality of information on 
which they were based and incorporated an evaluation of both the 
amount of neuroleptic (in terms of daily dose) and the duration of 
exposure.
Whether or not neuroleptics were being administered at the 
time of the examination made no difference to movements of the 
type recorded on the AIMS, and while RS totals were similarly, 
unaffected there was some evidence that limb movements covered by 
the wider Rockland concept of dyskinesia may be more influenced by 
this variable. Such a finding probably reflects an increase in tremor 
ratings in those receiving neuroleptics and is compatible with 
clinical experience. It is likely that such factors underly the 
differing correlates of limb as opposed to other body movements that 
have been reported over time (Kidger et al 1980). This point again 
emphasises the' different variables that may operate with different 
recording techniques.
By the criteria adopted in this investigation past neuroleptic 
treatment was the important drug component with regard to both the 
prevalence and the severity of abnormal movements, the effect being 
noted with both scales. General conclusions would be inappropriate,
but within this older population of severe, long-standing 
schizophrenics, the neuroleptic effect on prevalence, although 
substantial and strikingly significant, was of a much lesser order 
than that attributed to these drugs from calculations based on 
pooled data. That computed indirectly is approximately 3 - 4  fold, 
while in the present sample, using the liberal definition of 
normality implicit in a higher cut-off, it is approximately 30 % 
with both scales (in actual fact this figure is likely to be an 
underestimate in view of the incompletely compensated age differences 
in the neuroleptic treatment categories - vide supra). This 
discrepancy is due entirely to the high indigenous rates of abnormality 
in the unmodified illness.
The findings on severity emphasise the role of neuroleptics 
in not only promoting the development of involuntary movements but 
in exacerbating their degree. AIMS results indicate that high 
totals are approximately 35 % commoner in those exposed to neuroleptics 
compared to the base-line for untreated patients, while with the RS 
they are 54 % more frequently found. The fact that receiving 
neuroleptics at the time tended to be associated with high totals on 
the RS is likely to again reflect the augmenting effect of these drugs 
on tremor-like abnormality.
Two further points raised by the findings in this study are 
of interest but require cautious interpretation in view of insufficient 
detail. The first is the effect of recently having commenced 
neuroleptics and the second is the effect of discontinuation.
Although onset of ’ tardive dyskinesia' has been reported after 
3 - 6  months of neuroleptic treatment (Degtkwitz 1969; Moline 1975;
Stimmel 1976) and sometimes even less (Chouinard & Jones 1979), "the 
conclusion of the literature remains that 2 years or more are 
necessary to promote the involuntary movements. (APA Task Force 1979 
and 1980). It is of note therefore that those whose neuroleptics 
had been commenced for the first time between examinations - that is, 
whose duration of treatment was less than 2 years - did not exhibit 
greater total abnormality than their counterparts who had remained 
neuroleptic-free. They did however appear to be strikingly
i
susceptdble to lower limb disturbance of the type recordable on the 
RS. This is again likely to be tremor-like activity or possibly 
restless legs. It is not due to akathisia, strictly defined 
(i.e. inability to sit still with a subjective drive to pace) as 
this is item 42 on the RS which is rated separately from the lower 
limb items (33 - 40) on which this analysis was conducted. The 
caveat to this finding is the small number of subjects on whom it 
is based. It nonetheless is compatible with the bulk of the literature.
As was mentioned, the idea of irreversibility appears to be 
incorporated in the concept of 'tardive dyskinesia* as understood by 
some authorities, though the question of 'persistence* versus 
'reversibility' remains unclear. This study is unable to address ' 
this question properly as, in the two groups who had had neuroleptics 
discontinued at some time (categories 2 and 3), no information was 
available on precisely when the drugs were stopped, what form of 
preparation - oral or depot - was involved, or, of considerable 
importance, why drug treatment was terminated. It nonetheless remains 
of interest that with both scales, those whose drugs had been stopped 
continued to show a significant excess of movement disorder. With
the more tightly defined AIMS, that disorder in addition remained 
more severe.
It has been suggested that neuroleptic-related dyskinesias 
can be classified on their ability to resolve after discontinuation 
of the provoking agent (Jeste et al 1979) and that pathophysiologically, 
reversible and persistent syndromes may differ (Gerlach & Faurbye 
1980 ) though how long a time is necessary before the diagnosis 
becomes one of ’persistent' dyskinesia is uncertain. In the present 
sample, the period off neuroleptics varied from months to many years, 
but for the majority it was at least 2 years. It is thus striking 
that such abnormality remains detectable, although the proportion 
who retain the potential to resolve is unknown. Advanced age is 
one of the factors that have been proposed as being associated with 
persistence or irreversibility of neuroleptic-related dyskinesia 
(Paulson 1968; Itoh & Yaji 1979; Task Force 1979) > and the 
relatively old age of this analysed sub-sample of the total population 
is probably relevant to the continued deviation of their ratings from 
those of patients never on neuroleptics. However, more detailed data 
on the time span since stopping, type of preparation and the clinicians 
reasons would be required before much could be made of these findings.
Relevant to discontinuation is the general argument that 
past neuroleptic regimes may have been determined as much by the 
development of involuntary movements as by mental state and age 
considerations. In a cross - sectional, epidemiological study of this 
type, this cannot be refuted. However, many of those whose neuroleptics 
were discontinued had them stopped years previously - sometimes in 
the I960's - at a time when 'tardive dyskinesia' was little known, far
less a cause for concern. It seems unlikely that this was a major 
consideration in the management decisions involving this sample 
at that time.
It is concluded that the present findings support the view 
that increasing exposure to neuroleptic drugs - by daily dose 
increments, duration of treatment or both - is associated with an 
increased prevalence and severity of involuntary movement disorder 
above the high base-line inherent in severe long-standing 
schizophrenia; that the effect may for most require more than 2 years 
treatment to become detectable; and that these drugs may contribute 
to a permanent or at least durable change. These neuroleptic 
effects can be detected independent of age and length of illness 
factors.
7.4.4 THE ROLE OF ANTICHOLINERGIC DRUGS
According to the post-synaptic dopamine receptor 
supersensitivity hypothesis of pathophysiology, anticholinergics, by 
further disrupting the cholinergic-dopaminergic imbalance in the 
striatum, should theoretically act to promote 'tardive dyskinesia'. 
Indeed, manipulation of central cholinergic systems has been suggested 
as a useful method of provoking 'latent' dyskinesias in those at risk 
(Mackay & Sheppard 1979)> and of distinguishing neuroleptic-related 
movement disorders from other involuntary motor disorders of the face 
such as Meige's Syndrome (Stahl et al 1982).
It is surprising, in view of the importance of the theoretical 
implications and the widespread use of anticholinergics, that so
little formal examination of this question has been undertaken. Much 
of the advocacy for avoidance of anticholinergics in this situation 
is based on acceptance of a theory which, it was suggested earlier, 
is at best an oversimplification and at worst, quite wrong (Jeste & 
Wyatt 1981a).
Kane and Smith (1982) quote 5 significant findings in the 
literature in relation to anticholinergics, encompassing current 
and past use, total amount and duration of treatment, but noted 13 
negative reports. Thus there is little clinical evidence from this 
review to support the theoretical objection to concurrent 
anticholinergics.
In the specific context of the present findings, Crane 
demonstrated a relationship between movement disorder and current 
anticholinergic prescription (Crane 1974)5 while Asnis et al (1977) 
and Chouinard et al (l979)> both studying schizophrenic outpatients, 
found no association. The former group used the AIMS and the 
latter,their own comprehensive schedule.
The establishment of relationships between schedule scores 
and administration of anticholinergics in the present work depended 
on the scale from which data were drawn. Like Asnis et al, but in 
a different population, this investigation could not establish any 
relationships between AIMS data and anticholinergic prescription.
The position with the RS data however, was somewhat different. 
Relationships of a significant order were found especially when a 
higher normality cut-off was adopted. The prevalence of movement 
disorder was greater and high total scores more frequent in those 
receiving anticholinergics when examined, the latter finding being 
essentially confined to females.
These findings illustrate yet again the importance of the 
breadth of concept employed in the study of movement disorder. The 
major, though not the exclusive, difference between AIMS and RS 
is in tremor items. The RS includes as specific items, some 
abnormalities conventionally referred to as parkinsonian, for 
example rabbit syndrome, pill-rolling, akathisia. It is likely 
that those receiving anticholinergics had these commenced because 
of the presence of parkinsonian features or general tremor-like 
abnormality construed by the clinician as possibly parkinsonian.
This is compatible with the finding that limb abnormality - especially 
that of the legs - is more prevalent in those actually receiving 
neuroleptics when examined. Although this relationship did not 
reflect in RS totals, on which the anticholinergic analyses were 
conducted, the greater limb activity in these circumstances could, 
at a clinical level, have encouraged the concurrent prescription 
of anticholinergics. It might be anticipated in such a situation 
that higher scores would be more frequently noted in those receiving 
anticholinergic drugs, as was found.
Such an interpretation is compatible with the findings of 
Ezrin-Waters et al (l98l), who noted that the severity of oro- 
buccal dyskinesia (using R.C.Smith's schedule) did not correlate 
significantly with anticholinergic use during the assessment period, 
but that total body dyskinesia did. The implication is that the 
difference resides in the limbs. These authors likewise attributed 
their findings primarily to neuroleptics,(in their case, depots in 
particular), anticholinergics being prescribed because of the 
movements rather than causing them.
Understanding any relationship between anticholinergics 
and movement disorder is more than establishing a statistical 
correlation between the two. The mere demonstration of a 
worsening in severity of involuntary movements following the 
administration of anticholinergics would not of itself allow 
the implication of a direct cause and effect to be drawn. A 
general stimulant effect of these preparations on mental state has 
been described (Shader & Greenblatt 1971; Jellinek 1977>
Kaminer et al 1982), as also has the ability of anticholinergics 
to produce slight but significant exacerbation of 'positive* 
psychotic symptomatology (Singh & Kay 1975; Johnstone et al 1983)*
One point that is clear is that extra-pyramidally mediated 
movement abnormality can be modified by features of the mental 
state and the degree of the patient's alertness (Marsden et al 
1975)• Hence changes in movement pattern following the administration 
of these drugs may reflect nothing more than their ability to 
modify non-specific variables.
It remains possible that the appropriate explantion of 
the present findings is that anticholinergic drugs may themselves 
promote movements of the type recordable on the RS but not on the 
AIMS, or, with regard to the previous point, that mental state 
variables account for this difference. However, with the population 
the size of that studied here, with as much and as wide-ranging 
movement disorder as has been demonstrated, such non-specific effects 
would require to be consistently quite marked to be detected with 
the degree of significance reported, and the earlier explanation 
of the findings regarding anticholinergics seems more reasonable.
The sex differences at high cut-off also to some extent support 
this interpretation, as they can be explained as arising from the 
sort of prescribing differences noted earlier.
It can be concluded that caution must be exercised in the 
interpretation of drug-related data in general and anticholinergic 
data in particular in the study of involuntary movement disorder, 
but with a tight definition of both dyskinesia and normality no 
clear, causative relationships between administration of anticholinergic 
preparations and’movement disorder could be established in the present 
work.
7.4.5 THE ROLE OF HISTORICAL AND SPECIFIC MENTAL STATE FACTORS
A large number of studies have assessed the relevance of a 
range of historical variables in regard to 'tardive dyskinesia', with 
somewhat contradictory results (cf Chapter 1.8). Surprisingly few 
studies on the other hand have evaluated factors related to the 
schizophrenic illness itself, and none have as yet looked at these 
questions comprehensively.
In this study, the wider range of Recorded Information items
S
encompas'ing personal historical and past treatment variables shed no 
light on the correlates of movement disorder in severe long-standing 
schizophrenia. Of particular note is the absence of any relationship 
with past physical treatments other than neuroleptics. Apart from 
the Recorded Information variables of age, sex and past neuroleptic 
treatment reviewed earlier, there is no data in the literature 
suitable for comparison with the present work.
In connection with the question of organicity as a predisposing
factor, the lack of systematic enquiry and satisfactory criteria, 
and the resultant equivocal conclusion in the literature have been 
discussed (cf Chapter 1.8.2c). The present investigation established 
significant independent relationships between the presence of 
movement disorder on both assessment scales and impairment on the 
Withers and Hinton test battery. Indeed, it is possible that the 
actual relationships are stronger than those reported here 
(TABLES 2:5:10, 2:5:11, 2:6:10). The cognitive score ranges for
purposes of analysis were chosen to balance numbers in each cell 
and. thereby aid statistical evaluation. It is possible that the 
arbitrary ones used were not the most appropriate to demonstrate 
the relationship. These results would indicate therefore that in 
long-standing schizophrenics, cognitive impairment, especially that 
below a certain threshold, is likely.to be associated with 
involuntary movement disorder. This conclusion finds support in the 
literature (Edwards 1970, Famuyiwa et al 1979) in suggesting that 
cognitive impairment, which is after all the mental state hallmark 
of organic dysfunction, is a more appropriate parameter by which to 
assess ’organicity* in relation to movement disorders than surgical 
or other historical factors, some of which bear a putative rather 
than a proven relationship to organic brain change.
The question remains as to whether this finding is based on 
an association between long-standing schizophrenia and generalised 
brain dysfunction, or whether the involuntary movement disorder and 
severe schizophrenia share in common some more localised functional 
or structural substrate.
Scant attention has been paid to mental state and behavioural
variables either in diagnostically heterogeneous populations or in 
studies concentrating solely on schizophrenics. The present study 
is the first comprehensive examination of these questions.
Spontaneous involuntary movements were not found to be 
related to the ‘positive1 features of the mental state. The 
significant relationships concern the ‘negative* mental state 
features - that is the summated Krawiecka items for flattening of 
affect and poverty of speech/muteness - and in addition to behavioural 
deterioration in terms of overall impairment on the Current
Behavioural Schedule.
&\c
There is no comparison data available in the literature, 
but broadly speaking, these results are in keeping with the findings 
reported by Ital et al (l98l) and McCreadie et al (1982) referred 
to earlier. Mukhurjee et al on the other hand reported a significant 
relationship between "tardive dyskinesia" (AIMS) and a history of 
incoherence of speech and grandiose delusions, but information on 
these past events was obtained from case-note review, not direct 
examination of the patients (Mukhurjee et al 1982).
Kucharski et al (1980) related the discharge status of 265 
"schizophrenics" (criteria as mentioned earlier in the study of 
Smith et al 1979b) to involuntary movement scores assessed on the 
AIMS two years previously, and found that those discharged had had 
significantly lower AIMS scores than those remaining in hospital.
These authors considered several explanations of this finding including 
stigmatisation which, it has been suggested, impairs resocialisation 
(Baldessarini 1977)*
Social and administrative variables are clearly relevant to a
patient’s suitability for discharge from hospital, although it is 
of course likely that clinical factors relating to the illness itself 
are also important. In the case of schizophrenics, persisting 
psychotic features may not however be the determining clinical 
factors. The parallel study to the present one, reported by 
Johnstone et al (l98l) has been mentioned previously (Part 1 - 
Chapter 5*2.3)* As will be recalled, these authors found few 
differences in Assessed Abnormalities in a group of non-institutional- 
ised chronic schizophrenics discharged from Shenley Hospital over 
a 5 year period, when contrasted with those of the present group 
(age and length of illness accounted for). The non-institutional 
group however produced significantly better scores on cognitive 
testing than the in-patients. It was suggested that deductive, 
problem-solving abilities may be part of what is being assessed in 
’ dischargability*. As movement disorder correlates negatively with 
cognitive performance, it could be predicted that those of an in­
patient population who achieved discharge may have less movement 
disorder.
Kucharski et al considered the possibility of some additional 
factor linking AIMS disorder and discharge when they wrote that
"it is conceivable that (their) results are due to a
relationship between tardive dyskinesia, discharge, and
some other factor".
Their "other factor" could relate to the type of mental state and 
behavioural deficits under discussion here. Thus the alternative 
hypothesis they offer - mainly that patients with movement disorder 
"may be more psychiatrically disturbed than those not so affected" - 
is to some extent compatible with the present findings.
On a similar theme, Chouinard et al found that their 
Clinical Global Impression score assessing therapeutic effect was 
one of the best predictors of involuntary movement abnormality and 
concluded that "tardive dyskinesia" was more prevalent and more 
severe among patients with little therapeutic improvement (Chouinard 
et al 1979)* Bearing in mind evidence of this type and the pattern 
of mental state deficits associated with movement disorder in the 
present study, it is of interest that Jus et al (l97^a) reported 
that "tardive dyskinesia" is more frequently found in schizophrenics 
with a slow, insidious onset of illness than in those with an,acute 
onset.
Thus the present work confirms suggestions in the literature 
that illness-related variables may be associated with the development 
of involuntary movements in schizophrenics treated with neuroleptic 
medication. The present comprehensive evaluation of this question 
would indicate that the type of illness concerned is that characterised 
by ’negative* mental state features, cognitive impairment and general 
behavioural deterioration, and not the type in which 'positive* 
productive features predominate. This cannot be regarded as 
reflecting greater neuroleptic administration in those with deteriorated 
'negative' states, as, within the criteria adopted this, along with 
age and length of illness was accounted for.
7 .4 . 6 SUMMARY
This study has confirmed the validity of the concept of 
neuroleptic-caused movement disorder. The analyses have indicated 
however that the relationship between these drugs and abnormal
movements is complex. Neuroleptics of themselves are neither 
necessary nor sufficient with regard to the aetiology of 
spontaneous motor activity - especially in patients with long-standing 
schizophrenia - and a history of exposure to these preparations is 
on its own an inadequate parameter with which to validate the 
concept of tardive dyskinesia. Nonetheless with other relevant 
factors, particularly those reflecting the passage of time, accounted 
for, neuroleptic drugs are associated with both an increased 
prevalence and severity of spontaneous motor disorder, which may take 
more than 2 years to become established and which for some may 
persist long after neuroleptics are withdrawn.
7.5 CONCLUDING REMARKS
The question of whether the schizophrenic illness and some 
action of neuroleptic drugs produce motor disorders which represent 
the 'final common pathway' of dysfunction in different brain areas 
or whether the movement abnormalities arise from actions of the drugs 
on brain centres where the pathophysiological basis of the illness 
lies remains unanswered. It is worthy of note that the present findings 
have indicated that not only can movement disorder be associated with 
a specific diagnosis, but also that within this diagnosis patients 
with a particular pattern of deficit appear at special risk. Although 
the numbers of neuroleptic-free patients were too few to allow formal 
analysis, it is possible that the pathogenesis of 'negative' or 
defect type schizophrenia is associated with change which particularly 
encroaches on brain centres involved in the modulation of motor function.
Such illness-related change may then render these centres susceptible 
to a detrimental effect of drugs acting at these sites.
Jeste and Wyatt have written :
"There are probably few clinical entities that only the 
man-made drugs can produce. Usually the drugs produce 
syndromes similar to the naturally occurring ones, although 
the frequency may be different"
(Jeste & Wyatt 198l).
The case of involuntary movements in neuroleptic-treated
schizophrenics may be one such example.
It is widely accepted that 'individual susceptibility' is
one of the important factors with regard to the development of
neuroleptic-related movement disorder (APA Task Force 1979), ancL
most workers would agree with Simpson et al who have stated :
".... the TD phenomenon .... includes a sensitivity or 
idiosyncratic individual response to neuroleptics"
(Simpson et al 1978)*
In line with this statement the 'susceptibility' element is
generally construed in drug terms. While pharmacodynamic/kinetic
factors may clearly be of relevance (Jeste et al 1979; Widerlov et al
1982) especially in view of the wide variations in the individual
handling of neuroleptics (Sakalis et al 1972; Wiles et al 197&),
the possibility that 'susceptibility' in schizophrenics may reside
primarily within the form of their illness and not their treatment
requirements has not been widely discussed. The results of the
present investigation would suggest that in the search for risk
factors mental state and other illness-related variables require
serious consideration.
PART III
RADIOLOGICAL IMAGING
"The determination to find something new and to be original is 
usually futile .... The first requirement is always that one 
must absorb what has gone before ... in its entirety. In this 
way tradition can be deepened and widened and our own eyes 
opened"
KARL JASPERS 
GENERAL PSYCHOPATHOLOGY
PART III
RADIOLOGICAL IMAGING 
Chapter 1 - Literature Review
1.1 PNEUMOENCEPHALOGRAPHIC STUDIES
1.1.1 INTRODUCTION
Shortly after its introduction (Dandy 1918), the technique 
of pneumoencephalography (PEG) was applied to the search for 
structural abnormality of the brain in schizophrenia. In two 
reports, Jacobi and Winkler (1927, 1928) described a high prevalence 
of cortical and subcortical abnormality in schizophrenic patients. 
These initial studies stimulated a number of investigations, 
especially in Germany and Japan, the majority of publications 
supporting Jacobi and Winkler's original findings. Despite serious 
methodological problems, this work has been treated with a neglect 
which is out of all proportion to its potential importance.
It is beyond the scope of the present work to review in 
detail this substantial literature (Haug notes "more than 48 studies" 
up to 1982 (Haug 1982)), though it would be a mistake to assume 
that modem technicological advances have rendered it irrelevant.
It remains a valuable source of information. The more important 
and most accessible works in this field are summarised in TABLE 3:1:1* 
In general, the great bulk of this literature supports the 
contention of Jacobi and Winkler that signs of cerebral atrophy are
Qi
found frequently in long-standing 'chronic5 schizophrenia. For 
those who have considered the question, these abnormalities are
TABLE 3:1:1
PEG STUDIES IN SCHIZOPHRENIA : THE MAJOR ACCESSIBLE WORKS
STUDY NUMBER OF 
SCHIZOPHRENICS
VENTRICULAR
ABNORMALITY
AGE EXCHANGE
SITE
AIR
INSERTE
(CC's)
JACOBI & WINKLER 1927 19 18 (94.7$) 18-49 SUBOCCIPITAL 60-1^5
MOORE ET AL 1933 60 25 (41.7$) 17-47 LUMBAR 115-235
LEMKE 1936 100 50 (50$) 18-62 SUBOCCIPITAL 50-60
DONOVAN ET AL 1949 19 16 (84.2$) 16-60 ? ?
NOBILE & BRIZZI 1933 k3 8 (18.6$) ? ? 50-70
FROSHAUG.& RETTERSTOL 1936 24 4 (16.7#) 38-55 LUMBAR 20-30
BORENSTEIN ET AL 1957 13^ 118 (88$) 17-60 LUMBAR 35-i*0
HUBER 1957 190 131 (69% ) 2nd-6th
DECADE
LUMBAR
NAGY 1959 226 83 (36.7#) 2nd-7th
DECADE
SUBOCCIPITAL 50
BRATFOS & SAGEDAL 1960 40 17 (43$) ? ? 9
SITNIKOV 1961 50 ko (80$) 9 9 ?
HAUG 1962 137 66 ( 49$) 19-59 LUMBAR 30
ANSINK ET AL 1963 41 10 (24.4$) 21-69 SUBOCCIPITAL 10
NAGY 1963 260 152 (58.4$) MEAN
36.1
SUBOCCIPITAL 50-80
STOREY 1966 18 3 (-16.7#) 19-45 LUMBAR 40
ASANO 1967 53 3k (6k.2%) MEAN
28.9
9 100
SIEGEL & HEIDRICH 1970 350 290 (82.9#) 15-53 LUMBAR 60-100
YOUNG & CRAMFTON 1974 36 2k (66%) ? ? ?
HAUG 1982 38 3 (7.9SO 17-36 LUMBAR 30
TOTAL 1838 1092
AVERAGE %  ABNORMALITY 59.4$
FREQUENCY OF ABNORMALITY WITH LUMBAR METHOD (N = 931) = 67.3$ 
FREQUENCY OF ABNORMALITY WITH SUBOCCIPITAL METHOD (N = 646) = 48.5$
related to clinical ’deterioration’, and for some (e.g. Huber &
Haug), they are progressive.
It is important in the evaluation of this work to be clear 
about firstly, the methodological and secondly, the technical 
problems associated with PEG. These will be briefly summarised 
below. Furthermore, it is also important to appreciate that the very 
high prevalences of abnormality often reported partly reflect the 
fact that at the time when most of this work was carried out, 
asymmetry of the lateral ventricles was believed to represent 
abnormality. Many of these studies recorded this as such. It is 
now generally accepted however that left-right asymmetry of the 
ventricular system can be a normal finding in man (Last & Tompsett 
1953, Lemay 1976; Galaburda et al 1978)* The left lateral ventricle 
has been found to be larger than the right in 50 - 75 % of the 
normal population. Thus the true prevalence of abnormality in PEG 
studies in schizophrenia would probably now be reported as lower 
than the figures quoted in the older literature.
1.1.2 METHODOLOGICAL PROBLEMS
A number of studies were performed before standardised 
measures had been described in the evaluation of PEG, and hence 
reports were based on visual assessments. Storey (1966) has shown 
that interrater reliability is poorer with this method than with 
linear measures. If only one radiologist made the assessment, the 
room for variation was great. This problem was compounded by the 
fact that most assessments were not made blind to the subjects ' 
diagnosis or to the purposes of the study.
In view of the considerable morbidity and small but definite 
mortality associated with the procedure (Whittier 195l)> the 
American Roentgen Ray Society decreed in 1929 that it was not 
appropriate to use normal subjects for control purposes in PEG 
research (American Roentgen Ray Society 1929). Many studies in 
schizophrenia bypassed this difficulty by not including any comparison 
material, while others utilised routine encephalograms performed to 
exclude potential neurological abnormality but reported as normal. 
Unfortunately, as Lonnum has pointed out, ’normal1 encephalograms 
are relatively rare in patient populations when strict criteria of 
normality are applied (Lonnum 1966 ).
The problem of normal controls was effectively insuperable, 
but some authors minimised this difficulty by using standardised 
techniques with blind assessments in samples of different psychiatric 
diagnoses, or in schizophrenics of different clinical type.
Prevalences and patterns of abnormality were thus relative between 
diagnoses or types.
1.1.3 TECHNICAL PROBLEMS
PEG is a complex invasive procedure, the dynamics of which
are even yet not fully understood. Most reports did not specify
their technique but those which did showed considerable variation
which may have a bearing on results. Sources of variation cited include
Amount of CSP removed 
Amount of air introduced 
Site of introduction of air
Time from introduction of air to exposure of film 
Position of head 
Unequal filling of ventricles 
Film-focus distance
It is inappropriate to discuss the details of these 
technical problems here, but to aid understanding of their importance, 
some of the major ones will be briefly mentioned.
The volumes of air introduced varied greatly between studies - 
from Moore et al who drained the entire cerebrospinal space and 
introduced an equivalent volume of air (Moore et al 1933*1935)» to 
Hunter et al who used a modified technique involving introduction of 
only 8 mis (Hunter et al 1968). More importantly, the volumes in 
some investigations varied within their study sample with only the 
minimum to maximum limits quoted. While some authors used a volume 
for volume exchange, others introduced a greater quantity of air 
than CSF withdrawn.
The importance of such variations lies in the putative 
‘ballooning1 effect of air on the ventricular system - namely, that 
an introduced gas, especially air at room temperature, inflates the 
ventricular system, an effect more marked as body temperature expands 
the gas (Probst 1973 )• The more gas introduced (large volumes) or 
the less room for it to expand (discrepant volumes), the greater 
the possible distortion of the ventricles. It has also been 
suggested that the possibility of this effect is greatest in the 
Illrd ventricle, especially with the lumbar as opposed to the 
intracistemal site of exchange. Thus, studies which did not 
introduce a fixed and smaller amount of air in each subject at a 
constant site present possible sources of variation.
Although it is assumed that most films were taken immediately 
after the- exchange, this may not be the case. With larger volumes of 
air, films were sometimes reported at 24 hours, especially if ventricular
filling was initially unsatisfactory. It has been demonstrated that 
up to 49 % of patients show an absolute increase in ventricular size 
in 24 hour as opposed to immediate films (Lemay 1967). This is 
thought to result from resolution of the periventricular oedemagenic 
effect of an irritant exogenous substance. It is most marked with 
air (all studies on schizophrenics used air) and less so with oxygen 
as the exchange gas, and significantly, is seen most in those with 
degenerative brain disorders (Lemay 1967). As the worst schizophrenics 
may be those in whom, by lack of co-operation, satisfactory films 
are least possible initially and repeats more likely, this could 
bias findings in favour of apparent ’dilatation* in these subjects.
Thus the timing of film exposure is important. Even then, militating 
against the unpredictable yet contradictory effects of ’ballooning1 
and changes induced by local oedema requires adherence to a rigid 
and standardised protocol.
These points illustrate the complex dynamics of PEG and the 
necessity for a careful methodology that they impose. The fact that 
most studies were of inadequate design and execution to meet m o d e m  
standards is a major criticism to acceptance of their findings. It 
does not however justify them being completely disregarded. The most 
important and carefully executed studies will be briefly reviewed.
These are the works of Huber (1957)* Haug (1962), Nagy (1963),
Storey (1966), and Asano (1967)*
1.1.4 THE MAJOR WORKS
In a series of articles from 1953 (Huber 1953*1955) 
culminating in his 1957 monograph, Huber described his PEG work on 
a total of 195 unselected schizophrenics (Huber 1957)* In addition, 
he studied 16 "atypical schizophrenics" and 11 "cyclothymics". His 
sample covered all clinical subtypes with varying degrees of severity 
and durations of illness, and most were under 50 years of age. He 
found pathological changes based on standard linear measures in 68.7 % 
of the schizophrenics, especially in the internal liquor spaces, with 
the Illrd ventricle system most affected. Twenty seven patients had 
abnormalities of the brain surface. When patients were divided into 
4 groups on the basis of degree of deficit, ventricular enlargement 
occurred in 17• 4 % of those without "dementia", but in 81.8 % of 
those with "dementia". Abnormalities were least common in catatonic 
patients and most frequent in what he refers to as the "body- 
hypochondriacal" type. The results could not be attributed to somatic 
treatments.
Huber himself did not conduct a formal statistical evaluation 
of his data but this was subsequently undertaken by Vogel and Lange 
(1966). Although Huber's patients were young, statistical analysis 
revealed an increasing prevalence of abnormality with age, especially 
in sulcal assessments. However, the abnormalities could not be 
attributed to age alone. With regard to the site of abnormality and 
the clinical picture, anterior horn abnormalities were significantly 
related to a diagnosis of "body-hypochondriacal" type. Other 
significant relationships were demonstrated between length of illness 
and increasing prevalence of severe deficit and, most importantly,
between all assessments of ventricular abnormality and increasing 
severity of defect - this remaining significant when the effects of 
age were removed.
Huber subsequently repeated the encephalograms in 27 patients,
19 of whom showed no clinical progression in the degree of their 
personality deterioration. The radiological appearances of these 19 
were unchanged, whereas the 8 whose clinical deterioration had 
progressed, all exhibited progression in their PEG abnormalities.
Many of the original sample had been followed for over 20 years, with 
ventricular enlargement being associated with a chronic illness and 
poor outcome.
However striking his findings, Huber was aware they appeared 
qualitatively at least, non-specific as he found them in his "atypical" 
and "cyclothymic" groups also though with much lesser frequency. 
Nonetheless, he considered these radiological changes as morphological 
signs of the brain disorder underlying schizophrenia and postulated 
a primary striatal/diencephalic lesion that progressed with increasing 
duration of illness.
The work of Haug (1962) is the most impressive of the PEG 
studies because of his considerable attention to detail and the 
relative objectivity of his methodology. He assessed the results of 
PEG in 278 chronic psychiatric in-patients of mixed diagnoses. He 
accepts this represents a biased sample, but by using inter-group 
comparisons his work provides noteworthy findings. Standardised 
radiological techniques for performing and measuring encephalograms 
were adhered to, the radiologist being unaware of the psychiatric status. 
Liberal limits of normality were adopted to minimise inclusion of 
"big normal variants" in the pathological groups. Each of the
conventional schizophrenic subtypes (except simplex) was represented 
and a "subjective evaluation" of the presence or absence of "dementia" 
was made.
Haug found abnormalities in 84 of his 137 chronic schizophrenics 
a prevalence of 6l %. When 30 subjects were excluded because of 
inadequate case-note information and 1 for being over 60, the 
prevalence remained at 58 %• These abnormalities predominantly 
involved the ventricular system, cortical atrophy when present being 
mild and localised. All subtypes were equally affected. There was 
a highly significant relationship between severe clinical deterioration 
and definite ventricular dilatation, but no such relationship with 
cortical changes. While there appeared to be "a connection" between 
the degree of ventricular enlargement and length of illness this did 
not achieve statistical significance. These changes could not be 
attributed to age alone.
The overall prevalence of similar changes in his "non-organic" 
group was also high (49 %) - though two thirds of this category 
comprised patients diagnosed as having "reactive psychosis".
Nonetheless, prevalence of Illrd ventricular and right cella media 
abnormality was significantly greater in the schizophrenics.
Furthermore, the form and degree of abnormality was different, the 
schizophrenics being characterised by a predominantly diffuse, bilateral 
ventricular dilatation of greater degree than the mild, focal 
aberrations of the "non-organic" subjects. In repeat investigations 
Haug too noted a pathological progression paralleling the clinical one. 
Like Huber, he considers in detail the possible role of shock treatments 
in promoting these abnormalities, but both discount this on the basis
of their findings.
The study of Nagy is of interest because of its size, though 
its methodology is less rigorous than the two preceding works.
Nagy (1963) examined PEG's from 260 schizophrenic and 133 manic- 
depressive patients, all of whom were female. The selection criteria 
are not stated and the encephalographic technique was not standardised, 
though mesurements were. Of the schizophrenics, 58 % had enlarged 
ventricular indices, while the comparable figure for the manic- 
depressives was 23 %• There was a correlation between ventricular 
enlargement and both impaired social competence and chronicity of 
course.
Asano studied 53 yoi^g schizophrenics of mean age 28.9 years, 
using a fixed procedure (Asano 1967). This is the only encephalographic 
study of chronic schizophrenia to include area, in addition to linear, 
measures. The patients were divided on clinical parameters according 
to the classification of Mitsuda - 'nuclear' type (chronic deteriorating 
course) both mild and severe, and 'peripheral' type (episodic course) 
with and without deterioration.
Asano found an overall prevalence of abnormality of 64*2 % - 
remarkably similar to that of the 3 previously described works. When 
looked at by the type of schizophrenia determined from the course of 
illness, there was a significantly higher prevalence in the 'nuclear' 
than 'peripheral' groups, with the severe forms of 'nuclear' type 
having the highest prevalence of all (94«4 %) • Abnormalities were 
found in only 10 % of non-deteriorated patients whose illness had run 
an episodic course. The ventricular system exhibited abnormalities 
more frequently than cortex. When strict criteria were applied, both
Illrd and lateral ventricles showed aberrations with equal frequency, 
but mild abnormalities were commoner in the Illrd. There was an 
identical prevalence in the under and over 45's, and Asano concurs 
with Huber and Haug that these findings are not merely age-related.
Thus Asano demonstrated an association between the prevalence of 
essentially ventricular abnormalities and what are in effect measures 
of severity of the schizophrenic defect.
These authors all show considerable concordance and provide 
compelling evidence that structural brain changes, especially in the 
form of ventricular dilatation and distortion, may be an integral 
part of the schizophrenic process. They also suggest that signs of
cerebral atrophy may relate to the personality deterioration of the
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schizophrenic defect, and if present, may auger a poor outcome.
Storey however, in a small but careful study, could not 
confirm these findings (Storey 1966). He examined the encephalographic 
data from 18 chronic schizophrenics under 45 years of age, who had 
spent at least 2 years in hospital. These films were compared with 
those of an age matched group selected from the PEG's reported as 
normal in the routine work of the radiology department. Measurements 
were linear and performed blind by two neuroradiologists.
Storey found no difference between patients and*controls'in 
prevalence of abnormality, and no association between PEG variants 
and age, duration or severity of illness or past somatic treatments.
Apart from its small size, this study is marred by the 
selection of 'control' PEG's which was random and not influenced by 
the provisional clinical diagnosis on which referral for radiological 
investigation was based. 'Controls' therefore had been investigated
for potential - and in some cases definite - organic brain disease 
such as epilepsy, and as a group are likely to have had a greater 
frequency of atrophic change than a normal population.
This literature, although flawed and concerned with a
technique now little used, remains important and worthy of attention.
While its conclusions are not unanimous, there is a striking degree
of consistency in the better studies. As Bliss has written :
"It may be that these studies are in error, but they 
cannot be ignored"
(Bliss 1975)
1.2 C.T. SCAN STUDIES
1.2.1 INTRODUCTION
Computerised axial tomography (CT) was introduced by 
G.N. Hounsfield in 1973* as a safe, non-invasive radiological technique 
for visualising internal body structures. The procedure was the first 
to provide a clear graphic representation of soft tissue without the 
necessity of contrast enhancement, and soon found one of its major 
applications in intracranial imaging. Structures which previously 
could not be demonstrated in vivo could now be seen (e.g. internal 
capsule), and those which had hitherto required contract media for 
their visualisation, such as ventricles, could be clearly shown without 
distortion (Hounsfield 1973; Ambrose 1973)* A further advantage was 
the ease with which investigation could be undertaken, and if necessary 
repeated, even in unconscious or semi-unconscious patients or those who 
were behaviourally disturbed. Compared to PEG, scanning required
minimal co-operation from the subjects.
CT is now firmly established as a routine investigative 
tool in clinical practice, including psychiatry, where it plays an 
invaluable role in the diagnosis of organic brain disorders. Beyond 
this however, it has acquired considerable importance as an 
investigative technique in psychiatric research. In particular, 
computerised tomography offered the first opportunity for the 
hypothesis that structural cerebral change underlies schizophrenia 
to be examined in life, with minimum disturbance to the patient, 
and with the use of adequate control groups. Hence the major 
limitations of PEG could effectively be overcome.
A number of groups have applied CT to the study of 
schizophrenic brain structure in life, and although there is some 
consensus in the published reports, the literature is not unequivocal. 
Studies up to the end of 1982 are listed in TABLE The
following review will focus on the findings with regard to the lateral 
ventricles, the brain structure most consistently evaluated. The 
major inferences of this work concern ventricular volume. As area 
ratios (specifically VBR - vide infra - Chapter 2 - Methods) correlate 
better with assessments of volume than linear measures (Penn et al
1978), particular attention will be paid to those studies which used 
area ratio or direct volume computations.
1.2.2 STUDIES APPLYING AHEA/VOLIME METHODS TO THE EVALUATION OF
W T R I COLAR SIZE
Johnstone et al were the first to apply CT to the study of 
schizophrenic brain structure in vivo (Johnstone et al 197&;
Johnstone et al 1978b). They scanned 17 Feighner positive chronic
TABLE 3:1:2 C.T. SCAN STUDIES IN SCHIZOPHRENIA
STUDY BRAIN STRUCTURE(S) ASSESSED AND METHOD
JOHNSTONE et al 1976, 1978a LAT. VENTS. 
CORTEX
AREA MEASURES 
(incl. VBR)
TRIMBLE & KINGSLEY 1978 LAT. VENTS. EVAN's INDEX
WEINBERGER et al 1979a LAT. VENT. VBR
WEINBERGER et al 1979b CORTEX LINEAR MEASURES
WEINBERGER et al 1979c CEREBELLUM VISUAL ASSESSMENT
GLUCK et al 1980 IIIRD VENT. . 
ANT. HORNS 
CORTEX
LINEAR MEASURES 
VISUAL ASSESSMENTS
GOLDEN et al 1980a, 1981 'BRAIN DENSITIES'
MORIGUCHI 1981 LAT. VENT. 
IIIRD VENT. 
CORTEX
VOLUME ASSESSMENT 
AREA MEASURES 
LINEAR MEASURES
TAKAHASHI et al 1981 LAT. VENTS. 
IIIRD VENT. 
CORTEX
VISUAL ASSESSMENT 
LINEAR MEASURES .
TANAKA et al 1981 LAT VENTS. 
IIIRD VENTS. 
QUADRAGEMINAL 
CISTERN 
CORTEX
LINEAR MEASURES
ANDREASEN et al 1982c LAT. VENTS. VBR
JERNIGAN et al 1982a •VENT. AND SULCAL VOLUMES'
NASRALLAH et al 1982 LAT. VENTS. VBR
REVELEY et al 1982 LAT. VENTS. VENT. AREA + VBR
V/EINBERGER et al 1982 LAT. VENTS.
CORTEX
CEREBELLUM
VBR
VISUAL ASSESSMENT
OKASHA AND MADKAUR 1982 LAT. VENT. 
IIIRD VENT. 
CORTEX
LINEAR MEASURES
FRANGOS 8c ATHENASSENAS 1982 LAT. VENTS. 
CORTEX
VBR
NYBACK et al 1982 LAT. VENTS. 
IIIRD VENT. 
CORTEX
LINEAR MEASURE RATIO 
VISUAL ASSESSMENT
BENES et al 1982 LINEAR AND AREA RATIOS
schizophrenic males (mean age 57.4 - 9 years) institutionalised for 
many years (mean duration of hospitalisation 31*4 - 7*5 years). Four 
subjects had been leucotomised. Using planimetry to calculate YER, 
they demonstrated significant ventricular enlargement in this patient 
group compared to a normal group comprising hospital ancillary workers 
matched for age, sex and best occupational attainment. This finding 
was not attributable to past physical treatments including leucotomy, 
though psychosurgery was associated with ventricular dilatation. There 
was however no difference between schizophrenics and controls with 
regard to sulcal size (leucotomised patients excluded) assessed as 
an area measure by tracing the sulci onto millimetre square paper 
and counting squares. This study was in addition the first to 
demonstrate a relationship between impaired cognitive performance 
(Withers and Hinton battery) and an objective parameter of cerebral 
atrophy (increased YBR) in schizophrenic subjects. Cognitive 
impairment was also related to the presence of ’negative’ schizophreni 
features (Krawiecka Scale), though presence of the latter did not 
correlate with signs of brain atrophy.
This study was small, with subjects chosen not least by their 
willingness and ability to co-operate. The patients were relatively 
old with long hospitalisations, the ranges of both these’time’ 
variables in the sample being narrow. With cognitive testing, the 
use of control patients institutionalised for many years as a result 
of non-cerebral neurological disease made it unlikely that the 
intellectual disadvantage found in the schizophrenics could be 
attributed to the effects of institutionalisation, but these controls 
were not scanned. Thus the contribution of age to CT appearance and
the contribution of long-term institutional care to the CT differences 
in the schizophrenics could not be adequately assessed. Likewise, 
the small sample size precluded a precise evaluation of the role 
of past physical treatments (except leucotomy shown to be 
associated with significant cerebral damage). Finally, the specificity 
of the findings to schizophrenia could not be determined.
In a subsequent series of publications, Weinberger and 
colleagues have confirmed and extended the findings of Johnstone et al. 
They studied a total of 73 psychiatric patients defined by Research 
Diagnostic Criteria (Weinberger et al 1979 a). Apart from 4 
diagnosed as schizoaffective and 3 as affective (there was also one 
case of ’’mental retardation (aetiology unknown)”) the sample 
comprised 65 RDC schizophrenics under 50 years of age. Assessing 
ventricular size using VBR measured by planimetry, these workers 
found a highly significant difference in lateral ventricles between 
chronic schizophrenic patients and controls (schizophrenics >  controls). 
Indeed, 53 % of their chronic schizophrenic group had ventricular 
enlargement that was greater than 2 SD of the control mean, and 40% 
were completely outside the control range. Age, race, length of 
illness and duration of hospitalisation were not correlated with 
VBR. Those with a history of EGT did show a greater degree of 
ventricular dilatation than those with no such history, but this did 
not account for the basic finding.
Weinberger et al also reported that a significantly larger 
proportion of their schizophrenics compared with controls demonstrated 
some cortical atrophy (Weinberger et al 1979 k). Cortical 
abnormality was defined in terms of linear measures exceeding stated 
values for maximal width of the Sylvian fissure and interhemispheric
fissure and mean width of the three largest sulci, though the 
particular cut-off values for normality were arbitrarily adopted.
The cortical findings were less consistent than those for ventricle. 
Thirty two percent of patients demonstrated abnormality by their 
criteria on one of the above measures while only two (3.3 %) were 
outwith their stated normal range on all three. The commonest 
abnormality was in the area of the Sylvian fissure. Cortical 
abnormality did not correlate with the presence of ventricular 
dilatation.
One of the major criticisms of this work lies in the choice 
of controls, which were selected from material generated by other 
studies in the same hospital (National Institute for Mental 
Health and St. Elizabeth's Hospital, Washington B.C.). Of 56 
controls, 48 were first degree relatives of patients suffering from 
Huntington's Disease. Although these controls were described as 
"healthy" and "asymptomatic" insufficient is known about the CT 
scan appearances associated with preclinical Huntington's Chorea 
and of the genetic carrier state for such controls to be accepted 
with equanimity. In addition, it is likely that Weinberger et al's 
patients presented a particularly severe form of illness. Half the 
sample came from the research wards of NIMH, which has a national 
commitment and hence is likely to attract unusual cases presenting 
particular management problems. The other half were patients from 
a "general psychiatric unit" serving a designated catchment area. 
Although no statistical differences emerged between the VBR's of 
the two sets of patients, such a general comparison could deflect 
from very real differences in clinical presentation, course of 
illness, treatment patterns and demographic factors, any or all of
which could relate to YBR in either group. Such relationships 
would be masked by combining the groups. It is hard to imagine that 
the unique position of NIMH in American psychiatric research would 
not attract somewhat idiosyncratic patients to its wards.
This group have reported extensively on a number of variables 
that they found to be correlated with CT scan abnormalities in 
chronic schizophrenics and have proposed that enlarged ventricles 
in particular may be a meaningful basis on which to define a distinct 
subgroup of the illness. This is founded on increased ventricle size 
being associated with poor premorbid adjustment (Weinberger et al 
1980b), poor response to neuroleptic drugs (Weinberger et al 1980 a), 
increased prevalence of reversed cerebral asymmetries (Luchins et al
1979)» and the presence of 'soft* neurological signs (Weinberger and 
Wyatt 1982). This group’s published results on cognitive performance 
have been mentioned earlier (cf Part l). While such a concept is 
clearly of interest the findings on which it is based require 
replication, which, with regard to some variables - e.g. reversed 
asymmetries - has not been possible to date (Andreasen et al 1982a; 
Jemigan et al 1982b).
Golden and co-workers also reported on brain abnormalities 
in young (mean age 32-6 years) chronic schizophrenics fulfilling 
DSM - III criteria (Golden et al 1980a). The technique of scan 
assessment used by this group was somewhat novel in that they did 
not utilise polaroid pictures but rather calculated directly from 
the print-out of attenuation numbers. Using data from the maximal 
ventricular cut and adjacent two rostral cuts, they counted every 
fourth Hounsfield number (omitting a rim around the skull to reduce
artifactual radiological interference) and computed the mean value 
for each hemisphere which they referred to as "brain density". They 
-found the mean "density" values for their schizophrenics to be 
significantly lower than (radiology departmental) controls (Golden et 
al 1980 a) and further that this reduction was greatest in the left 
frontal area (Golden et al 198l). However, greater "densities" 
overall were found in the left than in the right hemisphere.
This technique has not been widely used in schizophrenia 
research, though Reveley et al reported findings using the print-out 
as opposed to photograms (vide infra). By using 'raw1.data from 
print-outs many of the assumptions implicit in constructing the 
pictorial analogue are avoided. However, the technique gives to 
analysis a degree of exactitude which is unlikely to be justified.
The CT system is very precise, being able to measure absorption 
coefficients to an accuracy of 0.5%. Hence very small differences 
in tissue "density" can be detected, though the basis of variability 
is poorly understood. Coefficients attributed to adjacent pixels 
can differ widely within discrete brain areas, even when pictures 
may show relative homogeneity. Thus mean attenuation values 
calculated for either hemisphere or any part of a hemisphere are to 
some extent influenced by chance. The differences reported by 
Golden et al are slight, as they themselves point out, and although 
reaching the 5 % significance level for most comparisons, are likely 
to fall within the variance of the method. As the authors note, 
a difference of 1 Hounsfield TJnit would have been sufficient to 
eliminate one of their statistically significant findings. It could 
be proposed that sampling every third or every fifth pixel may have
produced different results. Moreover, not only is the validity of 
this method in doubt, but recently its reliability has been 
seriously questioned (Levi et al 1982).
Criticisms of this work also arise from the choice of controls 
which were taken from radiology departmental scans reported as 
normal. While CT is more likely to be undertaken than PEG, the same 
objections apply to this type, of control - especially when the 
differences being sought are subtle and the mode of evaluation 
open to question.
Thus while the work of the Nebraska group can be taken as 
broadly in line with that reviewed previously in showing abnormality 
of the schizophrenic brain, it must be interpreted with some 
qualification.
In a large but rarely quoted study from Japan, Moriguchi 
compared the scans of 55 schizophrenics (criteria unspecified) with 
those of 65 controls who had migraine, epilepsy and neurotic 
diagnoses (Moriguchi 1981). Scan pictures were comprehensively 
evaluated. Cortical indices and third ventricle were measured 
linearly, the area of the anterior horns calculated, and an 
assessment made of lateral ventricular volume by summating areas 
on all relevant pictures.
Only with the number of parietal sulci did no difference 
emerge between schizophrenics and controls, though with a number of 
comparisons differences only achieved significance by omitting 
epileptics from the control sample. This illustrates the unsatisfactory 
nature of such organic diagnostic groups in work of this kind. The 
author also noted that enlargement of the interhemispheric fissure 
and increase in lateral ventricular volume both correlated with
length of illness but not age of onset. Two independent psychiatrists . 
made an assessment of the degree of deterioration in the schizophrenic 
patients but this did not correlate with any of the indices of 
cerebral damage.
This study is of some interest and worthy of greater attention. 
The major problems associated with it refer to the unspecified 
inclusion criteria for schizophrenia and as mentioned the choice of 
controls, some of whom appear to have been very young (ll years).
Most importantly, it is not clear from the author’s presentation 
whether or not the age effects demonstrated on all indices except 
interhemi spheric size and third ventricle width were accounted for 
in the statistical analyses.
Andreasen et al used VBR to assess ventricular size in a 
study of 52 young (mean age JO - 10.6 years), DSM - III and RDC 
type schizophrenics who were not institutionalised (Andreasen et al 
1982 c ). They concurred that their schizophrenic group had a 
significantly larger mean VBR than controls, though the magnitude of 
the difference was not great, and the considerable schizophrenic/ 
control overlap and the wide variance of the experimental group 
were emphasised. Age effects are not commented on, and although 
the distribution of VBR’s is taken to show a "trend” towards 
bimodality, no statistical confirmation of this is presented. ECT 
was the only physical treatment assessed but was not found to be a 
contributory factor. As none of the patients were chronically 
institutionalised this could not account for the findings. The controls 
comprised matched scans from radiology files which had been reported 
normal, though the authors acknowledge the difficulties associated 
with this. They further illustrate graphically the importance of the
controls used and the criteria for dilatation adopted.
Almost one-third of their sample had a history of either 
alcohol or drug abuse "at some time in the past", though the authors 
discount this as the relationship established between substance abuse
and VBR was a negative one. The type of abuse relevant to their sample
e.
is not mentioned but a tendstncy towards a negative relationship 
between indices of atrophy and opiate abuse has been reported (Hill 
and Mikhael 1979)* As drug history in the controls could not be 
assessed, it is impossible to say whether such an effect was tending 
to mask even greater differences in VBR between the groups than that 
found.
In a related publication, Andreasen et al explored the 
relationships between VBR changes in their schizophrenic patients 
and the presence of "negative symptoms" (Andreasen et al 1982b).
They compared the 16 schizophrenics who had "the greatest ventricular 
enlargement" with the 16 who had the smallest with regard to their 
"positive and negative symptoms". The authors concluded that "patients 
with ventricular enlargement tend to have a preponderance of negative 
symptoms.... while patients without ventricular enlargement tend to 
have a predominance of positive symptoms" and state that their 
investigation "provides support for a new way of subtyping schizophrenic 
disorders as negative (or defect) versus positive(or florid)".
These statements represent a somewhat emphatic interpretation 
of the authors' data. None of the five items comprising "negative 
symptoms " was significantly different between the groups and of the 
five "positive symptoms" only bizarre behaviour was significantly
* The difference between Andreasens "positive and negative symptoms" 
and the 'positive' and 'negative' features used in the present work 
has already been emphasised (cf Part l).
less common in the large ventricle group. As the probability values 
for none of the other nine items were less than 0.1, it is hard to 
interpret these data objectively as showing even the "trend" in 
the direction the authors suggest.
It is possible that the schizophrenic subjects of 
Andreasen et al were too young or had been ill for insufficient 
a period or were not 'chronic’ enough to achieve sufficiently high 
ratings to demonstrate a relationship between ventricular enlargement 
and specific 'negative' characteristics. It is of interest to note 
however that in failing to find such a relationship that conforms 
to conventional significance, yet demonstrating a significant 
correlation between cognitive impairment and ventricular dilatation, 
these workers have reproduced the original findings of Johnstone 
et al in an entirely different schizophrenic population (vide supra).
Recently, Jemigan et al have utilised a new technique 
to assess ventricular size in a group of J>0 chronic, relatively 
young (mean age 32.4 - 8.2 years) schizophrenics defined by DSM-III 
criteria (Jemigan et al 1982 a). These workers have developed a 
semi-automated method for quantifying cerebrospinal fluid volumes 
by applying computerised measurement algorithms directly to the 
attenuation matrices produced by the scan computer. The analysis 
uses a simple volume-averaging model to estimate the CSP content in 
local subsegments of the intracranial space. By summing throughout 
particular sets of subsegments, estimates of total ventricular 
volume and sulcal fluid volume can be obtained.
This study could demonstrate no difference in ventricular 
volume or sulcal volume between the chronic schizophrenic patients 
and a group of normal healthy controls who had been scanned as part
of a previous study. Although the mean age of the controls was 
greater than for the patients (age having been demonstrated by this 
technique to be a significant determinant of ventricular size in 
normals) statistical analysis took account of both age and cranial 
size.
In view of their novel technique of analysis the authors 
conducted a parallel investigation into the comparability of their . 
method with the more conventional planimetry adopted, in the 
literature. They submitted coded sets of films to the NIMH group 
and the Nebraska group for planimetric assessment of VBR. While 
the means achieved by each group differed widely (by approximately 
100 %) no difference could be demonstrated between schizophrenics 
and controls using either groups’ measurements.
This study is of considerable interest, not least for the 
fact that it included 16 subjects who were scanned as part of the 
study reported by Golden et al (cf Part 1, Chapter 1.3-3*) 
correlating ventricular enlargement with impairment on cognitive 
testing (Golden et al 1980 b). This latter work was an intra-group 
study of schizophrenics and used no normal controls. Despite the 
novel evaluation technique with its dependence on attenuation 
values and the inherent problems of this, visual measurement by 
planimetry by two other groups did not alter the findings.
This discrepancy with the published literature described 
above could result from selection factors. Of their JO subjects,
10 were outpatients who represented "all consenting outpatients 
seen over the study period".. They do not say what proportion of 
outpatients this figure represents. It is reasonable to suggest 
however that this apparently small number of consenting patients may
represent the most amenable and best preserved of that group.
Thirteen of the inpatients came from a research ward whose 
protocol included withdrawal of medication. Thus only those in 
whom this could be achieved were referred for scanning. A further 
25 patients who came through the research facility were lost to 
scanning because medication could not be withdrawn (refusal or 
clinical deterioration including patients being transferred to 
a locked ward), or because the patients discharged themselves against 
medical advice etc. Thus those scanned represent one-third of the 
possible sample who permitted medication to be discontinued and who 
survived long enough (? how long) in a drug-free state to allow a 
scan to be performed. The seven remaining subjects were from 
"other wards" and were selected "only for their willingness" to be 
scanned. It seems likely therefore that the sample of Jemigan 
et al is biased in favour of young schizophrenics with relatively 
little behavioural disturbance.
Nasrallah et al (1982) used planimetry to assess VBR in a 
group of 55 consecutive male admissions who conformed to DSM-III 
criteria for schizophrenia. All were under 45 years (mean 29-9 years). 
There was a strikingly significant difference (in terms of 
magnitude, the greatest in the published literature) between the 
mean VBR of the schizophrenics and that of controls in the direction 
of enlargement in the former group. The authors reported that 35 % 
of their schizophrenics had VBR's that lay outwith 2 SB's of the 
control mean.
The clarity of this finding is unfortunately dimmed by the 
authors’ choice of controls. In an attempt to avoid exposing normal
individuals to radiation while keeping the selection of controls 
random, they chose for comparison the scans of 27 consecutive, 
age-matched males investigated immediately following motor vehicle 
accidents. It is unlikely that CT scan parameters are unchanged 
following closed head injury in view of the variable cerebral 
oedema developing in these situations. This will be particularly 
so in cases where the injury is of sufficient degree to require . 
radiological investigation, the effect being to decrease the 
ventricular representation and hence reduce the’control'mean VBR.
On the other hand, if the injury is severe enough and scanning 
not immediate, ventricular enlargement may develop (Levin et al 
198l). The position is further complicated by the possible role 
of intoxicating drugs in road traffic accidents and -the effect of 
these on ventricular size. The objections inherent to such a 
group used for control purposes greatly outweigh the advantages 
of ramdom selection. Thus while these findings are in line with 
most of those discussed so far, acceptance of at least the magnitude 
of the difference if not the basic finding itself must be qualified.
Nasrallah et al subdivided their schizophrenic population 
into paranoid, non-paranoid hebephrenics and non-paranoid 
undifferentiated subtypes using the Tsuang-Winokur criteria. All 
three major subtypes of schizophrenia had significantly increased 
cerebral ventricular size compared to the head injury patients.
However, ventricular enlargement was significantly greater in the 
paranoid and non-paranoid hebephrenic subtypes than in the non-paranoid 
undifferentiated group, although no difference emerged between the 
first two groups. There were no differences between the Tsuang-Winokur
subtypes in terms of premorbid history, duration of illness, 
severity determined by the number of hospitalisations, or response 
to medication to account for these findings.
These results imply that schizophrenics who exhibit 
ventricular dilatation do not belong to any one clinical type, 
at least in terms of the Tsuang-Winokur criteria, and that studies 
using a high proportion of ’non-paranoid undifferentiated' subjects 
may show less striking degrees of enlargement than those using 
other types. The authors suggest that the lack of a difference 
in mean VBR between their paranoid and non-paranoid hebephrenic 
patients casts doubt on any direct relationship between ventricular 
enlargement in chronic schizophrenia and factors such as poor 
premorbid adjustment, poor response to neuroleptics, neuropsychological 
impairments, and 'negative' symptoms, all supposedly less common 
in paranoid subjects. While this conclusion is noteworthy, it does 
extend the results of the study which referred to 'paranoid' 
specifically defined. It is of interest however that no difference 
could be demonstrated in ventricular size between patients 
conventionally viewed as in general having different patterns of 
deficit.
An interesting and important variation on the above studies 
was reported by Reveley et al (1982) who examined the scans of 11 
healthy monozygotic and 8 dizygotic twin pairs and those of 7 pairs 
of monozygotic twins discordant for schizophrenia. Their findings 
confirmed that the schizophrenics of twin pairs have significantly 
larger ventricles than their non-affected co-twins and controls. This 
was the case in 6 out of 7 of their discordant pairs. Furthermore,
they showed that while ventricular size is strongly under genetic 
control there is greater variability of size in MZ twins 
discordant for schizophrenia, implying to the authors the 
imposition of some external environmental factor in the genesis of 
both the ventricular- enlargement and, subsequently, the schizophrenia. 
They speculate that perinatal complications may be relevant in this 
regard.
1.2.3 STUDIES APPLYING LINEAR/VISUAL ASSESSMENT METHODS TO THE
EVALUATIONS OF VENTRICULAR SIZE
A number of other studies have appeared in the literature 
which used either visual assessment or linear measures to evaluate 
CT scan images. Owing to the limitations of these techniques 
(which have been mentioned and which will be discussed in Chapter 2 
below) these studies will be reviewed in less detail than those 
previously.
Shortly after Johnstone et al's original publication,
Trimble and Kingsley (1978) reported an uncontrolled evaluation of 
scans from 11 schizophrenics aged from 17 to 66 years, using Evans' 
Index. Although one patient had been leucotomised and 2 had 
histories of coincidental epilepsy, with all their subjects the 
Evans' Index "fell within the normal range (<C0.3)"» In view of the 
methodological inadequacy, its findings must be viewed as anecdotal.
Gluck et al (1980) used a "prolective trohoc" analysis technique 
to assess the difference in linear measures of maximal Illrd ventricle 
width, maximal anterior horn distance and sulcal enlargement on the 
scans of 68 chronic schizophrenics (criteria unspecified) and 180
matched controls from radiology departmental records. The unusual 
statistical procedure was adopted to take account of the.fact that 
in a number of scans the chosen parameters were too small to be 
measured, though the exact number to which this applied or 
whether it applied to other than Illrd ventricle is not stated. No 
differences could be detected between the schizophrenics and controls 
on any of the selected measures.
In the largest CT study in schizophrenia, Takahashi et al 
(l98l) examined the scans of 280 patients tightly defined by both 
Carpenter’s Flexible Diagnostic System and a series of strict 
exclusion criteria. The 254 controls comprised both normal volunteers 
and neurotic patients, matched for age, sex and educational status.
The matching was close for 169 pairs. The study sample was young 
(mean age 27*9 years) and had been ill for a relatively short period 
(mean 6.5 years). Scans were evaluated by a visual assessment, by 
straight linear measurements, and by ratios of linear brain measures 
to internal skull diameter. Both lateral and Illrd ventricle were 
examined, as was cortex, both in general and by areas.
The authors reported significantly more overall cerebral 
abnormality in their schizophrenics than in controls using visual 
assessment. However, using linear measures, only Illrd ventricle 
width was significantly greater in the schizophrenics. It was 
recognised that the CT abnormalities found were slight.
Having taken considerable care with the selection of patients 
and controls, this work is deeply flawed by the inadequate scan 
assessment technique. Furthermore, in aiming for a large sample size, 
the authors adopted a multicentre approach with scans performed on
different machines. Data from different machines, especially 
earlier m o d e l s ,are not necessarily comparable and the practice 
of pooling results is questionable, especially when no comparability 
analysis is performed on findings from different centres.
Also from Japan, Tanaka et al (l98l) reported on the scans 
of 49 schizophrenic patients (criteria unspecified), of mean age 
35 years. No detail on length of illness is provided or on 
whether or not the patients were institutionalised. Their control 
group comprised 38 cases investigated mainly for headache " who 
showed neither neurologically abnormal findings nor any specific 
lesion except ventricular enlargement and cortical atrophy in CT 
findings". This presumably means that the presence of ventricular 
and/or cortical atrophy were not exclusion criteria for controls.
The authors found no difference in those under 40 • In the 
41 - 60 age group, schizophrenics had larger measures on left and 
right septum-caudate distances, maximal quadrageminal cistern,
Illrd ventricle and interhemisphere width, maximum width of 
hemispheric sulci and maximum distance between Sylvian fissure and 
inner skull.
Apart from the use of linear measures, unspecified diagnostic 
criteria and presentation of scant clinical detail, it is hard to 
accept the control group in this study without comment. In a 
randomly selected group of normal, healthy volunteers signs of atrophy 
could not be reasonably used for exclusion from a control group. 
However, in this study the population were not randomly selected, 
normal, healthy individuals by virtue of suffering cranial 
symptomatology of sufficient degree to warrent CT investigation.
Okasha and Madkour (l982)provide the only report in this
area from a Third World country (Egypt). They studied 43 chronic 
schizophrenics (criteria unspecified) of mean age 33 years who had 
been ill for at least 5 years. However, as the youngest of the 
sample was 15, it is doubtful if they would be considered 
representative of schizophrenia in most western countries. Seventy 
five per cent were hospitalised. They had as controls 39 patients 
(mean age 33 years) "with peculiar symptoms in the head and needing 
reassurance by CT".
The authors conclude that their results show that there were 
"no significant differences between chronic schizophrenics and 
controls" in cortical assessments, but that "a highly significant 
difference was obtained on Illrd ventricle and cella media index", 
both indicating atrophy in the schizophrenics. As no statistical 
analysis is presented, the use of the word "significant" with 
regard to these findings is inappropriate, though the differences 
were in the predicted direction.
In Greece, Frangos and Athanassenas (1982) compared the 
VBR's from scans of 70 Feighner positive schizophrenic in-patients 
(mean age 40 years) ill continuously for at least 2 years (mean 
length of illness 13 years), with the normal VBR values published 
by Barron et al, and found significant ventricular enlargement in 
their patients, even when age was accounted for. As was shown by 
Jernigan et al (vide supra) the practice of comparison of absolute 
values in the literature is unacceptable.
In addition the same authors also found significantly larger 
mean VBR's in their paranoid patients compared with hebephrenics 
and a trend in the same direction between paranoid and undifferentiated 
types, these types being defined according to ICD - 9 criteria.
Age was not considered to underly these findings. Using a different 
definition of ’paranoid1 these authors concur to some extent with 
Nasrallah et al (vide supra) though there is discordance between 
the studies on the relative placings of hebephrenics and 
undifferentiated patients in the hierarchy of ventricular size.
Nasrallah (1982) has published a further study on the 
paranoid - non-paranoid distinction using CT. This investigation 
used radiology department scans done "as part of the workup for 
headache" as controls and assessed pictures by means of linear 
measures. It is not clear if the study sample are the same 
schizophrenics reported in their previous work reviewed earlier.
While describing a number of trends, the only significant findings 
concerned a greater mean bicaudate distance in paranoids aged 
20 - 30 years compared with controls and more paranoids than non­
paranoids with bifrontal or bicaudate diameters that exceeded 
the control mean by more than 1 SD. In contrast to the author’s 
previous study this work provides little objective support for the 
validity of a paranoid - non-paranoid dichotomy on the basis of 
CT changes.
Nyback et al (1982) scanned 46 patients of mean age 32 years 
admitted to the Karolinska Hospital, Stockholm, with "acute psychosis" 
Of these, 28 conformed to the RDC for 'definite schizophrenia', a 
further 13 being classified as 'probable'. Nineteen were first 
admissions. As controls, 46 healthy volunteers were scanned. Using 
linear indices involving frontal horns they found significant 
enlargement in patients compared with controls, which was true of 
comparisons involving all patients, only those under 45 years of age,
RDC schizophrenic and all schizophrenics under 45 with no history 
of drug/alcohol abuse. No differences emerged between all 
schizophrenics with no history of substance abuse compared with 
controls. Mean Illrd ventricle measures were also greater in all 
patients under 45 compared with controls. Although cortical 
atrophy (visually assessed) was stated to be "more frequent" in 
the patient group, no statistical analysis is provided and it must 
be assumed that no significant differences emerged. Age correlated 
with both measures of ventricular size in the volunteers but only 
with Illrd ventricle size in the patients, leading the authors to 
suggest that schizophrenia may be associated with a process which 
obscures normal ageing in the lateral ventricles.
This is one of the better studies using linear measures 
in evaluation, though there is some evidence that the results may 
have been partly influenced by failure to exclude 10 subjects 
(22 % of the sample) with a history of drug or alcohol abuse.
Benes et al (1982) examined scans of "schizophrenics" and 
controls, all of which came from radiology records. Thus, even the 
"schizophrenics" were scanned for reasons that were not routine.
The authors state these patients were investigated for "varying 
degrees of cognitive impairment". It is relevant that of 40 
schizophrenics scanned, only 11 conformed to Feighner criteria, and 
of these, only 4 did so without a history of drug or alcohol abuse.
The diagnostic criteria to which the other patients conformed are not 
stated. Controls, (mean age 29 years) were considerably older than 
patients, and had been scanned as part of the investigation of 
headache and dizziness. Patients were young (mean age 21.2 - 5*5 years) 
with an average of 4*5 years of illness, and had spent just over one
year in hospital. The authors, calculating ratios based on both 
linear and area measures, found no differences between the 
experimental subjects and controls, and felt that the very short 
time the former had spent in hospital was relevant in this result, 
though this is speculative. They make no comment on the possibility 
that differential age effects could have obliterated subtle patient- 
control differences. Apart from their young age and the relatively 
'mild' form of illness they suffered from, it is highly doubtful 
that these subjects would be accepted by most workers as typical 
schizophrenics suitable for research purposes.
Thus the original work of Johnstone et al has stimulated great 
interest, and although some consistency in findings has emerged, 
studies using the CT technique of imaging also present fundamental 
methodological problems.
1.5 SUMMARY OF THE LITERATURE ON RADIOLOGICAL IMAGING IN SCHIZOPHRENIA
In summary, the literature on radiological imaging of brain 
structure in schizophrenia indicates the following:
1) In some cases, schizophrenia is associated with 
structural brain changes. The most consistent positive 
findings relate to enlargement of the lateral ventricular 
system, which has been demonstrated with both PEG- and, 
more recently, with CT in studies using different 
methodologies and control groups. The literature is
not however unequivocal.
2) CT studies, which have produced numerical data and 
which allowed the use of control groups, show that 
"ventricular enlargement" refers to a statistical 
difference between patient and control group mean 
values. In general, the variance is greater in 
schizophrenic groups than controls and the degree of 
overlap is considerable.
3) There is no evidence of a characteristic or 
pathognomonic appearance in the schizophrenic brain 
using either PEG or CT, and nothing as yet to support 
the view that a distinct subgroup of patients can be 
identified solely on the basis of radiological findings.
4) The specificity of the structural changes is unknown
5) The clinical correlates of ventricular enlargement 
remain unclear. PEG suggests that 'deterioration' is 
associated with brain change. There is as yet no 
substantial evidence from CT that 'deterioration' 
defined in terms of the 'negative' or 'defect' state
is particularly associated with ventricular enlargement, 
and suggestions that particular clinical subtypes may 
be more affected or that early environmental assaults 
may be relevant, remain speculative.
6) Other parameters of cerebral atrophy have either not 
been widely studied (e.g. Illrd ventricle) or have 
produced inconsistent or unreliable findings
(e.g. cortex).
1.4 THE PRESENT STUDY
1.4.1 GENERAL COMMENT
This review demonstrates the extent of work carried out in 
the field of radiological imaging of the schizophrenic brain in 
vivo. In addition, it illustrates the ongoing difficulties of 
methodology and interpretation of data in what remains a highly 
complex field of investigation. The newer CT system is precise in 
recording attenuation data, so minor variations in technique may 
reflect in results - for example, whether the patient is scanned 
parallel to the orbitomeatal line, as is customary in Europe, or 
at 20 0 to it as in the U.S. Furthermore, the attenuation data 
themselves are subject to a range of effects dependent on the 
physics of x-rays - for example, effects such as beam hardening 
(Dichiro et al 1978)> linear drift (Thaler et al 1979)5 "the energy 
dependence of the values (Zatz and Alvarez 1977) etc. Hence, the 
technicological problems inherent in PEG have been replaced by 
different problems of a subtler order associated with the new 
technology. When the changes being sought are unlikely to be gross 
in degree or characteristic in type there is all the more need for 
close attention to the selection of both experimental and control 
subjects in application of CT to clinical psychiatric research.
1.4.2 THE SPECIFIC QUESTIONS
This part of the work was concerned with determining whether 
structural brain change can be attributed to schizophrenia using 
in vivo radiological imaging (CT). Specifically, four main questions
were addressed, exploration of the last three being dependent on 
an affirmative answer to the first.
These questions were :
1) Is schizophrenia associated with lateral ventricular 
enlargement ?
If so:
2) How specific is this to schizophrenia ?
3) Are past physical treatments of relevance ?
4) What are the clinical correlates ?
In general, the literature on brain imaging reviewed above, 
could be taken as suggesting that ventricular enlargement is to be 
found in this condition in association with what are in effect 
parameters of severity - i.e. 'deterioration', the need for long­
term hospital care, referral to research wards, poor premorbid 
functioning, poor response to neuroleptic drugs etc. Hence the 
present population seemed ideally suited to answering these 
questions.
Chapter 2 - Methods
In order to answer the questions posed in this part of the
work, patients selected from within - the•basic population of 510 were
scanned and the results compared with scans from several control
groups.
The following diagnostic groups were studied :
a
b
d
e)
c
chronic schizophrenic in-patients
discharged (non-institutionalised) schizophrenics
first episode schizophrenics
manic depressives receiving long term in-patient care 
manic depressive outpatients
2.1 SELECTION OF TEE CHRONIC SCHIZOPHRENIC IN-PATIENTS
Matched groups comprising 112 cases were selected for scanning 
from the total group of 510*
2.1.1 THE DEFECT STATE
PEG work described earlier (Chapter 1.1.4) indicated that 
increased ventricular size in schizophrenia was associated with 
deterioration as assessed by global clinical judgement. In Part 1, 
it was noted that other elements of deterioration or defect, namely 
impaired behavioural performance, ’negative' schizophrenic features 
and neurological signs of an extra-pyramidal type, were all associated 
with cognitive impairment, though deficits in none of these areas 
correlated with the presence of ’positive' mental state features. As 
presented in the literature review, cognitive impairment has 
frequently been correlated with increased lateral ventricular size 
(Part 1,Chapter 1.3*3 )• Such findings are consistent with the concept
that the clinical presentations characterised by predominantly 
’positive’ and ’negative’ features represent relatively independent 
dimensions of pathology. It has been postulated that structural 
brain changes are more likely to be associated with ’negative’ or 
’defect’ features. For this part of the study, the term ’defect 
state’ was defined as in Part 1 (Chapter 4*3)* Patients with 
and without a ’defect state’ were matched on each of the following 
variables :
Age
Sex
Length of illness
Past academic record
Gross (’other1) neurology
Past treatment with: Insulin coma
ECT
Neuroleptic drugs
Past physical treatments were also matched in terms of 
’none’, ’some’, ’much’, as defined previously (Part l).
Seven identically matched pairs were scanned.
2.1.2 PAST PHYSICAL TREATMENTS
The question of the relationship between ventricular size 
and past exposure to physical forms of treatment, for which this 
population was particularly suitable, was examined in two ways. Firstly, 
a sample who had received no insulin, ECT or neuroleptic treatment 
was compared with a matched sample * who had been heavily treated by 
physical means. It was not possible to match those who had never 
received physical treatment with subjects heavily treated with all
* In this Part, the term ”a matched sample” refers to one 
comprising subjects matched for age, sex, and length of illness.
three modalities. Thus a numerical value of 1 - 3 was arbitrarily 
attributed to the ’none’, ’some’ and ’much1 categories respectively 
‘for each form of treatment. Those with no history of physical 
therapy were matched with subjects scoring at lease 6 on this 
arbitrary system. These latter subjects had thus been heavily 
treated in at least one modality or had received moderate degrees 
of exposure to all three. The two groups comprised a total of 16 
subjects.
Secondly, the relevance of individual treatments was assessed 
by comparing matched samples who had had equal exposure to treatments 
other than the one under consideration. For each modality in turn 
subjects never exposed were compared with those heavily exposed. Thus, 
for example, matched subjects never treated and heavily treated with 
insulin were compared, their exposure to ECT and neuroleptics being 
equal. For each treatment modality, 8 separate pairs were available.
2.1.3 COGNITIVE FUNCTIONING
It was not possible to assess the relationship between premorbid 
intelligence, ’defect state' and structural brain change because, of 
those with higher premorbid attainment or potential, only 2 had the 
'defect state' as currently defined. This undoubtedly reflects the 
strong correlation between premorbid and current cognitive ability. In 
addition matching of the higher academic group with others was 
complicated by a number of the former patients having had leucotomies.
In order to study patients in whom there could be little doubt 
that present poor cognitive performance represented a decline, those 
higher academic patients who achieved more than the mean Withers and
Hinton score for the total population were compared with a matched 
sample who achieved less than the mean. Even this comparison proved 
difficult however, yielding only 4 matched pairs. In order to increase 
the numbers the length of illness criterion was widened to allow 
matching of subjects one band above or below the ideal. If this was 
unsuccessful, the age criterion was likewise widened. In this way a 
total of 22 patients were made available.
In a similar fashion a group of higher academic subjects was 
compared with subjects in either of the other ranges of cognitive 
performance (average or poor), age and length of illness being controlled 
as closely as possible in the above mentioned way.
2.1.4 CATATONIC PATIENTS
As was described in Part 1, patients with a PSE designation of
catatonic syndrome tended to have particularly severe deficits and
might be predicted to show particularly marked ventricular enlargement.
Patients in CS + Catego subclasses (N = 16) were therefore compared
+ +
with a matched sample in either NS or PS subclasses.
2*1*5 UNDER - 45’s
Restricting the scanned subjects to those fulfilling these 
formal criteria would have resulted in a rather elderly study group.
In order to assess lateral ventricular size over a reasonably wide age 
range, a number of patients under 45 years of age were also included. 
Fifteen such patients were scanned, an additional 8 having been done 
as part of the above comparisons.
2.1.6 SELECTION
Computer prlnt-outs generated groupings of the patients 
(by code number) in terms of the major variables and detailed matching
4.
was made by hand. For those under 45 years and the CS patients, 
random lists were drawn up and every fifth and every alternate subject 
respectively was considered. The number of potentially suitable 
patients in other groups was so small that all who fulfilled the criteria 
(and consented) were included. Before consent was sought, the nursing 
staff and the consultant in charge of the patient’s care were asked 
for their views on the suitability of the patient for inclusion in the 
CT part of the study. In no case was a request for inclusion opposed.
The patients were asked for permission having had the procedure 
explained. Where a patient refused an attempt was made to find an 
alternative match, or, where this was not possible, the pair was 
dropped. Those under 45 years or with CS subclasses who refused, 
were replaced with the next patient on the random lists. For mute 
patients unable to give their verbal consent, a joint decision regarding 
suitability was made by both medical and nursing staff. In such cases, 
ward staff often accompanied the patient and remained with them 
throughout the procedure.
2.2.______ SELECTION OF THE CONTROL GROUPS
The control groups (except the first episode schizophrenics) 
were chosen to match the in-patient schizophrenics for sex and, as 
closely as possible, for age.
The non-institutionalised chronic schizophrenics were drawn
from patients with a case-note diagnosis of schizophrenia, discharged 
from Shenley Hospital during the years 1970 - 1974 inclusive 
(Johnstone et al 198l). Of these 210 patients, 120 conformed to the 
Feighner criteria for schizophrenia. One hundred and two were traced 
and 79 examined in a manner similar to that adopted for the present 
study. From these, a sample was selected which in addition to matching 
the in-patients on age, sex and length of illness, also approximated 
in terms of exposure to insulin, ECT and past neuroleptic drugs. 
Eighteen matched out-patients, whose mental state permitted and who 
lived in reasonable proximity to the hospital, co-operated in scanning.
The first episode schizophrenics were a small group of 8 
patients admitted with their first illness during the course of the 
study. All were placed in Catego Class S following PSE assessment.
The manic depressive in-patients were chosen from the 29 
patients of the total in-patient population (1227 cases) of Shenley 
who conformed to Feighner criteria for primary affective illness and 
had been receiving continuous in-patient care for at least one year. 
Eleven such patients could be closely matched with the in-patient 
schizophrenics and were scanned.
Out-patient manic depressives and neurotic subjects were drawn 
from individuals attending the outpatient clinics of Northwick Park 
Hospital. The former fulfilled the Feighner criteria for primary 
affective illness while the latter conformed to Feighner criteria for 
anxiety neurosis or undiagnosed psychiatric illness. The scanned 
out-patient manic depressive group comprised 22 subjects and the 
neurotic group 19*
2.5 PROCEDURE
All scans were performed on the same EMI 5005 whole body 
scanner at 120 Kv, with a 65 second scan time, and with patients in 
the supine position. Sedation was avoided where possible but in the 
11 patients in whom it was required (all schizophrenic in-patients) 
intravenous diazepam was used. The scans were examined by the 
collaborating radiologist using an EMI Mk 11 independent viewing 
console and bromide pictures obtained of the axial cut showing 
maximum lateral ventricular size. The window width at which these 
bromides were taken may affect the assessment of ventricular size 
on CT - increasing window width resulting in increasing representation 
of ventricle. For all scans a standard window width of JO was 
adopted, as the radiologist considered this to give the best 
representation of ventricular margins. Unfortunately, with the 
machine being used, that window width giving the best presentation of 
ventricular margin often gave a blurred image of brain/skull interface.
A second bromide was therefore taken of the same maximal ventricular 
cut but at a window width of 100, this value giving a clear delineation 
of brain and*skull. Window level - a less influential variable on 
ventricular representation - was kept as near to 15 as was compatible 
with the clearest ventricular appearances.
The pictures were presented in random order by the collaborating 
radiologist, the clinician being blind to the identities and diagnostic 
categories of the patients. Measurements were made using the 
Joyce-Loebl Magiscan Image Analyser, where areas were calculated from 
boundaries. Margins of the lateral ventricles were outlined manually
with a light pen, while those of brain were detected automatically 
by an edge-tracking computer programme. Areas were thus determined 
for brain and lateral ventricle, using the cuts of maximal ventricular 
size at window widths of 100 and JO respectively. Ventricular size 
was expressed as the ratio of ventricular area to brain area as a 
percentage (Ventricular/Brain Ratio or VBR). All scans were examined 
twice and the average of the two halves were taken as the VBR for 
each patient. The test-retest reliability was 0.97 • addition, 
alternate scans in the first half and in the latter half of the series 
were examined by a second and a third clinician respectively and the 
inter-rater reliabilities of the method were high, ranging from 
0.91 to O.99.
2.4 STATISTICAL NOTE
The same basic principles were adhered to as stated for the 
analysis of movement disorder data (Part II, Chapter J.2.j). Specific 
procedures will be mentioned as they arise.
Chapter 5 - Results
5.1 GENERAL
A total of 198 subjects were successfully scanned. All of these 
films were considered technically adequate for assessment. Two 
subjects, whose original scans were contaminated by artifact, allowed
ft
the investigation to be repeated, the original scans being discarded.
With only 2 patients (both chronically hospitalised schizophrenics)
did the procedure require to be aborted before completion. These
patients were substituted by the next ones on their respective lists.
Sedation prior to commencing the scan sequence was necessary to
settle 11 subjects, all of whom were long-stay schizophrenic in-patients.
*»
This was achieved by aflmlnjstration of intravenous diazepam to the 
point of inducing light sleep. The amount required ranged from 
10 - 70 mgms (mean 37*3 ~ SD 20.4 mgms).
Eleven scans were excluded from assessment and analyses. The 
reasons for these exclusions and the actual numbers analysed in each 
diagnostic category are shown in TABLE J'.J:!. The presence of 
unsuspected organic pathology was only considered a justifiable basis 
for exclusion if there was reasonable evidence that such pathology 
may exert a direct bearing on ventricular size. Thus, the 3 patients 
referred to in TABLE 3:3;1 as being excluded for non-operative organic 
reasons,all had signs of ventricular distortion or mid-line shift.
As will be referred to subsequently, several other subjects demonstrating 
unsuspected organic pathology (mainly isolated peripheral infarction) 
were not excluded as their lesions did not impinge on the central 
liquor spaces. Maintaining these subjects in the study did not alter
TABLE 3=3':1 NUMBERS OF SUBJECTS SCANNED AND EXCLUSIONS IN EACH DIAGNOSTIC CATEGORY
DIAGNOSTIC
CATEGORY
NUMBER
SCANNED
NUMBER
EXCLUDED
REASONS FOR EXCLUSION NUMBER
ANALYSE!
CHRONIC SCHIZOPHRENIC 
IN-PATIENTS
118 8 LEUCOTOMY 6 
SUBDURAL HAEMATOMA 1 
PORENCEPHALIC CYST 1 
(BIRTH TRAUMA)
110
OUT-PATIENT
SCHIZOPHRENICS
18 0 - 18
FIRST EPISODE 
SCHIZOPHRENICS
8 0 - 8
IN-PATIENT AFFECTIVES 11 1 NON-FULFILLMENT OF 1 
DIAGNOSTIC CRITERIA
10
OUT-PATIENT AFFECTIVES 2 b 2 (L) POSTERIOR QUADRANT 1 
ARTERIOVENOUS MALFORMATION 
■ NON-FULFILLMENT OF 1 
DIAGNOSTIC CRITERIA
22
NEUROTICS 19 0 - 19
187
the basic findings (vide infra).
5.2 COMPARISONS OF VENTRICULAR SIZE IN DIFFERENT DIAGNOSTIC GROUPS
3.2.1 STRAIGHT IHTER-GROHP COMPARISONS
The distributions of VBR’s in the total sample of 187, and 
in each diagnostic category separately, are shown in Pigs 3:3:1 and 
3:3:2 respectively. There is clearly considerable overlap in all 
groups. The mean VBR of the schizophrenic patients (long-stay in­
patients, out-patients and first episodes combined) was 11.87 - SB 
3.42, while that for the non-schizophrenics (in-patient manic 
depressives, out-patient manic depressives, neurotics combined) was 
10.87 - SB 2.34* This difference only narrowly missed conventional 
statistical significance (AEOVA: P - value (l,185) = 3*66, P = 0.057)* 
Analysis of variance of the group means reveals that this was due 
entirely to a significant difference between the mean VBR of the 
long-stay schizophrenic in-patients compared to that of the neurotics 
(TABLE 3:3j2). Ho other comparisons between the groups reached 
significance and there were no noteworthy trends.
3.2.2 AGE
Such an analysis does not however take account of the 
possible effects of age on VBR. Although not all workers have been 
able to establish a significant contribution to ventricular enlargement 
from increasing age, there is evidence in the literature that such a 
relationship exists, at least in normal samples.
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TABLE 3 :J:2 T-TEST MATRIX FOR GROUP MEANS (df = 181) - AGE NOT ACCOUNTED FOR
IN-PAT. SCH. OUT-PAT. SCH. NEUROTICS IN-PAT. AFF. OUT-PAT. AFF. 1st EPIS01 
SCH.
IN-PAT. SCHIZ. 0.00
OUT-PAT. SCHIZ. -1.^9 0.00
NEUROTICS -2.^5* -0.70 0.00
IN-PAT. AFF. -0.22 O .78 1.37 0.00
OUT-PAT. AFF. -1.55 0.05 O .78 -0.77 0.00
1st EPIS. SCHIZ. -1.69 -0.56 -0.02 -1.15 -0.62 0.00
* p = 0.015
The distribution of age in the total sample of 187 subjects 
and in each diagnostic group separately, is shorn in Pigs 3*3*3
4*3:3:4 respectively. The mean age of the scanned subjects was 55*99 - 
SD 12.7 years (range 22 - 87 years). As TABLE 3*3:3 demonstrates, 
the groups differed markedly in their mean ages, the in-patient manic 
depressive group being older and the first episode schizophrenics 
younger than the others. As would be anticipated by the nature of 
the constituent patients, the groups also differed markedly in mean 
lengths of illness (TABLE 3s 3:3)-
In the total sample of 187, the relationship between age and 
VBR is shown in Pig. 3*3*5* This was highly significant (P (l,184)=
38.8 , P <  0.0002). The above inter-group comparisons of VBR were 
thus repeated accounting for the effects of age.
3.2.3 IMER-GROUP COMPARISONS - AGE ACCOUNTED BOR
With age covaried, the mean “VBR of the schizophrenics remained 
significantly greater than that of the non-schizophrenics, the 
probability value decreasing considerably (P (l,184) = 6.1 , P = 0.015). 
Comparison between the six groups confirmed that with age effects 
accounted for, this difference was again due to the long-standing 
schizophrenic in-patients having a significantly larger group mean VBR 
than the neurotics (TABLE 3:3:4). The age adjusted group mean VBR's 
( i SE*s) are shown in TABLE 3*3*5*
fcr
As was mentioned above this result was not altered by om^ijing 
those patients with incidental intracranial pathology not impinging on 
the ventricular system (chronic schizophrenic in-patients v neurotics 
t = 2.27, df = 171, P <  0.025).
FIG 3:3:3
Age d is tribu tion  - Total sample (n =187)
40 - |
30 “
§ 20 -
a>
Q_
io -
21- 31- 41- 51- 61- 71- 81 +
30 40 50 60 70 80
Age
co
CD
“O
O
CO
C L
CD
-4— f
CO
L_
Ll_
co
o
13
CD
I CDO G
CD
vO
CD
'■'cr
CD
CVI
vr
cr\
cr\
O
CL
Z3
O
L_
Cn
o
CO
H—'
-t—» d
CO CD
o •_d
d CD
cn CL
co 1
-4—'
TD =3
jd O
o
CD
CD
k_
OM CO
d . E
o d
•H—' CD co
Z3 ■4
_Q Jd d
i— CD
-4—' o -4—*
CO NJ CD
*"5 Jd
C L
1
CD O (—
Cn oo
<
Jd
u
* — - j
o CD
CVI
CO
d
CD
CO
Q.
I
-s— •
Z3
O
CD
coH—>
d
CD
CO
C L
I
E
CD
u
CD
C O
CD
vO
O
■^ T
CD
CVJ
i r n  n r  r
CD
C O
C 3
VO
CD
CD
CVi
CD CD
VO
CD
'vT
CD
CVJ
CD
}U0O J0d
fA
r A
ME
AN
 
L
E
N
G
T
H
 
O
F
 
I
L
I
N
E
S
S
 
± 
SD
 
(
Y
E
A
R
S
)
*
CT\
l A  O J  
•
C O
C M  + 1
00
r -  f A  
• r *
co
v“ +1
31
.9
 
± 
10
.6
21
.9
 
± 
10
.7
__
__
__
. 1
f A  -J- 
O O
CVJ + 1
-J" 
A -  O J
• V "
O J
cvJ - H
L A  
• V O  
V O
+ 1
O N
L A  f A . O J
• O N
L A A -
§
L A  -fl L A - H
< C O O N O J - 3"
-Cf- O N
s  « O J  CVJ co r~ f A CVJ • a - • O
<  co • r * • r * • V O • V O r *
C O O N O N L A ~zt V O
§  + 1 l a  + l + l J A + I V O  + 1 uS+i L A  4*1
a
<
fcj o C O 00 0 CVJ O No v ~ C “ CVJ v—
E H *r~
Q
3  w
O  9
CO <
R
O N CVJ -n* C O r - O
W  & i I A V**
i
t o
« S * - v o - 3" CVJ O N
s A -
c n
g £
w
p q CO c n
c n Q CO c n  c nc n 0 W  CO
c n S  Eh
H cm s Pd H c n04 w w W  H 0« M w Q  H Q  E H MQ E H <3; 1 E H 1 < E H0 «C E H O  < O PU O
W Ph I S3 H  C M M I PSE< 1 « &  H«< H a  3 a
O H 0 Ph S  H H s  0 2
uM
E Hto cn cn
O 0 0S H MoaH 3 3« H 3Ph PUO 0
c n t>o
H HW S  «
O O  O
C O &  c n
VB
R
FIGURE 3:3:5 ' RELATIONSHIP BETWEEN AGE AND VBR
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TABLE 3:3:'t T-TEST MATRIX FOR GROUP MEANS- (df = 180) - AGE ACCOUNTED FOR
IN-PAT. SCH. OUT-PAT. SCH. NEUROTICS IN-PAT. AFF. OUT-PAT. AFF. 1st EPI, 
SCH.
IN-PAT. SCHIZ. 0.00
OUT-PAT. SCHIZ. - O M 0.00
NEUROTICS -2-32* -1.*+0 0.00
IN-PAT. AFF. -0.97 -0.51 0.65 0 .00
OUT-PAT. AFF. -1.1^ - 0 A 8 0.99 0 .1^ 0.00
1st EPIS. SCHIZ. 0.02 0.29 1-35 0.66 0.65 0.00
* p = 0.021
TAB IE 3:3:5
AGE CORRECTED GROUP MEAN VBR's (± S.E.'s)
LONG-STAY SCHIZOPHRENIC IN-PATIENTS 11.97 ± 0.28
SCHIZOPHRENIC OUT-PATIENTS 11.56 ± 0.69
FIRST EPISODE SCHIZOPHRENICS 11.90 ± 1.07
MANIC-DEPRESSIVE IN-PATIENTS 10.96 ± 0.93
MANIC-DEPRESSIVE OUT-PATIENTS 11.11 ± 0.62
NEUROTICS 10.20 ± 0.6?
3-2.4 LENGTH OF ILLNESS AND SEX
In keeping with previous Sections, length of illness was also 
evaluated as a separate component of the effect of the passage of time.
By the nature of the comparison population in the present Section, the 
term ’length of illness’ could not be consistently defined for each 
group. For the chronic schizophrenic in-patients and out-patients it 
was calculated as in Parts 1 and 11- i.e. length of time since first 
admission. For the first episode schizophrenics it was clearly zero, 
as fractions of a year were not considered. For the other groups the 
term was defined as the time since first psychiatric contact (TABLE 3:3:3)*
Using these definitions, analysis of covariance was conducted 
with age and length of illness as covariates and "VBR as dependent 
variable. This showed a highly significant effect of all covariates - 
i.e. of time factors (F 2,182) = 20.05 , P<0.000l). However, this 
relationship was entirely due to the striking effect of age alone 
(F 1,182 ) = 14*77 , P = 0.0002). There was no significant independent 
effect of length of illness (F 1,182) =1.77 > P = 0*19).
Sex likewise was not significantly related to ‘VBR (F 1,182) =
0.95 , p = 0.33).
3.3 THE MATPKE OF "EHE RELATIOHRHIP BETWEEN ARE A M  TOR
Having established a strong association between age and 
ventricular size as assessed by ‘VBR, the nature of this relationship 
was explored further.
The relationship between age and "VBR in non-schizophrenics and 
schizophrenics separately is shown in Fig. 3:3:&. There is a definite
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implication of a greater and premature effect of age in those with 
schizophrenic diagnoses. However, in statistical terms, no significant 
difference could be demonstrated in the equality of slopes for the 
age/VBR relationship when either the non-schizophrenics were compared 
with the schizophrenics (F 1,183) = 0.4 , P = N /s ) ,  or when the 
relationship within each diagnostic group was evaluated (F 5? 175 )=
0.99 » P = N/s). This suggests that the positive relationship 
between age and VBR is in fact consistent in schizophrenics and 
non-schizophrenics alike, and within the limits set by the relatively 
small number in some groups, in each diagnostic category likewise.
Further, however, there is evidence that such age effects as 
are demonstrable on the VBR’s of non-patient groups may only become 
manifest in middle life, ventricular size remaining fairly constant 
until approximately the 6th decade. Polynomial regression analysis 
was performed to determine the form of the best fit relationship 
between age and VBR in this mixed patient sample, with the expectation 
that the relationship would accelerate with increasing age.
Polynomial regression produces 3 coefficients. The coefficient 
of degree 1 is the linear coefficient; that of degree 2 is the quadratic 
coefficient; and that of degree 3 "the cubic coefficient. Only the 
coefficient of degree 1 (linear) reached conventional significance 
(t - value = 6.01 , df = I83 , P = O.OOl). However this analysis did 
show a non-significant trend to significance for the quadratic 
coefficient of degree 2 (t - value = 1.37 ? df = I84 , P <  0.08). Thus, 
although the quadratic component is not significant by conventional 
criteria, the best fit curve does show accelerating function with age.
The plots of observed and predicted values for the coefficients
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of degrees 1 and 2 are shown in Pig 3:3-7 and J:3:8. These suggest 
that the age relationship may differ below the early part of the 
5th decade compared to later in life. This trend to non-linearity 
may thus reflect a flatter, plateaued relationship of VBR to age in 
those in the present sample who were under approximately 40 years of 
age, while after this, the relationship becomes stronger and linear. 
This quadratic (degree 2) relationship may have failed to reach 
significance because of the relatively small proportion of the study 
sample under 40 years of age (14-4 %) • Because of this bias towards 
older subjects and the relatively small numbers in diagnostic groups, 
it was felt that data from the present study could not be used with 
any reliability to explore this question further within subgroups of 
the total population.
Thus while no definite premature or accelerated age effects 
could be demonstrated in schizophrenics as compared to non - 
schizophrenics in this study, it may be that ventricular appearances 
associated with age may occur earlier - up to one decade - in 
patients with functional psychiatric diagnoses than in the general, 
non-patient, population. Hence the present comparison may not be 
the appropriate one to demonstrate premature age differences in 
schizophrenia, which are likely to emerge only when patients with 
long-standing schizophrenia, representing a wide age range, are 
compared with appropriate normal controls.
5.4_______ DISTRIBUTIONS OF VBR's
5.4.1 SKEWNESS/KURTOSIS
The distributions of VBR and of age in the total sample 
were illustrated in Figs 3^  3s 1 3: 3^  3 respectively. While age
would appear to conform approximately to a normal distribution, 
that of the VBR's clearly deviates from normality. The distributions 
of VBR for different groupings of the total sample are shown in 
Fig 3:3:9* Statistical evaluation of the deviation or otherwise 
from normality of the distributions within these groups was 
performed by calculations of skewness and kurtosis for both YBR 
and age. The combinations shown in the figure were adopted to 
examine where the major source of the deviation lay, as some of the 
pure diagnostic categories contained too few subjects for tests of 
skewness and kurtosis to be reliably conducted directly. Skewness 
is a measure of asymmetricality of the deviation from normal, while 
kurtosis is a measure of symmetrical deviation.
As TABLE shows, the highly significant skew in
the distribution of the total sample is due to a significant 
positive skew in the schizophrenic patients, and this in its turn, 
emanates from an excess of long-stay schizophrenic in-patients 
with large YBR’s. These deviations are not the result of skew in 
the age distributions.
The significant kurtosis of the YBR distribution in 
the total sample reflects the high proportion (55*6 %) with 7BR‘s 
between 9*0 and 12.99 (Fig 3:3;9)«
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TABLE 3:3:6 ANALYSIS FOR SKEWNESS AND KURTOSIS OF DISTRIBUTIONS OF VBR AND AGE IN DIFFERENT DIAGNOSTIC 
GROUPINGS
PATIENT
GROUPING
TOTAL SAMPLE 
NON-
SCHIZQEHRENIC
GROUP
TOTAL SAMPLE 
EXCLUSIVE OF 
'CHRONIC 
SCHIZOHKENK 
IN-PATIENTS
TOTAL
SCHIZCEHRENtC
GROUP
NON-INSTI­
TUTIONALISED 
AND FIRST 
EPISODE 
SCHIZOfflRENTC 
GROUP
CHRONIC
schizcthffnic
IN-PATIENT
GROUP
C K E W N E S S K U R T 0 S I S
FOR VBR FOR AGE FOR VBR FOR AGE
N VALUE VALUE
S.E.
SIGNIF. VALUE VALUE
S.E.
SIGNIF. VALUE VALUE
S.E.
SIGNIF. VALUE VALUE
S.E.
SIGNI
18? 0.82 *+.57 p<0.001 -0.31 -1.73 N/S 0.99 2.76 p<0.01 0.19 0.52 N/S
51 O .36 1.05 N/S -O.56 -1.6*1 N/S ■ 0.15 0.22 N/S 0.1 0.15 N/S
77 0.5*+ 1.9*+ N/S -0.73 -2.63 p<0.02 0.9*f 1.68 N/S 0.1*+ 0 .26 N/S
136 0.7*+ 3.53 p<0.001 -0.21 -1.02 N/S 0.59 1 .*+0 N/S -o.*+8 -1.1*+ N/S
26 0.61 1.27 N/S -0.27 -0.56 N/S 0.19 0 .2 N/S -0.88 -0.91 N/S
110 0.86 3.69 p<0.001 -0 .2 -o.8*+ N/S 0.62 1.33 N/S -0.58 -1.2*+ N/S
It has been suggested that a VBR of greater than 2 Si's above 
the control mean is indicative of abnormality in schizophrenia 
studies (Weinberger et al 1979a), and hence that analysis based on 
distribution is valid. Although this criterion was adopted empirically, 
it has been used in a number of studies. The previous analysis would 
tend to support the use of distribution in the further study of VBR 
and its correlates. However, in view of the strong and possibly 
complicated association between age and ventricular size, it is 
necessary to make a specific age correction before proceeding further.
3.4.2 CALCULATION OF AGE - CORRECTION
The regression coefficient of VBR with age was 0.102. That is, 
for each year of variation in age, "VBR varied approximately by 0.102. 
Applying this term to the mean "VBR of the neurotic group and 
calculating from their mean age, an age-corrected mean VBR or predicted 
value for neurotics at all ages was derived. A range of variance 
for 1 and 2 standard deviations above and below these age-corrected 
or predicted VBR’ s was calculated from the observed standard 
deviations of the neurotic group at their mean VBR and group mean age. 
The observed VBR1 s were then categorised in terms of their relationship 
to those predicted, age-corrected means and standard deviations based 
on the neurotic sample.
Inherent in this procedure are two assumptions. Firstly it is
assumed that age bears a linear relationship to VBR. While in the
e
present study this is statistically so, the tendancy to a signficant 
quadratic relationship is ignored in the above calculation. Secondly 
is the assumption that standard deviation does not vary with age.
This may not be strictly correct, but the present study did not 
furnish sufficient data to allow resolution of this question. Any 
possible margin of error issuing from these two assumptions would 
however be small, and the likelihood of misclassification slight.
3.4.3 AGE-CORRECTED DISTRIBUTIONS
The VBR distributions relative to these age-corrected
predicted values are shown in Figs 3:3:10 and 3:3:11> which illustrate
each diagnostic group separately and the same groupings of the
population which were referred to previously. These distributions
were compared with the theoretical number that would be expected with
a normal distribution.
The distribution of the total population differed
significantly from normality (X ^ = 353*14 > df = 4 ? F <  O.OOOOl).
This deviation from normality is reflected in the distributions of
both the non-schizophrenic (X ^ = 26.83 , df = 4 » P<0.00l) and the
schizophrenic (X ^ = 319*16 , df = 4 > P<0.0000l) subsamples.
Furthermore the pattern of distribution in the schizophrenics was
significantly different from that of the non-schizophrenics
2
(Kolmogorov-Smimov two-sample test : X = 7*42 , df = 2 ,P<0.025) 
(Fig 3:3sll).
These findings result from an excess of patients with 
ventricles greater than 2 SDls above the age-corrected, predicted mean. 
Thus while both non-schizophrenic and schizophrenic subsamples had 
more patients with large ventricles than would have been expected by 
chance, the excess of such patients among the schizophrenics was 
strikingly greater than that found in those with non-schizophrenic
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FIG 3:3:11
D i s t r i b u t io n s  o f  V B R  r e la t i v e  to a g e - c o r r e c t e d  p r e d ic te d  v a lu e s  -  
V a r i o u s  p a t ie n t  g r o u p in g s
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T ota l  s c h i z o p h r e n ic
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i n - p a t i e n t s
I
 N o n - i n s t i t u t i o n a l i s e d  C h r o n i c  s c h i z o p h r e n i c  
+ l s t e p i s o d e  s c h i z o -  i n - p a t i e n t  g r o u p  
p h r e n i c s
g r o u p
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10 -
I&:
□  > 2 S D  below
□  <  1 S D above
2 - 1 S D  b e lo w  
1 - 2  S D  above
< 1  S D  below
> 2  S D above
diagnoses.
One further finding to emerge related to the distribution 
at the small end of the range. While neither all the schizophrenics 
considered together, nor the chronic in-patients alone appeared to 
differ from a normal pattern at the left-hand side of their 
distributions, the non-institutionalised and first episode 
schizophrenics considered as a single group, did. This group not 
only had an excess of subjects with large ventricles (greater than 
2 SD’s above mean), but also had an excess in the smallest range 
(smaller than 2 SD’s below mean). Analysing normality with small 
numbers becomes of dubious validity, though with 26 subjects 
represented it is unlikely that small numbers alone are the cause of 
unreliability in this result. Three (ll.5 %) of these patients had 
ventricle sizes in the smallest category, as opposed to the single 
one (in actual fact 0.5) predicted.
Thus, assessed in two different ways, the distribution of 
VBR’s in the present sample is markedly different from what whould be 
expected if ventricular size is normally distributed in the general 
population, and analysis of scanned data that are based on 
distribution appear to have some justification. The striking finding 
is the great excess of ventricle sizes outwith 2 SD’s in schizophrenic 
patients.
5.5 THE CLINICAL CORRELATES
3.5.1 ANALYSIS OF MATCHED PAIRS
The matched pairs differed only on the single variable 
under consideration. The ventricular size of those in whom the 
variable was present was compared with that of those in whom it 
was absent, analysis being by paired t - tests.
The results are shown in TABLE 3:3:7« No significant 
differences emerged in the ventricular sizes of the matched pair 
groups.
3.5.2 RELATIONSHIPS BETWEEN VENTRICULAR SIZE AND ITEMS OF 
RECORDED INFORMATION AND ASSESSED ABNORMALITY
a) GENERAL
Correlations were sought between ventricular size (VBR) and 
items of Recorded Information and Assessed Abnormality. As was 
shown earlier, only the long-stay schizophrenic in-patients had a 
group mean VSR that was significantly greater than that of the 
neurotics. Hence in searching for predisposing or promoting factors 
associated with ventricular enlargement, it was appropriate to 
restrict these analyses to the long-stay schizophrenics only.
The VBR!s of the 110 long-stay schizophrenics were categorised 
with reference to the age-corrected means and standard deviations 
described earlier.
TABLE 3 0 : 7  ANALYSIS OF MATCHED PAIRS
VARIABLE MEAN VBR ± SD
DEFECT STATE PRESENT 10.59 ± 1-97
ABSENT 12.35 ± 3-49
PAST PHYSICAL TREATMENTS NONE 13-15 ± 3-68
HEAVY 11.46 ± 2.67
INSULIN NONE 13.36 ± 2.01
MUCH 11.37 ± 4.81
ECT ' NONE 12.56 ± 2 .12
MUCH 13.01 ± 3.28
NEUROLEPTICS NONE 14.84 ± 3 .97 ■
MUCH 12-97 ± 3.5
PAST ACADEMIC RECORD HIGHER: HScW ABOVE MEAN 12.65 ± 3-01
H&W BELOW MEAN 13-2 ± 4.8
HIGHER 12.77 ± 3-55
AVERAGE/BACKWARD 13-1 ± 2.74
CATATONIC SYNDROME PRESENT
NS/DS PRESENT
12.59 ± 4.15 
11.39 ± 1.23
This produced six categories :
smaller than 2 SD below predicted value : 2 subjects
2 - 1  SD below predicted value : 10 subjects
b within 1 SD below predicted value : 20 subjects
c within 1 SD above predicted value : 33 subjects
d 1 - 2 SD above predicted value : 18 subjects
e greater than 2 SD above predicted value : 27 subjects
In view of there being only 2 subjects where VBR was outwith 2
standard deviations below the predicted value, the smallest two
categories were combined (i.e. category a - 12 subjects).
Statistical evaluation was by unified analysis of variance
by ranks (analysis of trends), which allows for significance to be
assessed across adjacent categories collapsed in any combination.
For trends that were in the direction of prediction, a 1 - tail
interpretation of significance was adopted. Where no prior prediction
had been formulated or where findings went in a direction contrary
to prediction, a 2 - tail interpretation was used.
b) RECORDED INFORMATION
The Recorded Information variables for which correlations
with ventricular size were sought were :
i) A family history of schizophrenia 
ii) A history of birth trauma and/or head injury
iii) A history of fits
iv 
v 
vi
EOT
neuroleptic drugs 
Physical treatments were considered in terms of the amount of past
treatment - i.e. ’none’, ’some', 'much', as defined previously.
Leucotomy, known to have a bearing on subsequent ventricular size 
and configuration (Bydder et al 1980; Naeser et al 1981) was not
Past academic record (as defined in Part l) 
PSE subclasses
Past physical treatments : insulin coma
considered in these analyses. The CT appearances of the leucotomised 
patients who were scanned will be described separately (vide infra 
Chapter 3-6).
No a priori hypotheses were formulated with regard to possible 
relationships between VBR and items of Recorded Information.
The only consistent significant relationships to emerge 
concerned family history and past insulin treatment (TABLE 3:3:8 
and 3:3:9). The relationship between categories of ventricular size 
and family history is illustrated in Fig 3:3:12. No subjects in the 
two smallest categories of ventricular size (i.e. those with ventricles 
smaller than 1 standard deviation below predicted mean) had a 
definite family history of schizophrenia. The difference between 
these groups and the prevalence found in VBR categories above the 
predicted mean value was highly significant (z = 3*06 , P = 0.0026). 
This remained the case when comparison was restricted only to those 
with a definitely positive family history and those with a definitely 
negative history, doubtful (’possible1) cases being omitted 
(z = 2.99 j P = O.OO32). Thus, by collapsing adjacent categories 
and analysing for relationships of an essentially linear type, 
ventricular enlargement was associated with a positive family history 
of schizophrenia. However, as TABLE 32328 and Fig 3:3J12 show, only 
about 12 % of those with the very largest ventricles ( >  2 SD above 
predicted mean) had a definite family history of schizophrenia.
Fig 3;3:12 does not point to any relationship being of a linear type.
In statistical terms the strongest relationship with the family 
history variable was the comparison between those at the extremes of 
ventricular size ( c  1 SD below and smaller and >  2 SD’s above) with
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FIG 3:3:12
Relationship between VBR categories and the 
presence of a definite family history of 
schizophrenia
5 0 - i
a b c d e
VBR categories
those in roughly average categories of ventricular size - i.e. a 
curvilinear type of comparison having the form 1-1-2-2-1 (z = 3.24)
P = 0.0016). In this way, a family history of schizophrenia was 
significantly more common in those with normal ventricle sizes, 
while patients at the extremes of ventricle size (both large and 
small) were much less likely to have a positive family history.
As TABLE 3:3;9 shows, a higher proportion of those in the 
two largest ventricular categories had received many insulin comas 
in the past. Accepting the medical prediction that hypoglycaemia 
predisposes to brain damage and hence adopting a 1 - tail 
interpretation, this finding is significant ( z = 1.75> P = O.O38). 
With a more stringent 2 - tail interpretation it represents a non­
significant trend. As the evidence on which to base a firm 
prediction is poor, the latter criterion was applied. Furthermore, 
an association between heavy past insulin treatment and a parameter 
of brain damage in the most general sense, would be somewhat at odds 
with the clinical findings reported in Part 1, where it was noted 
that certain deficits were less severe in those treated with insulin 
coma.
No other relationships emerged between ventricular size and 
items of Recorded Information.
c) ASSESSED ABNORMALITIES
i. GENERAL
The Assessed Abnormalities for which correlations with 
ventricular size were sought were :
a) Cognitive performance
b) ’Positive® mental state features
c) ®Negative® mental state features
d) Behavioural performance 
Withers and Hinton totals
Current Behavioural 
Schedule totals
AIMS and RS totals
Krawiecka scale 
Krawiecka scale
e) Spontaneous involuntary movement
disorder
The mean scores on Assessed Abnormality variables for the
basic study population of 510 and for the scanned subsample of 110 
are shown in TABLE 3:10. This shows that the subgroup selected 
for scanning did not significantly differ from the total population 
from which they were drawn in terms of their assessed clinical 
deficits, except that the scanned patients had a significantly higher 
mean score for ’negative* mental state features than the total sample. 
This reflects the predominant hypothesis that CT scan abnormalities 
would be related to features of ’deterioration* or ’defect’, 
typified characteristically in this study by ’negative’ features.
cut-off points were chosen largely on statistical considerations, and 
were based on the numbers of subjects available for analysis. With a 
sample size in the present section of only 27 % that of the group 
studied in Part II, use of the cut-offs which ensured equity of 
distribution in the previous part of the study may not have produced 
a like effect in this smaller, selected group. For this reason 
arbitrary comparison cut-offs for the Assessed Abnormality variables 
were redefined for this section of the study. Although essentially 
arbitrary, attempts were made to relate these cut-offs to definite 
findings in the patient sample.
The problems of analysing total scores from multi-item 
rating scales apply here as elsewhere. In Part II (Chapter 5*7)
For those variables in which an increasing total represents 
increasing abnormality - ’positive1 and ’negative’ mental state 
features, AIMS and RS - the comparison cut-off was progressively 
raised from unequivocal normality (0 - 1 ) to the mean score of the 
scanned group. For those variables where a decreasing total 
represents increasing impairment - Withers and Hinton and Current 
Behavioural Schedule - the comparison cut-off started from the group 
mean value and was progressively lowered to a limit of 1 standard 
deviation. The means and standard deviations are shown in TABLE 3:3:10.
It was assumed that ventricular enlargement is evidence of 
brain damage and as such, it was predicted that ventricular 
enlargement would correlate with :
a) cognitive impairment
b) the presence of ’negative’ but not 'positive’mental 
state features
c) behavioural deterioration
d) the presence of spontaneous involuntary movement disorder
The distributions for each Assessed Abnormality variable in
relation to VBR categories are shown in TABLE 3:3:11*
ii COGNITION
Using the mean Withers and Hinton for the scanned group 
(approximately 45) as the first cut-off, a relationship of a linear 
type was established between cognitive performance and ventricular 
size. This was such that cognitive impairment was more common in 
those in the two smallest categories of ventricular size (i.e. below 
the mean) than in those above the mean (z = 2.13, P = O.O32 , 2 -tail). 
This relationship persisted down to a Withers and Hinton cut-off of 
31, and especially rested on the very high prevalence of severe
TABLE 3:3:10
MEAN SCORES ON ASSESSED ABNORMALITY VARIABLES FOR TOTAL STUDY POPULATION AND SCANNED SUBGROUP
TOTAL SAMPLE SCANNED SUBGROUP
SIGNIFICANCE
MEAN (± SD) N MEAN (± SD) N
AGE 59.2 ± 13-9 510 58.2 ± 12.8 110 N/S
LENGTH OF ILLNESS 31 ± 11.1 510 31 .9 ± 10.6 110 N/s
F : M RATIO 0.89 510 0.55 110 -
'POSITIVE' MENTAL 
STATE FEATURES
3-6 ± 3-5 458 3-39 ± 3-52 109 N/S
'NEGATIVE' MENTAL 
STATE FEATURES
2.4 ± 2.3 ^58 3.01 ± 2.59 109 p=0.015
COGNITIVE PERFORMANCE 44. 6 ± 25-3 407 49.03 ± 30.39 100 N/S
BEHAVIOURAL PERFORMANCE 34.7
00+l 501 35.88 ± 8.18 109 N/S
MEAN AIMS TOTAL if. 26 ± 4.64 411 3-7 ± 4.17 110 N/S
MEAN R.S. TOTAL 8.63 ±  8.29 411 8.18 ± 7.89 108 N/S
>2 SD BELOW' 2-1 SD BELOW <1 SD BELOWI <1 SD ABOVII 1-2 SD ABOVE >2 SD ABOVE
TREND CATEGORIES a b c d e
WITHERS AND %  WITH TOTAL 
HINTON 0-45
75 50 37 38 42
%  WITH TOTAL 
0-38
58 5° 30 25 38
%  WITH TOTAL 
0-31
58 44 23 25 38
%  WITH TOTAL 
0-24
42 39 20 25 38
%  WITH TOTAL 
0-17
25 33 13 12 26
'POSITIVE' %  WITH TOTAL 
FEATURES 0-1
50 45 27 47 37
%  WITH TOTAL 
0-2
67 55 39 53 52
%  WITH TOTAL
0-3
67 55 48 59 59
%  WITH TOTAL 
0-4
75 65 70 65 74
'NEGATIVE' %  WITH TOTAL 
FEATURES • 0-1
25 30 33 35 37
%  WITH TOTAL 
0-2
25 50 45 59 56
%  WITH TOTAL 
0-3
42 60 67 65 63
%  WITH TOTAL 
0-4
50 60 76 76 67
CURRENT %  WITH TOTAL 
BEHAVIOURAL 0-34 
P^RTDTTT.F —
36 50 39 33 48
%  WITH TOTAL 
0-32
18 35 33 22 4i
%  WITH TOTAL 
0-30
9 20 27 17 33
%  WITH TOTAL 
0-28
0 20 18 11 26
%  WITH TOTAL 
0-26
0 15 15 11 26
AIMS %  WITH TOTAL 
0-1
33 40 52 44 22
%  WITH TOTAL 
0-2
42 50 70 44 22
%  WITH TOTAL
0-3
75 70 73 44 33
%  WITH TOTAL 
0-4
75 85 79 56 48
ROCKLAND %  WITH TOTAL 
0-1
30 25 15 11 19
%  WITH TOTAL 
0-2
50 30 48 17 26
%  WITH TOTAL 
0-4
60 45 64 33 33
%  WITH TOTAL 
0-6
70 55 70 33 41
%  WITH TOTAL 
0-8
90 65 73 41 56
cognitive impairment in those with the smallest ventricular sizes 
(category a).
This result is surprising and quite contrary to prediction 
(hence the 2 - tail interpretation). However, the findings raise 
the possibility that the relationship between ventricular size 
and cognitive impairment in patients such as these may not be a 
straightforward linear one. Pig. 3:3:13 is a graphic representation 
of the data presented in TABLE 3 :3 :11» and- shows the percentage of 
those in each "VBR category who score within each Withers and Hinton 
cut-off range - i.e. impairment increasingly severely defined. This 
once again strongly suggests a curvilinear relationship, especially 
with increasingly severe degrees of cognitive impairment.
Additional trend analyses were conducted to evaluate the
significance of such an interpretation. In these, the extreme “VBR
categories were compared against three different combinations of
intermediate categories. Hence the additional comparisons were :
1 - 2 - 2 - 2 - 1
1 - 2 - 2 - 1 - 1
1 - 1 - 2 - 2 - 1
Only the latter comparison produced significance (TABLE 3 :3 :12).
While, with a 2 - tail interpretation, only comparisons at Withers
and Hinton cut-off 31 and 24 are significant at less than 5 %» the
trend is clear.
Thus, the present findings support the view that a 
relationship exists between cognitive performance and ventricular 
size but strongly suggest that this relationship is not straightforward. 
The data support the view that in patients such as these cognitive 
impairment may be associated with both large and small ventricle sizes.
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FIG 3:3:13
Relationship between VBR categories and cognitive 
impairment at varying W&H cut-offs
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TABLE 3:3:12 COGNITION-ANALYSIS OF TRENDS: COMPARISON 1-1-2-2-1
H & W TOTAL 45 or LESS 38 OR LESS 31 OR LESS 24 OR LESS 17 OR LEf
Z-VALUE 1.48 1.84 2.13 1.84 1.99
P-VALUE (1-TAIL) 0.067 0.031 0.015 0.031 0.022
1 POSITIVE* MENTAL STATE EEATURES
No relationships emerged between ventricle size and 'positive* 
features of the mental state at any cut-off.
iv. 'NEGATIVE* MENTAL STATE FEATURES
The position regarding 'negative* mental state features and 
VBR categories was also complicated. Eig. 3:3;14 illustrates these 
relationships. (For comparability the figure is based on the 
complimentary percentages to those in TABLE - i.e. it shows
the relationship between VBR and increasingly severe degrees of 
impairment in terms of 'negative* feature scores). If those with no 
'negative* scores whatsoever (total 0 or l) were compared with the 
rest (i.e. - those scoring 2 or more) no relationship emerged. 
Increasing the cut-off (0 - 2 v 3 + ) produced a trend to significance 
for a relationship of linear type (Pig 3;3:14)> especially when VBR 
categories b/c and d/e were combined (z =1.88 , P = 0.028). This was 
considered as only a trend as it was in the opposite direction from 
prediction. When increasing severity of abnormality was considered, 
the *U - shaped* relationship noted with Withers and Hinton scores 
again emerged. O n a l - 1 - 2 - 2 - 1  curvilinear comparison, a 
trend towards significance emerged at a cut-off of 5 +? though this 
reached significance at a cut-off o f 6 + ( z = 2 . 4 2 , P =  0.014 >
2 - tail). That is, 'negative* feature scores of 6 or more were 
significantly more common at both extremes of ventricular size than in 
roughly average size VBR categories.
FIG 3:3:14
Relat ionship between VBR categories and 
'negat ive1 features at vary ing cu t-o f fs  
(krawiecka scale 'negative'  ITEMS)
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BEHAVIOURAL PERFORMANCE
Ventricular enlargement was increasingly associated with 
declining behavioural performance (CBS total cut-off 34 - 26) though 
conventional significance was only reached with the lowest behavioural 
score (z = 2.07 , P = 0.043)* Most striking was the linear relationship 
comparing the smallest VBR category (a), the three intermediate 
categories (b - c - d) and the largest (e) at total cut-off 26 
(z = 2.07 , P = 0.018). This was in line with prediction.
vi. MOVEMENT DISORDER
The most striking statistical relationships established in 
these analyses (and indeed some of the most striking established in 
the entire study) were between increasing ventricular size and the 
presence of spontaneous involuntary movement disorder recorded on 
the AIMS and RS. The prevalence of movement disorder, defined by 
increasing the AIMS and RS cut-offs for normality in each category of 
ventricular size is shown in Fig 3^  3*15-
At cut-off 0 - 1 ,  no significances were found with the RS, 
and those with the AIMS amounted mainly to trends. However, at all 
other cut-offs significance was of a consistently high order with both 
sets of data, and in line with prediction. Furthermore, when AIMS and 
RS totalswere arbitrarily divided into three ranges representing 
increasingly severe abnormality, more severe movement disorders were 
progressively found in the two largest VBR categories (d and e). This 
was especially true with the RS data representing the wider concept of 
involuntary movement. TABLE 3: 3:13 presents a summary of these results
FIG 3:3:15
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TABLE 3:3:13
SIGNIFICANCE LEVELS OF SELECTED COMPARISONS FOR RELATIONSHIP BETWEEN VBR AND INVOLUNTARY 
MOVEMENTS
TREND COMPARISON 
CUT-OFF
1 2 3 4 5 1 1 1 2 3 1 1 1 2  2 1 1 1 1 ;
H
<
0-1 v 2+ P=0.15 p=0.029 p=o .076 P=0.019
0-2 v 3+
PPFVATFNCF
p=0.025 P=0.001 P=0.0026 P=o.ooi6
0- 3 v 4+ p=0.0007 p=0.0003 p=0.0003 p=o.ooi5
0-4 v 5+ P=0.0025 P=0.001 p=0.0009 P=o.oo5
0-1 V
SEVERITY 2-6 v 
7+
P=0.082 P=0.021 p=0.035 P=0.027
RO
CK
LA
ND
 
SC
AL
E
0-1 v 2+ N/S N/S N/S N/S
0-2 v 3+ P=0.056 P=0.033 P=0.012 P=0.15
0-4 v 5+ P=0.033 P=0.01 p=0.007 P=0.o46
0 -6 v 7+ P=o.oi6 P=0.0076 P=0.0027 p=0.058
0 -2 v
SEVERITY 3-10 v 
11+
p=0.0067 P=0.004 P=o.ooi9 P=0.029
to illustrate as Pig 3:3:15 shows, that the major differences lay in 
the two largest VBR categories.
vii. INDIVIDUAL COMPONENTS OP THE KRAWIECKA SCALE AND CURRENT
BEHAVIOURAL SCHEDULE
Correlations were next sought between VBR and the individual 
items comprising the Krawiecka Scale and the Current Behavioural 
Schedule.
The distributions of those scoring at increasing cut-offs 
on each item of the Krawiecka Scale, are shown in TABLE 3:3:14 
(depression and anxiety received high ratings too infrequently for 
other than a single comparison to be performed). Analysis of trends 
produced significance only with hallucinations. The nature of this 
is shown in Pig J:3:l6 (complimentary percentages from TABLE 3:3;14)*
A linear relationship could be established such that hallucinations 
were less frequent in those with the largest ventricles (z = 2.29 
P = O.Ol). This would be compatible with the prediction that ventricular 
enlargement is associated with ‘defect state’, where this is defined 
in predominantly ’negative’ terms.
However, Pig 3:3;l6 once again suggests a curvilinear 
relationship. With a 1 - 2 - 2 - 2 - 1 comparison, hallucinations were 
significantly less frequently found at both extremes of ventricular 
size (z = 2.24 > P = 0.024 5 2 - tail).
In addition to these fairly consistent associations of 
hallucinations, incoherence of speech was significantly more common in 
those with the largest ventricles (z = 2.05 , P = O.O38). This 
occurred as an isolated finding on comparison of category e with the
>2 SD BELOW 2-1 SD BELOV, <1 SD BELOW <1 sd above; 1-2 SD ABOVE >2 sd above;
TREND CATEGORIES a b c d e
DEPRESSION %  WITH SCORE 
0-1
92 75 88 100 85
ANXIETY %  WITH SCORE 
0-1
92 85 88 9 b 93
AFFECTIVE %  WITH SCORE 
FLATTENING 0-1
25 35 36 35 52
%  WITH SCORE 
0-2
50 55 6b 71 7^
%  WITH SCORE 
0-3
83 80 91 88 89
AFFECTIVE %  WITH SCORE 
INCONGRUITY 0-1
100 90 88 82 85
%  WITH SCORE 
0-2
100 95 91 88 85
%  WITH SCORE 
0-3
100 95 97 9^ 93
PSYCHO- %  WITH SCORE 
MOTOR 0-1
b 2 55 6b 65 63
DATION %  WITH SCORE 
0-2
83 70 88 9*+ 85
%  WITH SCORE
0-3
100 100 100 9 b 96
DELUSIONS %  WITH SCORE 
0-1
67 70 b S 82 70
%  WITH SCORE 
0-2
75 75 61 88 7 b
%  WITH SCORE
0-3
83 90 73 88 78
HALLU- %  WITH SCORE 
CINATIONS 0-1
75 60 67 65 89
%  WITH SCORE 
0-2
73 65 73 65 89
%  WITH SCORE 
0-3
75 75 76 71 89
INCO- %  WITH SCORE 
HERENCE 0-1
75 75 79 88 59
%  WITH SCORE 
0-2
92 85 9^f 83 85
%  WITH SCORE 
0-3
100 95 100 9^ 93
POVERTY %  WITH SCORE 
OF SPEECH 0-1
b 2 55 67 65 52
%  WITH SCORE 
0-2
67 65 82 88 63
%  WITH SCORE 
0-3
92 90 91 9^ 85
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rest, with no consistency or trends showing in other comparisons. It 
is contrary to prediction with incoherence classified as a spositivev 
feature and may represent a random result in the context of multiple 
comparisons.
The 'negative* feature, flattening of affect, tended to he 
more common in those with small ventricles, in opposition to 
prediction, while poverty of speech tended to he more common at hoth 
extremes of ventricle size - though neither of these significances 
reached the 5 %  level.
The constituent items of the Current Behavioural Schedule 
were organised under six main headings :
Social Behaviour 
Activities
Exhibited Abnormal Behaviour 
Antisocial Behaviour 
Incontinence 
Stability of Behaviour
For the purposes of analysis, the total possible for each of
Wcl£
the first three constituents were simply halved, those scoring less 
than half being compared with those scoring more than half the maximum. 
For the last three constituents, which comprised essentially single 
items, presence of the feature was compared with absence (TABLE 3:3s15)-
In accordance with prediction, low scores on social behaviour, 
activities and exhibited behaviour were significantly associated with 
increasing ventricular size in a generally linear fashion. The major 
comparisons throwing light on the basis of the relationships 
(TABLE 3:3:16), indicate that low scores on each of these three items 
were much less common in category a (smallest ventricles) than in 
category e (largest ventricles), with the intervening categories being
tTABLE 3:3:15
COMPONENTS OF CURRENT BEHAVIOURAL SCHEDULE: DISTRIBUTIONS ( % )  IN RELATION TO VBR CATEGORIES
>2 SD BELOW 2-1 SD BELOW <1 SD BELOW <1 SD ABOVE 1-2 SD ABOVE >2 SD ABOVE
TREND CATEGORIES a b c d e
SOCIAL %  WITH SCORE 
BEHAVIOUR 0-8
18 25 21 17 b b
%  WITH SCORE 
0-7
18 15 12 11 33
ACTIVITIES %  WITH SCORE 
0-5
9 35 30 33 b 8
%  WITH SCORE 
0- b
9 10 15 22 30
EXHIBITED %  WITH SCORE 
BEHAVIOUR 0-6
9 10 12 6 2o
%  WITH SCORE 
0-5
0 10 9 6 19
ANTISOCIAL %  WITH SCORE 
BEHAVIOUR 0 - b
18 55 b 8 22 26
INCONTINENCE %  WITH SCORE 
0-2
9 20 9 28 15
STABILITY OF %  WITH SCORE 
BEHAVIOUR 0-1
18 25 27 . 17 22
TABLE 3:J:16
SIGNIFICANCE LEVELS OF SELECTED COMPARISONS FOR RELATIONSHIP BETWEEN VBR AND CONSTITUENTS 
OF CURRENT BEHAVIOURAL SCHEDULE
TREND COMPARISON 
CUT-OFF
1 2 3 ^ 5 1 1 1 2  3 1 1 1 1 2 1 2 2 2 3
SOCIAL 0-8 v 
BEHAVIOUR 9+
p=o.cy+5 P=0•022 P=0.0076 P=0 .0lif
ACTIVITIES 0 - b  v 
5+
P=0.021 p=0.023 P=o.039 P=0.038
EXHIBITED 0-6 v 
BEHAVIOUR 7+
P=0 .o68 p=o.cyi6 p=0.017 p=o.03i
approximately intermediate in prevalence. The presence of incontinence 
and a stable behavioural pattern were not related to VBR categories.
The position of antisocial behaviour was again atypical, in that the 
form of its relationship with VBR was curvilinear (Big 313^17)* Less 
antisocial behaviour was recorded in those at the extremes of 
ventricular size (a, d and e), than in those in intermediate positions 
(z = 2.99 , P = 0.0032 , 2 - tail).
3.6 THE STRUCTURAL CONSEQUENCES OF LEUCOTOMY
Of the 118 chronic schizophrenic in-patients successfully 
scanned, 6 had previously had leucotomy performed. It is of interest 
to note briefly the CT findings in these patients (TABLE 3s 3217)- 
All the operations were bilateral and five were of the prefrontal type. 
The sixth patient - the only one to have had the procedure carried 
out in the more modem era of stereotaxic standardisation - had had a 
bimedial leucotomy. Burr holes were readily seen in the 5 prefrontal 
cases. In the bimedial operation, the approach was higher with 'holes 
placed on the superior convexity of the mid-frontal region. In the 
axial cuts of the standard CT series, these may not show.
The striking feature of these scans was the great variability 
and irregularity of the lesions produced by the surgical intervention. 
Low-density lesions seen on CT varied in size, from 3*8 x 1.2 cms to 
0.7 x 1.5 cms, and also in shape, some forming distinct crescents, 
others being rounder. They extended to varying depths and were often 
continuous with the frontal horns of the lateral ventricles, to which 
they bore anything from an anterior to a posterolateral relationship.
TABLE 30:17 ' SUMMARY OF CT FINDINGS IN LEUCOTOMISED PATIENTS
PATIENT
AGE/SEX
LENGTH OF
ILLNESS
(YHS)
LEUCOTOMY
TYPI/YEAR
TIME FROM 
LEUCOTOMY TO 
CT SCAN (YRS)
OTHER PHYSICAL 
TREATMENTS
C.T. FINDINGS
1 65/F 3k BILATERAL PREFRONTAL 
IN 19^9
NO FURTHER DETAILS
' 30 INSULIN
ECT
NEUROLEPTICS
BILATERAL, CRESCENT, LOW-DENSITY 
REGIONS 3.6 x 1.2 cjns ON LEFT 
AND 3 A  x 1.6 cms (R)
2 63/F ^0 BILATERAL PREFRONTAL 
IN 19^8
"CUT MADE 3 cms DEEP 
IN PLANE 13 mm ABOVE 
NASION"
31 ECT
NEUROLEPTICS 
FOR MANY YEARS
LEFT CRESCENT, LOW-DENSITY 
3.8 x 1.2 cms, RIGHT LOW-DENSITY 
AREA 2.6 x 6 .3 cms IN FRONTO­
PARIETAL AREA AND 1.5 x 2 cms 
AREA IN POSTERIOR PARIETAL AREA 
BILATERAL BURR HOLES
3 62/M 35 NO OPERATION DETAILS 
1953
26 INSULIN-^
ECT-28
NEUROLEPTICS
RIGHT 3 x 1 cm LESION OPPOSITE 
JUNCTION OF FRONTAL HORNS AND 
BODY OF LATERAL VENTRICLES. 
LEFT 0.7 x 1.5 cm LESION IN 
SIMILAR POSITION WITH 1.5 cm 
LESION AT TIP OF FRONTAL POLE 
BILATERAL BURR HOLES
k  60/F 30 BIMEDIAL LEUCOTOMY 
1963
16 E C T - k b
NEUROLEPTICS 
SINCE 1956
BILATERAL LESIONS 2 cm in DIAMET 
ON RIGHT AND 2.5 cm IN DIAMETER I 
LEFT, ANTERIOR TO FRONTAL HORNS I 
LATERAL VENTRICLES. UNILATERAL 
BURR HOLE
5 67/M k G BIFRONTAL - 19^6 
"ON THE LEFT SIDE THE 
ANTERIOR PART OF THE 
VENTRICLES WAS FAR 
FORWARD. A VESSEL 
ON THE SURFACE OF 
THE HEMISPHERE 
NEEDED CONTROLLING 
WITH DIATHERMY.
THERE WAS NO INCIDENT 
ON THE RIGHT
33 • INSULUN-78 
BARBITURATES 
SINCE 1950's 
NEUROLEPTICS 
SINCE 1967
SYMMETRICAL 1.5 x 2 cm LESIONS 
LATERAL TO AND COEXTENSIVE WITH 
THE FRONTAL HORNS EXTENDING TO 
BURR HOLES. SULCAL WIDENING 
BENEATH BURR HOLES. BILATERAL 
BURR'HOLES
6 59/F k o PREFRONTAL - 19^7 32 ECT FOR 18 
MONTHS
NEUROLEPTICS 
SINCE 1960
BILATERAL SYMMETRICAL 3 x 1.2 cm 
LESIONS ANTEROLATERAL TO FRONTAL 
HORNS AT MEAN DEPTH OF 3 cms 
BELOW CORTEX. BILATERAL BURR 
HOLES
MODIFIED FROM BYDDER G.M. ET AL (1980)
In all cases, small, superficial, low density lesions were visible 
immediately beneath the burr holes, and were usually associated with 
widening of the cerebral sulci. However, no significant frontal lobe 
atrophy was noted. All the patients had been heavily treated by 
other physical means. (For examples, see Appendix VIII).
One case showed very extensive, low-density areas occupying 
a large part of the right hemisphere in the distribution of the middle 
cerebral artery, and which were compatible with post-operative 
infarction (Appendix VIII). It is of interest to note that this 
patient had no localising neurological signs, achieved one of the 
highest scores on cognitive testing in the series, and was one of only 
4 out of the 510 subjects of the basic study who managed to work 
independently in competitive (open) employment outside the hospital.
Thus these six scans demonstrated two main findings. Firstly, 
the brain lesions consequent upon leucotomy were very heterogeneous, 
varying considerably in size, shape and position. They often varied 
also from one side to the other in the same patient. Secondly, the 
size of the lesion could not be suspected clinically. Very considerable 
damage could ensue without any objective clinical evidence of its 
presence.
5.7 UNSUSPECTED INTRACRANIAL PATHOLOGY
A variety of intracranial pathologies, unsuspected clinically, 
were revealed during the CT part of the study. For the most part these 
did not necessitate removal of the patient from the investigation and 
as was noted above their inclusion did not alter the findings. The
TABLE 3:3:18
CT DIAGNOSES IN CASES OF UNSUSPECTED PATHOLOGY IN SCANNED SAMPLE (187 PATIENTS)
C.T. DIAGNOSIS NO. OF CASES
CEREBRAL INFARCTION 7
PORENCEPHALIC CYST 1
SUBDURAL HAEMATOMA 2
ARTERIOVENOUS MALFORMATION 1
CYSTIC ENLARGEMENT OF PINEAL 1
CT diagnoses are shown in TABLE 3*3;18 and the cases summarised in 
TABLE 3:3:19. Some examples are illustrated in Appendix VIII.
All but one of these unsuspected abnormalities were found in 
chronic schizophrenic in-patients. One manic depressive outpatient, 
on long term lithium carbonate, was found to have an extensive left 
posterior quadrant lesion believed to be an arteriovenous 
malformation. This could not be confirmed at the time as the patient 
refused to have the procedure repeated with contrast enhancement. * 
Intermittent episodes of headache and vomiting had been attributed 
clinically to lithium intoxication though serum levels were always 
normal. On the basis of his gross CT changes, he was excluded.
In the planning of the CT part of the study a non­
institutionalised schizophrenic who had been considered suitable in 
terms of matching criteria was admitted in florid relapse, and could 
not therefore be scanned as part of the project. She is thus not 
noted in TABLES 3:3J18 3:3:19* Investigations done as part of the
routine clinical work-up in this situation revealed her to have a 
2 x 1.8 cm left frontal meningeoma.
* Diagnosis subsequently confirmed.
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Chapter 4 - Discussion
4.1 METHOPOLOGICAL ISSUES
Certain methodological questions require comment.
4.1.1 SELECTION OF EXPERIMENTAL SUBJECTS (LONG-STANDING SCHIZOPHBENIC
i n-p a t i e n t s!
The long-stay schizophrenic in-patients who were scanned, were 
selected from the total pool of 510 who have formed the basis of this 
study. Thus, to begin with they represent a particular type of 
schizophrenia which may not nowadays be representative of the majority 
of schizophrenics in this country. It is known from the deficits 
described in Part I, that, regardless of the reasons for their 
remaining in the institution they represent schizophrenia in a severe 
form. That the subgroup, scanned is in its turn slightly 
unrepresentative of the in-patients as a whole is reflected in the 
fact of their mean 'negative' features score being significantly higher 
than that of the total sample (TABLE . As mentioned, this
undoubtedly reflects the dominant hypothesis running through the selection 
procedure - namely, that ventricular enlargement, if present, would 
be likely to be associated with 'deterioration' or 'defect'. Hence 
although the institutionalised schizophrenic group who participated in 
this part of the study have been clearly defined, it is important to 
emphasise that they represent severe, long-standing schizophrenia - 
and severe long-standing schizophrenia biased somewhat towards a 
particular pattern of clinical deficit. Prom what has been published 
using radiological imaging in the study of schizophrenia, it was
reasonable to postulate that this pattern of deficit would be the 
most likely one associated with CT scan change.
4.1.2 SELECTION OF COTOOL GROUPS
The choice of the best control group for studies of this kind 
is difficult, as reflected in the diverse groups used in the 
literature - e.g. *non-affected' relatives of patients with Huntingtons* 
Chorea (Weinberger et al 1979a-), scans reported as normal by radiology 
departments (Andreasen et al 1982c), the victims of road traffic 
accidents (Nasrallah et al 1982a) and *normal volunteers' obtained 
largely from hospital staff (Jemigan et al 1982a). Problems arise 
with all these groups as was mentioned in the Introduction to this 
Section. Truely normal asymptomatic volunteers would be the ideal, if 
they could be matched with the experimental sample for age and other 
factors of possible relevance such as social and academic background, 
and - most importantly - if a reliable and detailed history of 
possible CNS disease, alcohol and drug intake and family history of 
psychosis could be obtained. There may however be strong motivation 
to deny such facts, especially if the volunteers are colleagues.
In this study, all patients shared in common referral to, and 
management by, the specialist psychiatric services. Patients with 
neurotic illness were felt to be the most suitable basic control group. 
No patient in the neurotic group had a family history of schizophrenia, 
and full details of life-time ingestion of psychotropic drugs and 
alcohol were sought in every case. Patients in whom alcohol abuse and 
drug ingestion were felt to represent problems, were not included.
In the 19 selected, alcohol intake was said to be low, but all had been
prescribed psychotropic drugs in the past, mainly benzodiazepines and 
tricyclic ahtidepressants. However, in none could a history of abuse 
be established.
It could be argued that the use of a control group of neurotics, 
many of whom had received anxiolytics, would act to minimise the 
extent of the ventricular enlargement in other groups, as they themselves 
would have a degree of enlargement greater than what would be predicted 
in a normal population. A recent report has suggested an association 
between ventricular enlargement and benzodiazepine ingestion 
(Lader et al 1984). Because of this argument, it is not claimed that 
the neurotics are equivalent to normals, only that they are likely to 
approximate to normals, and certainly are closer to the general 
population than the other groups studied. However, the distinction in 
the present study may be largely semantic. The range of VBR’s in the 
neurotic sample was small and their distribution normal, suggesting 
that abnormally large ventricles are not found or are infrequently 
found in this group.
4.1.5 ASSESSMENT OF VENTRICULAR SIZE
In this study an area estimate of ventricular size from 
bromide films was used in preference to direct use of attenuation 
values, the reliability of which is uncertain (Levi et al 1982).
Linear measures correlate relatively poorly with computer estimates 
of volume whereas area assessments correlate well, the relationship 
only breaking down at very large ventricular sizes (Penn et al 1978)-
The use of a ratio eliminates the need to consider the 
minification factor inherent in the production of bromides and hence
removes another source of error, and VBR has become a commonly used 
measure for assessment of ventricular size. Whether or not it 
represents the best measure is however uncertain. It is worthy of 
note that one of the better studies reviewed earlier (Jemigan et al 
1982a) which obtained a negative result, in addition to examining 
’milder* subjects, used an alternative evaluation procedure, and it 
should be considered that this is the basis of the negative findings, 
rather than (or in addition to) factors of sample selection.
Partial volume effects are insurmountable with CT and are 
undoubtedly the basis of the widely differing acceptance of what is 
ventricle by different groups of workers, and hence the variability 
in absolute values, which Jemigan et al have demonstrated.
(Jemigan et al 1982a). These effects are likely to be less with 
greater degrees of ventricular enlargement where the normal slope of 
the lateral ventricular wall (the structural basis of the partial 
volume effect) is lost and a more vertical form has developed.
Nonetheless with all sizes of ventricle the problem is considerable.
In ignoring partial volume effects completely one is placing undue 
reliance on the measured cut being the maximal one.
VBR is strictly speaking the ’VBR for that cut* and the 
maximal VBR is the ’maximal VBR for the scan series’. What is maximal 
in any series depends where the beam scans through the ventricular 
system, which in turn, depends on the accurate positioning of the patient, 
their co-operation, and the relative size and shape of the skull, brain 
and ventricular system - of which the first (positioning) is of major 
importance. The assumption is that even if the majority of series 
have missed the true or anatomical maximal point, deviations above and 
below this will be randomly distributed throughout the sample - both
patients and controls. This statistically reasonable assumption 
would not take account of the fact that the room for variation in one 
diagnostic group may be much greater. In the present work, the 
impression was gained that the institutionalised schizophrenics were 
in general more difficult to position satisfactorily and had to be 
more strenuously encouraged to maintain their position than other groups, 
even their out-patient counterparts.
In this study attempts were made to accommodate partial 
volume effects in recognition of the fact that the maximal cut for 
the series may not represent the anatomical maximum. Simple guidelines 
were defined beforehand and agreed with those involved in reliability 
measures. The very high reliabilities obtained confirm the value of 
this procedure. However, it did mean that the absolute VBRITs 
obtained in the present study were considerably larger than those 
published by other workers. For this reason, ventricular enlargement 
is relative within studies and defining cut-off points for normality 
for general use (e.g. Weinberger et al 1982) is a misleading and 
inadviseable exercise. Moreover, variability in absolute VBR values 
internationally may be also contributed to by different scan positions 
adopted especially between the United Kingdom and the United States.
In this study all patients were scanned parallel to the orbito-meatal 
line, as is customary in the U.K.
Considerable care was taken in the present study to ensure that 
all bromides were taken at comparable window widths as this variable 
can considerably alter ventricular representation. Most studies do 
not comment on this and whether window width is held constant is in 
general unknown. The present method of using two bromides at 
different window widths to define ventricle and brain is novel, but
is believed to be valid.
4.2 GENERAL FINDINGS
4.2.1 AGE
Age was a major contributing factor to VBR in this large 
sample of psychiatric patients. Although the significant association 
between these two variables was linear, there was also a non­
significant quadratic relationship and it is likely that the 
association between ventricular size and age is not straightforward.
Had the sample contained a greater proportion of younger subjects 
(i.e. under 45 years) it is possible that the quadratic relationship 
would have reached significance. Nonetheless, the results still 
indicate a lesser effect of age up until the 5'th decade after which 
the age effects become more striking.
The idea of a non-linear relationship between ventricle size 
and age has support in the literature from the study of normal subjects 
using different methods of scan evaluation. Barron et al (1976) 
found a "gradually progressive" increase in VBR through the first 
six decades followed by a "dramatic increase" thereafter. Meese et al
(1980) reported relative consistency in a number of linear measures 
and ratios up to 60 years of age followed by an increase with age - 
a tendency they "encountered rather often" with different measures of 
the CSF spaces. Zatz et al (1982) computed intracranial fluid volumes 
and found that ventricular and sulcal volumes remained constant to 
60 years after which both "increase at an increasing rate". Other workers 
have confirmed the stability of ventricular indices up to middle life
(Hang 1977; Gala et al 1981).
This relative constancy of ventricular size in younger 
patients provides the likely explanation for an absence of age effects 
on VBR reported in a number of studies reviewed earlier. Most of 
these groups purposely sought to investigate only younger subjects 
within a narrow range of age in order to overcome the problem of 
contamination with interposing dementias. Samples with a 
predominantly young age bias may also not show an overall effect of 
age if they include a small number of young subjects with atypically 
large ventricles, the latter patients being sufficient to eliminate 
a statistically weak overall age effect. This is more likely to 
occur in samples drawn from specialist research facilities which 
tend to attract patients presenting unusual or intractable problems.
The present findings raise the interesting question of 
whether functional psychiatric patients in general and schizophrenics 
in particular experience the quantitative brain changes of aging 
earlier than do healthy normal people. No definite support for this 
view was forthcoming but the possibility is certainly raised. There 
is definitely a suggestion of an accelerated age effect in schizophrenics 
compared with non-schizophrenics, as Fig 5:3;6 showed. Although 
this difference did not reach statistical significance, analysis was 
conducted on a model which assumed a basically linear relationship 
between age and VBR. Furthermore, if the quadratic relationship is 
accepted as potentially valid, the present patient population 
appeared to develop the age effects roughly in the middle of the 5 ^  
decade - that is, approximately 10 - 15 years earlier than the 
literature on normal people would suggest.
The present study did not include an unequivocally normal 
population, and other CT scan work in this field has not included 
an adequate range of ages to explore this question. It is 
nonetheless a potentially important one, worthy of further 
investigation. While support for premature aging from structural 
studies is as yet unavailable, in the psychology literature a close 
qualitative parallel between cognitive test performance in younger 
schizophrenics and the normal elderly has been pointed out 
(Saccuzzo 1977)*
4.2.2 LENGTH OF ILLNESS AND SEX
Neither sex nor length of illness were related to VBR. While 
sex differences in certain brain measures on CT have been reported 
in normals (Gyldensted & Kosteljanetz 1976; Haug 1977)? the bulk of 
reports using area measures show no sex differences. The concept of 
length of illness however is not as refined here as in previous 
sections. This relates in particular to the question of how long a 
patient is to be considered as having been ’ill', when the illness in 
question is characterised by an episodic course interspersed with 
periods relatively free of psychological deficit. It remains unclear 
whether it is more appropriate in such circumstances to summate the 
cummulative symptomatic episodes as ’length of illness’ or whether 
this should be dated from the time of initial presentation. The 
latter has been adopted here. This provided consistency with 
previous parts of the study and avoided the considerable element of 
unreliability inherent in gauging symptomatic periods over many years.
Two other areas, peripheral to the basic problem but which 
nonetheless produced interesting findings, are most appropriately- 
discussed here. These concern the structural consequences of 
leucotomy and unsuspected intracranial pathology revealed by CT.
4.2.3 LEUCOTOMY
As was shown in Part 1, none of the deficits examined were 
found to be worse in those who had had leucotomy, and in Part 11 
having had a leucotomy was not associated with the presence or 
severity of involuntary movement disorder. In the present section, 
the unpredictability of the lesions and the often dramatic 
structural damage resulting from the ’free-hand’ form of the 
operation have been illustrated. Only 2 patients had lesions that 
were roughly bilaterally symmetrical, but these did not bear a 
constant relationship to the anterior horns. Even the single 
patient who had had the more standardised, bimedial procedure, did 
not have completely symmetrical lesions. In all cases, the 
variability resulted from lesions produced at the same operation 
by the same surgeon.
The marked variations in post-operative structural 
appearances following leucotomies thought to be technically similar, 
were demonstrated in vivo by Donovan et al (1949) using PEG, and 
at post-mortem by Eie (1954) and Beck et al (1950). Naeser et al
(l98l) who reported this phenomenon in a follow-up CT scan study, 
suggested that asymmetricality of lesion size may be associated 
with a better, long-term outcome in schizophrenia, especially when 
the lesions are large. Owing to the selective nature of the
leucotomised sample in the present study, no comment can he made 
on the efficacy of this procedure. The conclusions of Naeser 
et al may be based on a chance finding in a small, selected 
subsample.
The striking degree of brain damage, sometimes not restricted 
to the frontal lobes, occurring in the absence of objective clinical 
signs, is noteworthy, and findings such as these may force us to 
reconsider some of our basic concepts regarding brain function.
Benson et al have stated that a complete absence of so-called frontal 
release signs in their sample of leucotomised schizophrenics who 
had gross frontal damage, calls into question the accepted view on 
the origins of these features (Benson et al 198l). The gross
damage in the patient illustrated in Appendix VIII is an example of
the amount of ‘silent’ abnormality the brain can harbour.
Variability and gross, coincidental damage may be things 
of the past - with the use of newer, standardised techniques it has 
been shown that a consistent, predictable pattern of lesions can be 
produced by the same surgeon (Banna et al 1978) - not least because 
of the decline in leucotomy as a treatment for schizophrenia.
However, weighed against the appalling deficits of this condition 
in its severe form additional, sometimes extensive, structural 
damage to the frontal lobe would not appear to compound the disability.
4.2.4 INCIDENTAL ABNORMALITY
The organic abnormalities found in the course of the CT 
part of the study were of interest as they were clinically unsuspected - 
and occurred almost exclusively in the long-stay schizophrenic
population, though it is possible that with a larger manic depressive 
group, more pathology would have been found in these patients.
In only one patient (congenital hemiparesis) could some 
cerebral damage have been anticipated, but here the degree of 
abnormality found was surprising based on the mildness of the 
clinical deficits. However, in two patients, retrospective 
examination of the case notes identified episodes compatible with 
the cause. In one of the cases of subdural haematoma, (patient 9> 
TABLE 3:3:19 ) there was a history of road traffic accident 6 
weeks previously. While the nursing staff had noted the patient 
to be lethargic and withdrawn, this was attributed to the 
psychological 'shock' of the event. In patient 1 (TABLE 3:3J19 )> 
an acute episode had been recorded 3 years previously. Prior to 
this, the patient had been an independent woman working outside the 
institution though in sheltered employment. After losing her way 
home one day, she was noted to be suddenly much more disorganised 
in her behaviour and to have developed marked visual impairment.
She set her hair on fire trying to light a cigarette, attributed 
both to her worsening psychosis and the visual impairment, thought 
to be due to bilateral cataracts. These were operated on 2 years 
prior to scanning, with some improvement, though her vision remains 
poor. She has no field defect on opthalmological examination.
CT scanning revealed two sets of symmetrical, peripheral infarcts, 
one set parietal, the other at each occipital pole. In both these 
patients, a deterioration in mental state was attributed to 
psychogenic factors and accordingly both had changes made in their 
medication. CT scanning however, demonstrated a probable organic
cause in each.
Cystic enlargement of the pineal gland is an uncommon 
abnormality which is believed to produce symptoms only by compressing 
the aquaduct from above. However, the functional status of these 
lesions has not been investigated. Indeed it is only in recent 
years that the role of the pineal in the, secretion of melatonin has 
been established and the properties of this hormone explored. The 
interest of the present case lay in the exceptionally early onset 
of the patient's psychosis - he was first admitted to the hospital 
at the age of 11 - and its distinctly cyclic nature.. However, 
melatonin levels did not reveal any abnormality of pineal function 
now, though these were performed when the patient was going through 
an exceptionally long period of (relative) well being. Also in 
favour of the pineal abnormality being an authentically incidental 
finding is the fact that the patient's father suffered from a 
psychotic illness. It was more stable and 'chronic' than the son's 
and though atypical in its clinical features, was nonetheless 
thought to be schizophrenic.
Cerebral neoplasms on the other hand are not infrequently 
found in psychiatric populations, though whether or not they present 
an increased prevalence compared to non-psychiatric groups remains 
unclear (Lishman 1978). Among 1200 chronic schizophrenic patients 
having routine skull x-rays, Kraft et al (1965) found evidence of 
cerebral tumour in three, and there is general agreement that 
meningiomas contribute twice as many intracerebral neoplasms in 
psychiatric patients as they do in non-psychiatric patients. The 
association between both affective and schizophrenic type 
symptomatology and organic brain disorders is well known (Davison
& Bagley 1969; Lishman 1978) au-cl raises the question as to whether 
the patients with tumours (the definite member'of the manic- 
depressive group and the potential member of the schizophrenic 
out-patient group) actually had primarily psychiatric disorders 
or whether their symptomatology was secondary to their brain lesion.
As neither permitted surgical intervention the point cannot be 
clearly established.
None of the patients with CT changes suggestive of, 
infarction had obvious localising neurological signs. While the 
incidence of clinically manifest stroke appears to have declined 
in recent years (Garraway et al 1979)> the frequency of undetected 
cerebral infarction remains unknown. Jacoby et al (Jacoby et al 
1980; Jacoby & Levy 1980 a and b), studying a group of 41 dements;
40 affectively ill patients and 40 normal controls, all over 60, 
found a prevalence of unsuspected infarction of 10.8 %, over JO % 
of which occurred in the dementia patients. In the present study 
of much younger patients, the overall prevalence was only 3*7 % 
in the total sample. However this rose to 5*1 % when considering 
the schizophrenic group as a whole, and to 6.4 % in the long-stay 
schizophrenic in-patients. Whether this apparently high prevalence 
of 'silent* infarction is comparable with the general population, 
or is a consequence of the illness (for example an effect of 
premature aging) or a result of treatment such as neuroleptic 
drugs, is unclear.
Thus the present study revealed a high prevalence of 
unsuspected organic pathology, especially in the long-stay schizophrenic 
group. It is however important to note that this rarely necessitated
exclusion of the subject from this part of the work and its presence 
did not alter the basic findings reported. In long-stay, severe 
schizophrenic patients, who by the nature of their illness may be 
frequently disturbed and possess an impaired capacity to present 
symptoms, and in whom mental state changes - especially if sudden - 
may reflect organic factors, CT is a particularly safe and 
efficacious investigative tool.
4.5 THE BASIC QUESTIONS
The four basic questions posed at the start of this section 
will each be considered separately.
4.3.I IS SCHIZOPHRENIA ASSOCIATED WITH LATERAL VENTRICULAR ENLARGEMENT ?
The findings presented here indicate that patients with a 
diagnosis of schizophrenia have significantly greater group mean 
estimates of lateral ventricular size than patients with non­
schizophrenic, functional psychiatric conditions. The difference 
between schizophrenics and non-schizophrenics, although definite 
and significant, was far from striking, and rested largely on the 
fact that long-stay schizophrenic in-patients had, as a group, larger 
ventricles than neurotics. The point of the difference lying between 
the group means is emphasised because the overlap in absolute values 
for ventricular size was considerable across the different diagnostic 
groups, and there were severely disabled patients in each of the 
schizophrenic groups who showed no enlargement. Reference to the 
age-adjusted group means (TABLE 3:3:5) illustrates how slight the 
differences were.
The relative subtlety of these findings is further illustrated 
by noting the verbal reports on visual assessments of the scans 
conducted by two radiologists highly experienced in evaluating 
CT scans of the brain. Only 22 (20 %) of the long-stay 
schizophrenic in-patients were reported as having enlarged ventricles 
of any degree, and in three of these the qualification was made that 
the appearance may have been attributable to the subject's age. Thus, 
only 19 cases were visually reported as having ventricular 
enlargement without qualification. However, in 14 of these the 
enlargement was stated to be "slight". On the other hand, by 
measurement and introduction of an age-correction, 45 (40.1 %) of 
the schizophrenic in-patients had VBR's greater than 1 SB above 
the predicted value, 27 of whom (24-5 % of chronic in-patients) 
were outwith 2 SB's. This emphasises both the subtlety of the 
change and the inadequacy of visual assessment as an investigative 
technique in studies of this kind.
The method of assessment adopted in the present study made 
it possible to measure and obtain a VSR value on all scans ( the 
single scan that was unmeasurable belonged to the manic-depressive 
out-patient with a coincidental, large arteriovenous malformation 
who was excluded on this basis). Thus an absolute value could be 
obtained for even very small ventricles, thereby allowing their full 
participation in statistical analysis. Some schizophrenics did 
have ventricles in the smallest category by reference to predicted 
values. In the total group of schizophrenics and in the chronic 
institutionalised schizophrenics separately (in whom correlations were 
sought) this certainly did not amount to a statistical excess, and 
this has to be borne in mind in the subsequent discussion on
clinical correlates. The position with regard to the non­
institutionalised and first episode schizophrenics considered as 
one group is probably not dissimilar. Although there appeared 
to be some excess of patients with very small ventricles as well 
as very large ventricles among these subjects, this only seemed 
to emerge in one (the second) method of distribution analysis 
and was not evident in analysis of skewness and kurtosis. With 
a genuine excess below as well as above the mean, testing for 
kurtosis in particular could reasonably have been expected to 
produce significance with a genuine finding.
It has been suggested that institutional care of itself 
could account for the findings in the ventricles in schizophrenics 
(Jellinek 1976). This clearly cannot be the case in most of the 
work discussed in the literature review for this section as most 
of these studies refer to patients who had never come to long-term 
care. Although the present work cannot be dogmatic on this point, 
it is also unlikely that this is the basis of the findings reported 
here. There was no difference in mean VBR’s between schizophrenics 
and manic-depressives who had and who had not been in long-term 
institutional care. Thus, it does not seem probable that exposure 
to the environment of the institution could, of itself, account for 
ventricular enlargement associated with schizophrenia.
As was suggested (vide supra Chapter 1.4.2), one 
interpretation of the literature reviewed earlier could be that 
lateral ventricular enlargement in schizophrenia is associated with 
what are in fact parameters of severity - or ’chronicness1. The 
present findings are compatible with such a view. As has been
emphasised throughout this work, the institutionalised 
schizophrenics represent that condition in a severe form, and it 
was only they who significantly differed from neurotics. For 
reasons mentioned earlier, it is unlikely that this basic finding 
would have been altered by use of a ’normal' control group, though 
it must be admitted that surruptitious substance abuse could 
have tended to diminish the difference between neurotics and all 
other groups. It seems likely that those authors who have failed 
to find significant differences in their schizophrenic patients 
have either studied samples that are too small, or ones in which 
the population of ’severe’ or 'chronic’ patients is under­
represented for schizophrenic/control differences to emerge.
Nevertheless, even using the severely disabled subjects of the 
present work, such differences are not marked and studies reporting 
a difference of high magnitude undoubtedly reflect problems of 
selection - both of subjects and controls. It is of interest that 
recently, the NIMH group have reported differences of a lesser 
magnitude than those in their earlier work (Luchins 1982).
Thus it is concluded that the first question is answered 
affirmatively - schizophrenia is associated with lateral ventricular 
enlargement.
4.3.2 HOW SPECIFIC IS LATERAL VENTRICULAR ENLARGEMENT TO SCHIZOPHRENIA ?
The present study can give no unequivocal answer to this 
question, but the results make it unlikely that ventricular 
enlargement is diagnosis specific.
While the schizophrenic group's VBRs differed 
significantly from normality in their distribution, so too did 
those of the non-schizophrenics. This latter point is of 
considerable interest, but requires further comment. The deviation 
from normality of the non-schizophrenics arose from 4 out-patient 
and 2 in-patient manic depressives having ventricles greater than 
2 SB's above the predicted value (18.2 % and 20 % respectively of 
each sample). Of the 4 out-patients, 2 had been hypothyroid in 
the past, presumably consequent upon long-term lithium ingestion 
though the exact aetiology of their hypothyroidism was not 
confirmed. Both however were receiving replacement therapy and 
were clinically and biochemically euthyroid when scanned. These 
two patients, both female, had the two largest VBR's in the 
manic-depressive out-patient group. The question is raised as to 
whether these 2 cases should have been excluded, on the basis that 
their hypothyroidism contributed to the CT scan appearances 
independently of psychiatric factors.
While it has long been known that hypothyroid states can 
be associated with significant psychopathology, including features 
of dementia (Lishman 1978) no evidence is available to suggest that 
the type resulting from lithium ingestion produces features of 
brain atrophy, especially of the subtle variety being described here. 
Furthermore, and with specific regard to the design of the present 
study, clinical and biochemical euthyroid status were not designated 
as specific inclusion criteria. Hence, these two subjects were 
not excluded from the calculations. It is interesting to note that had 
they been omitted, the distribution of the non-schizophrenics would
p
still have significantly differed from normal (X = 10.83 , . 
df = 4 > ? <  O.O5). Thus, both the schizophrenic and non­
schizophrenic distributions are viewed as authentically differing 
from normality due to an excess, over that predicted, of subjects 
with very large ventricles. In the schizophrenic group it is 
only that this skew to the right is more marked - not that it 
is unique to them.
No significant differences emerged between the group of 
manic-depressives and either the schizophrenics or the neurotics. 
Other workers have claimed that increased lateral ventricular 
size may be present in patients with affective illness (Pearlson & 
Yerloff 1981; Standish-Barry et al 1982), though the present 
study can neither confirm nor refute this. The findings reported 
here are however in agreement with the recent report of Weinberger 
et al (1982). They compared the YBR’s of patients with different 
BSM - 111 diagnoses and found that while schizophreniform patients 
and chronic schizophrenics had significantly larger mean YBR's 
than (neurological) controls and patients with "other disorders" 
(mainly personality disorders),- neither schizophreniforms nor 
chronic schizophrenics differed significantly from affective 
patients, who in their turn did not differ from the neurological 
controls or those with "other disorders".
The age-corrected group mean YBR's point to a gradation of 
abnormality from neurotics through those with affective disorders 
to schizophrenics rather than to any clear-cut distinction between 
schizophrenics and other psychiatric patients.
Furthermore, within the group of schizophrenics themselves
the present findings do not support the view that ventricular 
enlargement is a characteristic feature of the illness - that is, 
that this feature is reliably found in significantly high proportion 
of typical cases as to be of diagnostic use - or that it can be 
used to define a specific subgroup of schizophrenics. Even if 
liberally defined as >  1 SB above the predicted value, ventricular 
enlargement was found in only the minority of schizophrenics 
(44*1 %)» and- if more appropriately defined as >  2 SB above 
prediction, could be ascribed to only 24*3 %• While the present 
data showed a skewed distribution to ventricular size, there was no 
evidence of bimodality, a finding now reproduced by several groups.
These results may be interpreted as indicating that 
functional psychosis per se is associated with lateral ventricular 
enlargement and that although this may be more frequent and/or more 
severe in schizophrenia, it is not specific to that condition. This 
is compatible with PEG findings(e.g. Huber 1957; Haug 1962). In the 
study of Haug for example the schizophrenic group had more abnormality 
than the non-schizophrenic, functional patients but less than those 
with organic psychiatric disorders.
4.3.3 ABE PAST PHYSICAL TREATMENTS OF RELEVANCE TO LATERAL 
VENTRICULAR ENLARGEMENT IN SCHIZOPHRENIA ?
An obvious explanation for the basic finding reported here 
is that ventricular enlargement is the consequence of repeated 
assaults on the brain by past physical treatments, though there is 
evidence from PEG studies performed before the widespread use of 
physical treatments that this is unlikely to be the case (Bonovan et al
1949).
While hypoglycaemia is known to he a potent cause of brain 
damage (Marks & Rose 1965), there is no evidence that when induced 
in controlled conditions this results in CT changes of the type 
described here. Although a non-significant trend existed in the 
present study between a past history of insulin coma and ventricular 
size, this as was mentioned, was felt to be insufficient evidence to 
assume a positive association between the two. Factors relating to 
the selection of those who received this treatment are likely to be 
important in determining its correlates. Most importantly, 
ventricular enlargement has regularly been demonstrated in patients 
never exposed to this form of treatment (this is the case in most 
of the studies referred to in the literature review).
Thus the above weak association is interpreted as reflecting 
incidental or chance factors and the present study is taken as 
providing no support for the view that insulin coma is of relevance 
to the ventricular enlargement associated with schizophrenia.
It has been suggested that ECT may damage the brain 
(Friedberg 1977)> though there is no evidence to support the view 
that such presumptive damage could be detected on CT scanning. CT 
change has not been found following even multiple ECT shocks (Menken 
et al 1979). Four PEG studies which addressed the question found no 
difference between those treated and those not treated with ECT 
(Huber 1957; Haug 1962; Nagy 1963; Storey 1966). Asano (1 967) stated 
that abnormal PEG's were more common in patients who had received 
more ECT’s, but provides no data or analysis on this. He does point out 
however that it was the most deteriorated patients who received most 
ECT. Hence the common phenomenon connecting ventricular abnormality
and ECT was the clinical one of severity. It is likely that a 
similar phenomenon was acting to produce the relationship between 
ECT and ventricular enlargement reported in the CAT scan study of 
Weinberger et al (1979 a)» as even those in their sample who had 
never received this type of treatment had significantly larger 
ventricles than controls. Andreasen et al (1982 c) found no 
relationship.
Marsden has suggested that administration of neuroleptic 
drugs may be associated with more widespread brain damage than has 
hitherto been appreciated and that this may account for the 
differences in ventricle size between schizophrenics and non­
schizophrenics (Marsden 1976). The animal evidence to support 
such a view is however equivocal (APA Task Force 1979)* While 
several studies have found no relationship between neuroleptic 
intake and CT scan findings (Weinberger et al 1979&;G-olden et al 
1981; Weinberger et al 1982), no investigations to date have been 
in a position to examine this question in detail.
The strategy adopted in this study of examining the scans of 
groups of schizophrenics matched for various factors but treated in 
different ways probably represents the best means now possible of 
evaluating the role of physical treatments in ventricle size. The 
results show that treatment with insulin or ECT, or neuroleptic 
drugs, and the degree of treatment with each, was unrelated to present 
ventricle size. Furthermore, the combination of physical treatments 
did not correlate with VBR, in that no differences in ventricle size 
were found between those with no history of physical treatment and 
matched subjects heavily treated.
Thus, it can be concluded that past physical methods of 
treatment (excluding leucotomy) are not the cause of ventricular 
enlargement associated with schizophrenia.
4.3.4 WHAT ARE THE CLINICAL CORRELATES OF LATERAL •VENTRICULAR 
ENLARGEMENT IN SCHIZOPHRENIA ?
Few clinical correlates of lateral ventricular enlargement 
were identified in this study and some of those which did emerge 
were unusual. It must, of course, be recalled that, as only the 
long-stay schizophrenic in-patients significantly differed from 
neurotics with regard to lateral ventricular size, correlations of 
enlargement were sought within this group alone.
Of the Recorded Information variables only family history of 
schizophrenia produced significant findings and these were 
unexpected. In general, those with a family history of schizophrenia 
fell into normal ventricular size categories (i.e. were distributed 
around the age-corrected predicted mean), while those in both large 
and small ventricular size categories tended to have negative family 
histories. Indeed none of those in the two smallest categories of 
VBR (a and b) on whom information was available (25 subjects) had a 
positive family history of schizophrenia.
In view of the strength of the relationships this finding 
cannot be ignored, but the interpretation placed on it depends largely 
on which analysis is considered the more appropriate. Firstly, a 
linear relationship between increasing VBR and a positive family history 
could be postulated. It has for example been suggested that 
schizophrenics with a positive family history manifest significant 
psychomotor differences from normal controls or schizophrenics without
a family history (Walker & Shaye 1982). Analysis of trends, 
allowing as it does the collapsing of adjacent categories of data 
will produce significance in line with this postulate as was 
demonstrated (vide supra p. 302 ). Alternatively, reference to the 
distribution of the data (Fig. 3^3:12) emphasises the curvilinear 
form of any potential relationship. If this is accepted as the 
basis for analysis, significance will again be obtained (vide supra 
p. 303 )* Clearly these different modes of analysis lead to 
contradictory conclusions - the one that large ventricles are 
associated with a positive family history, the other that they are 
associated with a negative family history (along with small ventricles).
In the present work it is felt that the data shown in 
Fig. 3:3:12 cannot be ignored. The distribution of the family history 
variable across VBR categories is clearly curvilinear and to produce 
significance by collapsing the two or three largest VBR categories 
is statistically misleading. Furthermore, in pure statistical terms 
the curvilinear relationship is the stronger. This therefore is the 
one accepted here.
This intriguing finding invites speculation, but some ..major 
qualifications must be stated. The relationship may reflect chance 
factors, though as a similar type of relationship was found with other 
variables this seems unlikely. Most importantly are three points 
relating to the information on family history on which the finding 
rests. Although these have been noted previously (Part 1 Chapter 5*l) 
they will again be noted in view of their relevance to the 
interpretation of this CT finding.
l) This finding is based on information given by relatives 
at the time of the patients admission. This was usually
taken when they were young, and obviously was early in 
the morbid risk for other family members. It would be 
expected that the actual prevalence of a positive family 
history corrected for the age of the index subject when 
scanned would be higher than that on which the analysis 
was conducted.
2) In the absence of a definite statement of diagnosis by 
the relatives completing the Enquiry Form, interpretation 
of their statements regarding psychiatrically ill family 
members was conservative in this study.
3) There is evidence that the case note method of extracting 
information on family history underestimates the 
prevalence found by direct interviewing of the next of 
kin. (Thompson et al 1982).
For these reasons the prevalence of a positive family history of 
schizophrenia in the scanned group almost certainly represents an 
underestimate.
Despite these major qualifications, this finding raises the 
intriguing possibility that the illness may have a different pathological 
substrate in those with a positive family history as opposed to those 
with no such history. In a large study of 249 chronic schizophrenics, 
Hays (1977) found that normal EEG traces were highly significantly 
correlated with a positive family history of major psychoses 
(schizophrenia and bipolar manic-depressive psychosis), whereas traces 
showing one or more variants of normality were more often found in those 
with no family history. Campbell et al (1979) subsequently postulated 
that CT scan abnormalities would be more frequently found in patients 
with no family history of psychosis than in those with a positive
family history. The authors were unable to confirm this in a study 
of 35 schizophrenic outpatients, though unfortunately assessment of 
scans was limited to visual inspection. More recently Reveley et al 
have found an association between negative family history of 
schizophrenia and relatively large ventricles in a series of 21 
schizophrenic patients (Reveley et al 1983). Although the results 
of the present study are less straightforward than those of Reveley 
and colleagues they may be seen as broadly in line with this group's 
work and with the hypothesis of the Canadian group.
While clinical studies have demonstrated the role of genetic 
factors in schizophrenia, little attention has been paid to biological 
variability based on family history. The results of the present 
investigation indicate that this may be a fruitful area for further 
study.
Of the five Assessed Abnormality variables initially examined 
(considering AIMS and RS as different ways of assessing the same 
variable - movement disorder), relationships with VBR categories 
could be established with four. Of these, the nature of the 
relationship was linear in two and curvilinear in two.
The absence of a straight, linear association between cognitive 
impairment and ventricular enlargement in this study could be understood 
in terms of the generally low order of the correlation between 
intellectual ability and brain structure in disease. Although the 
bulk of the literature concludes that such a relationship exists in 
schizophrenia (cf Part l), this conclusion refers to a statistical 
correlation which, although definite, is not strong. There is 
considerable variation in the range of intellectual performance 
associated with any given structural pattern and vice versa. This is
similar to what has been found in studies correlating neuro­
psychological performance and structural change in dementia (Roberts 
& Caird 1976; Earnest et al 1979; Jacoby and Levy 1980a). Furthermore, 
notwithstanding Johnstone et al's original findings (Johnstone et al 
1976, 1978b) in a small selected group of schizophrenics, it may be 
that the Withers and Hinton, devoid as it is of any performance 
measures, is less sensitive in detecting such a relationship than 
other varieties of cognitive testing (e.g. WAIS, Luria-Nebraska, 
Halstead-Reitan etc). However, the finding of a relationship that 
is curvilinear in nature has no precedent in the literature.
The same applies to 'negative' features, though this area 
has not been greatly studied. While ventricular enlargement has 
been claimed to be associated with 'negative' type features 
(Andreasen et al 1982b), the quality of this evidence is poor as 
was noted in the introduction to this section (Chapter 1.2.2).
With regard to the present study, it is perhaps not surprising that 
having found a curvilinear relationship between VBR and cognition 
the same sort of relationship emerged with 'negative* features, given 
that impairment on both these latter features was strongly correlated 
(cf Part l).
The findings of declining behavioural performance and 
spontaneous involuntary movements in association with ventricular 
enlargement are in line with prediction.
CT techniques have been used surprisingly infrequently to 
investigate patients with movement disorder. Gelenberg (1976) was 
the first to do so, reporting no visually assessed abnormalities in 
the scans of 8 dyskinetic patients.
Famuyiwa et al (1979) compared the CT findings from 17 
schizophrenics with "tardive dyskinesia” of mean age 49 years, with 
those of 33 schizophrenics without 'TD'. Scan assessments were 
both linear and visual. Only one difference was found - namely that 
"there were significantly more patients in the tardive dyskinesia 
group with a pathological rating on the ventricular index" than in 
the non-dyskinetic group. The ventricular index is a dubious way 
of assessing ventricular enlargement and the authors' carefully 
worded statement is justified. The ventricular index is "the ratio 
of the distance between choroid plexuses and greatest distance 
between anterior horns" (Meese et al 1980). It is thus a measure 
which is highly dependent on the angle of separation of the anterior 
horn, which with CT, may vary with individual anatomy and positioning • 
during the scan in addition to any change consequent upon disease.
Jeste et al (1980) studied a number of CT parameters from 
12 chronically hospitalised females (10 schizophrenics, 2 organics) 
with 'tardive dyskinesia' carefully defined, and compared these with 
findings from 12 closely matched subjects without dyskinesia. There 
were no differences between the groups on any parameter.
This study involved relatively small numbers and used only the 
global impression item of overall abnormality on the AIMS and not 
total scores, to evaluate movement disorder. Most surprisingly however, 
one patient in each group had a history of prefrontal leucotomy. In 
view of the wide variability in leucotomy lesions and their 
unpredictable effect on the ventricular system, one such subject could 
easily have eradicated any differences between the groups.
The lack of a relationship between VBR and 'positive' features 
of the mental state is in line with prediction and with other work in
the literature (Crow 1982). Only hallucinations of the individual 
Krawiecka items, produced a relationship with ventricular size which 
was statistically strong. Once again however, the nature of that 
relationship is open to two interpretations. With a linear model, 
hallucinations were less common in those with large ventricles - 
in line with prediction. However the curvilinear relationship was 
likewise significant, such that hallucinations were less common at 
both extremes of ventricular size. This latter interpretation is 
complimentary to that for cognition and 'negative' features, 
indicating that where these two variables predominate, hallucinations 
tend not to be found. Accepting that the curvilinear nature of 
these relationships is valid, this is compatible with prediction.
As mentioned, few workers have sought correlations of this 
type with ventricular size and Andreasen et al (1982b) are the only 
workers to do so in a standardised fashion. Owing to the different 
components of their "positive and negative symptoms", comparison 
is difficult. Only their items of hallucinations, delusions, thought 
disorder, and affective flattening are recognisable in terms of the 
Krawiecka Scale, and Andreasen and colleagues found no significant 
relationship between any of these and ventricular size.
Thus, in general, the search for individual mental state 
correlates of brain change in schizophrenia has not proved fruitful.
The rather weak overall association between behavioural 
deterioration (CBS totals) and ventricular size was the result of 
strong associations between dilatation and different components of 
behaviour - namely restricted social interaction, limited constructive 
activities and disturbed, disruptive exhibited behaviour. Antisocial
behaviour was significantly less frequently found at the extremes 
of ventricle size, and this was only open to a curvilinear 
interpretation.
4.3.5 SUMMARY
The results of this section have confirmed that schizophrenia 
is associated with lateral ventricular enlargement, and that this is 
a feature of severe forms of the illness. It is not a result of 
past physical treatments. While the specificity of ventricular 
dilatation to schizophrenia remains uncertain, the findings indicate 
that there is nothing characteristic or pathognomonic about these 
changes and that no subgroup of patients can be discretely delineated 
solely on the basis of radiological findings.
The correlates of ventricular enlargement were few and 
surprising in at least their form. The data relating to family 
history are of interest and suggest that this may be a valuable 
variable on which to base further study. By the application of CT, 
the major distinction to emerge in this severe long-stay population 
was not simply between those with and those without ventricular 
enlargement, but was in general between those with ventricles in 
roughly normal ranges of size and those at the extremes of the 
spectrum. These curvilinear correlates emphasise the complex 
relationships that exist between brain structure and clinical deficits 
in schizophrenia.
4.4 CONCLUDING REMARKS
Although it has been widely postulated that 'defect state' 
features (i.e. 'negative' mental state characteristics, intellectual 
impairment and behavioural deterioration) would be more likely to 
be found in association with structural brain change (Crow 1980;
Crow et al 1982), than would the 'positive' type of clinical picture, 
the findings of this study of lateral ventricles offer little 
support for this hypothesis in its simplest form. The patients with 
'negative' features and intellectual impairment did not have larger 
ventricles than a matched group without these features. Nor did 
patients with catatonic syndrome, in whom ’defect* type deficits 
were particularly severe (cf Part l), have larger lateral ventricles 
than those in other Catego subclasses. The lack of a linear 
relationship between ventricular enlargement and cognitive impairment 
is underlined by the fact that there was no difference in VSR in 
the patients with higher academic attainment and either high or low 
Withers and Hinton scores. While the association of increased VBR 
with behavioural impairment and the presence of involuntary movements 
indicate a link with deterioration in two of its aspects, the results 
of this study strongly suggest that the relationship between lateral 
ventricular size and the so-called 'defect state' is not straightforward. 
Thus, behavioural deterioration was linearly associated with ventricular 
enlargement which also had a very strong association with abnormal 
involuntary movements, but apparently no linear relationship with 
'negative' symptoms or intellectual impairment - despite the fact that 
all four clinical variables occured together in the total population 
from which the patients were drawn (cf Part l). The fact is that some
subjects in the present population who were incapacitated by 
profound and often multiple clinical deficits, had ventricles that 
were either well within the normal, predicted range or even fell 
within the 'small' end of the spectrum of size.
Perhaps such findings partly reflect the difficulties of 
defining what constitutes the clinical 'defect', but it seems from 
the results presented here that these clinical deficits relate in 
different fashions to underlying brain morphology.
PART IV
GENERAL COMMENT
"The commission of medical experts consisted of three unusually 
solemn gentlemen whose views were such that the view of each 
differed gloriously from any of the views of the other two"
JAROSLAV HASEK 
THE GOOD SOLDIER SVEJK
PART IV
GENERAL COMMENT
This study set out with two objectives. The first was to 
describe in standardised fashion, the deficits of long-standing 
schizophrenia, while the second was to see whether inferences 
regarding a cerebral basis for the disorder could be sustained from 
clinical and special investigative techniques.
While many subtle and varied areas of functioning could have 
been chosen in pursuance of the first of these objectives, those 
selected represent a broad range of activity of relevance to 
clinical psychiatric practice. The patients' disabilities were 
profound and often multiple. For this group at least medical inter­
vention had acted neither to their benefit nor their detriment.
Within a selected sample, particular explanations of this fact may 
pertain, but the implication is that the deterioration intrinsic 
to the disorder is largely autonomous. 'Deterioration' however, is 
itself a vague concept. At a purely clinical level this population, 
all of whom shared 'deterioration' in a general sense, nonetheless 
demonstrated two broad patterns of disability that were striking.
Most psychiatrists would acknowledge the florid, productive picture, 
but many would view the 'negative' pattern as unexceptional - the 
"burned out" phase of the clinically more relevant florid stage.
This study suggests that the term 'burned out' may refer more to the 
clinician's interest than to the realities of established schizo­
phrenia. Regardless of any possible relationships they may bear to 
one another in the earlier history of the illness, in the established 
state both clinical patterns appear to have validity and to be
worthy of separate study. The essential question however is whether 
clinical criteria alone are sufficient to allow implications of 
aetiology based on primary cerebral disorder - which raises the 
second objective of the project.
Notwithstanding historical references, the choice of involuntary 
movements as the clinical neurological parameter was to some extent 
influenced by the unique treatment characteristics of the study 
population. It can certainly be claimed that the present work 
provides some of the strongest evidence to date in validation of the 
concept of 'neuroleptic - caused movement disorder'. More than this 
however, it has demonstrated two points - firstly, that movement 
disorders are to be found in high prevalence in unmodified schizo­
phrenia, and secondly that over and above any neuroleptic factors 
relevant to their production, particular factors associated with the 
illness per se are of importance.
The first of these points must be noted with qualification.
This study was not in a position to demonstrate the uniqueness of 
such prevalence rates to schizophrenia. The lack of a suitable 
control group is evident here as in so many studies of long-standing 
schizophrenics, especially those in institutions. Straight comparisons 
with published figures must be cautious because of the problems of 
conceptualisation and variability between examiners noted in Part II. 
While the present author believed himself to have operated generally 
conservative criteria throughout, this must.not be given undue 
emphasis in quoting the figures published here as the 'true' ones 
for unmodified schizophrenia. All that is claimed is that these 
figures are very high - much higher than the present day literature 
using pooled data methods would lead one to suspect - making
involuntary movements a not uncommon feature of established,
unmodified schizophrenia. This is in keeping with the impression
£.
left by the early descriptive accounts, and is a sufficient conclusion.
Of greater interest than the suggestion of such a general 
association, however, is that when a range of potential aetiological 
factors were accounted for, the study was able to demonstrate 
significant relationships between the presence of certain mental 
state/behavioural characteristics of schizophrenia and the presence 
of clinical neurological disorder. As long as additional potential 
contributing factors remain hidden and unaccounted for, such a 
finding cannot be held up on its own as ’proof’ that schizophrenia - 
or schizophrenia taking a particular form - is a brain disease. It 
does however allow inferences of a cerebral aetiology for the 
’negative’ or 'defect1 type of disorder to be made with an enhanced 
probability of accuracy. Insofar as mental state patterns pre­
dominantly ’positive’ in nature do not appear to enhance such 
predictions, the simple 'positive'/'negative’ mental state dichotomy 
proposed in Part I would seem to have some merit. The word 'pre­
dominantly' is again emphasised. Within the limitations of a 
correlational methodology, these conclusions are the most that could 
be expected and in general support the original hypothesis.
At the outset, Part III offered the greater likelihood of 
establishing a neurological bridge to schizophrenia. If inter­
pretations are kept to the general, this part of the work did achieve 
its objective. The findings support a considerable body of evidence 
pointing to the fact that schizophrenia is associated with enlarge­
ment of the lateral ventricular system. These changes are not 
however characteristic nor absolute, though they could be said to
be a feature of the illness in its severe form(s). It can be 
stated with confidence that they are not the result of physical 
treatments.
Thus using both involuntary movements and structural brain 
change as parameters of neurological abnormality, relationships could 
be established between ’organicity’ and features comprising so-called 
’functional' illness. At this general level the study was largely 
successful. But to leave interpretation at this level is hardly 
sufficient. Such a general conclusion holds within it a caution to 
any simplistic.theories regarding the nature of schizophrenia - 
particularly when such theories are founded solely on clinical evidence. 
As Huxley has said :
The great tragedy of science (is) - the staying of
a beautiful hypothesis by an ugly fact.
One of the difficulties in marrying the present findings to 
the initial hypotheses lies in the design of the study. As is
often the case this sort of difficulty is highlighted in retrospect.
Part II was not in a position to demonstrate that the prevalence 
of abnormality found was significantly higher in schizophrenia 
compared to other non-schizophrenic diagnostic groups, whereas 
Part III was designed to show just that for the abnormality it 
considered. This in itself may not have been of great import had 
the detailed pattern of clinical correlations which related to each 
neurological feature been uncomplicated and the same. However, the 
study could not unravel a consistent pattern of clinical deficits 
which correlated with structural change as movement disorder did.
Or, to put it more accurately, it could not establish a consistent 
pattern which correlated in a straightforward fashion compatible
with prior prediction, as movement disorder did. The crucial
decision is what interpretation is to be placed on the curvilinear
O
relationships established in Part III. Either they are spurdjus 
and should be ignored or they are genuine and possibly tell us 
something hitherto undescribed regarding structural changes under­
lying long-standing schizophrenia.
As was shown, divergent conclusions could be reached by 
different applications of the statistical technique. But the 
illustrations of Part III demonstrated that ignoring curvilinear 
relationships neglected findings which were striking and occurred 
consistently across a number of variables. Statistical techniques 
must be applied to allow an accurate interpretation of data and 
not to support preconceptions. The curvilinear relationships have 
been interpreted here as genuine, established by judicious use of 
a robust statistical method.
If they are genuine, what then might they tell us about the 
nature of schizophrenia? Such unusual relationships may arise from 
a number of sources, of which the most obvious is probably hetero­
geneity within the population. Heterogeneity has remained since 
the time of Kraepelin and Bleuler, a favoured clinical view and 
is one which the present work has to some extent sought to elucidate. 
The family history data from Part III may, for example, be inter­
preted as showing a genetic and a non-genetic form of the condition, 
the latter associated with two strikingly different structural 
pictures. The one (enlargement of lateral ventricles) was clearly 
found in statistical excess and can be readily accepted as abnormality. 
The other (small ventricles) was not represented excessively overall 
in statistical terms. Within a homogeneous group these subjects at
the left hand end of the distribution should be considered as normal 
variants. It nonetheless remains theoretically possible that in 
a hetereogeneous grouping these subjects may represent abnormality 
occurring within the distribution of a sub-type of small ventricle 
patients who are less commonly found than those with normal or 
large sizes. For the reasons discussed however such detailed extra­
polations of family history, data, especially those from retrospective 
studies over a time span of decades, are risky. Nevertheless, family 
history data can be used to illustrate the possible influence of 
hetereogeneity. Family history data did not however correlate 
similarly with'both neurological parameters or with any other 
examination variables.
Here an inherent danger emerges. It is that of confusing 
clinical heterogeneity with pathological - and hence presumably 
aetiological - heterogeneity. Two basic assumptions can in 
retrospect be seen running through the present work. The first is 
that clinical features and ’syndromes’ derived from them, would 
relate to structural change in a uniform and predictable fashion,
The second is that clinical skills are sufficiently refined to 
identify these features and distinguish them with confidence from 
other similar but not identical phenomena. On reflection such 
assumptions are clearly fallacious, and force artificially 
restrictive interpretations on results. General medicine offers 
many examples to dispose the former, and were the latter true 
dissentions of the sort discussed in Fart I (pp 105-107) would not 
exist. Negative features may arise from divergent pathological 
changes at different brain sites; or what we rate as, say, flattening 
of affect may cover a number of varied clinical phenomena as yet
undistinguishable.
In a large scale correlational study such factors may account 
for a degree of inconsistency, but it is unlikely that they 
represent the total explanation. If they did it is improbable that 
movement disorder would have related linearly to both ventricular 
enlargement and the examination variables of ’negative' features 
and cognitive impairment.
Alternatively even simpler explanations of genuine curvilinear 
relationships may pertain. It may be said, for example, that those 
variables which failed to demonstrate straightforward relationships 
across both neurological parameters were the two for which it is 
most difficult to be confident of objectivity in assessment. The 
problem with ’negative’ features in this regard has been noted 
throughout the present work, and in Fart I the uncertainties 
surrounding the evaluation of cognitive performance in a setting 
of poverty of speech was discussed.
At the end of the day, however, such inconsistencies as the 
study did reveal may be irrelevant in the context of its'objectives, 
and attempted explanations of them an unprofitable exercise. It is 
perhaps more appropriate that the evidence in support of the basic 
hypothesis should be emphasised, with unexpected findings merely 
noted to await future elucidation. This is the favoured view, 
especially since such surprises as did emerge were outweighed by 
data which were consistent. If the analogy of dementia is taken, 
the results of the present study are in fact reassuring. The 
symptomatology, including the neurological sigps, associated with 
dementia is varied, even when specific subtypes of dementia such 
as Alzheimer’s Disease are studied, and the correlations between
clinical features and structural change are not of a high order.
Seen in this light, the data reported here are encouraging.
Reduced to their essence, the results of this study may be 
summarised as follows:
Kraepelinian schizophrenia is associated with lateral ventricular 
enlargement.
lateral ventricular enlargement is associated with the presence 
of involuntary movement disorder.
Involuntary movement disorder is associated with a particular 
pattern of established ('negative' type) schizophrenic deficit 
(though it is suggested that Kraepelinian schizophrenia in' 
general may be associated with movement disorder). Movement 
■ disorder is furthermore associated with neuroleptic exposure. 
These may be illustrated thus:
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/
Decrease in
(lateral)
Ventricles
\
\
Predominantly
'Positive'
Deficits
Increase in 
(lateral) 
Ventricles 
\
\
\
\
\
\
\
x Predominantly 
'Negative' 
Deficits
Involuntary 
Movements 
x
\
Furthermore:
’Negative* type deficits relate to lateral ventricular change 
in an unpredictable fashion (? usually but not always enlargement). 
Although in practice important, the role of neuroleptic drugs in 
promoting clinical disorder is, in this schema, aetiologically 
peripheral.
Taken at this general level of interpretation the initial 
hypotheses were supported. This study lends weight to a growing 
body of evidence which indicates that the old functional/organic 
dichotomy of psychoses is no longer adequate for the understanding 
of schizophrenia. In its detail however, the project also left one 
impressed by the obvious complexity of the relationships between 
some of the psychopathological features of established schizophrenia 
and the disorganisation of brain structure which underlies them. 
Notwithstanding the authenticity of the relationships reported within 
the population as a whole, some patients with profoundly incapacitating 
deficits showed neither ventricular change nor movement disorder.
This point is worth re-iterating, not only because it 
illustrates the complexity of cerebral function and structure in 
psychiatric disease, but also because it highlights the.fundamental 
disappointment of schizophrenia research up to the present time.
No matter the impressiveness and uniformity of association of variables 
within and between groups, biological research is not yet in a 
position to offer the clinician hard facts,of diagnostic and/or 
prognostic value to the individual case at the time they are most 
needed - i.e. at first presentation. That objectivity so much 
envied of general medicine remains elusive.
For the future, there is an urgent need for further study of
the deficits of established schizophrenia. For this to remain 'the 
poor relation' of psychiatric research is clinically, economically 
and scientifically indefensible.
Firstly, the nature of 'chronic' schizophrenic deficits must 
be agreed. The present contradictory jungle of proposals does 
psychiatry no credit, and obfuscates further a naturally complex 
situation. Increasingly detailed speculations based on 'theorising* 
must give way to proposals developed out of clinical study. The 
simple suggestions produced here are certainly not definitive, but 
the method must progress from observation — ^ proposal, and not 
the other way. -
Secondly, those deficits on which agreement exists must be 
studied objectively where this is possible. It is fortunate that a 
number of these deficits, such as poverty of speech, loss of affective 
resonance and neurological dysfunction, share the inherent potential 
for objective evaluation. The techniques to make a start - especially 
computer technology - already exist.
The combination of objective clinical observation with 
radiological imaging offers one of the most exciting avenues for 
future research, though the present work, and that preceding it, 
makes it clear that imaging techniques are not in themselves the 
sources of all knowledge about schizophrenia. By their very nature 
they demand more - not less - attention to research methodology and 
subject selection. At the end of the day -such technologies are only 
as useful as the expertise applied to the clinical material. Without 
that expertise they are little more than expensive toys for locating 
a pathological needle in the cerebral haystack.
In deciding future priorities, it may well be that the 'negative'
clinical picture, so long the subject of resignation and neglect 
in fact holds within it great potential for understanding the basis 
of at least some of the disabilities of this fe.ll and enigmatic 
disorder.
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KRAWIECKA SCALE
PATIENT'S N A M E .......................  DATE   INTERVIEWER'S
INITIALS ...
Key symptom,1: in tlie pnr»t:— I- - - ■ -L.
(Questions about past week should include: whether depresse d (? severe
? frequent); whether anxious (? severe, ? frequent); how getting on with othe
people; whether anyone seems against him; whether he can think clearly; any
interference with thoughts; thoughts read; reference to him on television
or newsparjors; hearing voices or seeing visions)
RATING REASON FOR MORBID RATING RATING
Rating made by replies to questions:
DEPRESSED 0 1 2 0 d
ANXIOUS 0 1 2 q d
COHERENTLY
EXPRESSED DELUSIONS 0 1 2 d
HALLUCINATIONS 0 1 2 y  d
Rating made by observations:
INCOHERENCE AND 
IRRELEVANCE OF 
SPEECH
0 1 2 y  d
POVERTY OF SPEECH 
MUTE 0 1 2 0 d
FLATTENED 0 1 2 0 d
INCONGRUOUS 0 1 2 0 d
PSYCHOMOTOR
RETARDATION 0 1 2  0 d
ocp
EH
SH
Q
WCP
1=3
cp
SoHCPH
>H
p
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TESTS OF THE SENSORIUM - FORM A
N,B. WITHERS & HINTON (W & H) Patient's Name
1. Unless instructed otherwise, record subject's 
answers verbatim,
2.RiCord any comments (e.g. on subject’s behaviour) 
on the test record.
3. Fill in date and time after ’Orientation’ has 
been administered.
U. Score during or immediately after the session. 
Maximum possible scores are shown in brackets 
in the scoring column.
Date
Tester
INTRODUCTION Test material Score
Says
I ara going to give you a few short tests which we give 
routinely to all patients. The tests are varied - some you 
may find easier than others - but we should like you to do \ 
your best in all of them.
ORIENTATION
Say:
We start with some questions:
1. Please will you give mo your full name?
2. What is the name of this place?
3. What is the address?
k. Can you give me to-day's date in full? 
(If necessary specify day of the week, 
date month and year)
5. Can yon, without looking, tell 
me what time it is?
1. (1 for surname and (2) 
(1 for Christian name
2. (1 for name of hospital (1)
3. 0  for London, W1, etc, (1)
. (1 for each item
5. Allow ^ 2  hr. deviation (1)
( h )
ATTENTION AND CONCENTRATION
6. Please say the days of the week backwards, 
starting from Tuesday.
7. Take 7 from 100 and keep on taking 7 
away. Ready?
6. Subtract the number of (7) 
errors from 7
7. Subtract the number of 
' errors from In
Start timing. Record total time for Serial 7’s.
(m)
MEMORY
Say:
I am going to give you an address and a telephone number.
I shall read each of them once. You are to repeat them 
immediately and after 2 minutes. Ready?
8. Mr. Percy White, 1U East Drive, Bath.
Will you repeat that? 8. 1 for each correct
word. (7)
9. And the telephone number is Birmingham 9. 1 for town and 1 for
1891. , number .
(Instructions for a test 01 copying digits inserted here; until;) ( 2 )
At the end of the 2 minute period say;
10. Can you remember the address? 10. 1. for each word (7)
11. And the telephone number? 11. 1 for town and 1
for number (2)
Here is a sentence which I should like you to repeat, word for 
word, after I have finished;
12. One thing a nation must have to become rich and
groat is a large, secure supply of wood. 12, Subtract number of
attempts from 9 (8)
If subject makes a mistake, ask him- to listen again.
Repeat the sentence, if necessary, 8 times.
Say:
I am going to read you a short-passage. Afterwards you 
are to repeat as much of it as you can. I shall ask you 
tv/ice. Ready?
13. A fire/last night/burnt/several houses/ 13. 1 for each idea
near the centre/of the city/It took some
timc/to put it out/The loss/was five thousand/ 
pounds/and seventeen/families/lost their homes/
In saving/a girl/who was asleep/in bed,/a fireman/ 
was burnt/on the hands./
All right. Now tell me all you can remember.
Start timing 5 mins. (when subject will be retested). Fill in the period 
by asking as many of the following questions as is convenient.
GENERAL INFORMATION
Say;
Here are some general questions:
14. Who is on the throne at the moment? 1u. In 'General Information
(If subject answers ‘Elizabeth* score 1 for all questions
Say; Elizabeth the ....?) exoe
15. V/ho was before her?
16. And before that?
17. What is the capital of the United States? ‘
18. And what is the capital of France?
19. And the capital of Scotland?
20. Anu the capital of Belgium?
21. And what is the capital of Yugoslavia?
22. Name five large English towns.
23. How many pence are there in two shillings and 
threepence?
2u. How many fourpence are there in two shillings?
25. How many pence are there in thirteen shillings?
22,
15* (1)
16. (1)
17. (1)
18. (1)
19. (1)
20. 0 )
21 , (1)
22. .(5)
23. (1)
?h. (D
25. (1)
I din going to name some famous people. You are to toll 
me for what they are known. Ready? They are:
26, Beethoven. 26. (1)
27. Keats. 2?. (1)
2 8. Const able. 2 8 . ( 1 )
(instructions giving additional names and tests for 
meanings of proverbs; until:)
I1EH0RY
5 nins after reading the short passage (13) say:
29. bill you once more repeat the short
passage about the fire v/hich you told me
before? 29. (21)
bay :
1 am going to say some numbers. Listen carefully because, 
when I have finished, you are to say them after me. Ready?
Read digits evenly, 1 per second. If subject fails any series, give 
the second of the pair. Discontinue when he fails both series in any 
pair. Record the number of the longest series at which ho succeeds.
8 6 3 1 (2) 30. Number of
1 Uf 2 5 8 3 (3) digits in
7f 9 3 6 9 7 2 (u) longest
n 9 -j 3 8 2 4 7 5 9 (5) correct
6 2 7 1 8 !, 4 9 4 8 s 7 1 (6) series
3 6 5 8 7 4 2 8 2 5 9 4 1 7 (7) (10)
5 1 u 6 2 7 9 3 1 8 5 9 2 7 3 6 (6)
9 4 8 3 6 2 7 5 1 6 3 1 7 a 9 2 8 h (9)
2 5 1 6 Q 3 a 1 4 7 4 2 7 9 6 1 4 3 5 8 (10)
Say:
I am going to say some more numbers but, this time when I .stop, you 
are to say them backwards. For example, if I said 6?4 you would say 
a?6. Ready?
6 7 9 1 (2)
2 6 9 6 3 8 (3)
4 0 5 8 2 7 h 9 (4)
1 7 3 9 4 8 k 1 5 2 (5)
7 4 0 6 1 3 1 5 9 6 k 7 (6)
c 8 3 7 2 1 6 3 6 0 4 2 9 5 (7)
8 2 4 7 9 5 3 1 4 1 2 9 3 5 9 6 (8)
3 6 9 5 7 1 8 4 2 8 1 4 6 5 2 9 7 3 (9)
Oy 4 2 1 7 3 6 8 3 5 7 9 6 9 3 6 8 5 7 4 (10)
31. Humber of digits in 
longest correct 
series (10)
Date of birth:
Year of admission:
W & H
Mow I am going to road a short story. Afterwards I shall ask you to tol'i
it in ycur own words. Heady?
32. A cowboy went to San Francisco with M s  dog, which he left 
at a friend's while he went to buy a new suit of clothes.
Dressed in his grand new suit, ho come back to the dog, 
whistled to it, called it by name and patted it. But the
dog would have nothing to do with him and his new hat
and coat mid gave a mournful howl.' Coaxing was of no 
avail, so the cowboy went away and put on his old suit, 
and then the dog immediately showed its wild joy on 
seeing its master as it thought he ought to ho*.
32, 1 each for following 
ideas (8)
Cowboy;
went to buy new clothes; 
loft dog behind; 
he came back wearing new 
clothes, unrecognized 
by dog;
He changed into old 
clothes;
dog greeted master; 
pleased to see him as 
it thought ho ought to 
be,
33. lihat do you consider was the point of the story? Rato 0 - 5 ,
CRC DTVTSION OF FMTCHIATRY 
SCHEME FOR BRIEF NEUROLOGICAL ASSESSMENT
IDENTIFICATION
Survey number 1 -3
Date of examination 4-9
FACE (Cranial nerves - modified) 10
PUPILS
Equal YES/NO 1/2
if no, specify.......... .
Reaction to light:
Left YES/NO 1/2 16
Right YES/NO 1/2 1?
Reaction to accommodation:
Left YES/NO/D.K. 1/2/3 18
Right YES/NO/D.K. 1/2/3 19
EYE MOVEMENTS Normal/Abnormal 1/2 20
if abnormal, specify .
NYSTAGMUS YES/NO 1/2 21
MOUTH MOVEMENTS Normal/Abnormal 1/2 22
if abnormal, specify.........
and proceed to:
ORBICULARIS OCULI
Left Normal/Weakness 1/2 23
Right Normal/Weakness 1/2 2U
VISUAL FIELDS Normal/Abnormal/Untestable 1/2/3 25
if abnormal, specify..........
FUNDOSCOPY
Left disc Normal/Abnormal 1/2 26
if abnormal, specify...........
Right disc Normal/Abnormal 1/2 27
if abnormal, specify...........
LIMBS
TONE
Upper limbs : Left Increased/Normal/
Decreased 1/2/3 28
Right Increased/Normal/
Decreased 1/2/3 29
Lower limbs : Left Increased/Normal/
Decreased 1/2/3 30
Right Increased/Normal/
Decreased 1/2/3 31
□
□
□
□
□
□
X W Y X J i i  x
Upper limbs : Left Absent/Present 1/2
if present, LT/ST V 2
Right Absent/Present 1/2
if present, LT/ST 1/2
32
33 
3h 
35
Lower limbs : Left Absent/Present 1/2
if present, LT/ST 1/2
Right Absent/Present 1/2
if present, LT/ST 1/2
36
37
38
39
CO-ORDINATION
Upper limbs :
Finger-nose test 
Left
Right
Hand-tapping test 
Left
Right
Lower limbs 
Heel-shin test
N o rmal/Equivoc al/ 
Definitely abnormal
N o rm al/E qui vo c al/ 
Definitely abnormal
No rmal/Equivo c al/ 
Definitely abnormal
Normal/Equivocal/ 
Definitely equivocal
1/2/3
1/2/3
1/2/3
1/2/3
UO
41
42
U3
Left Normal/Equivocal/
Definitely abnormal 1/2/3 uk
Right N o rinal/ Equivocal
Definitely abnormal 1/2/3 U5
TENDON JERKS
Upper limb :
Biceps
Left Reduced/Normal/Increased 1/2/3 h6
Right Reduced/Normal/lncreased 1/2/3 47
Supinator
Left Reduced/Normal/Increased 1/2/3 U8
Right Reduced/Normal/Increased 1/2/3 49
Triceps
Left Reduced/Normal/Increased 1/2/3 50
Right Reduced/Normal/Increased 1/2/3 51
Lower limbs :
Knee r--- -
Left Reduced/Normal/Increased 1/2/3 5 2 ----
Right Reduced/Normal/Increased 1/2/3 531
Ankle
Left Reduced/Normal/Increased 1/2/3 5u!-
Right Reduced/Normal/Increased 1/2/3 55;
-2-
PLANTAR RESPONSE
Left r vocal
Right Flexor/Extensor/Equivocal
MOVEMENT DISORDERS 
Face
Spontaneous involuntary move m ents 
Trunk
Spontaneous involuntary movements
UPPER LIMBS 
Left
Spontaneous involuntary movements Present/Absent 1/2 60
Rj ght
Spontaneous involuntary movements Present/Absent 1/2 61
LOWER LIMBS 
Left
Spontaneous involuntary movements Present/Absent 1/2 62
Right
Spontaneous involuntary movements Present/Absent 1/2 63
1/2 /3  56
1 /2 /3  57
Present/Absent 1/2 58
Present/Absent 1/2 59
□
GAIT
Mormal/Equivocal/Definitely abnormal 1/2/3 61
CURRENT BEHAVIOUR SCHEDULE
To be based on information given by ward staff 
Identification: Survey number
Date of inquiry h-9
1-3
10
Name of patient..............................................
Name of informant ............................... ......
How long has informant known patient:
years(2), mbnths(l), weeks(O) 11
Status of informant........................................,.
H I
□
A: SOCIAL BEHAVIOUR
Spontaneous contacts;
patient initiates full sensible conversations (2) 
patient initiates brief sensible verbal exchanges (1) 
(greetings, factual exchanges, etc.) 
no sensible spontaneous contacts (0)
Response to approaches;
patient will engage in full sensible conversations (2)
patient makes appropriate, but limited
verbal responses (l)
patient does not respond appropriately
or patient does not respond at all (0)
Ability to carry out instructions;
carries out complex instructions - (2)
carries out simple instructions (1)
does not carry out instructions (0)
General social behaviour;
feeding; acceptable (2), poor (1), very degraded (0) 
dressing; acceptable (2), poor (1), veiy degraded (0) 
cleanliness; acceptable (2), poor (1), 
very degraded (0)
12
13
□
□
-  □
■5 □
6 u
17 □
veroai nosT-muy, non-veroai nosuxLiey, suea-Ling, 
destruction, self mutilation etc.)
Specify..................................................
None (3), occasional (2), frequent, but mild (1), 
frequent and severe (0)
Appearance (dress, etc.); normal (2), slightly odd (1), 
bizarre (0)
Specify..................................................
Social withdrawal; mixes normally (2) 
usually solitary, but will mix (1) 
never mixes (0)
B: ACTIVITIES
Employment: open employment outside hospital (u)
sheltered employment outside (3)
work outside ward (2)
work on ward (1)
no work (0)
Specify..................................................
Leisure activities; major activities (clubhouse, 
arts Sc crafts, outings, etc.) (2)
minor activities (television, newspaper, 
solitary walks) (1)
no activities (0)
Specify..................................................
General level of activity;
patient grossly overactive (3)
keeps active without encouragement (2)
some underactivity (e.g. stays in bed) (1)
gross underactivity (0)
Nature of activity: activity mostly useful (2)
some purposeless activity (l),
all activity purposeless (0)
C: EXHIBITED BEHAVIOUR
Does the patient laugh and talk to himself; 
never (2)
sometimes (1)
often (0)
18
21
23
2U
□
19 □
20 □
□
2 2  □
□
25 □
2
no evidence (2)
indirect evidence (1)
direct evidence from patient (0) 26 (~
Specify...............................................
Delusions:
no evidence (2)  27 j ~ |
indirect evidence (1)
direct evidence from patient (0)
Specify.......................... ...................
Posturing and mannerisms (e.g. odd, stylised movements
r— ior acts, maintaining strange postures, etc.) 28
never, (2), sometimes, (1), often, (0)
Specify..............................................
Obsessional activities (e.g. repetitive and purposeless 
behaviours)
never (2), sometimes (1), often (0) 29 □
Specify..............................................
Does the patient talk nonsense;
never (2), sometimes (1), often (0) 30 □
Uncontrolled, aggressive outbursts;
never (2), sometimes (1), often (0) 31 [ |
Incontinence: never (3)
occasional urinary (at least once a month), (2) 
frequent urinary (at least twice a week) (1)
urinary and faecal incontinence (0) 32
Stability of behaviour:
very stable (2), some variation (1), much variation (0) 33 j
D: MEDICATION
Does the patient take medication; 
without difficulty (2) 
with some difficulty (1)
with great difficulty (0) 3-U | |
What is the current medication.................................
ANY OTHER COMMENTS:
3
INPATIENT SCHIZOPHRENIA SURVEY PAGE 1
IDENTIFICATION 
Survey number 
Date of form
DATE OF BIRTH - Day/Month/Year 
SEX - M/F 1/2
DATE OF 1st ADMISSION - YEAR
DATE OF CURRENT ADMISSION - YEAR
NUMBER OF PSYCHIATRIC ADMISSIONS 
(Transfer does not equal admission)
EARLY HISTORY
Informant - mother/relative/other 1/2/3
Specify. ..... .........
Any relatives with schizophrenia? - DK/YES/NO 0/1/2 
How many?
Any relatives with other psych, illness? - DK/YES/NC 0/1/2 
How many?
Birth trauma? - DK/YES/NO 0/1/2 
Normal infant development? - DK/YES/NO 0/1/2 
Any febrile illnesses? - DK/YES/NO 0/1/2 
Specify. ....................
Any head injuries? - DK/YES/NO 0/1/2
Specify.  ..... .
Ahy fits? - DK/YES/NO 0/1/2
Specify ........ ........... .
School record - DK/ESN/NORMAL/HIGHER 0/1/2/3
Specify....................... «...
Job record - DK/UNEMPLOYED/MANY JOBS/STEADY 0/1/2/3 
Specify. ......................
1 3
r
__L
□
□
□
| '1^1
IN-PATIENT SCHIZOPHRENIA SURVEY PAGE 2
Social adjustment (friends, hobbies, etc.) 
-DK/POOR/GOOD 0/1/2
History of alcoholism - DK/YES/NO 0/1/2
Any other comments .................. .
How many?
ECT - DK/YES/No 0/1/2
How many?
Phenothiazenes - DK/YES/NO 0/1/2
Specify...................
Barbiturates - DK/YES/NO 0/1/2
Specify.....................
Paraldehyde - DK/YES/NO 0/1/2
Specify.....................
Chemical convulsants - DK/YES/NO 0/1/2
Specify.....................
□
□
TREATMENT
Leucotomy - DK/YES/NO 0/1/2
Insulin - DK/YES/NO 0/1/2 □
□
n
□
□
□
Serious illnesses while in hospital YES/N© 1/2 □
- DK/DETERIORATING/FLU CTUATING/NO CHANGE/IMPROVEMENT j ^
0/1/2/3A
ANY OTHER COMMENTS
ABNORMAL INVOLUNTARY 
MOVEMENT SCALE 
(AIMS)
PATIENT'S NAME
APPENDIX VI
RATER
DATE
IN STR U C TIO N S : Complete Examination Procedure (reverse side) before 
making ratings.
M O V E M E N T  R A TIN G S : Rate highest severity observed. 
Rate movements that occur upon activation one less than 
those observed spontaneously.
Code: 0  ■ None
1 *  M inim al, may be extremi
2 -  Mild
3 *  Moderate
4 » Severe
FACIAL  
AND ORAL  
MOVEMENTS:
Muscles of Facial Expression
e.g., movements of forehead, eyebrows, periorbital area, cheeks; 
include frowning, blinking, smiling, grimacing
Lips and Perioral Area
e.g., puckering, pouting, smacking
Jaw
e.g., biting, clenching, chewing, mouth opening, lateral movement
Tongue
Rate only increase in movement both in and out of mouth, 
NO T inability to sustain movement
(Circle One)
0 1
0  1 2  3
0  1 2  3
EXTREMITY
MOVEMENTS:
Upper (arms, wrists, hands, fingers)
Include choreic movements, (i.e., rapid, objectively purposeless, 
irregular, spontaneous), athetoid movements (i.e., slow, irregular, 
complex, serpentine).
Do N O T include tremor (i.e., repetitive, regular, rhythmic)
Lower (legs, knees, enkles, toes)
e.g., lateral knee movement, foot tapping, heel dropping, foot 
squirming, inversion and aversion of foot
0 1
T R U N K
MOVEMENTS.
Neck, shoulders, hips
e.g., rocking, twisting, squirming, pelvic gyrations
8. Severity of abnormal movements
GLOBAL
JUDGMENTS:
9. Incapacitation due to abnormal movements
10. Patient's awareness of abnormal movements 
Rate only patient's report
None, normal 0
MinimtH 1
M ild • 2
Moderate 3
Severe 4
None, normal 0
Minimal 1
Mild 2
Moderate 3
Severe 4
No awareness 0
Aware, no distress 1
Aware, mild distress 2
Aware, moderate distress 3
Aware, severe distress 4
No 0
Yes 1
DENTAL
STATUS:
11. Current problems w ith teoth and/or dentures
12. Does patient usually wear dentures?
No
Yes
c h ! I n d o r e  or o i t ;1! corn; A u n g  the E xa m in a t io n  Procedure observe the p a t ie n t 
uno '. . .r i ic -c  ly , at root (e.g., in w a it ing  room ).
chair to be used in ‘ his e xam ina t ion  shou ld  tie a hard, f i rm  one w i th o u t  arms.
1. Ash p a t ie n t  whet her there is any th ing  in h is /her m o u th  (i.e., gum, candy, etc.) 
ana i f  there is. to  remove it.
7 Ask p a t ie n t about the c u rren t c o n d i t io n  o f  h is /her teeth. Ask pa tier:! if he/she 
wear:; dentures. Do te«.-:h or dentures bo the r  p a t ie n t now?
a. Ask p a t ie n t  w he ther  he/she notices any m ovements  in m ou th ,  face, hands, or fee'
!f yes, ask to  describe and to w ha t e x te n t  they cu r re n t ly  bo ther  p a t ie n t o r  in terfere  
v / t t ' i  his/!tec actc.-ipes
A.  Have pa t ien t sit in chair w i th  hands on knees, legs s l igh t ly  apart, and feet f la t  on 
t ioor. ( L o o k  at entire  body  fo r  rnoyements w h i le  in this pos it ion } .
b. Ask pa t ien t to sit w i th  hands hanging unsupported. If male, between legs, i f  female 
and wearing a dress, hanging over knees. (Observe.hands and o the r b ody  areas.)
0. Ask p a t ie n t to  open m ou th . (Observe tongue at rest w i th in  m o u th . )  Do this twice.
7. Ask p a t ie n t  to  p ro tru d e  tongue. (Observe abnorm a lit ies  o f  tongue m ovem ent.)
Do ib is  tw ice.
■ • Ask p a t ie n t  to tap thum b, w i th  .each finger, as rap id ly  as possible fo r  10—15 seconds; 
separately w i th  r ight hand, then w i th  le f t  hand. (Observe facial and leg movements.)
> Flex and ex tend  pa tien t 's  le f t  and r ight arms (one at a rime.) (N o te  any r ig id i ty  
and rate on D O T L S  )
10. Ask p a t ie n t  to stand up. (Observe in p ro f i le . Observe all b ody  areas again, hips
i i i c l u d e d . )
o 11. Ask p a t ie n t to es tend  b o th  arms ou ts tre tched  in f ron t  w i th  palms d ow n . (Observe 
Tiunk. legs, and m o u th .1
» 12. Have p a t ie n t w a lk  a few paces, tu rn , and w a lk  back to  chair. (Observe hands and 
gait.) D o  this tw ice
a A c \ iva ted  rnovermens
m.vio PAGE 2
ROCKIAND RESEARCH INSTITUTE
TARDIVE DYSKINESIA RATING SCALE 0
u0
Patient a.m. 0
■   m
Date Time p.m.
Mo
de
ra
te
H
0
0
0|>
Setting Rater 
FACE Ab
se
nt
o- Mi
ld
-P
U
0
Ti
o
S
0
CQ
t>2
u
0
>
1. Blinking of eyes 0 1 2 3 b 5
2. Tremor of eyelids 0 1 2 3 b 5
3- Tremor of upper lip (Rabbit Syndrome) 0 1 2 3 b 5
b. Pouting of the (lower) lip 0 1 2 3 b 5
3. Puckering of lips 0 1 2 3 b 5
6. Sucking movements 0 1 2 3 b 5
7. Chewing, movements 0 1 2 3 b 5
8 . Smacking of lips 0 1 2 3 b 5
9. Bon Bon sign 0 1 2 3 b 5
10. Tongue protursion 0 1 2 3 b 5
11. Tongue tremor 0 1 2 3 b 5
12. Choreoathetoid movements of the tongue 0 1 2 3 b 5
'13- Facial Tics 0 1. 2 3 b 5
1 ^ . Grimacing 0 1 2 3 b 5
15. Other movements (when periorbital in 
situation)
0 1 2 3 b 5
16. Other movements (when perioral in 
situation)
0 1 2 3 b 5
NECK AND TRUNK.
17. Head nodding : 0 1 2 3 b 5
18. Retrocollis 0 1 2 3 b 5
19. Spasmodic Torticollis 0 1 2 3 b 5
20. Torsion movements (trunk) 0 1 2 3 b 5
21. Axial Hyperkinesia 0 1 2 3 b 5
<D
Pi
rH O0 <1) f>-p -P O
-p cd cd 03Pi Pi Pid) •xi <D <U >■503 rH Td rd Pi
•H O 0 Oc- s S S >
0 1 2 3 b 3
0 1 2 3 b 3
22. Rocking movement
23. Other movements (when involving upper 
limb girdle)
2b. Other movements (when involving axial 0 1 2 3 ^ 3
musculature)
EXTREMITIES
(Upper)
25. Ballistic movements 0 1 2 3 k 5
26. Choreoathetoid movements - fingers 0 1 2 3 k 3
27. Choreoathetoid movements - wrists 0 1 2 3 k 5
28. Pill-rolling movements 0 1 2 3 k 3
29. Carressing or rubbing face and hair 0 1 2 3 k 3
30. Rubbing of thighs 0 1 2 3 h 5
31. Other (fine regular tremor of upper 
limbs)
0 1 2 3 b 3
32. Other (additional involuntary movements 
involving upper limbs)
0 1 2 3 b 3
(Lower)
33. Rotation and/or flexion of ankles 0 1 2 3 b 3
3^. Toe movements 0 1 2 3 b 3
33- Stamping movements - standing 0 1 2 3 b 3
36. Stamping movements - sitting 0 1 2 3 b 3
37. Restless legs . 0 1 2 3 b 5
38. Crossing/uncrossing legs - sitting 0 1 2 3 b 3
39. Other (fine regular tremor of lower 
limbs)
0 1 2 3 b 5
bo. Other (additional involuntary movements 0 1 2 3 b 3
involving lower limbs)
ENTIRE BODY
b']. Holokinetic movements 
b2. Akathisia
bj>. Other (whole-body) movements 
COMMENTS
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0 1 2 3 b 3
0 1 2 3 b 3
0 1 2 3 b 3
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